data_2e5k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e5k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.937 0.398 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.1 m -130.63 130.89 44.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.9 mt -129.73 150.45 51.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -108.68 131.53 54.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.37 128.69 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.9 pt -104.06 -16.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 79.2 m-85 -158.42 144.46 12.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.74 0.781 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 157.53 60.21 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.698 2.265 . . . . 0.0 112.332 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.434 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 15.6 t80 -148.83 127.67 12.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -96.53 107.0 33.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.549 0.69 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 170.92 15.44 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.335 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -125.81 -15.04 6.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.432 ' C ' ' OE1' ' A' ' 272' ' ' GLU . 65.9 m-80 -150.37 -175.71 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 9.0 t70 -72.76 -42.27 64.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 37.8 t70 -37.7 -38.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 269' ' ' ASN . 1.2 pm0 -102.54 168.22 9.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.8 tp -127.12 149.23 50.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.459 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 15.7 tt0 -69.72 143.9 52.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 309' ' ' LEU . 10.2 mt -113.36 141.28 47.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.53 134.72 25.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 111.157 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 112.66 3.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.32 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.39 6.66 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -109.48 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -115.43 167.14 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 29.2 mm -145.35 115.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.02 118.7 24.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -102.31 137.95 39.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.49 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.2 p -134.66 140.26 34.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.67 0.748 . . . . 0.0 110.843 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -26.54 27.42 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.35 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.0 mtp -81.05 -1.72 45.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 71.8 mm-40 -126.91 18.52 7.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -77.14 127.8 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.4 p -148.93 113.4 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 63.78 25.15 14.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.4 p -88.59 -45.78 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.0 m -44.33 -24.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.31 -49.4 19.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 179.9 -26.55 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -80.23 -179.45 7.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.74 0.305 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.47 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.0 OUTLIER -153.47 127.14 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 27.6 t80 -88.0 120.23 29.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -148.67 -173.71 19.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 38.8 m -130.42 139.06 50.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.333 . . . . 0.0 111.16 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.3 t -75.17 158.3 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.14 -34.83 9.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 62.9 m -73.6 -61.29 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 67.5 p -78.62 -49.96 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.95 11.65 31.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.456 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.57 149.71 21.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.8 t -118.18 154.41 32.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 172.61 -173.29 45.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.415 ' C ' HD22 ' A' ' 309' ' ' LEU . 20.6 mt -91.73 137.1 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.5 155.48 63.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.6 Cg_endo -69.8 119.99 6.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -57.06 -12.55 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.75 20.42 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.514 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.2 m-85 -129.04 -3.62 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.47 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -129.89 177.27 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 4.7 t -152.49 159.81 43.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -59.55 149.63 29.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 20.3 pt-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.895 0.378 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 18.2 m -116.02 137.08 52.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 mt -134.02 150.62 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -108.79 132.69 53.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.63 129.71 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 3.0 pt -107.38 -14.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.472 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 89.3 m-85 -159.28 143.26 11.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.654 0.74 . . . . 0.0 110.958 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 160.05 51.18 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -154.61 127.05 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.955 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.75 109.61 47.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.74 172.12 13.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -123.96 -14.28 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -162.49 -177.46 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -63.89 -36.67 84.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.42 -42.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.437 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.2 pm0 -105.23 175.11 5.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -130.58 143.11 50.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.63 144.01 56.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 309' ' ' LEU . 6.4 mt -112.51 142.51 44.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.37 128.21 19.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 104.31 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.277 . . . . 0.0 112.368 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.22 5.16 8.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -112.55 171.31 7.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.52 162.06 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 17.5 mm -135.09 132.38 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.432 ' CE2' HD12 ' A' ' 301' ' ' LEU . 25.5 m-85 -99.49 106.21 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.7 tmm? -98.97 134.21 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.5 ' N ' ' SD ' ' A' ' 283' ' ' MET . 8.5 p -126.12 143.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.661 0.743 . . . . 0.0 110.875 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -24.47 29.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.351 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 44.2 mtp -81.53 -3.19 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.554 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 66.3 mm-40 -126.33 9.69 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -69.27 87.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.9 p -104.99 128.9 53.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m 48.09 26.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 294' ' ' GLY . 29.4 p -86.05 -54.48 4.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.2 t -35.36 -36.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 18.4 tp10 -62.66 -47.72 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.15 -26.2 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -79.93 -179.78 7.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.89 125.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.7 t80 -84.2 111.14 19.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -134.29 -177.77 15.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 97.2 m -133.18 129.6 38.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.123 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.4 t -66.17 154.77 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.432 HD12 ' CE2' ' A' ' 282' ' ' PHE . 9.3 tp -99.82 -29.94 12.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 5.2 m -72.65 -52.64 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.0 p -88.8 -55.37 3.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.93 23.36 6.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.6 t -96.15 166.28 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 81.1 p -129.02 143.39 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.85 47.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.412 ' C ' HD21 ' A' ' 309' ' ' LEU . 10.9 mt -88.95 139.17 30.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 110.914 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.482 HD21 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.21 157.19 63.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.559 0.695 . . . . 0.0 110.946 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.3 Cg_endo -69.79 120.7 7.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.657 2.238 . . . . 0.0 112.344 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -58.68 -11.62 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -93.03 20.5 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.512 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.6 m-85 -128.74 -3.06 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -130.16 177.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.8 t -153.34 162.63 41.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -66.31 148.01 52.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.084 179.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.941 0.4 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.8 m -133.03 126.78 32.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.4 mt -129.95 151.41 50.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -108.77 133.72 52.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.5 142.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.447 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -119.99 -14.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.3 m-85 -158.33 143.78 12.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.68 0.752 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.49 69.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.472 ' CB ' HD11 ' A' ' 275' ' ' LEU . 41.3 t80 -138.46 144.82 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 11.8 m -115.45 97.66 49.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.69 171.52 14.24 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.341 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.59 -13.22 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -157.32 -179.54 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 271' ' ' ASP . 2.1 p30 -66.87 -38.71 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.67 -38.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -111.49 172.9 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 5.3 tp -129.02 143.62 50.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 275' ' ' LEU . 7.0 tt0 -65.44 150.13 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 265' ' ' TYR . 22.8 mt -117.48 127.12 53.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.56 132.39 23.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.736 . . . . 0.0 111.129 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 110.75 2.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.726 2.284 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.26 4.56 20.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -110.76 171.67 7.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 281' ' ' ILE . 32.1 m-85 -112.74 167.99 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.461 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 12.3 mm -144.98 131.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 40.4 m-85 -91.68 120.2 32.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 284' ' ' SER . 1.9 tmm? -99.84 128.24 45.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.443 ' N ' ' SD ' ' A' ' 283' ' ' MET . 39.6 p -126.63 130.17 23.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.676 0.75 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 288' ' ' GLN . 53.8 Cg_endo -69.7 -13.0 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 0.0 112.369 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.87 -22.45 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.599 ' OE1' ' CE2' ' A' ' 297' ' ' TYR . 13.7 mt-10 -112.27 36.0 3.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.456 ' CG ' ' HA ' ' A' ' 285' ' ' PRO . 9.3 mm100 -84.16 86.79 7.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.9 p -110.74 108.63 18.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.3 m 61.62 30.73 18.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 293' ' ' GLU . 43.6 p -92.56 -59.67 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.9 m -34.06 -34.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . 9.9 tp10 -63.59 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -174.57 -30.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -80.13 -179.99 7.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.737 0.303 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.77 121.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.599 ' CE2' ' OE1' ' A' ' 287' ' ' GLU . 38.9 t80 -72.76 110.92 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -128.89 166.47 21.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 94.5 m -125.79 111.86 15.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.8 t -47.79 147.25 2.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.574 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -96.73 -45.47 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 97.8 m -63.25 -42.37 99.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 33.7 p -96.37 -53.28 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 110.82 0.2 28.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 99.6 m -69.97 151.67 45.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.6 p -124.19 138.14 54.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.65 -175.92 47.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 14.4 mt -88.38 144.98 26.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.1 156.49 50.76 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.79 122.0 8.68 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.706 2.27 . . . . 0.0 112.309 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.36 -10.84 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -94.22 23.11 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.523 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -130.95 -3.33 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.462 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -130.42 176.56 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.9 t -154.47 152.52 30.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -55.09 141.93 32.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -133.16 128.79 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.4 mt -129.51 149.27 51.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 25.6 tm0? -108.78 124.59 50.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 85.2 t -58.32 138.45 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.5 pt -115.85 -11.86 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 84.6 m-85 -161.76 144.18 8.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.726 0.774 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.33 64.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.716 2.277 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 38.3 t80 -138.85 135.51 34.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -104.68 105.43 50.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.58 0.705 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 170.68 15.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -125.18 -16.82 5.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.452 ' CG ' ' OE2' ' A' ' 272' ' ' GLU . 0.2 OUTLIER -152.94 173.41 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 271' ' ' ASP . 3.9 t70 -59.62 -41.07 89.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -35.11 -44.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.452 ' OE2' ' CG ' ' A' ' 269' ' ' ASN . 11.6 pm0 -99.29 178.41 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.9 tp -135.37 148.81 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.78 140.68 55.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 11.3 mt -111.98 141.17 45.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.08 135.24 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.643 0.735 . . . . 0.0 111.129 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 104.78 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.69 13.2 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.17 167.74 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.878 0.371 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -107.3 166.0 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 12.5 mm -144.85 119.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 28.7 m-85 -87.41 115.86 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -98.88 141.38 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.5 ' N ' ' SD ' ' A' ' 283' ' ' MET . 5.3 t -133.94 142.33 43.05 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -32.63 17.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.638 2.225 . . . . 0.0 112.352 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 63.7 mtp -74.97 -0.55 19.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 15.7 mm-40 -125.43 15.04 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.19 87.59 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.2 p -114.46 122.32 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.3 m 56.26 25.84 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 31.8 p -89.42 -42.22 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.3 t -48.31 -29.61 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.28 -36.26 76.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.75 -25.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -80.01 -179.67 7.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.407 ' HA ' ' CG2' ' A' ' 291' ' ' THR . 1.2 pt -157.2 128.41 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.556 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 25.1 t80 -86.19 112.47 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -135.35 172.42 22.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 74.0 m -125.96 113.56 17.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.9 t -50.08 174.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 11.7 tp -114.46 -26.96 7.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -81.46 -54.2 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.3 p -86.73 -27.54 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.07 82.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.2 m -84.63 148.97 26.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 91.0 p -120.3 130.72 54.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.77 -174.69 38.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 309' ' ' LEU . 19.7 mt -87.71 149.39 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.476 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -154.95 157.03 31.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.903 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.521 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.2 Cg_endo -69.83 122.43 9.09 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.696 2.264 . . . . 0.0 112.289 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.92 -10.07 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -95.48 22.77 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.521 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.4 m-85 -130.47 -2.03 4.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.9 pp -133.23 172.15 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.5 t -147.17 164.46 33.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.61 151.31 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.117 179.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.944 0.402 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -131.64 127.42 36.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.4 mt -130.18 149.83 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -108.77 136.83 47.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.16 129.14 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.17 -28.67 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -145.52 143.9 21.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 154.16 68.14 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.448 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.0 t80 -147.88 127.55 13.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -94.8 109.13 42.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 172.82 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -124.08 -13.14 7.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -163.4 -178.14 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.3 t70 -64.4 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -37.66 -40.31 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.29 173.09 6.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.99 145.36 51.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -63.84 146.13 54.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 309' ' ' LEU . 6.5 mt -117.27 121.37 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.64 134.33 23.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.713 . . . . 0.0 111.144 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.56 2.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.339 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.12 1.32 16.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -106.65 169.63 8.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -116.03 155.16 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.469 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 40.6 mm -133.49 123.15 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 20.1 m-85 -87.39 119.11 27.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -102.72 141.14 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.499 ' N ' ' SD ' ' A' ' 283' ' ' MET . 23.9 p -134.86 139.35 31.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.684 0.754 . . . . 0.0 110.846 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.04 35.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 2.237 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 39.7 mtp -86.4 2.49 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.566 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 80.7 mm-40 -131.38 12.97 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.24 88.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.6 p -110.26 123.51 49.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.1 m 54.27 25.61 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 28.2 p -88.56 -43.45 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 m -45.0 -34.04 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -65.12 -42.03 94.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 169.37 -23.58 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -79.93 -179.72 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.8 pt -155.93 128.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.5 t80 -89.75 113.43 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.469 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -137.03 176.37 20.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.2 m -128.4 126.3 40.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.7 t -62.13 155.99 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.902 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.6 tp -97.8 -33.55 11.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 99.2 m -75.05 -55.69 5.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 49.2 p -84.79 -39.57 18.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.02 10.33 62.75 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.467 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.05 153.41 26.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 59.9 p -122.5 140.7 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -176.76 179.15 47.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 309' ' ' LEU . 11.3 mt -89.23 139.42 30.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.464 ' CD1' HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -143.84 156.67 58.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.602 0.715 . . . . 0.0 110.923 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.513 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.75 121.08 7.78 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.352 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.68 -11.23 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.17 19.97 7.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.513 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -128.22 -3.03 5.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.465 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -127.07 -176.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 163.78 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 152.73 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.902 0.382 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -134.29 135.29 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.36 152.79 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -108.66 129.93 55.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.41 134.13 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -109.14 -17.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.6 m-85 -158.55 143.89 12.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.655 0.741 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 152.57 69.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 2.269 . . . . 0.0 112.368 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -144.47 138.54 27.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.9 m -106.74 107.75 60.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.553 0.692 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 169.46 18.89 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -123.2 -14.2 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.432 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 0.3 OUTLIER -154.71 179.48 9.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.84 -35.49 80.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -40.59 -43.82 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 13.6 pm0 -100.28 177.66 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.6 tp -136.54 147.71 47.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.429 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 19.8 tt0 -63.35 148.84 47.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 309' ' ' LEU . 11.3 mt -120.61 134.32 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.8 133.09 24.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.656 0.741 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 105.98 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.719 2.28 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.45 11.35 10.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -112.1 171.58 7.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -112.06 161.15 16.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 20.1 mm -140.08 123.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -88.25 110.37 20.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.6 tmm? -98.88 132.24 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.474 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.3 t -126.06 144.15 47.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.752 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -31.61 20.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.714 2.276 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 28.7 mmm -76.33 4.27 9.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 19.5 mt-10 -133.13 18.41 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -77.74 82.39 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.462 ' N ' HG21 ' A' ' 291' ' ' THR . 40.5 p -103.11 134.92 45.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 41.79 25.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.462 HG21 ' N ' ' A' ' 289' ' ' THR . 32.2 p -85.68 -45.07 12.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 45.6 m -45.93 -31.89 2.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.45 -35.99 81.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.05 -25.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.98 -179.81 7.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.74 0.305 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.466 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.92 130.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 21.4 t80 -86.53 120.44 27.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -146.4 171.67 27.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.5 m -121.7 133.96 54.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 33.4 t -70.02 151.16 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.2 tp -96.08 -34.04 11.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -72.83 -43.06 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 68.8 p -96.78 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.13 8.68 14.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.3 m -83.95 155.23 22.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.6 p -124.12 132.92 53.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -170.5 -175.68 39.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.435 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.42 ' C ' HD21 ' A' ' 309' ' ' LEU . 18.3 mt -87.78 151.28 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.477 HD21 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -155.25 157.32 31.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 110.946 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.523 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 116.07 4.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 2.248 . . . . 0.0 112.336 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.66 -14.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -90.06 20.52 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.523 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.9 m-85 -129.08 2.68 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.466 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -132.62 175.43 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 12.8 t -149.64 154.38 38.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.2 OUTLIER -61.98 144.91 54.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.914 0.388 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -112.69 138.56 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 mt -135.54 150.93 49.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 17.3 tm0? -108.76 137.14 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 49.8 t -66.44 137.22 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 4.5 pt -116.97 -14.39 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 91.2 m-85 -162.03 142.63 7.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.743 0.782 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 154.39 67.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.481 ' CB ' ' CD1' ' A' ' 275' ' ' LEU . 25.8 t80 -137.31 156.57 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.8 m -124.15 97.3 40.68 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.558 0.694 . . . . 0.0 111.108 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 171.17 14.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.318 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -125.24 -14.8 6.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.75 -178.5 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 271' ' ' ASP . 6.6 m-20 -65.49 -36.77 84.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -36.52 -42.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -107.64 175.46 5.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -131.61 141.24 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.52 154.28 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.481 ' CD1' ' CB ' ' A' ' 265' ' ' TYR . 23.7 mt -121.63 124.78 45.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 261' ' ' VAL . 71.2 t -113.83 130.23 24.01 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.687 0.756 . . . . 0.0 111.104 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.42 6.75 19.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -111.9 171.52 7.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.22 164.86 12.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.459 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 12.1 mm -145.35 121.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -89.88 111.69 22.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.9 tmm? -99.52 136.14 39.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.499 ' N ' ' SD ' ' A' ' 283' ' ' MET . 0.9 OUTLIER -128.43 136.98 29.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.669 0.747 . . . . 0.0 110.85 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -18.81 36.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 20.4 mmt -66.58 -37.54 85.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 4.9 mt-10 -120.21 44.94 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.488 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 3.7 pp0? -96.94 52.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 34.1 p -76.58 143.13 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 m 52.67 25.83 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.423 HG22 ' C ' ' A' ' 288' ' ' GLN . 44.2 p -95.94 -49.24 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.183 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 t -46.68 -25.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.52 -35.95 70.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.26 -22.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -86.31 178.96 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.97 122.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.431 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 19.5 t80 -78.81 110.09 13.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.18 175.78 19.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.4 m -126.47 127.48 45.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 36.4 t -66.1 153.03 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.2 tp -100.46 -43.17 6.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -62.79 -39.79 95.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 64.8 p -102.28 -55.3 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 112.94 1.57 25.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.2 t -71.84 166.18 22.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.6 m -137.9 143.81 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -174.81 47.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 12.1 mt -88.19 138.78 31.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.472 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.74 155.9 66.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.93 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.565 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.77 125.34 12.02 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.32 -8.2 5.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.25 23.39 7.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.565 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.6 m-85 -130.72 -3.92 4.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.0 -179.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 11.9 t -155.97 162.62 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.54 153.49 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.459 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 19.3 pt-20 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.0 m -109.05 130.38 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.143 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.7 mt -131.67 149.31 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 0.7 OUTLIER -108.63 132.42 53.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 54.6 t -64.74 132.3 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.6 -20.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -152.0 144.24 16.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.667 0.746 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.84 69.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -142.09 132.7 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.7 m -103.89 102.55 32.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.098 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 171.18 14.96 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -125.25 -15.15 6.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -152.29 -175.99 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.4 t70 -71.9 -37.64 70.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.4 OUTLIER -35.57 -39.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 pm0 -107.9 179.57 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 9.3 tp -133.92 145.48 49.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.53 141.52 58.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.98 130.7 56.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.52 135.1 25.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.623 0.725 . . . . 0.0 111.124 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.05 4.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.22 1.08 29.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.39 175.95 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -115.34 165.4 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.47 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 25.8 mm -141.46 127.6 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.01 109.51 21.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.0 tmm? -99.93 133.27 44.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.488 ' N ' ' SD ' ' A' ' 283' ' ' MET . 8.9 t -132.04 137.48 30.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.758 . . . . 0.0 110.815 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.3 mmt -88.27 -11.69 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 1.8 pt-20 -129.55 26.57 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -85.59 84.76 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 20.1 p -100.43 118.32 36.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 20.6 m 62.06 25.07 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 294' ' ' GLY . 35.9 p -86.35 -53.35 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 291' ' ' THR . 65.6 m -37.85 -32.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 4.8 tp10 -66.32 -47.12 74.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 179.05 -28.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -79.89 -179.79 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.302 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.463 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.2 pt -158.99 125.33 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 23.2 t80 -80.13 114.31 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -135.21 162.83 24.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 17.1 m -114.03 132.73 55.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 31.0 t -67.96 148.42 51.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.7 -31.02 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -78.09 -48.85 15.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 75.5 p -91.48 -42.46 10.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.48 4.72 57.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 87.1 m -73.55 168.84 18.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 110.844 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 10.5 m -138.63 139.22 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.68 -176.7 47.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.13 148.25 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -150.54 155.6 36.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.602 0.715 . . . . 0.0 110.927 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.1 Cg_endo -69.77 125.49 12.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.68 -8.76 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 312' ' ' ASN . 28.9 t-20 -96.14 22.01 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.1 m-85 -130.32 -3.27 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -129.85 175.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 159.19 40.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.69 155.52 2.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.827 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.945 0.402 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.6 m -122.76 131.52 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 12.6 mt -133.95 150.63 51.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -108.71 134.25 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.03 135.29 28.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -113.03 -12.5 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 92.3 m-85 -161.31 142.86 8.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.657 0.741 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.48 68.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 0.0 112.318 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.538 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.7 t80 -147.57 126.18 12.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.1 m -96.96 108.3 42.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.571 0.7 . . . . 0.0 111.125 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.409 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 54.0 Cg_endo -69.75 166.69 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -115.93 -21.3 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -153.72 -177.43 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 271' ' ' ASP . 25.6 t0 -65.33 -37.25 86.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.7 OUTLIER -37.83 -40.69 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.409 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.4 pm0 -105.83 175.34 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.9 tp -129.9 147.3 51.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.52 145.67 54.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 309' ' ' LEU . 10.4 mt -116.06 132.58 56.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.25 129.77 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.688 0.756 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.71 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.49 10.6 9.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -113.26 178.21 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.42 159.88 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.415 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 12.1 mm -135.25 138.0 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' HD13 ' A' ' 301' ' ' LEU . 31.3 m-85 -101.73 113.36 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.5 tmm? -99.04 140.55 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.497 ' N ' ' SD ' ' A' ' 283' ' ' MET . 6.0 t -133.81 141.78 41.16 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.893 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -37.42 9.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 36.8 mtp -74.14 1.34 11.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 37.8 mm-40 -128.36 17.15 6.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -77.98 86.14 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 29.9 p -105.17 126.8 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.9 m 48.47 29.46 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 17.3 p -89.49 -50.0 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 59.1 p -39.9 -38.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.47 -46.36 89.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 175.03 -25.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -80.58 -179.84 7.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.1 pt -156.52 125.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 38.5 t80 -80.13 111.2 16.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.56 169.33 22.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 91.4 m -124.8 116.36 22.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.9 t -54.48 153.43 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.402 HD13 ' CE2' ' A' ' 282' ' ' PHE . 10.9 tp -96.81 -50.7 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 16.0 m -53.46 -52.79 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.4 p -87.22 -53.45 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.8 4.54 31.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.426 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 9.3 t -77.72 166.72 22.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 84.1 p -134.85 147.91 50.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 174.84 -176.84 47.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 309' ' ' LEU . 12.3 mt -88.98 137.57 32.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.83 156.01 65.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.943 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 124.4 11.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.61 -8.81 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -95.62 21.93 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.538 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.6 m-85 -129.07 -1.5 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.85 -177.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.5 t -158.43 162.65 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -62.47 143.49 57.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.112 179.815 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.73 138.66 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.181 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.8 mt -135.56 149.53 49.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.915 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -109.16 131.5 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 80.6 t -66.02 128.39 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -103.89 -21.71 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -150.94 143.61 16.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.675 0.75 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.36 68.08 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.569 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 34.6 t80 -147.5 123.92 10.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.3 m -93.37 106.25 19.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.577 0.703 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.416 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.3 Cg_endo -69.75 171.6 14.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.624 2.216 . . . . 0.0 112.421 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.58 -14.94 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -158.9 -179.26 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 271' ' ' ASP . 38.7 t0 -64.77 -37.92 89.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -36.38 -39.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.9 pm0 -109.39 171.83 7.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 3.3 tp -125.73 142.38 51.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -64.44 135.59 56.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.7 mt -106.05 128.32 53.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.31 130.76 24.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.65 0.738 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 112.73 3.15 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.651 2.234 . . . . 0.0 112.368 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.88 1.29 22.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.53 175.84 5.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -114.91 165.07 13.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.448 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 26.5 mm -143.34 140.85 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -109.16 116.04 31.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -101.76 136.93 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.428 ' N ' ' SD ' ' A' ' 283' ' ' MET . 13.4 p -125.55 138.68 32.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 0.0 110.883 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.491 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.78 -21.68 33.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 49.9 mmm -77.16 -24.15 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -118.03 29.51 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 15.1 pt20 -88.41 60.3 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 t -86.83 141.23 28.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.5 m 50.6 24.92 1.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 36.6 p -94.54 -41.55 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.18 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.6 m -51.41 -26.64 8.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.1 -30.99 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -81.21 179.51 7.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 314' ' ' ILE . 2.1 pt -160.02 119.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.83 111.44 10.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.4 167.41 23.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.522 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 61.5 m -121.32 126.91 50.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 111.143 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.6 t -66.01 153.58 41.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.1 tp -92.75 -48.71 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -58.84 -57.68 11.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.7 p -78.61 -50.11 12.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.78 46.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.9 t -84.3 166.81 17.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 78.5 p -129.53 145.89 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.31 179.38 46.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.9 144.24 26.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -147.37 155.36 46.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.595 0.712 . . . . 0.0 110.897 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.78 128.73 16.43 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.22 -6.19 6.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -99.23 21.39 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.569 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 9.2 m-85 -129.73 -1.79 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.461 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -134.53 177.02 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.8 t -153.68 164.74 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -64.49 144.87 56.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.92 130.34 41.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 12.6 mt -130.99 150.18 52.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 22.4 tm0? -108.69 133.01 53.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 65.9 t -64.43 133.92 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pt -111.06 -19.59 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -152.97 141.71 14.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 148.55 65.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.497 ' CB ' ' CD1' ' A' ' 275' ' ' LEU . 29.3 t80 -133.93 157.15 46.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.418 ' N ' ' CG ' ' A' ' 265' ' ' TYR . 6.4 m -126.28 101.05 28.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 169.73 18.17 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.382 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -124.57 -14.68 6.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -152.82 -175.57 5.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -28.9 61.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -42.97 7.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -101.45 178.8 4.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 6.9 tp -132.96 143.68 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.14 147.31 53.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.497 ' CD1' ' CB ' ' A' ' 265' ' ' TYR . 17.5 mt -115.9 124.67 51.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.4 t -115.61 130.59 24.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.634 0.731 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 111.43 2.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.63 2.64 19.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -111.19 175.16 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -115.38 164.63 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.45 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 34.9 mm -138.77 121.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -85.71 115.73 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -99.47 130.18 45.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.447 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.6 p -126.1 142.85 43.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -30.26 22.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.692 2.262 . . . . 0.0 112.364 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 65.2 mtp -76.6 -3.44 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.562 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 20.2 mm-40 -122.28 5.28 9.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.38 92.54 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 40.6 p -115.19 123.79 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.7 m 50.83 29.09 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 294' ' ' GLY . 16.7 p -86.52 -55.51 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 291' ' ' THR . 31.3 t -34.41 -37.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.27 -49.03 79.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.15 -26.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -79.87 -179.77 7.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.6 pt -158.38 119.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 19.9 t80 -78.44 112.77 15.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.46 175.25 21.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 57.0 m -125.33 133.26 52.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.3 t -71.14 150.62 45.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 13.9 tp -95.49 -40.29 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 93.3 m -69.88 -44.95 68.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -91.88 -53.06 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 105.58 8.73 34.55 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 8.9 t -78.34 166.55 22.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 54.0 p -139.17 133.88 32.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.2 -175.11 45.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.72 140.1 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.474 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.76 156.05 62.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 122.88 9.55 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.43 -10.4 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -94.6 22.77 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.516 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.9 m-85 -129.87 -2.83 4.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.14 -179.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.2 t -157.38 167.77 29.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 142.13 55.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 179.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.915 0.388 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.5 m -129.3 129.83 45.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.9 mt -130.41 150.66 51.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -110.19 128.35 55.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.4 133.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.36 -21.12 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -152.24 144.09 16.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.67 68.68 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.49 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 29.3 t80 -147.8 127.08 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.8 m -95.84 108.22 39.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 111.162 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.9 Cg_endo -69.73 172.04 13.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.234 . . . . 0.0 112.354 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -123.3 -13.38 7.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -162.44 -179.15 6.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.6 p-10 -63.63 -37.45 87.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.5 OUTLIER -37.3 -41.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.0 pm0 -107.63 174.62 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.453 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 4.5 tp -128.32 144.93 51.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.58 128.93 38.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 309' ' ' LEU . 7.7 mt -97.18 129.45 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.55 130.57 24.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.624 0.726 . . . . 0.0 111.134 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 103.74 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.34 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.47 5.37 7.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -111.29 169.97 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -113.32 145.44 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 300' ' ' SER . 32.1 mm -124.21 120.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.438 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 17.9 m-85 -83.33 119.29 24.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -99.66 137.85 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.497 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.8 p -138.97 120.12 9.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.82 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 0.51 5.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -94.85 -24.12 17.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.538 ' O ' ' CD1' ' A' ' 297' ' ' TYR . 16.9 mm-40 -122.06 41.41 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 143.11 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 24.9 p -147.79 116.51 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 23.4 m 64.4 25.4 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 294' ' ' GLY . 28.1 p -83.02 -52.3 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 291' ' ' THR . 12.5 m -36.66 -41.51 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -56.88 -45.37 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 172.53 -23.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -79.88 -179.9 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.736 0.303 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.36 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 287' ' ' GLU . 40.4 t80 -94.3 108.45 20.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -132.85 -177.29 14.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.0 m -132.48 126.29 32.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 281' ' ' ILE . 1.0 OUTLIER -62.6 166.32 5.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.438 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 12.7 tp -107.08 -30.32 8.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -75.63 -54.17 7.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 9.3 p -90.28 -34.46 15.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.76 62.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.453 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 61.9 m -86.65 145.9 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.4 p -114.1 132.7 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.97 179.22 42.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -89.5 142.64 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.466 ' CD1' HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -146.77 156.42 48.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 120.89 7.6 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.718 2.279 . . . . 0.0 112.364 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.37 -11.57 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -92.86 19.9 7.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.514 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.8 m-85 -128.24 -1.6 5.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.44 174.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 5.6 t -146.84 159.49 43.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 3.5 mptt -64.74 143.82 57.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.913 0.387 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.9 m -131.21 129.49 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.5 mt -130.21 149.43 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -108.84 124.76 51.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.33 131.32 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -106.93 -12.08 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 75.3 m-85 -161.55 143.45 8.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.68 0.753 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.12 11.46 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.457 ' CD2' HD21 ' A' ' 275' ' ' LEU . 3.1 t80 -171.77 118.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.2 m -83.75 113.4 47.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.579 0.704 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 171.95 13.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.395 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -119.89 -13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.405 ' OD1' ' CD ' ' A' ' 272' ' ' GLU . 2.5 p30 -167.63 -178.26 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.38 -29.67 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -45.33 -42.08 9.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.405 ' CD ' ' OD1' ' A' ' 269' ' ' ASN . 11.7 pm0 -106.82 177.28 4.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 12.7 tp -130.45 147.5 52.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.67 151.87 46.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 275' ' ' LEU . 3.7 mm? -115.87 128.75 56.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.87 127.15 26.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.606 0.717 . . . . 0.0 111.139 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 104.55 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.65 2.233 . . . . 0.0 112.309 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.07 11.19 8.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -114.64 174.67 5.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -115.41 165.22 13.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 15.1 mm -143.82 128.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -93.02 116.91 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -101.76 134.82 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.435 ' N ' ' SD ' ' A' ' 283' ' ' MET . 0.7 OUTLIER -125.66 141.46 39.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.684 0.754 . . . . 0.0 110.799 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.83 19.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 8.7 mtp -77.47 -2.07 33.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 12.4 mt-10 -121.77 8.09 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -67.98 85.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 p -109.05 121.81 45.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.3 m 55.26 26.0 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 32.9 p -86.97 -44.15 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.2 t -43.15 -40.73 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.97 -40.43 80.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.81 -21.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -80.01 -179.78 7.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.404 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.6 pt -156.74 122.04 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 36.5 t80 -84.59 111.71 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -137.19 -172.9 12.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 65.5 m -138.01 124.1 20.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.17 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.1 t -62.21 168.89 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.17 -41.07 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -67.23 -65.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.3 p -75.12 -31.92 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.03 63.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.496 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.68 152.59 18.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 33.5 p -121.34 136.85 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.1 -179.46 47.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 309' ' ' LEU . 10.8 mt -87.93 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.76 156.68 65.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.603 0.716 . . . . 0.0 110.927 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.522 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 0.0 112.347 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -54.5 -14.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.26 19.14 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.522 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.68 -0.19 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -131.82 178.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.2 t -148.74 157.95 43.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -65.67 151.46 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.834 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.901 0.381 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.61 132.04 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.2 mt -135.03 150.97 50.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -108.74 131.74 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.52 126.48 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 2.2 pt -102.56 -18.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 70.1 m-85 -158.24 144.06 12.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 158.31 57.37 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.722 2.281 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -150.54 133.07 15.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.6 m -102.46 106.94 51.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.621 0.724 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.432 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.7 Cg_endo -69.75 170.89 15.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.725 2.283 . . . . 0.0 112.345 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.87 -15.37 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -150.66 -175.71 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.58 -40.76 69.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -38.59 -42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.3 pm0 -99.75 171.06 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 5.8 tp -131.9 150.96 52.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.412 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 35.3 tt0 -68.81 150.67 47.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.464 HD23 ' CD1' ' A' ' 309' ' ' LEU . 10.9 mt -119.71 130.83 55.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.38 129.26 25.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.32 3.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.83 0.31 22.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.67 166.23 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.468 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 21.1 mm -142.35 124.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 22.7 m-85 -90.68 114.78 27.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.4 tmm? -100.3 141.61 32.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.491 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.1 t -141.27 138.72 17.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.664 0.745 . . . . 0.0 110.866 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.439 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.4 Cg_endo -69.78 -18.47 36.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 0.0 112.331 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 11.2 mtp -64.11 -31.61 72.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -123.0 41.74 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 8.3 pt20 -91.38 66.95 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.3 t -93.65 142.27 27.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.1 m 45.48 25.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 294' ' ' GLY . 40.5 p -91.53 -58.32 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 291' ' ' THR . 26.8 m -36.2 -38.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.59 -46.69 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.52 -26.88 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -83.17 -179.98 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.752 0.31 . . . . 0.0 110.892 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.33 136.53 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.493 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 38.6 t80 -89.48 111.72 22.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.46 167.66 22.98 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 92.6 m -126.14 116.49 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.2 t -55.28 147.66 16.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.575 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -89.24 -43.04 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.1 m -65.25 -60.95 2.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 30.4 p -75.2 -50.35 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.99 9.58 42.17 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.01 153.37 23.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.7 p -125.0 137.96 54.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -175.46 -173.42 41.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 309' ' ' LEU . 20.5 mt -90.99 140.86 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 0.0 110.867 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.464 ' CD1' HD23 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -144.15 156.02 58.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 110.883 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.528 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.72 117.61 5.18 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.0 -14.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -90.44 21.21 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.528 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.18 -5.51 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.461 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -125.93 169.69 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.7 t -150.24 167.49 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.42 143.76 44.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.455 ' O ' ' CB ' ' A' ' 317' ' ' ALA . 1.7 m -129.2 127.24 40.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.2 mt -127.54 150.03 49.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.11 127.21 53.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.89 138.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.468 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -114.89 -14.93 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 81.7 m-85 -159.2 146.7 13.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.686 0.755 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 165.34 31.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.556 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 44.2 t80 -160.75 123.4 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.8 m -90.29 110.07 38.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.584 0.706 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 52.9 Cg_endo -69.84 171.13 15.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.681 2.254 . . . . 0.0 112.269 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -119.7 -14.38 9.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -167.26 -178.67 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.43 -34.9 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -38.87 -44.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.435 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 2.6 pm0 -105.32 177.38 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.504 ' O ' ' CD2' ' A' ' 275' ' ' LEU . 4.0 tp -132.72 142.38 49.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.67 150.82 18.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 273' ' ' LEU . 1.8 mm? -114.45 127.33 55.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.61 123.44 29.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 103.97 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.92 12.76 7.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.469 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -115.31 178.64 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -116.54 160.5 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.473 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 18.2 mm -138.98 133.28 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 301' ' ' LEU . 25.8 m-85 -96.02 110.55 22.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -101.34 134.11 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 283' ' ' MET . 22.1 t -137.6 140.83 31.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.651 0.738 . . . . 0.0 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.434 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.73 -26.01 28.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -61.26 -33.61 73.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -117.45 41.39 2.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 288' ' ' GLN . 11.5 pt20 -96.08 95.91 8.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.6 p -115.11 137.31 52.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 9.5 m 48.49 25.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 43.5 p -88.53 -38.47 14.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.0 t -55.4 -24.84 32.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.94 -29.64 63.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 156.48 -18.57 0.44 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -86.99 179.6 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.3 pt -158.14 124.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -80.19 111.15 16.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.84 175.09 19.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 70.3 m -131.7 132.46 43.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.2 t -65.58 150.56 48.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 282' ' ' PHE . 13.6 tp -95.4 -35.42 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 48.4 m -77.18 -49.91 14.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 82.1 p -84.12 -52.46 6.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.05 3.16 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.462 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.43 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 82.9 m -77.44 147.89 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 89.6 p -120.73 140.37 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.28 -177.25 46.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.18 149.56 23.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -153.06 155.54 32.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.553 0.692 . . . . 0.0 110.961 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.7 126.84 13.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.692 2.261 . . . . 0.0 112.369 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.22 -7.27 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -97.62 21.63 10.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.7 m-85 -129.35 -3.88 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.28 177.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.6 t -149.77 156.69 42.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -59.24 137.57 57.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.915 0.388 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 317' ' ' ALA . 5.6 m -123.54 125.24 44.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.99 149.82 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -108.83 130.8 55.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.92 144.2 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -121.61 -14.6 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 71.4 m-85 -161.5 145.71 9.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.654 0.74 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 163.8 36.9 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.495 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 50.8 t80 -160.81 128.3 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.8 m -97.78 108.92 48.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.565 0.698 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.419 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.81 165.15 31.99 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.342 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -113.68 -21.9 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -154.02 -179.16 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.6 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -39.24 -45.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.8 pm0 -105.21 178.96 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.447 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.7 tp -132.24 151.94 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 31.3 tt0 -64.9 155.85 32.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' A' ' 275' ' ' LEU . 1.3 mm? -121.31 131.54 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.91 126.26 25.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.666 0.746 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.01 2.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.649 2.233 . . . . 0.0 112.358 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.69 9.66 20.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -112.85 178.69 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -117.16 169.49 9.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.461 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 17.3 mm -146.14 125.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' A' ' 301' ' ' LEU . 24.7 m-85 -91.77 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -99.23 135.57 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.474 ' N ' ' SD ' ' A' ' 283' ' ' MET . 30.6 t -128.56 142.41 44.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.717 0.77 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -30.83 21.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.258 . . . . 0.0 112.345 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 47.7 mtp -77.26 4.39 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.566 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 66.9 mm-40 -127.41 -0.54 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -58.8 85.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -109.32 107.92 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.0 m 66.82 28.02 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.9 p -88.24 -48.01 8.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.155 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 81.1 p -39.8 -39.57 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.18 -44.95 92.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 171.63 -23.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -79.73 -179.85 7.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.754 0.312 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.8 pt -157.93 121.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 32.0 t80 -79.92 113.7 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.77 175.52 20.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 13.8 m -125.18 131.92 53.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.31 . . . . 0.0 111.133 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.4 t -66.1 148.74 51.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 282' ' ' PHE . 12.3 tp -97.17 -37.18 10.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.8 m -73.55 -44.78 56.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -94.07 -46.47 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.86 3.36 49.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.551 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.65 176.9 4.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 6.7 m -149.07 140.26 23.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.19 48.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.98 136.2 33.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -138.77 153.44 72.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 0.0 110.908 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.533 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.4 Cg_endo -69.85 123.9 10.52 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.339 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.73 -11.14 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -92.49 19.36 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.533 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 8.1 m-85 -128.91 -2.5 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -134.06 177.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.9 t -153.05 159.49 42.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -55.16 148.2 14.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.104 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.917 0.389 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.0 m -121.96 130.55 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.3 150.21 50.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -108.57 131.09 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.18 133.17 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -103.48 -28.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -145.01 144.95 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 151.91 69.46 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.475 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 24.3 t80 -148.49 120.35 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.9 m -91.3 107.4 21.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.49 16.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -120.41 -14.66 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -157.81 176.63 12.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 271' ' ' ASP . 12.3 p-10 -62.92 -39.72 95.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.1 -39.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -105.82 175.14 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.435 ' CD1' ' SG ' ' A' ' 305' ' ' CYS . 5.5 tp -125.67 143.97 50.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.19 130.27 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.2 mt -101.89 131.96 47.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.79 132.87 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.713 . . . . 0.0 111.124 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 103.45 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.311 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.56 14.51 6.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -116.73 177.99 4.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -120.48 161.36 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.472 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 38.6 mm -142.51 139.39 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.3 m-85 -101.17 113.53 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -100.26 133.69 44.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.456 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.0 OUTLIER -133.76 136.94 27.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 0.0 110.869 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 54.0 Cg_endo -69.78 -20.36 34.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.29 -32.28 73.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -119.29 42.73 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 12.3 pt20 -94.21 81.78 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 291' ' ' THR . 35.9 p -94.83 137.5 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.7 m 39.45 31.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 294' ' ' GLY . 34.6 p -88.33 -58.37 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 291' ' ' THR . 17.8 m -35.89 -43.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.35 -46.45 62.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.71 -26.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -82.77 179.92 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.0 110.926 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.469 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -160.17 123.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -78.18 115.83 18.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.45 167.74 24.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 90.2 m -122.41 137.63 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.7 t -69.16 151.3 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.535 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 9.1 tp -100.02 -31.18 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 98.8 m -76.98 -36.76 56.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 20.2 p -102.12 -65.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.34 6.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.435 ' SG ' ' CD1' ' A' ' 273' ' ' LEU . 28.5 p -72.09 155.07 40.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.424 ' C ' HD11 ' A' ' 273' ' ' LEU . 30.1 p -124.52 154.57 40.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 173.92 179.52 44.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.56 147.52 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.492 HD21 ' N ' ' A' ' 309' ' ' LEU . 0.3 OUTLIER -150.0 155.23 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.907 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 120.03 6.88 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.06 -12.43 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -92.67 21.9 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.525 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.45 -3.83 4.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -127.11 -179.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.9 t -156.2 160.03 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -59.37 143.74 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 258' ' ' THR . 11.1 tp10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' THR . . . . . 0.445 ' N ' ' HG3' ' A' ' 257' ' ' GLU . 8.3 m -123.72 123.11 39.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' A' ' 257' ' ' GLU . 6.9 mt -125.41 151.9 45.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -108.87 130.36 55.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.8 126.57 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -100.19 -17.01 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -156.27 145.63 15.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.671 0.748 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 162.79 40.72 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.675 2.25 . . . . 0.0 112.396 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.517 ' CB ' ' CD1' ' A' ' 275' ' ' LEU . 28.1 t80 -147.81 144.3 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.4 m -114.74 99.42 51.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.55 21.23 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.369 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -124.88 -14.01 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -147.64 -178.99 6.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.8 m-20 -71.87 -42.47 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 270' ' ' ASP . 29.4 t70 -37.34 -39.93 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.55 176.89 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.1 tp -137.8 153.6 49.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.455 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 21.9 tt0 -74.98 150.83 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.517 ' CD1' ' CB ' ' A' ' 265' ' ' TYR . 26.0 mt -117.71 133.66 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.23 130.87 24.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.634 0.731 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 105.65 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.24 . . . . 0.0 112.346 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.32 16.13 7.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -118.34 171.08 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.8 159.76 17.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.483 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 32.2 mm -136.76 133.95 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.33 111.64 23.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -100.41 138.92 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.491 ' N ' ' SD ' ' A' ' 283' ' ' MET . 7.7 t -137.74 134.22 18.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.731 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.405 ' HA ' ' CD ' ' A' ' 288' ' ' GLN . 53.2 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.247 . . . . 0.0 112.329 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.3 mmt -82.04 -27.95 32.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -126.1 42.14 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.405 ' CD ' ' HA ' ' A' ' 285' ' ' PRO . 12.8 pt20 -98.14 75.04 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.4 p -88.59 142.8 27.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 13.0 m 40.44 33.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.799 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 294' ' ' GLY . 54.9 p -91.58 -57.46 2.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.8 t -38.59 -40.41 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -53.82 -44.42 70.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 175.37 -25.34 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -85.01 179.86 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.3 pt -159.55 123.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.123 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 26.2 t80 -76.81 114.78 15.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . 0.483 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -134.55 163.82 24.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 93.1 m -116.26 129.08 56.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 111.131 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -65.62 151.64 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.819 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.9 tp -102.5 -29.5 11.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.7 m -81.87 -38.54 25.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 77.3 p -103.47 -38.96 6.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 -13.63 60.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 95.4 m -53.05 166.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.0 m -146.83 128.3 15.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.07 33.8 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 18.1 mt -89.09 143.5 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.473 HD21 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.44 156.9 49.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.719 . . . . 0.0 110.886 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.7 117.01 4.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.248 . . . . 0.0 112.362 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.07 -13.21 1.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.26 23.45 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.532 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.3 m-85 -130.57 -3.1 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.1 177.2 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.7 t -151.97 159.35 43.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -61.78 151.08 35.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.963 0.411 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.1 m -125.89 126.56 44.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.03 151.94 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -108.74 130.75 55.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.1 131.8 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.9 pt -107.93 -19.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.157 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -155.82 143.86 14.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.693 0.759 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 153.9 68.46 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.717 2.278 . . . . 0.0 112.314 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.421 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 35.9 t80 -150.69 125.65 9.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.947 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.14 109.43 44.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.569 0.7 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.73 166.79 26.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -115.69 -20.71 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -153.32 -179.2 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -64.87 -32.39 74.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -41.6 -44.09 2.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.2 pm0 -102.98 171.33 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.2 tp -124.59 147.05 48.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.56 140.26 57.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.461 HD22 ' CD1' ' A' ' 309' ' ' LEU . 5.9 mt -112.13 127.68 55.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 87.2 t -124.47 133.5 24.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.629 0.728 . . . . 0.0 111.103 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.335 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.56 2.94 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -111.18 162.6 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.06 159.19 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 300' ' ' SER . 20.0 mm -137.76 120.2 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.98 114.76 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -99.47 138.03 37.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.496 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.1 p -137.66 125.73 14.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -10.71 29.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 40.5 mtp -83.04 -28.94 29.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 297' ' ' TYR . 50.5 mm-40 -117.65 40.41 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.448 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 2.9 pp0? -96.15 123.68 39.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.5 p -129.06 126.92 40.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.0 m 55.1 25.18 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 294' ' ' GLY . 41.8 p -87.51 -54.53 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 291' ' ' THR . 28.0 t -36.35 -37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -61.57 -48.7 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -179.44 -27.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -79.82 -179.76 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.726 0.298 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.417 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.7 pt -152.34 134.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 287' ' ' GLU . 53.6 t80 -96.21 111.03 23.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -138.38 177.48 20.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 305' ' ' CYS . 58.6 m -127.37 119.55 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 111.16 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 281' ' ' ILE . 1.1 t -55.26 168.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.8 tp -111.31 -28.65 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -74.38 -47.87 31.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.6 p -95.23 -28.95 14.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 80.7 16.04 76.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.442 ' O ' ' CG2' ' A' ' 299' ' ' THR . 5.9 t -88.55 169.04 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 79.6 p -131.34 142.78 50.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.95 48.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.403 ' C ' HD21 ' A' ' 309' ' ' LEU . 11.4 mt -92.25 151.45 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.461 ' CD1' HD22 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -157.54 157.5 30.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 110.958 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.481 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 123.76 10.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.757 2.305 . . . . 0.0 112.34 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.29 -8.97 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.21 19.18 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.481 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.0 m-85 -126.56 -1.18 6.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -131.25 175.94 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.4 t -149.71 165.4 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 4.7 mptt -67.16 143.8 56.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.854 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.5 m -127.87 133.63 49.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 mt -132.67 155.12 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -110.3 132.52 54.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.65 137.65 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.32 -18.69 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -155.02 142.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.75 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 158.17 57.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -153.3 125.33 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 m -95.62 109.99 48.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 171.07 15.19 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -125.64 -13.69 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ASN . . . . . 0.431 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 23.3 m-80 -151.42 -175.39 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.18 -21.94 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 0.9 OUTLIER -104.76 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 305' ' ' CYS . 6.7 tp -120.35 148.42 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.4 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 36.7 tt0 -72.48 145.56 47.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 309' ' ' LEU . 11.1 mt -115.73 135.51 53.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.54 134.81 26.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 113.54 3.41 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 109.57 5.78 29.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.525 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -110.82 165.4 11.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.342 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -107.28 163.46 13.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 15.1 mm -146.09 122.85 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 301' ' ' LEU . 41.3 m-85 -81.93 128.83 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -98.96 129.39 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 108.21 19.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.723 0.773 . . . . 0.0 110.901 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -3.11 11.34 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -88.88 -24.89 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 297' ' ' TYR . 55.3 mm-40 -122.97 40.85 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.34 109.12 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 21.0 p -114.05 119.26 36.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.9 m 67.36 27.78 8.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.837 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 33.6 p -87.85 -41.22 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.8 t -49.28 -27.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 294' ' ' GLY . 4.9 pt-20 -70.9 -42.96 69.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 293' ' ' GLU . . . 173.77 -25.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -80.54 179.28 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.717 0.294 . . . . 0.0 110.902 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.1 pt -156.83 126.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 287' ' ' GLU . 29.9 t80 -84.66 111.76 19.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -133.65 -173.56 13.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 300' ' ' SER . 91.8 m -133.21 141.03 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.45 ' N ' HG23 ' A' ' 299' ' ' THR . 13.7 t -74.74 149.6 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.54 HD11 ' CE2' ' A' ' 282' ' ' PHE . 13.1 tp -96.08 -39.36 9.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.5 m -71.35 -39.95 71.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.0 p -100.04 -63.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.84 10.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.431 ' SG ' ' CD1' ' A' ' 273' ' ' LEU . 2.3 p -79.53 153.77 29.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.4 p -120.25 147.86 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.79 -175.54 47.65 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 309' ' ' LEU . 18.1 mt -94.79 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.74 157.13 62.31 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.59 0.71 . . . . 0.0 110.913 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.654 2.236 . . . . 0.0 112.327 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -55.0 -15.52 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -88.74 19.69 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.52 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.69 -2.57 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.9 pp -128.41 173.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.3 t -147.79 151.78 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.464 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -59.49 142.83 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.882 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 47.9 t -109.85 132.21 54.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.822 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 53.7 m -93.03 87.03 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.27 108.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.4 t -56.29 176.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.0 t -52.69 -55.66 21.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.05 179.23 53.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.1 t -162.73 158.56 23.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.911 0.386 . . . . 0.0 110.795 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 53.7 mtt85 -62.62 -31.01 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -128.43 153.41 47.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 4.4 mp -89.38 106.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.509 ' HB3' ' CD1' ' A' ' 253' ' ' PHE . 6.2 ttm180 -124.55 -48.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' A' ' 252' ' ' ARG . 6.7 m-85 -111.44 12.52 21.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.0 157.48 17.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -106.03 46.12 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 19.2 m80 -74.59 136.73 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -85.21 162.77 19.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.944 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.1 m -130.63 130.89 44.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.9 mt -129.73 150.45 51.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -108.68 131.53 54.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.37 128.69 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.9 pt -104.06 -16.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 79.2 m-85 -158.42 144.46 12.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.74 0.781 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 157.53 60.21 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.698 2.265 . . . . 0.0 112.332 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.434 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 15.6 t80 -148.83 127.67 12.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -96.53 107.0 33.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.549 0.69 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 170.92 15.44 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.335 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -125.81 -15.04 6.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.432 ' C ' ' OE1' ' A' ' 272' ' ' GLU . 65.9 m-80 -150.37 -175.71 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 9.0 t70 -72.76 -42.27 64.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 37.8 t70 -37.7 -38.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 269' ' ' ASN . 1.2 pm0 -102.54 168.22 9.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.8 tp -127.12 149.23 50.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.459 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 15.7 tt0 -69.72 143.9 52.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 309' ' ' LEU . 10.2 mt -113.36 141.28 47.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.53 134.72 25.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 111.157 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 112.66 3.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.32 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.39 6.66 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -109.48 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -115.43 167.14 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 29.2 mm -145.35 115.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.02 118.7 24.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -102.31 137.95 39.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.57 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 1.2 p -134.66 140.26 34.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.67 0.748 . . . . 0.0 110.843 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -26.54 27.42 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.35 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.0 mtp -81.05 -1.72 45.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 71.8 mm-40 -126.91 18.52 7.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -77.14 127.8 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.4 p -148.93 113.4 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 63.78 25.15 14.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.4 p -88.59 -45.78 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.0 m -44.33 -24.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.31 -49.4 19.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 179.9 -26.55 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -80.23 -179.45 7.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.74 0.305 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.47 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.0 OUTLIER -153.47 127.14 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 27.6 t80 -88.0 120.23 29.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -148.67 -173.71 19.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 38.8 m -130.42 139.06 50.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.333 . . . . 0.0 111.16 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.3 t -75.17 158.3 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 13.0 tp -100.14 -34.83 9.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 62.9 m -73.6 -61.29 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 67.5 p -78.62 -49.96 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.95 11.65 31.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.456 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.57 149.71 21.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.8 t -118.18 154.41 32.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 172.61 -173.29 45.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.415 ' C ' HD22 ' A' ' 309' ' ' LEU . 20.6 mt -91.73 137.1 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.5 155.48 63.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.6 Cg_endo -69.8 119.99 6.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -57.06 -12.55 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.75 20.42 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.514 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.2 m-85 -129.04 -3.62 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.47 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -129.89 177.27 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 4.7 t -152.49 159.81 43.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -59.55 149.63 29.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -84.16 108.37 17.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.56 24.26 12.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -97.05 -39.26 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.62 140.93 32.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 83.0 p -128.79 142.69 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 3.1 p -72.74 -177.05 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.117 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.446 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.4 p-90 -108.48 -41.28 4.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.446 HG12 ' CE3' ' A' ' 323' ' ' TRP . 6.2 mm -130.09 -31.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -47.6 116.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -89.55 -53.78 4.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 82.72 -80.28 1.82 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.535 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 82.7 p -174.13 141.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 95.9 p -157.18 153.58 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 145.97 -93.8 0.16 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.7 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.31 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 331' ' ' PRO . 4.1 t 37.27 41.77 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 40.6 m -111.82 138.88 47.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 89.5 p -74.27 -44.08 54.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.7 t -77.11 96.79 4.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.13 135.88 12.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 19.3 t -88.66 117.88 27.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.6 m -60.97 151.13 31.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -172.52 102.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 88.4 p -141.59 166.11 25.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.88 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -73.82 121.58 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -48.92 141.87 7.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 282' ' ' PHE . 86.1 mt -71.29 -37.43 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 251' ' ' ILE . 13.6 mmt180 38.33 44.85 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 47.95 53.48 11.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -86.06 -179.32 6.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 255' ' ' ASN . 2.4 p30 -77.96 47.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 9.5 m80 -98.75 141.27 31.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.467 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 20.3 pt-20 -98.35 155.0 17.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 18.2 m -116.02 137.08 52.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.1 mt -134.02 150.62 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -108.79 132.69 53.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.63 129.71 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 3.0 pt -107.38 -14.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.472 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 89.3 m-85 -159.28 143.26 11.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.654 0.74 . . . . 0.0 110.958 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 160.05 51.18 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -154.61 127.05 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.955 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.75 109.61 47.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.74 172.12 13.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -123.96 -14.28 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -162.49 -177.46 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -63.89 -36.67 84.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.42 -42.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.437 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.2 pm0 -105.23 175.11 5.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -130.58 143.11 50.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.63 144.01 56.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 309' ' ' LEU . 6.4 mt -112.51 142.51 44.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.37 128.21 19.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 104.31 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.277 . . . . 0.0 112.368 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.22 5.16 8.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -112.55 171.31 7.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.52 162.06 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 17.5 mm -135.09 132.38 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.432 ' CE2' HD12 ' A' ' 301' ' ' LEU . 25.5 m-85 -99.49 106.21 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.7 tmm? -98.97 134.21 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.566 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 8.5 p -126.12 143.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.661 0.743 . . . . 0.0 110.875 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -24.47 29.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.351 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 44.2 mtp -81.53 -3.19 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.554 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 66.3 mm-40 -126.33 9.69 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -69.27 87.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.9 p -104.99 128.9 53.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m 48.09 26.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 294' ' ' GLY . 29.4 p -86.05 -54.48 4.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.2 t -35.36 -36.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 18.4 tp10 -62.66 -47.72 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.15 -26.2 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -79.93 -179.78 7.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.89 125.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.7 t80 -84.2 111.14 19.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -134.29 -177.77 15.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 97.2 m -133.18 129.6 38.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.123 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 2.4 t -66.17 154.77 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.432 HD12 ' CE2' ' A' ' 282' ' ' PHE . 9.3 tp -99.82 -29.94 12.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 5.2 m -72.65 -52.64 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.0 p -88.8 -55.37 3.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.93 23.36 6.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.6 t -96.15 166.28 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 81.1 p -129.02 143.39 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.85 47.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.412 ' C ' HD21 ' A' ' 309' ' ' LEU . 10.9 mt -88.95 139.17 30.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 110.914 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.21 157.19 63.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.559 0.695 . . . . 0.0 110.946 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.3 Cg_endo -69.79 120.7 7.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.657 2.238 . . . . 0.0 112.344 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -58.68 -11.62 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -93.03 20.5 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.512 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.6 m-85 -128.74 -3.06 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -130.16 177.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.8 t -153.34 162.63 41.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -66.31 148.01 52.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.54 92.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.084 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -108.86 22.18 16.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.71 -55.9 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.96 118.21 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 34.6 t -144.96 157.54 44.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 15.1 p -66.6 -176.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.542 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.0 p-90 -119.5 -46.94 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.542 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.1 mm -124.15 -48.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 324' ' ' ILE . 12.5 m-30 -34.32 143.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.66 97.65 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.84 113.49 2.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 329' ' ' SER . 46.6 m -88.39 112.78 23.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 328' ' ' SER . 18.9 p 37.58 43.84 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -130.36 82.81 0.32 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -7.82 22.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 16.2 t -56.71 -50.76 71.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 57.6 m -78.38 -44.67 24.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.2 t -125.33 132.47 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.2 p -52.63 129.88 30.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.23 111.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 92.7 p -87.08 145.34 26.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.381 . . . . 0.0 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 94.9 p -61.34 -50.81 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.814 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.78 -172.38 43.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.6 t -96.4 110.08 22.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.864 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.29 140.95 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -172.56 143.21 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 256' ' ' HIS . 75.7 mt -83.13 -41.89 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 253' ' ' PHE . 5.6 mmm180 39.3 44.58 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 252' ' ' ARG . 5.5 m-85 35.69 47.41 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -104.19 -43.27 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -132.54 -53.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.567 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 33.8 m80 -74.36 138.41 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -101.88 175.54 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 1.8 m -133.03 126.78 32.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.4 mt -129.95 151.41 50.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -108.77 133.72 52.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.5 142.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.447 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -119.99 -14.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.3 m-85 -158.33 143.78 12.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.68 0.752 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.49 69.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.472 ' CB ' HD11 ' A' ' 275' ' ' LEU . 41.3 t80 -138.46 144.82 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 11.8 m -115.45 97.66 49.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.69 171.52 14.24 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.341 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.59 -13.22 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -157.32 -179.54 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 271' ' ' ASP . 2.1 p30 -66.87 -38.71 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.67 -38.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -111.49 172.9 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 5.3 tp -129.02 143.62 50.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 275' ' ' LEU . 7.0 tt0 -65.44 150.13 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 265' ' ' TYR . 22.8 mt -117.48 127.12 53.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 93.7 t -118.56 132.39 23.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.736 . . . . 0.0 111.129 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 110.75 2.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.726 2.284 . . . . 0.0 112.318 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.26 4.56 20.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -110.76 171.67 7.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 281' ' ' ILE . 32.1 m-85 -112.74 167.99 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.461 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 12.3 mm -144.98 131.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 40.4 m-85 -91.68 120.2 32.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 284' ' ' SER . 1.9 tmm? -99.84 128.24 45.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.567 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 39.6 p -126.63 130.17 23.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.676 0.75 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.456 ' HA ' ' CG ' ' A' ' 288' ' ' GLN . 53.8 Cg_endo -69.7 -13.0 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 0.0 112.369 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.87 -22.45 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.599 ' OE1' ' CE2' ' A' ' 297' ' ' TYR . 13.7 mt-10 -112.27 36.0 3.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.456 ' CG ' ' HA ' ' A' ' 285' ' ' PRO . 9.3 mm100 -84.16 86.79 7.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.9 p -110.74 108.63 18.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.3 m 61.62 30.73 18.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 293' ' ' GLU . 43.6 p -92.56 -59.67 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.9 m -34.06 -34.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . 9.9 tp10 -63.59 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -174.57 -30.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -80.13 -179.99 7.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.737 0.303 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.77 121.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.599 ' CE2' ' OE1' ' A' ' 287' ' ' GLU . 38.9 t80 -72.76 110.92 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -128.89 166.47 21.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 94.5 m -125.79 111.86 15.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.8 t -47.79 147.25 2.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.574 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -96.73 -45.47 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 97.8 m -63.25 -42.37 99.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 33.7 p -96.37 -53.28 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 110.82 0.2 28.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 99.6 m -69.97 151.67 45.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.6 p -124.19 138.14 54.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.65 -175.92 47.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 14.4 mt -88.38 144.98 26.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.1 156.49 50.76 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.79 122.0 8.68 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.706 2.27 . . . . 0.0 112.309 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.36 -10.84 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -94.22 23.11 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.523 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -130.95 -3.33 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.462 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -130.42 176.56 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.9 t -154.47 152.52 30.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -55.09 141.93 32.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.21 89.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.92 -38.4 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -64.9 -63.72 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 3.1 t 48.96 44.96 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 79.6 p -120.73 92.24 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' A' ' 325' ' ' PHE . 0.9 OUTLIER -96.64 140.96 30.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.564 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.4 p-90 -72.58 -41.95 65.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.564 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.6 mm -125.36 -55.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 324' ' ' ILE . 96.5 m-85 -34.36 139.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.89 -49.76 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 137.1 151.83 6.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.524 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.5 m -81.4 52.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.866 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 60.4 p -167.51 174.16 8.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -175.03 84.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 172.24 13.06 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.644 2.229 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.4 t -82.98 104.65 13.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 67.7 p -38.99 -42.25 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 12.8 m -86.78 104.08 15.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 0.0 110.857 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.1 p -131.27 145.77 52.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 143.23 -120.92 1.6 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.8 p -130.28 169.0 16.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -90.42 109.5 20.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.38 123.94 34.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.5 m -64.58 115.86 5.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.867 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -135.52 163.45 30.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.821 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.45 148.3 33.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.1 121.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.425 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -123.52 -36.44 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -66.29 -53.69 33.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -83.52 176.67 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.12 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -125.85 83.21 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 9.9 m80 -100.0 140.18 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -86.73 171.05 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -133.16 128.79 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.4 mt -129.51 149.27 51.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 25.6 tm0? -108.78 124.59 50.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 85.2 t -58.32 138.45 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.5 pt -115.85 -11.86 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 84.6 m-85 -161.76 144.18 8.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.726 0.774 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.33 64.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.716 2.277 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.513 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 38.3 t80 -138.85 135.51 34.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -104.68 105.43 50.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.58 0.705 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 170.68 15.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -125.18 -16.82 5.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.452 ' CG ' ' OE2' ' A' ' 272' ' ' GLU . 0.2 OUTLIER -152.94 173.41 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 271' ' ' ASP . 3.9 t70 -59.62 -41.07 89.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -35.11 -44.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.452 ' OE2' ' CG ' ' A' ' 269' ' ' ASN . 11.6 pm0 -99.29 178.41 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.9 tp -135.37 148.81 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.78 140.68 55.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 11.3 mt -111.98 141.17 45.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.1 t -129.08 135.24 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.643 0.735 . . . . 0.0 111.129 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 104.78 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.69 13.2 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.17 167.74 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.878 0.371 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -107.3 166.0 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 12.5 mm -144.85 119.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 28.7 m-85 -87.41 115.86 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -98.88 141.38 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 5.3 t -133.94 142.33 43.05 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -32.63 17.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.638 2.225 . . . . 0.0 112.352 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 63.7 mtp -74.97 -0.55 19.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 15.7 mm-40 -125.43 15.04 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.19 87.59 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.2 p -114.46 122.32 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.3 m 56.26 25.84 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.407 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 31.8 p -89.42 -42.22 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.3 t -48.31 -29.61 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.28 -36.26 76.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.75 -25.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -80.01 -179.67 7.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.407 ' HA ' ' CG2' ' A' ' 291' ' ' THR . 1.2 pt -157.2 128.41 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.556 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 25.1 t80 -86.19 112.47 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -135.35 172.42 22.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 74.0 m -125.96 113.56 17.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.9 t -50.08 174.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 11.7 tp -114.46 -26.96 7.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -81.46 -54.2 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.3 p -86.73 -27.54 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.07 82.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.2 m -84.63 148.97 26.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 91.0 p -120.3 130.72 54.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.77 -174.69 38.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 309' ' ' LEU . 19.7 mt -87.71 149.39 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -154.95 157.03 31.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.903 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.521 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.2 Cg_endo -69.83 122.43 9.09 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.696 2.264 . . . . 0.0 112.289 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.92 -10.07 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -95.48 22.77 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.521 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.4 m-85 -130.47 -2.03 4.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.9 pp -133.23 172.15 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.5 t -147.17 164.46 33.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.61 151.31 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.22 90.19 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.117 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.52 24.93 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -89.59 84.17 6.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 58.3 m -69.54 127.58 33.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.7 m -92.13 -59.0 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 1.3 p -118.68 149.54 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.185 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.549 ' CH2' HD13 ' A' ' 324' ' ' ILE . 2.1 p-90 -72.09 -39.01 69.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.549 HD13 ' CH2' ' A' ' 323' ' ' TRP . 27.4 mt -129.96 -53.52 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 324' ' ' ILE . 66.3 m-85 -34.9 133.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -116.18 101.4 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.47 101.8 1.44 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.453 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.5 m -121.84 165.96 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 57.8 m -86.24 134.16 33.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -111.34 166.93 12.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 125.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.325 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -132.39 122.91 25.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -52.6 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.519 179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.9 m 52.03 46.63 26.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -88.41 129.51 35.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.825 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -144.3 -40.92 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 52.0 m -46.73 -49.48 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.877 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -136.64 173.45 11.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.04 34.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -80.77 122.42 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -91.37 168.44 11.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.93 157.91 31.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.81 137.86 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -41.89 -58.63 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -65.22 -46.71 79.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 65.82 42.67 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -120.59 40.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.565 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 2.3 m80 -102.84 154.44 19.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -89.81 166.66 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -131.64 127.42 36.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.4 mt -130.18 149.83 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -108.77 136.83 47.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.16 129.14 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.17 -28.67 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -145.52 143.9 21.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 154.16 68.14 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.448 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.0 t80 -147.88 127.55 13.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -94.8 109.13 42.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 172.82 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -124.08 -13.14 7.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -163.4 -178.14 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.3 t70 -64.4 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -37.66 -40.31 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.29 173.09 6.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.99 145.36 51.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -63.84 146.13 54.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 309' ' ' LEU . 6.5 mt -117.27 121.37 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.64 134.33 23.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.713 . . . . 0.0 111.144 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 110.56 2.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.339 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.12 1.32 16.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -106.65 169.63 8.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -116.03 155.16 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.469 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 40.6 mm -133.49 123.15 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 20.1 m-85 -87.39 119.11 27.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -102.72 141.14 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.565 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 23.9 p -134.86 139.35 31.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.684 0.754 . . . . 0.0 110.846 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.04 35.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 2.237 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 39.7 mtp -86.4 2.49 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.566 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 80.7 mm-40 -131.38 12.97 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.24 88.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.6 p -110.26 123.51 49.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.1 m 54.27 25.61 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 28.2 p -88.56 -43.45 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 m -45.0 -34.04 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -65.12 -42.03 94.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 169.37 -23.58 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -79.93 -179.72 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.8 pt -155.93 128.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.5 t80 -89.75 113.43 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.469 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -137.03 176.37 20.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.2 m -128.4 126.3 40.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 43.7 t -62.13 155.99 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.902 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.6 tp -97.8 -33.55 11.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 99.2 m -75.05 -55.69 5.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 49.2 p -84.79 -39.57 18.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.02 10.33 62.75 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.467 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.05 153.41 26.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 59.9 p -122.5 140.7 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -176.76 179.15 47.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 309' ' ' LEU . 11.3 mt -89.23 139.42 30.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.464 ' CD1' HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -143.84 156.67 58.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.602 0.715 . . . . 0.0 110.923 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.513 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.75 121.08 7.78 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.352 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.68 -11.23 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.17 19.97 7.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.513 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -128.22 -3.03 5.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.465 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -127.07 -176.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 163.78 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 152.73 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.61 65.14 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.44 ' CG ' ' N ' ' A' ' 319' ' ' GLU . 3.9 p-10 -92.16 -54.0 4.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 320' ' ' CYS . 43.1 mp0 34.62 45.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 319' ' ' GLU . 5.6 t 34.26 51.04 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 322' ' ' THR . 2.9 m -82.41 -75.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.57 ' HB ' ' CD1' ' A' ' 325' ' ' PHE . 1.4 m -34.6 145.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.502 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.6 p-90 -63.03 -48.22 79.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.502 HG12 ' CE3' ' A' ' 323' ' ' TRP . 15.4 mm -135.0 94.26 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.57 ' CD1' ' HB ' ' A' ' 322' ' ' THR . 0.1 OUTLIER -164.23 163.35 22.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -144.44 169.96 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -166.78 37.17 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 37.6 m -44.15 130.2 6.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 13.8 m -63.2 -39.58 95.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -89.19 138.44 14.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -31.1 21.4 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.367 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 32.8 t -95.94 163.28 13.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.8 m -105.11 85.3 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.8 t -79.54 -46.12 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.4 t 45.64 41.62 7.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.04 1.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 80.8 p -99.04 126.06 44.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 92.5 p -80.46 132.5 35.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.13 127.1 5.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.5 t -70.61 164.15 25.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 151.3 49.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -134.07 104.3 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 mm -52.9 -48.8 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.495 ' CD ' ' O ' ' A' ' 252' ' ' ARG . 1.0 OUTLIER 44.97 31.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 55.25 45.78 25.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -166.12 174.78 8.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 43.62 38.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.57 ' CE1' ' HB2' ' A' ' 284' ' ' SER . 1.7 t60 -172.85 142.83 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.66 156.97 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -134.29 135.29 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.36 152.79 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -108.66 129.93 55.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.41 134.13 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -109.14 -17.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.6 m-85 -158.55 143.89 12.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.655 0.741 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 152.57 69.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 2.269 . . . . 0.0 112.368 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -144.47 138.54 27.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.9 m -106.74 107.75 60.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.553 0.692 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 169.46 18.89 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -123.2 -14.2 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.432 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 0.3 OUTLIER -154.71 179.48 9.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.84 -35.49 80.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -40.59 -43.82 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 13.6 pm0 -100.28 177.66 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.6 tp -136.54 147.71 47.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.429 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 19.8 tt0 -63.35 148.84 47.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 309' ' ' LEU . 11.3 mt -120.61 134.32 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.8 133.09 24.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.656 0.741 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 105.98 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.719 2.28 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.45 11.35 10.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -112.1 171.58 7.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -112.06 161.15 16.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 20.1 mm -140.08 123.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 41.2 m-85 -88.25 110.37 20.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.6 tmm? -98.88 132.24 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.57 ' HB2' ' CE1' ' A' ' 256' ' ' HIS . 1.3 t -126.06 144.15 47.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.752 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -31.61 20.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.714 2.276 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 28.7 mmm -76.33 4.27 9.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 19.5 mt-10 -133.13 18.41 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -77.74 82.39 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.462 ' N ' HG21 ' A' ' 291' ' ' THR . 40.5 p -103.11 134.92 45.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 41.79 25.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.462 HG21 ' N ' ' A' ' 289' ' ' THR . 32.2 p -85.68 -45.07 12.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 45.6 m -45.93 -31.89 2.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.45 -35.99 81.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.05 -25.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -79.98 -179.81 7.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.74 0.305 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.466 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.92 130.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 21.4 t80 -86.53 120.44 27.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -146.4 171.67 27.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.5 m -121.7 133.96 54.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 33.4 t -70.02 151.16 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.2 tp -96.08 -34.04 11.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -72.83 -43.06 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 68.8 p -96.78 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.13 8.68 14.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.3 m -83.95 155.23 22.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.6 p -124.12 132.92 53.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -170.5 -175.68 39.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.435 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.42 ' C ' HD21 ' A' ' 309' ' ' LEU . 18.3 mt -87.78 151.28 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.477 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -155.25 157.32 31.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 110.946 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.523 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 116.07 4.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 2.248 . . . . 0.0 112.336 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.66 -14.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -90.06 20.52 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.523 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.9 m-85 -129.08 2.68 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.466 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -132.62 175.43 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 12.8 t -149.64 154.38 38.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.2 OUTLIER -61.98 144.91 54.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.45 99.14 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.35 -43.99 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.438 ' OE2' ' N ' ' A' ' 320' ' ' CYS . 1.2 pp20? -53.77 -40.88 66.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.438 ' N ' ' OE2' ' A' ' 319' ' ' GLU . 4.7 t -44.13 161.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.7 m -135.77 -179.67 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 4.1 p -108.94 138.59 45.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.436 ' CD2' HG12 ' A' ' 324' ' ' ILE . 2.6 p-90 -67.17 -41.27 86.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 323' ' ' TRP . 16.9 mm -126.89 -51.14 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -41.49 156.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -117.63 -51.53 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 119.12 -106.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.464 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 11.3 m 41.33 53.43 3.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 3.6 m -95.74 140.8 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.826 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 168.37 -95.03 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.642 2.228 . . . . 0.0 112.378 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.2 m -80.5 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.3 p -42.32 141.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.816 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.499 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 23.1 t -87.31 103.1 15.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 m -146.0 137.02 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 123.19 -71.29 0.42 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 40.7 t -52.98 134.66 37.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 75.0 m -62.65 158.32 18.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -152.76 -145.07 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.8 t -79.04 131.09 36.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -64.1 123.8 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.23 139.03 57.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.02 128.4 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.447 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 8.8 tpt180 -94.96 35.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 0.8 OUTLIER 56.45 44.12 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -91.81 -175.42 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.62 76.32 2.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.533 ' CD2' ' OG ' ' A' ' 284' ' ' SER . 29.5 m80 -100.16 154.28 18.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.65 152.75 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -112.69 138.56 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.7 mt -135.54 150.93 49.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 17.3 tm0? -108.76 137.14 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 49.8 t -66.44 137.22 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 4.5 pt -116.97 -14.39 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 91.2 m-85 -162.03 142.63 7.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.743 0.782 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 154.39 67.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.481 ' CB ' ' CD1' ' A' ' 275' ' ' LEU . 25.8 t80 -137.31 156.57 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.8 m -124.15 97.3 40.68 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.558 0.694 . . . . 0.0 111.108 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 171.17 14.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.318 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -125.24 -14.8 6.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.75 -178.5 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 271' ' ' ASP . 6.6 m-20 -65.49 -36.77 84.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -36.52 -42.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -107.64 175.46 5.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -131.61 141.24 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.52 154.28 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.481 ' CD1' ' CB ' ' A' ' 265' ' ' TYR . 23.7 mt -121.63 124.78 45.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 261' ' ' VAL . 71.2 t -113.83 130.23 24.01 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.687 0.756 . . . . 0.0 111.104 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.42 6.75 19.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -111.9 171.52 7.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.22 164.86 12.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.459 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 12.1 mm -145.35 121.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -89.88 111.69 22.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.9 tmm? -99.52 136.14 39.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 256' ' ' HIS . 0.9 OUTLIER -128.43 136.98 29.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.669 0.747 . . . . 0.0 110.85 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -18.81 36.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 20.4 mmt -66.58 -37.54 85.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 4.9 mt-10 -120.21 44.94 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.488 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 3.7 pp0? -96.94 52.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 34.1 p -76.58 143.13 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 m 52.67 25.83 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.423 HG22 ' C ' ' A' ' 288' ' ' GLN . 44.2 p -95.94 -49.24 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.183 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 t -46.68 -25.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.52 -35.95 70.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.26 -22.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -86.31 178.96 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.97 122.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.431 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 19.5 t80 -78.81 110.09 13.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.18 175.78 19.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.4 m -126.47 127.48 45.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 36.4 t -66.1 153.03 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.2 tp -100.46 -43.17 6.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -62.79 -39.79 95.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 64.8 p -102.28 -55.3 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 112.94 1.57 25.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.2 t -71.84 166.18 22.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.6 m -137.9 143.81 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -174.81 47.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 12.1 mt -88.19 138.78 31.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.472 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.74 155.9 66.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.93 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.565 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.77 125.34 12.02 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.32 -8.2 5.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.25 23.39 7.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.565 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.6 m-85 -130.72 -3.92 4.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.0 -179.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 11.9 t -155.97 162.62 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.54 153.49 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -79.14 57.23 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.98 24.41 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -95.0 -43.06 8.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 62.2 m -88.74 155.93 19.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 24.3 p -110.96 166.17 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -111.26 149.55 30.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.554 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.9 p-90 -41.27 -43.37 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.554 HG12 ' CE3' ' A' ' 323' ' ' TRP . 10.6 mm -125.58 -64.92 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 324' ' ' ILE . 85.7 m-85 -34.24 140.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -113.52 -46.44 3.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 111.34 -125.46 7.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.2 t -165.75 127.11 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 11.6 t 56.45 46.28 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -100.03 -162.0 28.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.9 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 331' ' ' PRO . 29.2 t -34.75 115.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.1 m -100.97 120.03 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.48 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 24.7 m -78.66 134.6 37.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.818 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.1 p 40.2 42.14 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -132.01 -137.25 3.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.492 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -64.02 124.19 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 247' ' ' GLY . 89.1 p -136.89 118.59 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 246' ' ' SER . . . 36.85 72.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 p -107.44 127.76 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -71.08 112.21 7.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -100.92 145.42 28.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.24 121.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -123.76 -51.34 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.41 37.37 4.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -107.52 177.29 4.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -57.09 -58.25 9.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.566 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 33.8 m80 -38.52 131.43 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.459 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 19.3 pt-20 -100.03 151.54 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.0 m -109.05 130.38 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.143 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.7 mt -131.67 149.31 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 0.7 OUTLIER -108.63 132.42 53.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 54.6 t -64.74 132.3 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.6 -20.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -152.0 144.24 16.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.667 0.746 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.84 69.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -142.09 132.7 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.7 m -103.89 102.55 32.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.098 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 171.18 14.96 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -125.25 -15.15 6.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -152.29 -175.99 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.4 t70 -71.9 -37.64 70.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.4 OUTLIER -35.57 -39.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 pm0 -107.9 179.57 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 9.3 tp -133.92 145.48 49.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.53 141.52 58.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 11.1 mt -114.98 130.7 56.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.52 135.1 25.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.623 0.725 . . . . 0.0 111.124 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.05 4.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.22 1.08 29.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.39 175.95 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -115.34 165.4 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.47 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 25.8 mm -141.46 127.6 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.01 109.51 21.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.0 tmm? -99.93 133.27 44.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.566 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 8.9 t -132.04 137.48 30.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.758 . . . . 0.0 110.815 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.3 mmt -88.27 -11.69 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 1.8 pt-20 -129.55 26.57 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -85.59 84.76 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 20.1 p -100.43 118.32 36.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 20.6 m 62.06 25.07 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 294' ' ' GLY . 35.9 p -86.35 -53.35 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 291' ' ' THR . 65.6 m -37.85 -32.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 4.8 tp10 -66.32 -47.12 74.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 179.05 -28.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -79.89 -179.79 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.302 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.463 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.2 pt -158.99 125.33 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 23.2 t80 -80.13 114.31 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -135.21 162.83 24.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 17.1 m -114.03 132.73 55.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 31.0 t -67.96 148.42 51.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.7 -31.02 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -78.09 -48.85 15.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 75.5 p -91.48 -42.46 10.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.48 4.72 57.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 87.1 m -73.55 168.84 18.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 110.844 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 10.5 m -138.63 139.22 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.68 -176.7 47.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.13 148.25 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.476 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -150.54 155.6 36.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.602 0.715 . . . . 0.0 110.927 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.1 Cg_endo -69.77 125.49 12.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.68 -8.76 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 312' ' ' ASN . 28.9 t-20 -96.14 22.01 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.1 m-85 -130.32 -3.27 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.463 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -129.85 175.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 159.19 40.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.69 155.52 2.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -74.92 97.23 3.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.75 -34.43 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -42.65 -36.57 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 14.1 p -149.49 164.36 35.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' THR . 4.2 m -138.2 -176.71 4.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 321' ' ' SER . 0.4 OUTLIER -34.02 140.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.561 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.5 p-90 -41.24 -42.32 2.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.561 HG12 ' CE3' ' A' ' 323' ' ' TRP . 10.7 mm -119.54 -70.24 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.459 ' C ' ' O ' ' A' ' 324' ' ' ILE . 94.8 m-85 -33.76 119.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -110.26 -38.37 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.65 28.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.439 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 22.7 t -84.66 119.17 24.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 46.6 t -60.6 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -145.33 156.99 27.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 157.55 60.1 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 92.9 p -51.31 114.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.0 m 56.22 43.16 27.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.534 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 59.5 p -124.02 -45.72 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.834 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.7 p -69.16 157.7 36.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -167.33 106.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 t -98.4 149.62 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.7 p -169.15 177.56 4.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.4 11.6 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 53.2 m -38.55 107.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 110.836 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.441 ' HG2' ' CD1' ' A' ' 251' ' ' ILE . 15.2 ttm180 -98.77 -35.39 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 57.62 52.69 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 249' ' ' ARG . 11.0 mm -82.13 -35.94 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.437 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 2.3 tpt180 39.2 35.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 1.2 m-85 57.76 54.13 6.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.64 -178.95 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.27 89.56 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.565 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 14.9 m80 -109.93 135.14 51.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.47 160.36 30.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.6 m -122.76 131.52 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 12.6 mt -133.95 150.63 51.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -108.71 134.25 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.03 135.29 28.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -113.03 -12.5 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 92.3 m-85 -161.31 142.86 8.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.657 0.741 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.48 68.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 0.0 112.318 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.538 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.7 t80 -147.57 126.18 12.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.1 m -96.96 108.3 42.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.571 0.7 . . . . 0.0 111.125 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.409 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 54.0 Cg_endo -69.75 166.69 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -115.93 -21.3 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -153.72 -177.43 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 271' ' ' ASP . 25.6 t0 -65.33 -37.25 86.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.7 OUTLIER -37.83 -40.69 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.409 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.4 pm0 -105.83 175.34 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.9 tp -129.9 147.3 51.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.52 145.67 54.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.865 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 309' ' ' LEU . 10.4 mt -116.06 132.58 56.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.25 129.77 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.688 0.756 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.71 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.49 10.6 9.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -113.26 178.21 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.42 159.88 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.415 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 12.1 mm -135.25 138.0 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' HD13 ' A' ' 301' ' ' LEU . 31.3 m-85 -101.73 113.36 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.5 tmm? -99.04 140.55 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.565 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 6.0 t -133.81 141.78 41.16 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.893 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -37.42 9.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 36.8 mtp -74.14 1.34 11.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 37.8 mm-40 -128.36 17.15 6.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -77.98 86.14 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 29.9 p -105.17 126.8 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.9 m 48.47 29.46 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 17.3 p -89.49 -50.0 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 59.1 p -39.9 -38.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.47 -46.36 89.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 175.03 -25.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -80.58 -179.84 7.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.1 pt -156.52 125.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.553 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 38.5 t80 -80.13 111.2 16.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.56 169.33 22.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 91.4 m -124.8 116.36 22.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.155 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.9 t -54.48 153.43 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.402 HD13 ' CE2' ' A' ' 282' ' ' PHE . 10.9 tp -96.81 -50.7 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 16.0 m -53.46 -52.79 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.4 p -87.22 -53.45 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.8 4.54 31.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.426 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 9.3 t -77.72 166.72 22.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 84.1 p -134.85 147.91 50.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 174.84 -176.84 47.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 309' ' ' LEU . 12.3 mt -88.98 137.57 32.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.83 156.01 65.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.943 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 124.4 11.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.61 -8.81 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -95.62 21.93 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.538 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.6 m-85 -129.07 -1.5 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.85 -177.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.5 t -158.43 162.65 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.471 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -62.47 143.49 57.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.51 94.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -100.54 -45.3 5.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 319' ' ' GLU . 13.2 pt-20 -94.0 100.28 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 48.3 m -110.93 -48.72 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.3 p -54.21 -59.17 5.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.86 145.18 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.154 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.52 ' CD2' HG13 ' A' ' 324' ' ' ILE . 2.4 p-90 -47.58 -38.47 14.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.52 HG13 ' CD2' ' A' ' 323' ' ' TRP . 8.2 mt -121.92 -67.12 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.146 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 324' ' ' ILE . 83.3 m-85 -36.67 148.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.13 163.58 13.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -106.96 50.03 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 26.3 m -87.88 114.22 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.844 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 4.3 t -70.02 -56.86 5.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 143.95 72.6 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.95 15.09 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.0 t -75.2 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.9 m -44.94 142.32 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 243' ' ' SER . 51.0 m -130.55 112.96 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 242' ' ' SER . 77.3 p -36.39 103.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -98.13 125.23 8.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.5 p -49.76 140.4 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.5 m -90.53 147.05 23.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 141.13 116.52 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.498 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.5 p -131.36 -175.82 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -77.87 149.35 34.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.58 92.7 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 4.4 mp -40.86 120.72 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -99.43 52.62 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 54.23 44.86 28.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 255' ' ' ASN . . . -89.18 -178.65 5.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 256' ' ' HIS . 67.9 m-80 -36.44 -48.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.457 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 31.1 m80 -35.36 140.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -113.6 163.22 15.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.73 138.66 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.181 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.8 mt -135.56 149.53 49.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.915 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -109.16 131.5 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 80.6 t -66.02 128.39 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -103.89 -21.71 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -150.94 143.61 16.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.675 0.75 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.36 68.08 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.569 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 34.6 t80 -147.5 123.92 10.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.3 m -93.37 106.25 19.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.577 0.703 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.416 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.3 Cg_endo -69.75 171.6 14.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.624 2.216 . . . . 0.0 112.421 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.58 -14.94 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -158.9 -179.26 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 271' ' ' ASP . 38.7 t0 -64.77 -37.92 89.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -36.38 -39.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.9 pm0 -109.39 171.83 7.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 3.3 tp -125.73 142.38 51.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -64.44 135.59 56.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.7 mt -106.05 128.32 53.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.31 130.76 24.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.65 0.738 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 112.73 3.15 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.651 2.234 . . . . 0.0 112.368 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.88 1.29 22.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.53 175.84 5.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -114.91 165.07 13.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.448 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 26.5 mm -143.34 140.85 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -109.16 116.04 31.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -101.76 136.93 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 13.4 p -125.55 138.68 32.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 0.0 110.883 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.491 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.78 -21.68 33.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 49.9 mmm -77.16 -24.15 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -118.03 29.51 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 15.1 pt20 -88.41 60.3 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 t -86.83 141.23 28.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.5 m 50.6 24.92 1.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 36.6 p -94.54 -41.55 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.18 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.6 m -51.41 -26.64 8.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.1 -30.99 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -81.21 179.51 7.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 314' ' ' ILE . 2.1 pt -160.02 119.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.83 111.44 10.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.4 167.41 23.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.522 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 61.5 m -121.32 126.91 50.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 111.143 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.6 t -66.01 153.58 41.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.1 tp -92.75 -48.71 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -58.84 -57.68 11.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.7 p -78.61 -50.11 12.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.78 46.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.9 t -84.3 166.81 17.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 78.5 p -129.53 145.89 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.31 179.38 46.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.9 144.24 26.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.469 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -147.37 155.36 46.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.595 0.712 . . . . 0.0 110.897 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.78 128.73 16.43 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.22 -6.19 6.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -99.23 21.39 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.569 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 9.2 m-85 -129.73 -1.79 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.461 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -134.53 177.02 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.8 t -153.68 164.74 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -64.49 144.87 56.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.6 92.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.34 -34.87 16.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -45.34 -56.9 4.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 28.3 p -80.56 173.96 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.5 m -61.28 174.04 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 13.3 p -59.04 158.72 8.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.522 ' CZ2' HD13 ' A' ' 324' ' ' ILE . 2.1 p-90 -83.33 -39.4 20.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.522 HD13 ' CZ2' ' A' ' 323' ' ' TRP . 21.8 mt -128.88 -49.45 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 324' ' ' ILE . 29.0 m-85 -34.61 135.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -121.8 156.3 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.88 -68.42 1.66 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 14.7 t -133.74 134.26 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.835 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 4.2 m -87.49 163.89 16.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -100.99 141.86 15.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.99 19.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.27 . . . . 0.0 112.377 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 52.4 m -76.98 -43.31 35.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.8 m -57.06 100.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.464 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.1 t -166.67 153.47 8.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.852 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.1 m -92.2 119.6 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -59.22 179.1 1.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.511 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 55.0 m -49.56 156.07 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.7 m -83.68 113.04 20.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -66.96 84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 99.8 p -120.05 141.17 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.24 131.48 48.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -103.6 170.96 7.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.5 mt -87.59 122.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.424 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -89.7 32.38 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 71.2 39.98 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.03 -178.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 256' ' ' HIS . 4.5 m120 -43.94 -43.58 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.489 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 31.7 m80 -35.82 131.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -90.26 167.14 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.92 130.34 41.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 12.6 mt -130.99 150.18 52.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 22.4 tm0? -108.69 133.01 53.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 65.9 t -64.43 133.92 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.4 pt -111.06 -19.59 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -152.97 141.71 14.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 148.55 65.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.497 ' CB ' ' CD1' ' A' ' 275' ' ' LEU . 29.3 t80 -133.93 157.15 46.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.418 ' N ' ' CG ' ' A' ' 265' ' ' TYR . 6.4 m -126.28 101.05 28.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 169.73 18.17 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.382 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -124.57 -14.68 6.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -152.82 -175.57 5.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -28.9 61.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -42.97 7.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -101.45 178.8 4.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 6.9 tp -132.96 143.68 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.14 147.31 53.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.497 ' CD1' ' CB ' ' A' ' 265' ' ' TYR . 17.5 mt -115.9 124.67 51.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.4 t -115.61 130.59 24.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.634 0.731 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 111.43 2.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.63 2.64 19.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -111.19 175.16 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -115.38 164.63 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.45 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 34.9 mm -138.77 121.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -85.71 115.73 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -99.47 130.18 45.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 1.6 p -126.1 142.85 43.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -30.26 22.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.692 2.262 . . . . 0.0 112.364 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 65.2 mtp -76.6 -3.44 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.562 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 20.2 mm-40 -122.28 5.28 9.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.38 92.54 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 40.6 p -115.19 123.79 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.7 m 50.83 29.09 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 294' ' ' GLY . 16.7 p -86.52 -55.51 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 291' ' ' THR . 31.3 t -34.41 -37.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.27 -49.03 79.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.15 -26.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -79.87 -179.77 7.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.6 pt -158.38 119.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 19.9 t80 -78.44 112.77 15.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.46 175.25 21.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 57.0 m -125.33 133.26 52.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.3 t -71.14 150.62 45.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 13.9 tp -95.49 -40.29 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 93.3 m -69.88 -44.95 68.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -91.88 -53.06 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 105.58 8.73 34.55 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 8.9 t -78.34 166.55 22.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 54.0 p -139.17 133.88 32.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.2 -175.11 45.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.72 140.1 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.76 156.05 62.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 122.88 9.55 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.43 -10.4 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -94.6 22.77 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.516 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.9 m-85 -129.87 -2.83 4.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.14 -179.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.2 t -157.38 167.77 29.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 142.13 55.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -63.91 -44.1 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -48.75 101.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.4 t 69.98 42.46 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 8.2 t -85.0 124.01 31.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 22.1 p -95.32 -175.67 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.133 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.565 ' CZ2' HD11 ' A' ' 324' ' ' ILE . 2.4 p-90 -130.49 -33.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.565 HD11 ' CZ2' ' A' ' 323' ' ' TRP . 59.5 mt -128.16 -44.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -47.39 144.28 3.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -120.17 131.8 55.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.39 82.86 1.65 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 60.3 p -89.42 116.31 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.366 . . . . 0.0 110.851 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 40.6 m -118.67 170.99 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.09 163.36 24.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.6 Cg_endo -69.74 -30.39 22.46 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.722 2.282 . . . . 0.0 112.31 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 331' ' ' PRO . 9.9 t -37.57 102.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 68.9 m -86.65 42.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.863 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 29.7 t -87.19 149.32 24.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -61.86 110.31 1.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 115.54 45.79 0.6 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.1 p -142.24 159.42 42.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.5 t -151.39 116.5 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 141.32 55.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -126.15 89.19 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 57.4 46.83 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.21 92.0 7.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . 0.518 HD11 ' CE1' ' A' ' 282' ' ' PHE . 14.1 mt -94.93 116.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -84.6 29.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 60.43 45.28 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.13 7.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -122.71 -44.16 2.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 6.2 m80 -90.97 142.67 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -92.36 166.75 12.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.5 m -129.3 129.83 45.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.9 mt -130.41 150.66 51.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -110.19 128.35 55.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.4 133.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.36 -21.12 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -152.24 144.09 16.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.67 68.68 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.49 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 29.3 t80 -147.8 127.08 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.8 m -95.84 108.22 39.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 111.162 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.402 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.9 Cg_endo -69.73 172.04 13.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.234 . . . . 0.0 112.354 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -123.3 -13.38 7.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -162.44 -179.15 6.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.6 p-10 -63.63 -37.45 87.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.5 OUTLIER -37.3 -41.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.0 pm0 -107.63 174.62 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.453 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 4.5 tp -128.32 144.93 51.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.58 128.93 38.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 309' ' ' LEU . 7.7 mt -97.18 129.45 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.55 130.57 24.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.624 0.726 . . . . 0.0 111.134 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 103.74 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.34 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.47 5.37 7.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -111.29 169.97 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -113.32 145.44 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 300' ' ' SER . 32.1 mm -124.21 120.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.518 ' CE1' HD11 ' A' ' 251' ' ' ILE . 17.9 m-85 -83.33 119.29 24.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -99.66 137.85 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.566 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 12.8 p -138.97 120.12 9.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.82 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 0.51 5.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -94.85 -24.12 17.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.538 ' O ' ' CD1' ' A' ' 297' ' ' TYR . 16.9 mm-40 -122.06 41.41 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 143.11 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 24.9 p -147.79 116.51 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 23.4 m 64.4 25.4 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 294' ' ' GLY . 28.1 p -83.02 -52.3 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 291' ' ' THR . 12.5 m -36.66 -41.51 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -56.88 -45.37 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 172.53 -23.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -79.88 -179.9 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.736 0.303 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.36 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 287' ' ' GLU . 40.4 t80 -94.3 108.45 20.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -132.85 -177.29 14.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.0 m -132.48 126.29 32.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 281' ' ' ILE . 1.0 OUTLIER -62.6 166.32 5.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.438 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 12.7 tp -107.08 -30.32 8.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -75.63 -54.17 7.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 9.3 p -90.28 -34.46 15.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.76 62.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.453 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 61.9 m -86.65 145.9 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.4 p -114.1 132.7 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.97 179.22 42.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -89.5 142.64 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.466 ' CD1' HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -146.77 156.42 48.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.514 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 120.89 7.6 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.718 2.279 . . . . 0.0 112.364 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.37 -11.57 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -92.86 19.9 7.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.514 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.8 m-85 -128.24 -1.6 5.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.44 174.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 5.6 t -146.84 159.49 43.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 3.5 mptt -64.74 143.82 57.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.2 95.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.22 -43.62 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.65 -17.26 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 153.35 41.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 47.9 t -88.34 84.9 6.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 325' ' ' PHE . 8.2 p -51.75 127.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.504 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.2 p-90 -69.5 -32.23 70.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.504 HG12 ' CD2' ' A' ' 323' ' ' TRP . 20.8 mm -133.84 -54.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.45 ' HB2' ' CG2' ' A' ' 322' ' ' THR . 85.4 m-85 -35.18 135.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -85.22 84.09 7.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -143.75 33.29 1.77 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 92.2 p -40.21 131.27 2.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.837 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 2.5 t -81.67 -179.63 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.85 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.48 85.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -25.99 27.98 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 98.2 p -114.08 130.03 56.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.3 t -142.01 127.66 19.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.555 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 66.1 m -90.13 91.87 8.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.3 t -52.96 121.73 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.838 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 106.62 -112.5 3.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 57.7 m -150.73 160.15 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 110.85 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.2 t -69.52 86.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 134.81 148.74 5.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.5 m -85.54 90.46 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -51.89 -29.85 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.77 147.81 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.22 117.78 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -120.78 -49.19 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -75.36 -45.0 42.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.11 172.13 11.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.76 94.63 3.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.567 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 20.9 m80 -99.55 136.13 39.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.15 168.65 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.9 m -131.21 129.49 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.5 mt -130.21 149.43 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -108.84 124.76 51.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.33 131.32 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -106.93 -12.08 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 75.3 m-85 -161.55 143.45 8.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.68 0.753 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.12 11.46 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.457 ' CD2' HD21 ' A' ' 275' ' ' LEU . 3.1 t80 -171.77 118.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.2 m -83.75 113.4 47.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.579 0.704 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 171.95 13.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.395 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -119.89 -13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.405 ' OD1' ' CD ' ' A' ' 272' ' ' GLU . 2.5 p30 -167.63 -178.26 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.38 -29.67 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -45.33 -42.08 9.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.405 ' CD ' ' OD1' ' A' ' 269' ' ' ASN . 11.7 pm0 -106.82 177.28 4.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 12.7 tp -130.45 147.5 52.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.67 151.87 46.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 275' ' ' LEU . 3.7 mm? -115.87 128.75 56.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.87 127.15 26.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.606 0.717 . . . . 0.0 111.139 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 104.55 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.65 2.233 . . . . 0.0 112.309 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.07 11.19 8.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -114.64 174.67 5.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -115.41 165.22 13.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 15.1 mm -143.82 128.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -93.02 116.91 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -101.76 134.82 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.567 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 0.7 OUTLIER -125.66 141.46 39.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.684 0.754 . . . . 0.0 110.799 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.83 19.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 8.7 mtp -77.47 -2.07 33.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.557 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 12.4 mt-10 -121.77 8.09 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -67.98 85.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 p -109.05 121.81 45.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.3 m 55.26 26.0 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.402 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 32.9 p -86.97 -44.15 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.2 t -43.15 -40.73 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.97 -40.43 80.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.81 -21.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -80.01 -179.78 7.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.404 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.6 pt -156.74 122.04 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 36.5 t80 -84.59 111.71 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -137.19 -172.9 12.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 65.5 m -138.01 124.1 20.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.17 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.1 t -62.21 168.89 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.17 -41.07 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -67.23 -65.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.3 p -75.12 -31.92 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.03 63.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.496 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.68 152.59 18.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 33.5 p -121.34 136.85 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.1 -179.46 47.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 309' ' ' LEU . 10.8 mt -87.93 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.76 156.68 65.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.603 0.716 . . . . 0.0 110.927 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.522 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 0.0 112.347 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -54.5 -14.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.26 19.14 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.522 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.68 -0.19 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -131.82 178.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.2 t -148.74 157.95 43.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -65.67 151.46 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.47 97.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -120.59 -53.75 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -54.16 -45.13 71.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.5 p -51.87 176.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.934 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 98.2 p -102.91 138.14 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 19.2 p -67.0 -179.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.55 ' CE3' HG12 ' A' ' 324' ' ' ILE . 6.1 p-90 -112.17 -40.39 4.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.55 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.8 mm -127.51 -34.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -45.39 142.73 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -116.98 150.5 38.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -126.26 -42.14 0.31 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 52.8 m -67.23 139.41 57.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 56.9 p -55.17 172.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 165.84 177.45 38.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.32 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.378 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m 37.6 42.19 0.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 334' ' ' GLY . 5.4 t -68.65 107.39 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 333' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.6 t -74.64 88.75 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 95.41 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 170.18 50.23 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.517 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.2 t -116.47 104.3 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 0.0 110.837 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.6 t -78.93 89.9 4.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 41.51 58.91 2.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 51.0 p -152.01 131.15 12.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.83 0.348 . . . . 0.0 110.839 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 5.3 ttp85 74.96 29.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -100.77 135.55 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.77 -41.32 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . 0.416 ' CD ' ' O ' ' A' ' 252' ' ' ARG . 1.5 tmt_? 45.65 34.78 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 1.5 m-85 58.12 47.23 14.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -88.31 -70.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -128.87 -38.58 1.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 8.2 m80 -70.36 139.43 51.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -77.53 151.89 34.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.61 132.04 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.2 mt -135.03 150.97 50.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -108.74 131.74 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.52 126.48 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 2.2 pt -102.56 -18.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 70.1 m-85 -158.24 144.06 12.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 158.31 57.37 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.722 2.281 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -150.54 133.07 15.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.6 m -102.46 106.94 51.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.621 0.724 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.432 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.7 Cg_endo -69.75 170.89 15.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.725 2.283 . . . . 0.0 112.345 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.87 -15.37 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -150.66 -175.71 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.58 -40.76 69.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -38.59 -42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.3 pm0 -99.75 171.06 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 5.8 tp -131.9 150.96 52.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.412 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 35.3 tt0 -68.81 150.67 47.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.464 HD23 ' CD1' ' A' ' 309' ' ' LEU . 10.9 mt -119.71 130.83 55.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.38 129.26 25.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.32 3.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.83 0.31 22.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -108.67 166.23 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.468 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 21.1 mm -142.35 124.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 22.7 m-85 -90.68 114.78 27.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.4 tmm? -100.3 141.61 32.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.568 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 1.1 t -141.27 138.72 17.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.664 0.745 . . . . 0.0 110.866 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.439 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.4 Cg_endo -69.78 -18.47 36.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 0.0 112.331 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 11.2 mtp -64.11 -31.61 72.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -123.0 41.74 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 8.3 pt20 -91.38 66.95 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.3 t -93.65 142.27 27.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.1 m 45.48 25.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 294' ' ' GLY . 40.5 p -91.53 -58.32 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 291' ' ' THR . 26.8 m -36.2 -38.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.59 -46.69 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.52 -26.88 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -83.17 -179.98 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.752 0.31 . . . . 0.0 110.892 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.461 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.33 136.53 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.493 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 38.6 t80 -89.48 111.72 22.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.46 167.66 22.98 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 92.6 m -126.14 116.49 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.2 t -55.28 147.66 16.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.575 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -89.24 -43.04 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.1 m -65.25 -60.95 2.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 30.4 p -75.2 -50.35 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.99 9.58 42.17 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.01 153.37 23.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.7 p -125.0 137.96 54.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -175.46 -173.42 41.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.422 ' C ' HD21 ' A' ' 309' ' ' LEU . 20.5 mt -90.99 140.86 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 0.0 110.867 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.464 ' CD1' HD23 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -144.15 156.02 58.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 110.883 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.528 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.72 117.61 5.18 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.0 -14.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -90.44 21.21 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.528 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.18 -5.51 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.461 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -125.93 169.69 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.7 t -150.24 167.49 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.42 143.76 44.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.89 96.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.63 -33.91 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.34 72.04 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.49 -65.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 68.8 m -69.28 101.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.59 143.94 44.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.502 ' CD2' HG13 ' A' ' 324' ' ' ILE . 2.1 p-90 -46.74 -33.96 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.502 HG13 ' CD2' ' A' ' 323' ' ' TRP . 21.9 mt -121.81 -72.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.452 ' C ' ' O ' ' A' ' 324' ' ' ILE . 82.3 m-85 -33.99 123.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -96.73 138.17 34.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.05 160.0 17.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 2.3 t -123.18 145.29 48.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 18.6 t -159.11 132.26 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -173.79 -158.71 18.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 119.05 6.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 17.6 m -132.04 134.86 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.2 p -82.91 152.38 25.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.487 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.6 m 41.63 42.03 1.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.9 m -97.04 -43.99 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 125.64 -162.81 19.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.523 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' SER . 12.2 m -125.8 94.92 4.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.861 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' SER . 46.0 m -36.7 -48.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.69 143.45 6.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.8 p -130.14 -44.05 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -97.17 -31.53 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.64 111.68 21.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.6 mt -85.41 110.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -125.59 -47.48 1.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -114.96 40.33 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -134.22 153.45 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.0 82.32 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.565 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 39.1 m80 -111.44 132.16 54.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.12 168.03 11.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.455 ' O ' ' CB ' ' A' ' 317' ' ' ALA . 1.7 m -129.2 127.24 40.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.2 mt -127.54 150.03 49.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.11 127.21 53.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.89 138.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.468 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -114.89 -14.93 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 81.7 m-85 -159.2 146.7 13.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.686 0.755 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 165.34 31.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.556 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 44.2 t80 -160.75 123.4 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.8 m -90.29 110.07 38.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.584 0.706 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 52.9 Cg_endo -69.84 171.13 15.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.681 2.254 . . . . 0.0 112.269 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -119.7 -14.38 9.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -167.26 -178.67 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.43 -34.9 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -38.87 -44.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.435 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 2.6 pm0 -105.32 177.38 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.504 ' O ' ' CD2' ' A' ' 275' ' ' LEU . 4.0 tp -132.72 142.38 49.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.67 150.82 18.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.504 ' CD2' ' O ' ' A' ' 273' ' ' LEU . 1.8 mm? -114.45 127.33 55.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.61 123.44 29.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 103.97 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.92 12.76 7.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.469 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -115.31 178.64 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -116.54 160.5 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.473 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 18.2 mm -138.98 133.28 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.57 ' CE2' HD11 ' A' ' 301' ' ' LEU . 25.8 m-85 -96.02 110.55 22.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -101.34 134.11 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.565 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 22.1 t -137.6 140.83 31.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.651 0.738 . . . . 0.0 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.434 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.73 -26.01 28.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -61.26 -33.61 73.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -117.45 41.39 2.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 288' ' ' GLN . 11.5 pt20 -96.08 95.91 8.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.6 p -115.11 137.31 52.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 9.5 m 48.49 25.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 43.5 p -88.53 -38.47 14.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.0 t -55.4 -24.84 32.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.94 -29.64 63.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 156.48 -18.57 0.44 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -86.99 179.6 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.3 pt -158.14 124.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -80.19 111.15 16.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.84 175.09 19.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 70.3 m -131.7 132.46 43.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.2 t -65.58 150.56 48.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 282' ' ' PHE . 13.6 tp -95.4 -35.42 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 48.4 m -77.18 -49.91 14.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 82.1 p -84.12 -52.46 6.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.05 3.16 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.462 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.43 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 82.9 m -77.44 147.89 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 89.6 p -120.73 140.37 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.28 -177.25 46.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.18 149.56 23.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.927 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -153.06 155.54 32.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.553 0.692 . . . . 0.0 110.961 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.7 126.84 13.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.692 2.261 . . . . 0.0 112.369 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.22 -7.27 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -97.62 21.63 10.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.7 m-85 -129.35 -3.88 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.28 177.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.6 t -149.77 156.69 42.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -59.24 137.57 57.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 258' ' ' THR . . . -52.4 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -41.22 10.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.96 91.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 91.2 m -135.89 172.25 13.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 18.3 m -50.62 179.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.83 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.9 147.46 27.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.154 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.505 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.2 p-90 -40.25 -35.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.505 HG12 ' CD2' ' A' ' 323' ' ' TRP . 11.2 mm -132.26 -67.44 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 324' ' ' ILE . 87.9 m-85 -34.06 136.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.08 -53.42 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 117.61 73.5 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 40.0 p -173.7 148.83 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 39.7 m 58.52 41.32 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 156.85 70.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.523 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 100.88 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.7 t -57.95 149.48 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.8 m -86.81 -58.82 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.419 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.2 m -132.12 -47.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 m -81.34 162.85 23.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 144.81 85.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.8 t -150.99 173.11 14.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.6 t -109.17 147.94 31.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.87 110.6 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.507 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 p -80.39 -59.59 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 249' ' ' ARG . 13.8 mtp-105 -77.25 119.57 21.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -106.36 123.89 48.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.27 115.65 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -123.66 -63.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -104.91 44.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -106.83 174.87 5.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -72.9 -48.98 32.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.558 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 17.7 m80 -37.91 134.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -87.5 160.92 18.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 317' ' ' ALA . 5.6 m -123.54 125.24 44.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.8 mt -125.99 149.82 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -108.83 130.8 55.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.92 144.2 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -121.61 -14.6 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 71.4 m-85 -161.5 145.71 9.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.654 0.74 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 163.8 36.9 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.495 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 50.8 t80 -160.81 128.3 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.8 m -97.78 108.92 48.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.565 0.698 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.419 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.81 165.15 31.99 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.342 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -113.68 -21.9 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -154.02 -179.16 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.6 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -39.24 -45.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.8 pm0 -105.21 178.96 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.447 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.7 tp -132.24 151.94 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 31.3 tt0 -64.9 155.85 32.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' A' ' 275' ' ' LEU . 1.3 mm? -121.31 131.54 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.91 126.26 25.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.666 0.746 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.01 2.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.649 2.233 . . . . 0.0 112.358 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.69 9.66 20.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -112.85 178.69 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -117.16 169.49 9.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.461 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 17.3 mm -146.14 125.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' A' ' 301' ' ' LEU . 24.7 m-85 -91.77 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -99.23 135.57 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 30.6 t -128.56 142.41 44.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.717 0.77 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -30.83 21.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.258 . . . . 0.0 112.345 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 47.7 mtp -77.26 4.39 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.566 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 66.9 mm-40 -127.41 -0.54 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -58.8 85.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -109.32 107.92 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.0 m 66.82 28.02 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.9 p -88.24 -48.01 8.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.155 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 81.1 p -39.8 -39.57 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.18 -44.95 92.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 171.63 -23.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -79.73 -179.85 7.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.754 0.312 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.8 pt -157.93 121.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 32.0 t80 -79.92 113.7 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.77 175.52 20.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 13.8 m -125.18 131.92 53.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.31 . . . . 0.0 111.133 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.4 t -66.1 148.74 51.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 282' ' ' PHE . 12.3 tp -97.17 -37.18 10.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.8 m -73.55 -44.78 56.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -94.07 -46.47 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.86 3.36 49.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.551 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.65 176.9 4.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 6.7 m -149.07 140.26 23.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.19 48.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.98 136.2 33.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -138.77 153.44 72.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 0.0 110.908 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.533 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.4 Cg_endo -69.85 123.9 10.52 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.339 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.73 -11.14 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -92.49 19.36 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.533 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 8.1 m-85 -128.91 -2.5 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -134.06 177.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.9 t -153.05 159.49 42.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -55.16 148.2 14.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 258' ' ' THR . . . -61.79 94.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.104 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.52 -40.55 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.29 103.02 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 7.7 m -153.19 161.52 42.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 35.1 m -90.03 -179.26 5.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 325' ' ' PHE . 1.7 p -53.33 144.13 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.177 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.559 ' CH2' HD13 ' A' ' 324' ' ' ILE . 2.0 p-90 -75.14 -39.73 60.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.559 HD13 ' CH2' ' A' ' 323' ' ' TRP . 17.2 mt -127.21 -52.99 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.45 ' HB2' ' CG2' ' A' ' 322' ' ' THR . 96.5 m-85 -34.8 130.46 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -109.15 97.13 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 140.23 118.31 1.51 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 97.2 p -111.59 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.878 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 20.1 m -117.73 128.14 54.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 95.35 146.79 21.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 334' ' ' GLY . 53.8 Cg_endo -69.77 -2.08 9.58 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 331' ' ' PRO . 1.7 t -35.85 132.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.7 p 43.94 35.84 1.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 331' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 60.9 p -150.38 138.57 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.0 p -80.07 -45.74 17.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -141.27 137.75 8.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.528 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 50.2 m -113.41 -57.59 2.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.4 m -113.15 88.49 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 155.11 -51.8 0.45 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -47.23 123.32 5.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -140.8 141.89 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -163.7 169.74 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.52 122.29 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -81.47 41.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 59.79 40.59 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.52 -179.52 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -82.41 44.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.56 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 11.2 m80 -76.2 142.6 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -89.93 157.34 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.0 m -121.96 130.55 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 11.6 mt -128.3 150.21 50.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -108.57 131.09 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.18 133.17 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -103.48 -28.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -145.01 144.95 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 151.91 69.46 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.475 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 24.3 t80 -148.49 120.35 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.9 m -91.3 107.4 21.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.49 16.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -120.41 -14.66 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -157.81 176.63 12.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 271' ' ' ASP . 12.3 p-10 -62.92 -39.72 95.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.1 -39.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -105.82 175.14 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.435 ' CD1' ' SG ' ' A' ' 305' ' ' CYS . 5.5 tp -125.67 143.97 50.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.19 130.27 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.2 mt -101.89 131.96 47.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.79 132.87 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.713 . . . . 0.0 111.124 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 103.45 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.311 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.56 14.51 6.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -116.73 177.99 4.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -120.48 161.36 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.472 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 38.6 mm -142.51 139.39 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.3 m-85 -101.17 113.53 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -100.26 133.69 44.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.56 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 1.0 OUTLIER -133.76 136.94 27.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 0.0 110.869 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 54.0 Cg_endo -69.78 -20.36 34.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.29 -32.28 73.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -119.29 42.73 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 12.3 pt20 -94.21 81.78 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 291' ' ' THR . 35.9 p -94.83 137.5 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.7 m 39.45 31.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 294' ' ' GLY . 34.6 p -88.33 -58.37 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 291' ' ' THR . 17.8 m -35.89 -43.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.35 -46.45 62.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.71 -26.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -82.77 179.92 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.0 110.926 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.469 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -160.17 123.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -78.18 115.83 18.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.45 167.74 24.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 90.2 m -122.41 137.63 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.7 t -69.16 151.3 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.535 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 9.1 tp -100.02 -31.18 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 98.8 m -76.98 -36.76 56.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 20.2 p -102.12 -65.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.34 6.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.435 ' SG ' ' CD1' ' A' ' 273' ' ' LEU . 28.5 p -72.09 155.07 40.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.424 ' C ' HD11 ' A' ' 273' ' ' LEU . 30.1 p -124.52 154.57 40.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 173.92 179.52 44.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 12.1 mt -87.56 147.52 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.492 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.3 OUTLIER -150.0 155.23 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.907 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 120.03 6.88 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.06 -12.43 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -92.67 21.9 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.525 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.45 -3.83 4.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.9 pp -127.11 -179.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.9 t -156.2 160.03 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -59.37 143.74 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -54.91 92.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -85.38 -41.95 14.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.81 43.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 31.4 p -80.32 160.89 25.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.3 t -121.08 170.36 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 325' ' ' PHE . 5.9 p -75.54 163.96 26.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.507 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.4 p-90 -131.96 -41.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.507 HG12 ' CD2' ' A' ' 323' ' ' TRP . 26.4 mm -125.04 -12.89 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 325' ' ' PHE . 0.1 OUTLIER -34.23 141.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -107.41 151.69 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -149.98 159.8 28.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.5 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 99.8 p -72.23 127.08 31.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 110.826 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 52.5 m -103.88 140.02 38.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 79.07 -147.67 30.65 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 146.1 59.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 35.6 m -89.89 82.03 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.8 p -84.61 155.65 21.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.7 m -106.31 92.58 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 0.0 110.934 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 m 57.41 48.99 13.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -132.22 -53.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 78.0 p -119.85 -55.18 2.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.857 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -77.5 -68.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.54 -93.06 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 59.6 p -171.77 171.32 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 250' ' ' ASP . 33.3 mtm180 -95.97 85.66 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 249' ' ' ARG . 4.5 m-20 -162.3 127.09 3.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.25 116.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.183 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.84 47.51 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.74 44.14 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -76.0 -176.01 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.01 44.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 26.4 m80 -78.84 136.18 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 258' ' ' THR . 11.1 tp10 -95.92 159.04 15.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' THR . . . . . 0.445 ' N ' ' HG3' ' A' ' 257' ' ' GLU . 8.3 m -123.72 123.11 39.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' A' ' 257' ' ' GLU . 6.9 mt -125.41 151.9 45.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -108.87 130.36 55.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.8 126.57 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -100.19 -17.01 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -156.27 145.63 15.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.671 0.748 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 162.79 40.72 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.675 2.25 . . . . 0.0 112.396 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.517 ' CB ' ' CD1' ' A' ' 275' ' ' LEU . 28.1 t80 -147.81 144.3 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.4 m -114.74 99.42 51.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.55 21.23 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.369 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -124.88 -14.01 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -147.64 -178.99 6.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.8 m-20 -71.87 -42.47 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 270' ' ' ASP . 29.4 t70 -37.34 -39.93 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.55 176.89 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.1 tp -137.8 153.6 49.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.455 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 21.9 tt0 -74.98 150.83 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.517 ' CD1' ' CB ' ' A' ' 265' ' ' TYR . 26.0 mt -117.71 133.66 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.23 130.87 24.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.634 0.731 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 105.65 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.24 . . . . 0.0 112.346 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.32 16.13 7.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -118.34 171.08 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.8 159.76 17.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.483 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 32.2 mm -136.76 133.95 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.33 111.64 23.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -100.41 138.92 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.557 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 7.7 t -137.74 134.22 18.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.731 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.405 ' HA ' ' CD ' ' A' ' 288' ' ' GLN . 53.2 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.247 . . . . 0.0 112.329 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.3 mmt -82.04 -27.95 32.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -126.1 42.14 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.405 ' CD ' ' HA ' ' A' ' 285' ' ' PRO . 12.8 pt20 -98.14 75.04 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.4 p -88.59 142.8 27.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 13.0 m 40.44 33.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.799 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 294' ' ' GLY . 54.9 p -91.58 -57.46 2.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.8 t -38.59 -40.41 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -53.82 -44.42 70.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 175.37 -25.34 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -85.01 179.86 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.3 pt -159.55 123.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.123 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 26.2 t80 -76.81 114.78 15.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . 0.483 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -134.55 163.82 24.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 93.1 m -116.26 129.08 56.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 111.131 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -65.62 151.64 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.819 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.9 tp -102.5 -29.5 11.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.7 m -81.87 -38.54 25.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 77.3 p -103.47 -38.96 6.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 -13.63 60.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 95.4 m -53.05 166.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.0 m -146.83 128.3 15.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.07 33.8 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 18.1 mt -89.09 143.5 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.473 ' N ' HD21 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.44 156.9 49.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.719 . . . . 0.0 110.886 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.7 117.01 4.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.248 . . . . 0.0 112.362 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.07 -13.21 1.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.26 23.45 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.532 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.3 m-85 -130.57 -3.1 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.1 177.2 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.7 t -151.97 159.35 43.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -61.78 151.08 35.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -77.32 46.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.69 23.06 11.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.37 99.23 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.2 m 53.38 36.61 23.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 54.5 p -161.01 125.83 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.556 HG21 ' CD2' ' A' ' 325' ' ' PHE . 8.3 p -77.35 166.97 22.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.556 ' CE3' HG12 ' A' ' 324' ' ' ILE . 3.4 p-90 -133.66 -45.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.556 HG12 ' CE3' ' A' ' 323' ' ' TRP . 20.4 mm -117.51 -16.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.602 ' CD1' ' O ' ' A' ' 325' ' ' PHE . 0.1 OUTLIER -34.2 138.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -101.61 165.82 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 114.09 115.64 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.8 m -115.0 174.53 5.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 0.0 110.824 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 90.5 p -134.57 121.02 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 147.54 -94.9 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.28 7.02 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.718 2.278 . . . . 0.0 112.332 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.8 p -86.62 141.74 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 90.4 p -103.85 42.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 11.4 m -123.13 169.66 11.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 244' ' ' GLY . 75.1 p -83.22 87.08 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 243' ' ' SER . . . 37.23 -146.66 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 19.8 m -98.45 110.28 22.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.6 t -72.97 154.74 40.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 248' ' ' SER . . . 79.86 -49.91 3.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' GLY . 14.6 m -35.15 136.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.08 147.92 25.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -106.21 156.49 18.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 5.0 mp -73.09 115.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -123.6 -49.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -116.52 34.35 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -110.46 174.44 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -108.81 43.96 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.482 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 22.2 m80 -98.97 136.7 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.72 163.65 12.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.1 m -125.89 126.56 44.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.03 151.94 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -108.74 130.75 55.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.1 131.8 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.9 pt -107.93 -19.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.157 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -155.82 143.86 14.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.693 0.759 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 153.9 68.46 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.717 2.278 . . . . 0.0 112.314 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.421 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 35.9 t80 -150.69 125.65 9.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.947 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.14 109.43 44.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.569 0.7 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.4 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.73 166.79 26.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -115.69 -20.71 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -153.32 -179.2 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -64.87 -32.39 74.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -41.6 -44.09 2.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.4 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.2 pm0 -102.98 171.33 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.2 tp -124.59 147.05 48.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.56 140.26 57.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.461 HD22 ' CD1' ' A' ' 309' ' ' LEU . 5.9 mt -112.13 127.68 55.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 87.2 t -124.47 133.5 24.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.629 0.728 . . . . 0.0 111.103 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.335 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.56 2.94 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -111.18 162.6 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -106.06 159.19 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 300' ' ' SER . 20.0 mm -137.76 120.2 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -81.98 114.76 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -99.47 138.03 37.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.496 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.1 p -137.66 125.73 14.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -10.71 29.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 40.5 mtp -83.04 -28.94 29.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 297' ' ' TYR . 50.5 mm-40 -117.65 40.41 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.448 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 2.9 pp0? -96.15 123.68 39.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.5 p -129.06 126.92 40.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.0 m 55.1 25.18 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 294' ' ' GLY . 41.8 p -87.51 -54.53 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 291' ' ' THR . 28.0 t -36.35 -37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -61.57 -48.7 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -179.44 -27.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -79.82 -179.76 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.726 0.298 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.417 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.7 pt -152.34 134.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 287' ' ' GLU . 53.6 t80 -96.21 111.03 23.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -138.38 177.48 20.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 305' ' ' CYS . 58.6 m -127.37 119.55 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 111.16 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 281' ' ' ILE . 1.1 t -55.26 168.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.8 tp -111.31 -28.65 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -74.38 -47.87 31.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.6 p -95.23 -28.95 14.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 80.7 16.04 76.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.442 ' O ' ' CG2' ' A' ' 299' ' ' THR . 5.9 t -88.55 169.04 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 79.6 p -131.34 142.78 50.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.95 48.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.403 ' C ' HD21 ' A' ' 309' ' ' LEU . 11.4 mt -92.25 151.45 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.461 ' CD1' HD22 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -157.54 157.5 30.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 110.958 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.481 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 123.76 10.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.757 2.305 . . . . 0.0 112.34 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.29 -8.97 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.21 19.18 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.481 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.0 m-85 -126.56 -1.18 6.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 296' ' ' ILE . 2.8 pp -131.25 175.94 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.4 t -149.71 165.4 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 4.7 mptt -67.16 143.8 56.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.07 95.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.58 -54.94 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.847 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 40.61 43.02 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 14.7 t -48.84 -45.09 40.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 74.7 m -113.74 102.25 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 1.3 p -99.95 156.43 17.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -80.94 -39.42 26.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 325' ' ' PHE . 4.0 mm -130.0 -53.64 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.412 ' C ' ' O ' ' A' ' 324' ' ' ILE . 83.9 m-85 -36.23 146.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -131.17 135.55 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -166.99 -121.47 0.56 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.3 t -67.86 111.65 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 30.4 t -72.01 98.75 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 55.82 -158.21 8.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 85.44 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.362 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 m -81.62 143.14 32.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m 52.0 35.65 16.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.4 m -65.26 137.77 57.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 110.848 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 60.6 p -77.82 149.68 34.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.851 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.38 69.22 0.17 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 54.0 p -97.91 115.36 27.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 t -123.1 139.05 54.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.52 68.44 1.63 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.0 t -75.49 110.84 10.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 110.834 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -70.44 -29.48 66.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -104.05 161.66 13.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.76 116.27 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -126.58 -35.22 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.57 -40.95 22.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -82.79 158.89 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.59 40.48 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 18.8 m80 -74.29 144.1 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -96.17 163.0 13.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.5 m -127.87 133.63 49.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.2 mt -132.67 155.12 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -110.3 132.52 54.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.65 137.65 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.32 -18.69 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -155.02 142.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.75 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 158.17 57.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -153.3 125.33 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 m -95.62 109.99 48.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 171.07 15.19 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -125.64 -13.69 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.431 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 23.3 m-80 -151.42 -175.39 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.18 -21.94 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 0.9 OUTLIER -104.76 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.431 ' CD1' ' SG ' ' A' ' 305' ' ' CYS . 6.7 tp -120.35 148.42 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.4 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 36.7 tt0 -72.48 145.56 47.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 309' ' ' LEU . 11.1 mt -115.73 135.51 53.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.54 134.81 26.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 113.54 3.41 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 109.57 5.78 29.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.525 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -110.82 165.4 11.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.342 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -107.28 163.46 13.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 15.1 mm -146.09 122.85 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.54 ' CE2' HD11 ' A' ' 301' ' ' LEU . 41.3 m-85 -81.93 128.83 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -98.96 129.39 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.471 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 0.4 OUTLIER -128.12 108.21 19.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.723 0.773 . . . . 0.0 110.901 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -3.11 11.34 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -88.88 -24.89 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 297' ' ' TYR . 55.3 mm-40 -122.97 40.85 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.34 109.12 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 21.0 p -114.05 119.26 36.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.9 m 67.36 27.78 8.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.837 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 33.6 p -87.85 -41.22 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.8 t -49.28 -27.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 294' ' ' GLY . 4.9 pt-20 -70.9 -42.96 69.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 293' ' ' GLU . . . 173.77 -25.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -80.54 179.28 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.717 0.294 . . . . 0.0 110.902 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.1 pt -156.83 126.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 287' ' ' GLU . 29.9 t80 -84.66 111.76 19.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -133.65 -173.56 13.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 300' ' ' SER . 91.8 m -133.21 141.03 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.45 ' N ' HG23 ' A' ' 299' ' ' THR . 13.7 t -74.74 149.6 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.54 HD11 ' CE2' ' A' ' 282' ' ' PHE . 13.1 tp -96.08 -39.36 9.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.5 m -71.35 -39.95 71.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.0 p -100.04 -63.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.84 10.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.431 ' SG ' ' CD1' ' A' ' 273' ' ' LEU . 2.3 p -79.53 153.77 29.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.4 p -120.25 147.86 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.79 -175.54 47.65 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 309' ' ' LEU . 18.1 mt -94.79 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.74 157.13 62.31 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.59 0.71 . . . . 0.0 110.913 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.654 2.236 . . . . 0.0 112.327 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -55.0 -15.52 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -88.74 19.69 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.52 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.69 -2.57 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 2.9 pp -128.41 173.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.3 t -147.79 151.78 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.464 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -59.49 142.83 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.39 86.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -106.38 16.91 24.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.457 ' CD ' ' O ' ' A' ' 319' ' ' GLU . 2.5 pp20? -104.17 106.85 17.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 56.5 m 48.67 35.81 6.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -145.28 120.93 10.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' THR . . . . . 0.406 ' CG2' ' HB2' ' A' ' 325' ' ' PHE . 1.5 p -48.89 161.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' TRP . . . . . 0.57 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -90.17 -39.62 12.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.57 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 20.7 mt -130.16 -46.57 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 324' ' ' ILE . 61.9 m-85 -34.51 126.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -91.92 172.66 8.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -42.82 -39.99 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.518 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 1.5 t -153.04 136.31 15.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.818 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 53.2 m -101.66 149.94 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -159.87 -97.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.532 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.02 29.94 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.682 2.255 . . . . 0.0 112.382 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.3 m -114.19 107.71 15.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.7 t -58.45 -59.41 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.937 0.398 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.1 m -130.63 130.89 44.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 10.9 mt -129.73 150.45 51.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -108.68 131.53 54.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.37 128.69 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.9 pt -104.06 -16.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 79.2 m-85 -158.42 144.46 12.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.74 0.781 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 157.53 60.21 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.698 2.265 . . . . 0.0 112.332 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 15.6 t80 -148.83 127.67 12.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -96.53 107.0 33.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.549 0.69 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 170.92 15.44 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.335 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -125.81 -15.04 6.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ASN . . . . . 0.432 ' C ' ' OE1' ' A' ' 272' ' ' GLU . 65.9 m-80 -150.37 -175.71 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 9.0 t70 -72.76 -42.27 64.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 37.8 t70 -37.7 -38.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 269' ' ' ASN . 1.2 pm0 -102.54 168.22 9.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.8 tp -127.12 149.23 50.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.471 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 15.7 tt0 -69.72 143.9 52.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -113.36 141.28 47.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 277' ' ' PRO . 57.6 t -131.53 134.72 25.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.77 112.66 3.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.32 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.39 6.66 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -109.48 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -115.43 167.14 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 309' ' ' LEU . 29.2 mm -145.35 115.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.439 ' CE2' HD13 ' A' ' 301' ' ' LEU . 29.2 m-85 -85.02 118.7 24.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -102.31 137.95 39.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.49 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.2 p -134.66 140.26 34.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.67 0.748 . . . . 0.0 110.843 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -26.54 27.42 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.35 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.0 mtp -81.05 -1.72 45.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 71.8 mm-40 -126.91 18.52 7.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -77.14 127.8 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.815 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.4 p -148.93 113.4 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 63.78 25.15 14.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.4 p -88.59 -45.78 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.0 m -44.33 -24.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.31 -49.4 19.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 179.9 -26.55 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -80.23 -179.45 7.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.74 0.305 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 314' ' ' ILE . 1.0 OUTLIER -153.47 127.14 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 27.6 t80 -88.0 120.23 29.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -148.67 -173.71 19.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 38.8 m -130.42 139.06 50.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.333 . . . . 0.0 111.16 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.451 ' HA ' HD13 ' A' ' 281' ' ' ILE . 27.3 t -75.17 158.3 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.439 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.0 tp -100.14 -34.83 9.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 62.9 m -73.6 -61.29 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 67.5 p -78.62 -49.96 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.95 11.65 31.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.456 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.57 149.71 21.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.8 t -118.18 154.41 32.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 172.61 -173.29 45.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.815 HD21 ' O ' ' A' ' 289' ' ' THR . 20.6 mt -91.73 137.1 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.5 155.48 63.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.541 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.6 Cg_endo -69.8 119.99 6.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -57.06 -12.55 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.75 20.42 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.541 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.2 m-85 -129.04 -3.62 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -129.89 177.27 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 4.7 t -152.49 159.81 43.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -59.55 149.63 29.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.486 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 20.3 pt-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.895 0.378 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 18.2 m -116.02 137.08 52.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.929 HD13 HD13 ' A' ' 314' ' ' ILE . 9.1 mt -134.02 150.62 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -108.79 132.69 53.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.63 129.71 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 3.0 pt -107.38 -14.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.472 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 89.3 m-85 -159.28 143.26 11.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.654 0.74 . . . . 0.0 110.958 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 160.05 51.18 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -154.61 127.05 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.955 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.75 109.61 47.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.74 172.12 13.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -123.96 -14.28 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -162.49 -177.46 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -63.89 -36.67 84.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.42 -42.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.437 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.2 pm0 -105.23 175.11 5.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -130.58 143.11 50.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.63 144.01 56.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 309' ' ' LEU . 6.4 mt -112.51 142.51 44.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.37 128.21 19.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 104.31 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.277 . . . . 0.0 112.368 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.22 5.16 8.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -112.55 171.31 7.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.52 162.06 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 300' ' ' SER . 17.5 mm -135.09 132.38 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -99.49 106.21 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.7 tmm? -98.97 134.21 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.5 ' N ' ' SD ' ' A' ' 283' ' ' MET . 8.5 p -126.12 143.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.661 0.743 . . . . 0.0 110.875 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -24.47 29.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.351 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 44.2 mtp -81.53 -3.19 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 66.3 mm-40 -126.33 9.69 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -69.27 87.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 308' ' ' LEU . 19.9 p -104.99 128.9 53.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m 48.09 26.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 294' ' ' GLY . 29.4 p -86.05 -54.48 4.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.2 t -35.36 -36.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 18.4 tp10 -62.66 -47.72 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.15 -26.2 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.457 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.3 m95 -79.93 -179.78 7.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.903 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.519 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.89 125.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.7 t80 -84.2 111.14 19.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -134.29 -177.77 15.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 305' ' ' CYS . 97.2 m -133.18 129.6 38.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.123 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.407 ' HA ' HD13 ' A' ' 281' ' ' ILE . 2.4 t -66.17 154.77 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.3 tp -99.82 -29.94 12.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 5.2 m -72.65 -52.64 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.0 p -88.8 -55.37 3.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.93 23.36 6.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.555 ' O ' HG23 ' A' ' 299' ' ' THR . 11.6 t -96.15 166.28 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 81.1 p -129.02 143.39 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.85 47.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 289' ' ' THR . 10.9 mt -88.95 139.17 30.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 110.914 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.21 157.19 63.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.559 0.695 . . . . 0.0 110.946 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.3 Cg_endo -69.79 120.7 7.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.657 2.238 . . . . 0.0 112.344 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -58.68 -11.62 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -93.03 20.5 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.538 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.6 m-85 -128.74 -3.06 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -130.16 177.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.8 t -153.34 162.63 41.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -66.31 148.01 52.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.084 179.82 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.941 0.4 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.4 ' O ' HD23 ' A' ' 259' ' ' LEU . 1.8 m -133.03 126.78 32.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.95 151.41 50.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -108.77 133.72 52.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.5 142.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.447 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -119.99 -14.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.3 m-85 -158.33 143.78 12.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.68 0.752 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.49 69.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.977 ' HB2' HD12 ' A' ' 275' ' ' LEU . 41.3 t80 -138.46 144.82 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 11.8 m -115.45 97.66 49.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.69 171.52 14.24 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.341 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.59 -13.22 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -157.32 -179.54 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 271' ' ' ASP . 2.1 p30 -66.87 -38.71 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.67 -38.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -111.49 172.9 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 5.3 tp -129.02 143.62 50.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 275' ' ' LEU . 7.0 tt0 -65.44 150.13 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 265' ' ' TYR . 22.8 mt -117.48 127.12 53.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 277' ' ' PRO . 93.7 t -118.56 132.39 23.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.736 . . . . 0.0 111.129 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.76 110.75 2.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.726 2.284 . . . . 0.0 112.318 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.26 4.56 20.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -110.76 171.67 7.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 281' ' ' ILE . 32.1 m-85 -112.74 167.99 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 280' ' ' PHE . 12.3 mm -144.98 131.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 40.4 m-85 -91.68 120.2 32.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 284' ' ' SER . 1.9 tmm? -99.84 128.24 45.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.443 ' N ' ' SD ' ' A' ' 283' ' ' MET . 39.6 p -126.63 130.17 23.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.676 0.75 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.514 ' HA ' ' CG ' ' A' ' 288' ' ' GLN . 53.8 Cg_endo -69.7 -13.0 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 0.0 112.369 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.87 -22.45 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.599 ' OE1' ' CE2' ' A' ' 297' ' ' TYR . 13.7 mt-10 -112.27 36.0 3.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.514 ' CG ' ' HA ' ' A' ' 285' ' ' PRO . 9.3 mm100 -84.16 86.79 7.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.565 ' O ' HD11 ' A' ' 308' ' ' LEU . 15.9 p -110.74 108.63 18.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.3 m 61.62 30.73 18.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 293' ' ' GLU . 43.6 p -92.56 -59.67 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.9 m -34.06 -34.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . 9.9 tp10 -63.59 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -174.57 -30.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.524 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -80.13 -179.99 7.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.737 0.303 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.554 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.77 121.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.599 ' CE2' ' OE1' ' A' ' 287' ' ' GLU . 38.9 t80 -72.76 110.92 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -128.89 166.47 21.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 94.5 m -125.79 111.86 15.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.8 t -47.79 147.25 2.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.574 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -96.73 -45.47 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 97.8 m -63.25 -42.37 99.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 33.7 p -96.37 -53.28 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 110.82 0.2 28.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 99.6 m -69.97 151.67 45.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.6 p -124.19 138.14 54.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.65 -175.92 47.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 289' ' ' THR . 14.4 mt -88.38 144.98 26.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.594 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.1 156.49 50.76 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.677 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.5 Cg_endo -69.79 122.0 8.68 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.706 2.27 . . . . 0.0 112.309 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.36 -10.84 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -94.22 23.11 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.753 ' HB3' HD13 ' A' ' 275' ' ' LEU . 10.5 m-85 -130.95 -3.33 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.996 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -130.42 176.56 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.9 t -154.47 152.52 30.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -55.09 141.93 32.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.835 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -133.16 128.79 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.966 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.51 149.27 51.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 25.6 tm0? -108.78 124.59 50.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 85.2 t -58.32 138.45 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.5 pt -115.85 -11.86 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 84.6 m-85 -161.76 144.18 8.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.726 0.774 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.33 64.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.716 2.277 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 38.3 t80 -138.85 135.51 34.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -104.68 105.43 50.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.58 0.705 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 170.68 15.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -125.18 -16.82 5.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ASN . . . . . 0.452 ' CG ' ' OE2' ' A' ' 272' ' ' GLU . 0.2 OUTLIER -152.94 173.41 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 271' ' ' ASP . 3.9 t70 -59.62 -41.07 89.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -35.11 -44.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.452 ' OE2' ' CG ' ' A' ' 269' ' ' ASN . 11.6 pm0 -99.29 178.41 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.9 tp -135.37 148.81 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.78 140.68 55.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -111.98 141.17 45.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.513 HG13 ' HD2' ' A' ' 277' ' ' PRO . 96.1 t -129.08 135.24 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.643 0.735 . . . . 0.0 111.129 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.75 104.78 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.69 13.2 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.17 167.74 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.878 0.371 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.444 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.5 m-85 -107.3 166.0 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.703 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.5 mm -144.85 119.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 28.7 m-85 -87.41 115.86 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -98.88 141.38 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.5 ' N ' ' SD ' ' A' ' 283' ' ' MET . 5.3 t -133.94 142.33 43.05 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -32.63 17.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.638 2.225 . . . . 0.0 112.352 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 63.7 mtp -74.97 -0.55 19.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 15.7 mm-40 -125.43 15.04 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.19 87.59 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.664 ' O ' HD21 ' A' ' 308' ' ' LEU . 8.2 p -114.46 122.32 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.3 m 56.26 25.84 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 31.8 p -89.42 -42.22 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.3 t -48.31 -29.61 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.28 -36.26 76.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.75 -25.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 296' ' ' ILE . 66.2 m95 -80.01 -179.67 7.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.2 pt -157.2 128.41 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 25.1 t80 -86.19 112.47 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.43 ' HA3' HG22 ' A' ' 281' ' ' ILE . . . -135.35 172.42 22.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.472 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 74.0 m -125.96 113.56 17.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.703 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.9 t -50.08 174.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 11.7 tp -114.46 -26.96 7.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -81.46 -54.2 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.3 p -86.73 -27.54 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.07 82.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.2 m -84.63 148.97 26.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 91.0 p -120.3 130.72 54.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.77 -174.69 38.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 289' ' ' THR . 19.7 mt -87.71 149.39 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.64 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -154.95 157.03 31.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.903 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.2 Cg_endo -69.83 122.43 9.09 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.696 2.264 . . . . 0.0 112.289 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.92 -10.07 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -95.48 22.77 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.549 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.4 m-85 -130.47 -2.03 4.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -133.23 172.15 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.5 t -147.17 164.46 33.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.61 151.31 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.117 179.816 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.944 0.402 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -131.64 127.42 36.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.774 HD13 HD13 ' A' ' 314' ' ' ILE . 9.4 mt -130.18 149.83 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -108.77 136.83 47.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.16 129.14 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.17 -28.67 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -145.52 143.9 21.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 154.16 68.14 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.468 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.0 t80 -147.88 127.55 13.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -94.8 109.13 42.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 172.82 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -124.08 -13.14 7.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -163.4 -178.14 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.3 t70 -64.4 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -37.66 -40.31 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.29 173.09 6.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.99 145.36 51.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 275' ' ' LEU . 60.9 tt0 -63.84 146.13 54.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 309' ' ' LEU . 6.5 mt -117.27 121.37 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 277' ' ' PRO . 99.4 t -117.64 134.33 23.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.713 . . . . 0.0 111.144 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.76 110.56 2.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.339 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.12 1.32 16.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -106.65 169.63 8.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.437 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.9 m-85 -116.03 155.16 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 300' ' ' SER . 40.6 mm -133.49 123.15 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 20.1 m-85 -87.39 119.11 27.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -102.72 141.14 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.499 ' N ' ' SD ' ' A' ' 283' ' ' MET . 23.9 p -134.86 139.35 31.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.684 0.754 . . . . 0.0 110.846 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.04 35.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 2.237 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 39.7 mtp -86.4 2.49 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.582 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 80.7 mm-40 -131.38 12.97 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.24 88.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.6 p -110.26 123.51 49.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.1 m 54.27 25.61 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 28.2 p -88.56 -43.45 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 m -45.0 -34.04 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -65.12 -42.03 94.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 169.37 -23.58 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -79.93 -179.72 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 110.899 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -155.93 128.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.5 t80 -89.75 113.43 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -137.03 176.37 20.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.2 m -128.4 126.3 40.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.65 ' HA ' HD13 ' A' ' 281' ' ' ILE . 43.7 t -62.13 155.99 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.6 tp -97.8 -33.55 11.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 99.2 m -75.05 -55.69 5.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 49.2 p -84.79 -39.57 18.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.02 10.33 62.75 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.467 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.05 153.41 26.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 59.9 p -122.5 140.7 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -176.76 179.15 47.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 11.3 mt -89.23 139.42 30.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -143.84 156.67 58.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.602 0.715 . . . . 0.0 110.923 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.75 121.08 7.78 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.352 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.68 -11.23 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.17 19.97 7.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -128.22 -3.03 5.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.07 -176.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 163.78 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 152.73 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.837 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.902 0.382 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.409 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.8 m -134.29 135.29 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 314' ' ' ILE . 7.4 mt -137.36 152.79 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.514 ' O ' HG22 ' A' ' 315' ' ' THR . 22.5 tm0? -108.66 129.93 55.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.41 134.13 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -109.14 -17.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.6 m-85 -158.55 143.89 12.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.655 0.741 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 152.57 69.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 2.269 . . . . 0.0 112.368 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 42.0 t80 -144.47 138.54 27.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.9 m -106.74 107.75 60.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.553 0.692 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG3' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.78 169.46 18.89 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -123.2 -14.2 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ASN . . . . . 0.432 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 0.3 OUTLIER -154.71 179.48 9.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.84 -35.49 80.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.498 ' OD1' HD12 ' A' ' 308' ' ' LEU . 26.0 t0 -40.59 -43.82 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 13.6 pm0 -100.28 177.66 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.6 tp -136.54 147.71 47.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.537 ' O ' HD23 ' A' ' 275' ' ' LEU . 19.8 tt0 -63.35 148.84 47.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -120.61 134.32 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.8 133.09 24.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.656 0.741 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 105.98 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.719 2.28 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.45 11.35 10.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -112.1 171.58 7.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -112.06 161.15 16.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.472 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 20.1 mm -140.08 123.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -88.25 110.37 20.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.6 tmm? -98.88 132.24 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.474 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.3 t -126.06 144.15 47.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.752 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -31.61 20.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.714 2.276 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 28.7 mmm -76.33 4.27 9.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.585 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 19.5 mt-10 -133.13 18.41 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -77.74 82.39 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.5 p -103.11 134.92 45.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 41.79 25.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 289' ' ' THR . 32.2 p -85.68 -45.07 12.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 45.6 m -45.93 -31.89 2.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.45 -35.99 81.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.05 -25.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.441 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.5 m95 -79.98 -179.81 7.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.74 0.305 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.92 130.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 21.4 t80 -86.53 120.44 27.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -146.4 171.67 27.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.5 m -121.7 133.96 54.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.423 ' HA ' HD13 ' A' ' 281' ' ' ILE . 33.4 t -70.02 151.16 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.2 tp -96.08 -34.04 11.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -72.83 -43.06 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 68.8 p -96.78 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.13 8.68 14.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.3 m -83.95 155.23 22.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.6 p -124.12 132.92 53.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -170.5 -175.68 39.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.435 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 18.3 mt -87.78 151.28 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 308' ' ' LEU . 0.2 OUTLIER -155.25 157.32 31.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 110.946 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 116.07 4.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 2.248 . . . . 0.0 112.336 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.66 -14.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -90.06 20.52 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.545 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.9 m-85 -129.08 2.68 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -132.62 175.43 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 260' ' ' GLN . 12.8 t -149.64 154.38 38.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.463 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.2 OUTLIER -61.98 144.91 54.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.41 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 12.9 pt-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.914 0.388 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -112.69 138.56 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 314' ' ' ILE . 9.7 mt -135.54 150.93 49.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 17.3 tm0? -108.76 137.14 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.496 HG11 ' C ' ' A' ' 276' ' ' VAL . 49.8 t -66.44 137.22 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 4.5 pt -116.97 -14.39 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 91.2 m-85 -162.03 142.63 7.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.743 0.782 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 154.39 67.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.986 ' CB ' HD12 ' A' ' 275' ' ' LEU . 25.8 t80 -137.31 156.57 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 18.8 m -124.15 97.3 40.68 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.558 0.694 . . . . 0.0 111.108 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.75 171.17 14.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.318 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -125.24 -14.8 6.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.75 -178.5 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 271' ' ' ASP . 6.6 m-20 -65.49 -36.77 84.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -36.52 -42.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -107.64 175.46 5.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -131.61 141.24 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.52 154.28 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.986 HD12 ' CB ' ' A' ' 265' ' ' TYR . 23.7 mt -121.63 124.78 45.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.496 ' C ' HG11 ' A' ' 261' ' ' VAL . 71.2 t -113.83 130.23 24.01 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.687 0.756 . . . . 0.0 111.104 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.42 6.75 19.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -111.9 171.52 7.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.22 164.86 12.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 309' ' ' LEU . 12.1 mm -145.35 121.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HE2' HD13 ' A' ' 301' ' ' LEU . 84.6 m-85 -89.88 111.69 22.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.9 tmm? -99.52 136.14 39.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.499 ' N ' ' SD ' ' A' ' 283' ' ' MET . 0.9 OUTLIER -128.43 136.98 29.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.669 0.747 . . . . 0.0 110.85 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -18.81 36.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 20.4 mmt -66.58 -37.54 85.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 4.9 mt-10 -120.21 44.94 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.488 ' CD ' ' O ' ' A' ' 288' ' ' GLN . 3.7 pp0? -96.94 52.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.424 ' O ' HD21 ' A' ' 308' ' ' LEU . 34.1 p -76.58 143.13 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 m 52.67 25.83 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 289' ' ' THR . 44.2 p -95.94 -49.24 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.183 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 t -46.68 -25.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.52 -35.95 70.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.26 -22.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.49 ' O ' HG23 ' A' ' 296' ' ' ILE . 68.7 m95 -86.31 178.96 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.97 122.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.431 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 19.5 t80 -78.81 110.09 13.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.18 175.78 19.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.4 m -126.47 127.48 45.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.559 ' HA ' HD13 ' A' ' 281' ' ' ILE . 36.4 t -66.1 153.03 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.722 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.2 tp -100.46 -43.17 6.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -62.79 -39.79 95.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 64.8 p -102.28 -55.3 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 112.94 1.57 25.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.2 t -71.84 166.18 22.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.6 m -137.9 143.81 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -174.81 47.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 289' ' ' THR . 12.1 mt -88.19 138.78 31.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.74 155.9 66.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.93 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.723 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.8 Cg_endo -69.77 125.34 12.02 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.32 -8.2 5.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.25 23.39 7.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 275' ' ' LEU . 11.6 m-85 -130.72 -3.92 4.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 259' ' ' LEU . 2.7 pp -131.0 -179.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 11.9 t -155.97 162.62 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.54 153.49 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 19.3 pt-20 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 23.0 m -109.05 130.38 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.143 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 314' ' ' ILE . 11.7 mt -131.67 149.31 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 0.7 OUTLIER -108.63 132.42 53.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 54.6 t -64.74 132.3 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.6 -20.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -152.0 144.24 16.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.667 0.746 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.84 69.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 56.4 t80 -142.09 132.7 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.7 m -103.89 102.55 32.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.098 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 171.18 14.96 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -125.25 -15.15 6.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -152.29 -175.99 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.4 t70 -71.9 -37.64 70.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.4 OUTLIER -35.57 -39.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 pm0 -107.9 179.57 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 9.3 tp -133.92 145.48 49.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.53 141.52 58.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -114.98 130.7 56.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 277' ' ' PRO . 60.9 t -123.52 135.1 25.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.623 0.725 . . . . 0.0 111.124 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.77 117.05 4.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.22 1.08 29.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.39 175.95 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -115.34 165.4 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.478 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 25.8 mm -141.46 127.6 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.01 109.51 21.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.0 tmm? -99.93 133.27 44.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.488 ' N ' ' SD ' ' A' ' 283' ' ' MET . 8.9 t -132.04 137.48 30.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.758 . . . . 0.0 110.815 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.3 mmt -88.27 -11.69 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 1.8 pt-20 -129.55 26.57 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -85.59 84.76 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.442 ' O ' HD21 ' A' ' 308' ' ' LEU . 20.1 p -100.43 118.32 36.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 20.6 m 62.06 25.07 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 35.9 p -86.35 -53.35 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 291' ' ' THR . 65.6 m -37.85 -32.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 4.8 tp10 -66.32 -47.12 74.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 179.05 -28.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.529 ' O ' HG23 ' A' ' 296' ' ' ILE . 60.6 m95 -79.89 -179.79 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.302 . . . . 0.0 110.907 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -158.99 125.33 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 23.2 t80 -80.13 114.31 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.478 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -135.21 162.83 24.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 17.1 m -114.03 132.73 55.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 31.0 t -67.96 148.42 51.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.7 -31.02 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -78.09 -48.85 15.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 75.5 p -91.48 -42.46 10.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.48 4.72 57.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 87.1 m -73.55 168.84 18.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 110.844 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 10.5 m -138.63 139.22 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.68 -176.7 47.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -88.13 148.25 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -150.54 155.6 36.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.602 0.715 . . . . 0.0 110.927 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.1 Cg_endo -69.77 125.49 12.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.68 -8.76 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 312' ' ' ASN . 28.9 t-20 -96.14 22.01 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.574 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.1 m-85 -130.32 -3.27 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -129.85 175.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 260' ' ' GLN . 13.5 t -154.86 159.19 40.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.69 155.52 2.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.945 0.402 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.6 m -122.76 131.52 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.928 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -133.95 150.63 51.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -108.71 134.25 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.03 135.29 28.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -113.03 -12.5 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 92.3 m-85 -161.31 142.86 8.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.657 0.741 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.48 68.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 0.0 112.318 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.7 t80 -147.57 126.18 12.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.1 m -96.96 108.3 42.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.571 0.7 . . . . 0.0 111.125 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.0 Cg_endo -69.75 166.69 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -115.93 -21.3 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -153.72 -177.43 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 271' ' ' ASP . 25.6 t0 -65.33 -37.25 86.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.7 OUTLIER -37.83 -40.69 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.413 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.4 pm0 -105.83 175.34 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.9 tp -129.9 147.3 51.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.41 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.0 tt0 -67.52 145.67 54.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 309' ' ' LEU . 10.4 mt -116.06 132.58 56.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.25 129.77 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.688 0.756 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.71 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.49 10.6 9.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -113.26 178.21 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.42 159.88 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.1 mm -135.25 138.0 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -101.73 113.36 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.5 tmm? -99.04 140.55 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.497 ' N ' ' SD ' ' A' ' 283' ' ' MET . 6.0 t -133.81 141.78 41.16 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.893 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -37.42 9.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 36.8 mtp -74.14 1.34 11.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 37.8 mm-40 -128.36 17.15 6.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -77.98 86.14 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.739 ' O ' HD21 ' A' ' 308' ' ' LEU . 29.9 p -105.17 126.8 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.9 m 48.47 29.46 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 17.3 p -89.49 -50.0 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 59.1 p -39.9 -38.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.47 -46.36 89.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 175.03 -25.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 296' ' ' ILE . 59.6 m95 -80.58 -179.84 7.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.1 pt -156.52 125.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 38.5 t80 -80.13 111.2 16.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.56 169.33 22.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 305' ' ' CYS . 91.4 m -124.8 116.36 22.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.155 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 281' ' ' ILE . 4.9 t -54.48 153.43 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.81 -50.7 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 16.0 m -53.46 -52.79 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.4 p -87.22 -53.45 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.8 4.54 31.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.433 ' O ' HG23 ' A' ' 299' ' ' THR . 9.3 t -77.72 166.72 22.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 84.1 p -134.85 147.91 50.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 174.84 -176.84 47.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 289' ' ' THR . 12.3 mt -88.98 137.57 32.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.6 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.83 156.01 65.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.943 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 124.4 11.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.61 -8.81 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -95.62 21.93 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.559 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.6 m-85 -129.07 -1.5 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.85 -177.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.5 t -158.43 162.65 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -62.47 143.49 57.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.112 179.815 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.1 m -117.73 138.66 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.181 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 9.8 mt -135.56 149.53 49.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -109.16 131.5 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 80.6 t -66.02 128.39 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -103.89 -21.71 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -150.94 143.61 16.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.675 0.75 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.36 68.08 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.587 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 34.6 t80 -147.5 123.92 10.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.3 m -93.37 106.25 19.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.577 0.703 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.3 Cg_endo -69.75 171.6 14.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.624 2.216 . . . . 0.0 112.421 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.58 -14.94 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -158.9 -179.26 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 271' ' ' ASP . 38.7 t0 -64.77 -37.92 89.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -36.38 -39.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.9 pm0 -109.39 171.83 7.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 3.3 tp -125.73 142.38 51.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -64.44 135.59 56.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 313' ' ' TYR . 7.7 mt -106.05 128.32 53.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.31 130.76 24.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.65 0.738 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 112.73 3.15 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.651 2.234 . . . . 0.0 112.368 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.88 1.29 22.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.53 175.84 5.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.532 ' O ' HD13 ' A' ' 281' ' ' ILE . 8.9 m-85 -114.91 165.07 13.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 300' ' ' SER . 26.5 mm -143.34 140.85 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HE2' HD13 ' A' ' 301' ' ' LEU . 67.3 m-85 -109.16 116.04 31.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -101.76 136.93 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.428 ' N ' ' SD ' ' A' ' 283' ' ' MET . 13.4 p -125.55 138.68 32.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 0.0 110.883 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.491 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.78 -21.68 33.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 49.9 mmm -77.16 -24.15 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -118.03 29.51 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 15.1 pt20 -88.41 60.3 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 291' ' ' THR . 1.6 t -86.83 141.23 28.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.5 m 50.6 24.92 1.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 289' ' ' THR . 36.6 p -94.54 -41.55 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.6 m -51.41 -26.64 8.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.1 -30.99 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.8 m95 -81.21 179.51 7.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 314' ' ' ILE . 2.1 pt -160.02 119.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.83 111.44 10.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.455 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.4 167.41 23.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.522 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 305' ' ' CYS . 61.5 m -121.32 126.91 50.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 111.143 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.651 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.6 t -66.01 153.58 41.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.422 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.1 tp -92.75 -48.71 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -58.84 -57.68 11.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.7 p -78.61 -50.11 12.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.78 46.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.615 ' O ' HG23 ' A' ' 299' ' ' THR . 11.9 t -84.3 166.81 17.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 78.5 p -129.53 145.89 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.31 179.38 46.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -87.9 144.24 26.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.604 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -147.37 155.36 46.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.595 0.712 . . . . 0.0 110.897 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.78 128.73 16.43 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.22 -6.19 6.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -99.23 21.39 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.587 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 9.2 m-85 -129.73 -1.79 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.53 177.02 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.8 t -153.68 164.74 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -64.49 144.87 56.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 317' ' ' ALA . 0.8 OUTLIER -131.92 130.34 41.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -130.99 150.18 52.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 22.4 tm0? -108.69 133.01 53.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 65.9 t -64.43 133.92 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 263' ' ' TYR . 2.4 pt -111.06 -19.59 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.442 ' CE2' HD12 ' A' ' 262' ' ' ILE . 80.6 m-85 -152.97 141.71 14.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 148.55 65.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 1.009 ' CB ' HD12 ' A' ' 275' ' ' LEU . 29.3 t80 -133.93 157.15 46.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.418 ' N ' ' CG ' ' A' ' 265' ' ' TYR . 6.4 m -126.28 101.05 28.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.72 169.73 18.17 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -124.57 -14.68 6.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -152.82 -175.57 5.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -28.9 61.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -42.97 7.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -101.45 178.8 4.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 6.9 tp -132.96 143.68 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.14 147.31 53.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 1.009 HD12 ' CB ' ' A' ' 265' ' ' TYR . 17.5 mt -115.9 124.67 51.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.4 t -115.61 130.59 24.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.634 0.731 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 111.43 2.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.63 2.64 19.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -111.19 175.16 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -115.38 164.63 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 309' ' ' LEU . 34.9 mm -138.77 121.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.504 ' CE2' HD13 ' A' ' 301' ' ' LEU . 20.6 m-85 -85.71 115.73 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -99.47 130.18 45.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.447 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.6 p -126.1 142.85 43.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -30.26 22.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.692 2.262 . . . . 0.0 112.364 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 65.2 mtp -76.6 -3.44 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.58 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 20.2 mm-40 -122.28 5.28 9.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.38 92.54 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.751 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.6 p -115.19 123.79 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.7 m 50.83 29.09 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 294' ' ' GLY . 16.7 p -86.52 -55.51 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 291' ' ' THR . 31.3 t -34.41 -37.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.27 -49.03 79.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.15 -26.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 296' ' ' ILE . 65.2 m95 -79.87 -179.77 7.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -158.38 119.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 19.9 t80 -78.44 112.77 15.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.46 175.25 21.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 305' ' ' CYS . 57.0 m -125.33 133.26 52.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 281' ' ' ILE . 28.3 t -71.14 150.62 45.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.9 tp -95.49 -40.29 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 93.3 m -69.88 -44.95 68.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -91.88 -53.06 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 105.58 8.73 34.55 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 299' ' ' THR . 8.9 t -78.34 166.55 22.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 54.0 p -139.17 133.88 32.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.2 -175.11 45.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.751 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -88.72 140.1 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.76 156.05 62.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.748 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.78 122.88 9.55 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.43 -10.4 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -94.6 22.77 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.688 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.9 m-85 -129.87 -2.83 4.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -132.14 -179.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.2 t -157.38 167.77 29.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 142.13 55.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.915 0.388 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.424 ' O ' HD23 ' A' ' 259' ' ' LEU . 3.5 m -129.3 129.83 45.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 314' ' ' ILE . 11.9 mt -130.41 150.66 51.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 315' ' ' THR . 6.2 tt0 -110.19 128.35 55.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.4 133.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.36 -21.12 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -152.24 144.09 16.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.67 68.68 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.509 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 29.3 t80 -147.8 127.08 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.8 m -95.84 108.22 39.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 111.162 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.9 Cg_endo -69.73 172.04 13.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.234 . . . . 0.0 112.354 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -123.3 -13.38 7.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -162.44 -179.15 6.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.6 p-10 -63.63 -37.45 87.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.5 OUTLIER -37.3 -41.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.0 pm0 -107.63 174.62 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 4.5 tp -128.32 144.93 51.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.58 128.93 38.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 309' ' ' LEU . 7.7 mt -97.18 129.45 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.55 130.57 24.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.624 0.726 . . . . 0.0 111.134 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 103.74 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.34 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.47 5.37 7.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -111.29 169.97 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 281' ' ' ILE . 15.6 m-85 -113.32 145.44 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 300' ' ' SER . 32.1 mm -124.21 120.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.541 ' CE2' HD13 ' A' ' 301' ' ' LEU . 17.9 m-85 -83.33 119.29 24.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -99.66 137.85 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.497 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.8 p -138.97 120.12 9.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.82 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 0.51 5.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -94.85 -24.12 17.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.538 ' O ' ' CD1' ' A' ' 297' ' ' TYR . 16.9 mm-40 -122.06 41.41 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 143.11 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.639 ' O ' HD11 ' A' ' 308' ' ' LEU . 24.9 p -147.79 116.51 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 23.4 m 64.4 25.4 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 294' ' ' GLY . 28.1 p -83.02 -52.3 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 291' ' ' THR . 12.5 m -36.66 -41.51 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -56.88 -45.37 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 172.53 -23.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -79.88 -179.9 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.736 0.303 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.36 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 287' ' ' GLU . 40.4 t80 -94.3 108.45 20.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -132.85 -177.29 14.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.0 m -132.48 126.29 32.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.613 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.0 OUTLIER -62.6 166.32 5.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.7 tp -107.08 -30.32 8.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -75.63 -54.17 7.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 9.3 p -90.28 -34.46 15.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.76 62.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 61.9 m -86.65 145.9 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.4 p -114.1 132.7 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.97 179.22 42.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 289' ' ' THR . 11.4 mt -89.5 142.64 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.77 156.42 48.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 120.89 7.6 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.718 2.279 . . . . 0.0 112.364 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.37 -11.57 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -92.86 19.9 7.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.8 m-85 -128.24 -1.6 5.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.981 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.44 174.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 260' ' ' GLN . 5.6 t -146.84 159.49 43.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 3.5 mptt -64.74 143.82 57.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.913 0.387 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.9 m -131.21 129.49 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.775 HD13 HD13 ' A' ' 314' ' ' ILE . 10.5 mt -130.21 149.43 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -108.84 124.76 51.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.33 131.32 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -106.93 -12.08 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 75.3 m-85 -161.55 143.45 8.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.68 0.753 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.12 11.46 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 275' ' ' LEU . 3.1 t80 -171.77 118.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.2 m -83.75 113.4 47.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.579 0.704 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 171.95 13.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.395 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -119.89 -13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ASN . . . . . 0.405 ' OD1' ' CD ' ' A' ' 272' ' ' GLU . 2.5 p30 -167.63 -178.26 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.38 -29.67 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -45.33 -42.08 9.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.405 ' CD ' ' OD1' ' A' ' 269' ' ' ASN . 11.7 pm0 -106.82 177.28 4.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 12.7 tp -130.45 147.5 52.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.67 151.87 46.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.676 HD23 ' CD2' ' A' ' 265' ' ' TYR . 3.7 mm? -115.87 128.75 56.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.87 127.15 26.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.606 0.717 . . . . 0.0 111.139 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 104.55 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.65 2.233 . . . . 0.0 112.309 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.07 11.19 8.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -114.64 174.67 5.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -115.41 165.22 13.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.737 HD13 ' HA ' ' A' ' 300' ' ' SER . 15.1 mm -143.82 128.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -93.02 116.91 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -101.76 134.82 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.435 ' N ' ' SD ' ' A' ' 283' ' ' MET . 0.7 OUTLIER -125.66 141.46 39.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.684 0.754 . . . . 0.0 110.799 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.83 19.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 8.7 mtp -77.47 -2.07 33.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 12.4 mt-10 -121.77 8.09 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.98 85.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.658 ' O ' HD21 ' A' ' 308' ' ' LEU . 2.4 p -109.05 121.81 45.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.3 m 55.26 26.0 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 32.9 p -86.97 -44.15 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.2 t -43.15 -40.73 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.97 -40.43 80.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.81 -21.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.453 ' HB3' HD22 ' A' ' 308' ' ' LEU . 72.0 m95 -80.01 -179.78 7.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -156.74 122.04 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 36.5 t80 -84.59 111.71 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -137.19 -172.9 12.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 65.5 m -138.01 124.1 20.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.17 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.737 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -62.21 168.89 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.17 -41.07 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -67.23 -65.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.3 p -75.12 -31.92 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.03 63.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.496 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.68 152.59 18.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 33.5 p -121.34 136.85 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.1 -179.46 47.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.658 HD21 ' O ' ' A' ' 289' ' ' THR . 10.8 mt -87.93 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.76 156.68 65.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.603 0.716 . . . . 0.0 110.927 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 0.0 112.347 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -54.5 -14.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.26 19.14 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.546 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.68 -0.19 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.82 178.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.2 t -148.74 157.95 43.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -65.67 151.46 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.834 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.901 0.381 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.61 132.04 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -135.03 150.97 50.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -108.74 131.74 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.52 126.48 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 2.2 pt -102.56 -18.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 70.1 m-85 -158.24 144.06 12.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 158.31 57.37 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.722 2.281 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -150.54 133.07 15.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.6 m -102.46 106.94 51.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.621 0.724 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.432 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.7 Cg_endo -69.75 170.89 15.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.725 2.283 . . . . 0.0 112.345 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.87 -15.37 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ASN . . . . . 0.404 ' H ' ' CD ' ' A' ' 272' ' ' GLU . 56.7 m-80 -150.66 -175.71 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.58 -40.76 69.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -38.59 -42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.3 pm0 -99.75 171.06 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 5.8 tp -131.9 150.96 52.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.3 tt0 -68.81 150.67 47.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 309' ' ' LEU . 10.9 mt -119.71 130.83 55.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.38 129.26 25.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.32 3.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.83 0.31 22.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 281' ' ' ILE . 26.9 m-85 -108.67 166.23 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 300' ' ' SER . 21.1 mm -142.35 124.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 22.7 m-85 -90.68 114.78 27.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.4 tmm? -100.3 141.61 32.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.491 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.1 t -141.27 138.72 17.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.664 0.745 . . . . 0.0 110.866 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.439 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.4 Cg_endo -69.78 -18.47 36.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 0.0 112.331 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 11.2 mtp -64.11 -31.61 72.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -123.0 41.74 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 8.3 pt20 -91.38 66.95 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 291' ' ' THR . 1.3 t -93.65 142.27 27.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.1 m 45.48 25.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 289' ' ' THR . 40.5 p -91.53 -58.32 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 291' ' ' THR . 26.8 m -36.2 -38.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.59 -46.69 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.52 -26.88 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.1 m95 -83.17 -179.98 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.752 0.31 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.33 136.53 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.493 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 38.6 t80 -89.48 111.72 22.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.475 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.46 167.66 22.98 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 92.6 m -126.14 116.49 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.601 ' HA ' HD13 ' A' ' 281' ' ' ILE . 7.2 t -55.28 147.66 16.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.575 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -89.24 -43.04 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.1 m -65.25 -60.95 2.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 30.4 p -75.2 -50.35 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.99 9.58 42.17 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.01 153.37 23.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.7 p -125.0 137.96 54.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -175.46 -173.42 41.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 20.5 mt -90.99 140.86 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.597 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -144.15 156.02 58.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 110.883 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.552 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.72 117.61 5.18 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.0 -14.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -90.44 21.21 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.552 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.18 -5.51 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -125.93 169.69 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.7 t -150.24 167.49 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.483 ' HD3' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -74.42 143.76 44.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 1.7 m -129.2 127.24 40.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -127.54 150.03 49.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.11 127.21 53.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.89 138.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.468 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -114.89 -14.93 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 81.7 m-85 -159.2 146.7 13.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.686 0.755 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 165.34 31.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 44.2 t80 -160.75 123.4 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.8 m -90.29 110.07 38.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.584 0.706 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 52.9 Cg_endo -69.84 171.13 15.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.681 2.254 . . . . 0.0 112.269 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -119.7 -14.38 9.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -167.26 -178.67 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.43 -34.9 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -38.87 -44.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.435 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 2.6 pm0 -105.32 177.38 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.504 ' O ' ' CD2' ' A' ' 275' ' ' LEU . 4.0 tp -132.72 142.38 49.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.589 ' C ' HD22 ' A' ' 275' ' ' LEU . 34.4 tt0 -57.67 150.82 18.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.589 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.8 mm? -114.45 127.33 55.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.61 123.44 29.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 103.97 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.92 12.76 7.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.469 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -115.31 178.64 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -116.54 160.5 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.481 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 18.2 mm -138.98 133.28 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.8 m-85 -96.02 110.55 22.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -101.34 134.11 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 283' ' ' MET . 22.1 t -137.6 140.83 31.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.651 0.738 . . . . 0.0 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.434 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.73 -26.01 28.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -61.26 -33.61 73.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -117.45 41.39 2.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 288' ' ' GLN . 11.5 pt20 -96.08 95.91 8.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.45 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.6 p -115.11 137.31 52.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 9.5 m 48.49 25.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 43.5 p -88.53 -38.47 14.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.0 t -55.4 -24.84 32.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.94 -29.64 63.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 156.48 -18.57 0.44 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 55.9 m95 -86.99 179.6 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.14 124.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -80.19 111.15 16.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.84 175.09 19.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 70.3 m -131.7 132.46 43.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.2 t -65.58 150.56 48.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.56 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.6 tp -95.4 -35.42 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 48.4 m -77.18 -49.91 14.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 82.1 p -84.12 -52.46 6.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.05 3.16 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.462 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 82.9 m -77.44 147.89 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 89.6 p -120.73 140.37 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.28 -177.25 46.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.7 mt -88.18 149.56 23.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -153.06 155.54 32.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.553 0.692 . . . . 0.0 110.961 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.7 126.84 13.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.692 2.261 . . . . 0.0 112.369 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.22 -7.27 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -97.62 21.63 10.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.7 m-85 -129.35 -3.88 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.28 177.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.6 t -149.77 156.69 42.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -59.24 137.57 57.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.915 0.388 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 5.6 m -123.54 125.24 44.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.997 HD13 HD13 ' A' ' 314' ' ' ILE . 11.8 mt -125.99 149.82 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -108.83 130.8 55.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.92 144.2 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -121.61 -14.6 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 71.4 m-85 -161.5 145.71 9.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.654 0.74 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 163.8 36.9 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.551 ' HD2' HD23 ' A' ' 275' ' ' LEU . 50.8 t80 -160.81 128.3 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.8 m -97.78 108.92 48.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.565 0.698 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.43 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.81 165.15 31.99 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.342 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -113.68 -21.9 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -154.02 -179.16 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.6 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -39.24 -45.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.8 pm0 -105.21 178.96 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.7 tp -132.24 151.94 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.748 ' C ' HD22 ' A' ' 275' ' ' LEU . 31.3 tt0 -64.9 155.85 32.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.3 mm? -121.31 131.54 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.91 126.26 25.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.666 0.746 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.01 2.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.649 2.233 . . . . 0.0 112.358 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.69 9.66 20.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -112.85 178.69 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -117.16 169.49 9.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.467 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 17.3 mm -146.14 125.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.557 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 24.7 m-85 -91.77 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -99.23 135.57 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.474 ' N ' ' SD ' ' A' ' 283' ' ' MET . 30.6 t -128.56 142.41 44.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.717 0.77 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -30.83 21.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.258 . . . . 0.0 112.345 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 47.7 mtp -77.26 4.39 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 66.9 mm-40 -127.41 -0.54 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -58.8 85.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.587 ' O ' HD21 ' A' ' 308' ' ' LEU . 1.4 p -109.32 107.92 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.0 m 66.82 28.02 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.9 p -88.24 -48.01 8.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.155 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 81.1 p -39.8 -39.57 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.18 -44.95 92.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 171.63 -23.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 62.9 m95 -79.73 -179.85 7.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.754 0.312 . . . . 0.0 110.916 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.643 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -157.93 121.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 32.0 t80 -79.92 113.7 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.77 175.52 20.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 305' ' ' CYS . 13.8 m -125.18 131.92 53.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.31 . . . . 0.0 111.133 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.4 t -66.1 148.74 51.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 12.3 tp -97.17 -37.18 10.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.8 m -73.55 -44.78 56.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -94.07 -46.47 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.86 3.36 49.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.551 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 299' ' ' THR . 56.2 m -71.65 176.9 4.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 6.7 m -149.07 140.26 23.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.19 48.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 289' ' ' THR . 12.2 mt -88.98 136.2 33.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -138.77 153.44 72.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 0.0 110.908 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.4 Cg_endo -69.85 123.9 10.52 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.339 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.73 -11.14 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -92.49 19.36 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 8.1 m-85 -128.91 -2.5 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.997 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.06 177.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.9 t -153.05 159.49 42.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -55.16 148.2 14.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.104 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.917 0.389 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 3.0 m -121.96 130.55 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 314' ' ' ILE . 11.6 mt -128.3 150.21 50.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 315' ' ' THR . 8.8 tt0 -108.57 131.09 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.18 133.17 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -103.48 -28.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -145.01 144.95 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 151.91 69.46 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.494 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 24.3 t80 -148.49 120.35 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.9 m -91.3 107.4 21.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.49 16.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -120.41 -14.66 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -157.81 176.63 12.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 271' ' ' ASP . 12.3 p-10 -62.92 -39.72 95.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.1 -39.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -105.82 175.14 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.633 HD11 ' SG ' ' A' ' 305' ' ' CYS . 5.5 tp -125.67 143.97 50.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.19 130.27 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.442 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -101.89 131.96 47.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.3 t -123.79 132.87 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.713 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.81 103.45 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.311 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.56 14.51 6.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -116.73 177.99 4.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.44 ' O ' HD13 ' A' ' 281' ' ' ILE . 9.8 m-85 -120.48 161.36 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 300' ' ' SER . 38.6 mm -142.51 139.39 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.3 m-85 -101.17 113.53 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -100.26 133.69 44.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.456 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.0 OUTLIER -133.76 136.94 27.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 0.0 110.869 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 54.0 Cg_endo -69.78 -20.36 34.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.29 -32.28 73.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -119.29 42.73 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 12.3 pt20 -94.21 81.78 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 291' ' ' THR . 35.9 p -94.83 137.5 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.7 m 39.45 31.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 289' ' ' THR . 34.6 p -88.33 -58.37 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 291' ' ' THR . 17.8 m -35.89 -43.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.35 -46.45 62.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.71 -26.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 296' ' ' ILE . 74.2 m95 -82.77 179.92 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.0 110.926 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -160.17 123.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -78.18 115.83 18.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.45 167.74 24.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 90.2 m -122.41 137.63 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.541 ' HA ' HD13 ' A' ' 281' ' ' ILE . 23.7 t -69.16 151.3 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.535 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 9.1 tp -100.02 -31.18 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 98.8 m -76.98 -36.76 56.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 20.2 p -102.12 -65.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.34 6.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 273' ' ' LEU . 28.5 p -72.09 155.07 40.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.1 p -124.52 154.57 40.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 173.92 179.52 44.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 309' ' ' LEU . 12.1 mt -87.56 147.52 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.585 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.3 OUTLIER -150.0 155.23 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.907 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.551 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 120.03 6.88 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.06 -12.43 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -92.67 21.9 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.551 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.45 -3.83 4.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.11 -179.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 260' ' ' GLN . 6.9 t -156.2 160.03 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -59.37 143.74 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 258' ' ' THR . 11.1 tp10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 8.3 m -123.72 123.11 39.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.746 HD13 HD13 ' A' ' 314' ' ' ILE . 6.9 mt -125.41 151.9 45.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -108.87 130.36 55.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.8 126.57 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -100.19 -17.01 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -156.27 145.63 15.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.671 0.748 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 162.79 40.72 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.675 2.25 . . . . 0.0 112.396 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 1.028 ' CB ' HD12 ' A' ' 275' ' ' LEU . 28.1 t80 -147.81 144.3 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.4 m -114.74 99.42 51.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.55 21.23 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.369 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -124.88 -14.01 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -147.64 -178.99 6.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.8 m-20 -71.87 -42.47 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 270' ' ' ASP . 29.4 t70 -37.34 -39.93 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.55 176.89 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.1 tp -137.8 153.6 49.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 21.9 tt0 -74.98 150.83 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 1.028 HD12 ' CB ' ' A' ' 265' ' ' TYR . 26.0 mt -117.71 133.66 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.23 130.87 24.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.634 0.731 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 105.65 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.24 . . . . 0.0 112.346 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.32 16.13 7.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -118.34 171.08 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.425 ' CD1' HG22 ' A' ' 258' ' ' THR . 9.0 m-85 -110.8 159.76 17.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.493 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 32.2 mm -136.76 133.95 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 301' ' ' LEU . 28.9 m-85 -99.33 111.64 23.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -100.41 138.92 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.491 ' N ' ' SD ' ' A' ' 283' ' ' MET . 7.7 t -137.74 134.22 18.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.731 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.417 ' HA ' ' CD ' ' A' ' 288' ' ' GLN . 53.2 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.247 . . . . 0.0 112.329 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.3 mmt -82.04 -27.95 32.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -126.1 42.14 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 285' ' ' PRO . 12.8 pt20 -98.14 75.04 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.558 ' O ' HD21 ' A' ' 308' ' ' LEU . 35.4 p -88.59 142.8 27.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 13.0 m 40.44 33.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.799 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 289' ' ' THR . 54.9 p -91.58 -57.46 2.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.8 t -38.59 -40.41 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -53.82 -44.42 70.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 175.37 -25.34 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.531 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.9 m95 -85.01 179.86 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -159.55 123.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 26.2 t80 -76.81 114.78 15.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLY . . . . . 0.493 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -134.55 163.82 24.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 93.1 m -116.26 129.08 56.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 111.131 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -65.62 151.64 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.819 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.9 tp -102.5 -29.5 11.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.7 m -81.87 -38.54 25.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 77.3 p -103.47 -38.96 6.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 -13.63 60.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 95.4 m -53.05 166.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.0 m -146.83 128.3 15.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.07 33.8 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.558 HD21 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -89.09 143.5 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.44 156.9 49.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.719 . . . . 0.0 110.886 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.655 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.7 117.01 4.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.248 . . . . 0.0 112.362 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.42 ' HA ' HD11 ' A' ' 296' ' ' ILE . 7.7 pt-20 -56.07 -13.21 1.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.26 23.45 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.612 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.3 m-85 -130.57 -3.1 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.746 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -126.1 177.2 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.7 t -151.97 159.35 43.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -61.78 151.08 35.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.963 0.411 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.1 m -125.89 126.56 44.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.974 HD13 HD13 ' A' ' 314' ' ' ILE . 14.3 mt -124.03 151.94 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -108.74 130.75 55.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.1 131.8 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.9 pt -107.93 -19.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.157 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -155.82 143.86 14.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.693 0.759 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 153.9 68.46 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.717 2.278 . . . . 0.0 112.314 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 35.9 t80 -150.69 125.65 9.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.947 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.14 109.43 44.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.569 0.7 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.406 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.73 166.79 26.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -115.69 -20.71 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -153.32 -179.2 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -64.87 -32.39 74.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -41.6 -44.09 2.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.2 pm0 -102.98 171.33 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.2 tp -124.59 147.05 48.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.433 ' C ' HD23 ' A' ' 275' ' ' LEU . 26.9 tt0 -66.56 140.26 57.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 309' ' ' LEU . 5.9 mt -112.13 127.68 55.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 277' ' ' PRO . 87.2 t -124.47 133.5 24.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.629 0.728 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.9 Cg_endo -69.71 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.56 2.94 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -111.18 162.6 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 281' ' ' ILE . 19.9 m-85 -106.06 159.19 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 300' ' ' SER . 20.0 mm -137.76 120.2 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.458 ' CE2' HD13 ' A' ' 301' ' ' LEU . 35.1 m-85 -81.98 114.76 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -99.47 138.03 37.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.496 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.1 p -137.66 125.73 14.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -10.71 29.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 40.5 mtp -83.04 -28.94 29.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 297' ' ' TYR . 50.5 mm-40 -117.65 40.41 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.448 ' CD ' ' O ' ' A' ' 288' ' ' GLN . 2.9 pp0? -96.15 123.68 39.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.481 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.5 p -129.06 126.92 40.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.0 m 55.1 25.18 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 294' ' ' GLY . 41.8 p -87.51 -54.53 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 291' ' ' THR . 28.0 t -36.35 -37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -61.57 -48.7 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -179.44 -27.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -79.82 -179.76 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.726 0.298 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.428 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.7 pt -152.34 134.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 287' ' ' GLU . 53.6 t80 -96.21 111.03 23.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -138.38 177.48 20.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 305' ' ' CYS . 58.6 m -127.37 119.55 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 111.16 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.854 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -55.26 168.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.458 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.8 tp -111.31 -28.65 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -74.38 -47.87 31.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.6 p -95.23 -28.95 14.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 80.7 16.04 76.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.753 ' O ' HG23 ' A' ' 299' ' ' THR . 5.9 t -88.55 169.04 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 79.6 p -131.34 142.78 50.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.95 48.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.643 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -92.25 151.45 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -157.54 157.5 30.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 110.958 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 123.76 10.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.757 2.305 . . . . 0.0 112.34 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.29 -8.97 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.21 19.18 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.506 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.0 m-85 -126.56 -1.18 6.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.974 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.25 175.94 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.4 t -149.71 165.4 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 4.7 mptt -67.16 143.8 56.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.854 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.5 m -127.87 133.63 49.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 314' ' ' ILE . 9.2 mt -132.67 155.12 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -110.3 132.52 54.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.65 137.65 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.32 -18.69 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -155.02 142.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.75 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 158.17 57.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -153.3 125.33 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 m -95.62 109.99 48.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG2' ' A' ' 272' ' ' GLU . 54.1 Cg_endo -69.8 171.07 15.19 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -125.64 -13.69 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ASN . . . . . 0.431 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 23.3 m-80 -151.42 -175.39 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.18 -21.94 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 0.9 OUTLIER -104.76 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' A' ' 305' ' ' CYS . 6.7 tp -120.35 148.42 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.414 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 36.7 tt0 -72.48 145.56 47.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -115.73 135.51 53.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.492 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.5 t -127.54 134.81 26.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 111.16 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.492 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.3 Cg_endo -69.76 113.54 3.41 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 109.57 5.78 29.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.525 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -110.82 165.4 11.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.342 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.536 ' O ' HD13 ' A' ' 281' ' ' ILE . 28.2 m-85 -107.28 163.46 13.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 280' ' ' PHE . 15.1 mm -146.09 122.85 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.51 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 41.3 m-85 -81.93 128.83 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -98.96 129.39 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 108.21 19.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.723 0.773 . . . . 0.0 110.901 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -3.11 11.34 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -88.88 -24.89 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 297' ' ' TYR . 55.3 mm-40 -122.97 40.85 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.34 109.12 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.452 ' O ' HD11 ' A' ' 308' ' ' LEU . 21.0 p -114.05 119.26 36.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.9 m 67.36 27.78 8.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.837 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 33.6 p -87.85 -41.22 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.8 t -49.28 -27.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 294' ' ' GLY . 4.9 pt-20 -70.9 -42.96 69.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 293' ' ' GLU . . . 173.77 -25.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 296' ' ' ILE . 73.5 m95 -80.54 179.28 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.717 0.294 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 311' ' ' GLU . 1.1 pt -156.83 126.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 287' ' ' GLU . 29.9 t80 -84.66 111.76 19.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -133.65 -173.56 13.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 91.8 m -133.21 141.03 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.7 t -74.74 149.6 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.51 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.1 tp -96.08 -39.36 9.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.5 m -71.35 -39.95 71.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.0 p -100.04 -63.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.84 10.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' A' ' 273' ' ' LEU . 2.3 p -79.53 153.77 29.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.4 p -120.25 147.86 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.79 -175.54 47.65 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -94.79 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.622 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.74 157.13 62.31 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.59 0.71 . . . . 0.0 110.913 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.654 2.236 . . . . 0.0 112.327 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.415 ' HA ' HD11 ' A' ' 296' ' ' ILE . 5.2 pt-20 -55.0 -15.52 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -88.74 19.69 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.544 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.69 -2.57 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.963 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -128.41 173.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.3 t -147.79 151.78 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -59.49 142.83 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.882 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 47.9 t -109.85 132.21 54.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.822 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 53.7 m -93.03 87.03 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.27 108.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.4 t -56.29 176.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.0 t -52.69 -55.66 21.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.05 179.23 53.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.1 t -162.73 158.56 23.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.911 0.386 . . . . 0.0 110.795 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 53.7 mtt85 -62.62 -31.01 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -128.43 153.41 47.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 254' ' ' ALA . 4.4 mp -89.38 106.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.516 ' HB3' ' CD1' ' A' ' 253' ' ' PHE . 6.2 ttm180 -124.55 -48.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 252' ' ' ARG . 6.7 m-85 -111.44 12.52 21.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.553 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -106.0 157.48 17.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -106.03 46.12 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.571 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 19.2 m80 -74.59 136.73 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -85.21 162.77 19.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.944 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.1 m -130.63 130.89 44.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 10.9 mt -129.73 150.45 51.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -108.68 131.53 54.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.37 128.69 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.9 pt -104.06 -16.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 79.2 m-85 -158.42 144.46 12.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.74 0.781 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 157.53 60.21 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.698 2.265 . . . . 0.0 112.332 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 15.6 t80 -148.83 127.67 12.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -96.53 107.0 33.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.549 0.69 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 170.92 15.44 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.335 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -125.81 -15.04 6.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.432 ' C ' ' OE1' ' A' ' 272' ' ' GLU . 65.9 m-80 -150.37 -175.71 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 9.0 t70 -72.76 -42.27 64.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 37.8 t70 -37.7 -38.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 269' ' ' ASN . 1.2 pm0 -102.54 168.22 9.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.8 tp -127.12 149.23 50.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.471 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 15.7 tt0 -69.72 143.9 52.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -113.36 141.28 47.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 277' ' ' PRO . 57.6 t -131.53 134.72 25.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.77 112.66 3.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.32 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.39 6.66 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -109.48 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -115.43 167.14 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 309' ' ' LEU . 29.2 mm -145.35 115.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.439 ' CE2' HD13 ' A' ' 301' ' ' LEU . 29.2 m-85 -85.02 118.7 24.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -102.31 137.95 39.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.571 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 1.2 p -134.66 140.26 34.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.67 0.748 . . . . 0.0 110.843 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -26.54 27.42 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.35 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.0 mtp -81.05 -1.72 45.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 71.8 mm-40 -126.91 18.52 7.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -77.14 127.8 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.815 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.4 p -148.93 113.4 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 63.78 25.15 14.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.4 p -88.59 -45.78 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.0 m -44.33 -24.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.31 -49.4 19.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 179.9 -26.55 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -80.23 -179.45 7.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.74 0.305 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 314' ' ' ILE . 1.0 OUTLIER -153.47 127.14 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 27.6 t80 -88.0 120.23 29.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -148.67 -173.71 19.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 38.8 m -130.42 139.06 50.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.333 . . . . 0.0 111.16 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.451 ' HA ' HD13 ' A' ' 281' ' ' ILE . 27.3 t -75.17 158.3 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.439 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.0 tp -100.14 -34.83 9.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 62.9 m -73.6 -61.29 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 67.5 p -78.62 -49.96 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.95 11.65 31.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.456 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.57 149.71 21.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.8 t -118.18 154.41 32.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 172.61 -173.29 45.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.815 HD21 ' O ' ' A' ' 289' ' ' THR . 20.6 mt -91.73 137.1 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.5 155.48 63.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.541 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.6 Cg_endo -69.8 119.99 6.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -57.06 -12.55 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.75 20.42 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.541 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.2 m-85 -129.04 -3.62 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -129.89 177.27 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 4.7 t -152.49 159.81 43.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -59.55 149.63 29.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -84.16 108.37 17.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.56 24.26 12.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -97.05 -39.26 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.62 140.93 32.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 83.0 p -128.79 142.69 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.518 HG21 ' HB2' ' A' ' 325' ' ' PHE . 3.1 p -72.74 -177.05 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.469 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.4 p-90 -108.48 -41.28 4.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.469 HG12 ' CE3' ' A' ' 323' ' ' TRP . 6.2 mm -130.09 -31.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.518 ' HB2' HG21 ' A' ' 322' ' ' THR . 30.8 m-85 -47.6 116.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -89.55 -53.78 4.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 82.72 -80.28 1.82 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.535 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 82.7 p -174.13 141.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 95.9 p -157.18 153.58 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 145.97 -93.8 0.16 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.7 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.31 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 331' ' ' PRO . 4.1 t 37.27 41.77 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 40.6 m -111.82 138.88 47.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 89.5 p -74.27 -44.08 54.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.7 t -77.11 96.79 4.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.13 135.88 12.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 19.3 t -88.66 117.88 27.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.6 m -60.97 151.13 31.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -172.52 102.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 88.4 p -141.59 166.11 25.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.88 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -73.82 121.58 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -48.92 141.87 7.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 252' ' ' ARG . 86.1 mt -71.29 -37.43 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 251' ' ' ILE . 13.6 mmt180 38.33 44.85 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 47.95 53.48 11.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -86.06 -179.32 6.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 255' ' ' ASN . 2.4 p30 -77.96 47.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.571 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 9.5 m80 -98.75 141.27 31.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.486 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 20.3 pt-20 -98.35 155.0 17.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 18.2 m -116.02 137.08 52.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.929 HD13 HD13 ' A' ' 314' ' ' ILE . 9.1 mt -134.02 150.62 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -108.79 132.69 53.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.63 129.71 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 3.0 pt -107.38 -14.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.472 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 89.3 m-85 -159.28 143.26 11.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.654 0.74 . . . . 0.0 110.958 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 160.05 51.18 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -154.61 127.05 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.955 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.75 109.61 47.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.74 172.12 13.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -123.96 -14.28 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -162.49 -177.46 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -63.89 -36.67 84.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.42 -42.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.437 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.2 pm0 -105.23 175.11 5.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -130.58 143.11 50.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.63 144.01 56.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 309' ' ' LEU . 6.4 mt -112.51 142.51 44.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.37 128.21 19.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 104.31 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.277 . . . . 0.0 112.368 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.22 5.16 8.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -112.55 171.31 7.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.52 162.06 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 300' ' ' SER . 17.5 mm -135.09 132.38 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -99.49 106.21 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.7 tmm? -98.97 134.21 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.571 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 8.5 p -126.12 143.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.661 0.743 . . . . 0.0 110.875 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -24.47 29.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.351 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 44.2 mtp -81.53 -3.19 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 66.3 mm-40 -126.33 9.69 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -69.27 87.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 308' ' ' LEU . 19.9 p -104.99 128.9 53.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m 48.09 26.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 294' ' ' GLY . 29.4 p -86.05 -54.48 4.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.2 t -35.36 -36.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 18.4 tp10 -62.66 -47.72 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.15 -26.2 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.457 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.3 m95 -79.93 -179.78 7.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.903 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.519 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.89 125.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.7 t80 -84.2 111.14 19.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -134.29 -177.77 15.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 305' ' ' CYS . 97.2 m -133.18 129.6 38.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.123 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.407 ' HA ' HD13 ' A' ' 281' ' ' ILE . 2.4 t -66.17 154.77 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.3 tp -99.82 -29.94 12.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 5.2 m -72.65 -52.64 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.0 p -88.8 -55.37 3.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.93 23.36 6.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.555 ' O ' HG23 ' A' ' 299' ' ' THR . 11.6 t -96.15 166.28 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 81.1 p -129.02 143.39 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.85 47.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 289' ' ' THR . 10.9 mt -88.95 139.17 30.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 110.914 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.21 157.19 63.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.559 0.695 . . . . 0.0 110.946 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.3 Cg_endo -69.79 120.7 7.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.657 2.238 . . . . 0.0 112.344 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -58.68 -11.62 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -93.03 20.5 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.538 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.6 m-85 -128.74 -3.06 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -130.16 177.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.8 t -153.34 162.63 41.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -66.31 148.01 52.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.54 92.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.084 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -108.86 22.18 16.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.71 -55.9 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.96 118.21 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 34.6 t -144.96 157.54 44.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 15.1 p -66.6 -176.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.568 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.0 p-90 -119.5 -46.94 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.568 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.1 mm -124.15 -48.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 324' ' ' ILE . 12.5 m-30 -34.32 143.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.66 97.65 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.84 113.49 2.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 329' ' ' SER . 46.6 m -88.39 112.78 23.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 328' ' ' SER . 18.9 p 37.58 43.84 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -130.36 82.81 0.32 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -7.82 22.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 16.2 t -56.71 -50.76 71.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 57.6 m -78.38 -44.67 24.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.2 t -125.33 132.47 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.2 p -52.63 129.88 30.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.23 111.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 92.7 p -87.08 145.34 26.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.381 . . . . 0.0 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 94.9 p -61.34 -50.81 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.814 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.78 -172.38 43.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.6 t -96.4 110.08 22.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.864 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.29 140.95 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -172.56 143.21 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 256' ' ' HIS . 75.7 mt -83.13 -41.89 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 253' ' ' PHE . 5.6 mmm180 39.3 44.58 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 252' ' ' ARG . 5.5 m-85 35.69 47.41 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -104.19 -43.27 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -132.54 -53.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 251' ' ' ILE . 33.8 m80 -74.36 138.41 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -101.88 175.54 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.4 ' O ' HD23 ' A' ' 259' ' ' LEU . 1.8 m -133.03 126.78 32.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.95 151.41 50.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -108.77 133.72 52.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.5 142.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.447 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -119.99 -14.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.3 m-85 -158.33 143.78 12.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.68 0.752 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.49 69.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.977 ' HB2' HD12 ' A' ' 275' ' ' LEU . 41.3 t80 -138.46 144.82 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 11.8 m -115.45 97.66 49.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.69 171.52 14.24 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.341 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.59 -13.22 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -157.32 -179.54 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 271' ' ' ASP . 2.1 p30 -66.87 -38.71 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.67 -38.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -111.49 172.9 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 5.3 tp -129.02 143.62 50.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 275' ' ' LEU . 7.0 tt0 -65.44 150.13 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 265' ' ' TYR . 22.8 mt -117.48 127.12 53.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 277' ' ' PRO . 93.7 t -118.56 132.39 23.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.736 . . . . 0.0 111.129 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.76 110.75 2.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.726 2.284 . . . . 0.0 112.318 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.26 4.56 20.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -110.76 171.67 7.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 281' ' ' ILE . 32.1 m-85 -112.74 167.99 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 280' ' ' PHE . 12.3 mm -144.98 131.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 40.4 m-85 -91.68 120.2 32.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 284' ' ' SER . 1.9 tmm? -99.84 128.24 45.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.58 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 39.6 p -126.63 130.17 23.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.676 0.75 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.514 ' HA ' ' CG ' ' A' ' 288' ' ' GLN . 53.8 Cg_endo -69.7 -13.0 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 0.0 112.369 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.87 -22.45 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.599 ' OE1' ' CE2' ' A' ' 297' ' ' TYR . 13.7 mt-10 -112.27 36.0 3.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.514 ' CG ' ' HA ' ' A' ' 285' ' ' PRO . 9.3 mm100 -84.16 86.79 7.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.565 ' O ' HD11 ' A' ' 308' ' ' LEU . 15.9 p -110.74 108.63 18.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.3 m 61.62 30.73 18.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 293' ' ' GLU . 43.6 p -92.56 -59.67 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.9 m -34.06 -34.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . 9.9 tp10 -63.59 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -174.57 -30.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.524 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -80.13 -179.99 7.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.737 0.303 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.554 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.77 121.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.599 ' CE2' ' OE1' ' A' ' 287' ' ' GLU . 38.9 t80 -72.76 110.92 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -128.89 166.47 21.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 94.5 m -125.79 111.86 15.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.8 t -47.79 147.25 2.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.574 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -96.73 -45.47 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 97.8 m -63.25 -42.37 99.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 33.7 p -96.37 -53.28 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 110.82 0.2 28.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 99.6 m -69.97 151.67 45.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.6 p -124.19 138.14 54.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.65 -175.92 47.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 289' ' ' THR . 14.4 mt -88.38 144.98 26.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.594 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.1 156.49 50.76 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.677 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.5 Cg_endo -69.79 122.0 8.68 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.706 2.27 . . . . 0.0 112.309 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.36 -10.84 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -94.22 23.11 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.753 ' HB3' HD13 ' A' ' 275' ' ' LEU . 10.5 m-85 -130.95 -3.33 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.996 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -130.42 176.56 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.9 t -154.47 152.52 30.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -55.09 141.93 32.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.21 89.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.92 -38.4 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -64.9 -63.72 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 3.1 t 48.96 44.96 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 79.6 p -120.73 92.24 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 325' ' ' PHE . 0.9 OUTLIER -96.64 140.96 30.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.584 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.4 p-90 -72.58 -41.95 65.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.584 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.6 mm -125.36 -55.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.505 ' HB2' HG21 ' A' ' 322' ' ' THR . 96.5 m-85 -34.36 139.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.89 -49.76 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 137.1 151.83 6.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.524 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.5 m -81.4 52.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.866 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 60.4 p -167.51 174.16 8.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -175.03 84.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 172.24 13.06 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.644 2.229 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.4 t -82.98 104.65 13.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 67.7 p -38.99 -42.25 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 12.8 m -86.78 104.08 15.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 0.0 110.857 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.1 p -131.27 145.77 52.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 143.23 -120.92 1.6 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.8 p -130.28 169.0 16.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -90.42 109.5 20.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.38 123.94 34.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.5 m -64.58 115.86 5.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.867 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -135.52 163.45 30.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.821 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.45 148.3 33.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.1 121.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.417 ' C ' ' HD3' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -123.52 -36.44 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -66.29 -53.69 33.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -83.52 176.67 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.12 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -125.85 83.21 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.543 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 9.9 m80 -100.0 140.18 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -86.73 171.05 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -133.16 128.79 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.966 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.51 149.27 51.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 25.6 tm0? -108.78 124.59 50.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 85.2 t -58.32 138.45 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.5 pt -115.85 -11.86 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 84.6 m-85 -161.76 144.18 8.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.726 0.774 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.33 64.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.716 2.277 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 38.3 t80 -138.85 135.51 34.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -104.68 105.43 50.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.58 0.705 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 170.68 15.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -125.18 -16.82 5.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.452 ' CG ' ' OE2' ' A' ' 272' ' ' GLU . 0.2 OUTLIER -152.94 173.41 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 271' ' ' ASP . 3.9 t70 -59.62 -41.07 89.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -35.11 -44.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.452 ' OE2' ' CG ' ' A' ' 269' ' ' ASN . 11.6 pm0 -99.29 178.41 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.9 tp -135.37 148.81 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.78 140.68 55.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -111.98 141.17 45.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.513 HG13 ' HD2' ' A' ' 277' ' ' PRO . 96.1 t -129.08 135.24 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.643 0.735 . . . . 0.0 111.129 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.75 104.78 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.69 13.2 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.17 167.74 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.878 0.371 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.444 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.5 m-85 -107.3 166.0 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.703 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.5 mm -144.85 119.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 28.7 m-85 -87.41 115.86 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -98.88 141.38 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.543 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 5.3 t -133.94 142.33 43.05 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -32.63 17.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.638 2.225 . . . . 0.0 112.352 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 63.7 mtp -74.97 -0.55 19.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 15.7 mm-40 -125.43 15.04 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.19 87.59 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.664 ' O ' HD21 ' A' ' 308' ' ' LEU . 8.2 p -114.46 122.32 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.3 m 56.26 25.84 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 31.8 p -89.42 -42.22 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.3 t -48.31 -29.61 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.28 -36.26 76.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.75 -25.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 296' ' ' ILE . 66.2 m95 -80.01 -179.67 7.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.2 pt -157.2 128.41 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 25.1 t80 -86.19 112.47 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.43 ' HA3' HG22 ' A' ' 281' ' ' ILE . . . -135.35 172.42 22.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.472 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 74.0 m -125.96 113.56 17.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.703 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.9 t -50.08 174.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 11.7 tp -114.46 -26.96 7.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -81.46 -54.2 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.3 p -86.73 -27.54 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.07 82.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.2 m -84.63 148.97 26.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 91.0 p -120.3 130.72 54.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.77 -174.69 38.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 289' ' ' THR . 19.7 mt -87.71 149.39 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.64 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -154.95 157.03 31.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.903 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.2 Cg_endo -69.83 122.43 9.09 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.696 2.264 . . . . 0.0 112.289 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.92 -10.07 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -95.48 22.77 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.549 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.4 m-85 -130.47 -2.03 4.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -133.23 172.15 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.5 t -147.17 164.46 33.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.61 151.31 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.22 90.19 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.117 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.52 24.93 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -89.59 84.17 6.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 58.3 m -69.54 127.58 33.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.7 m -92.13 -59.0 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.3 p -118.68 149.54 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.843 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -72.09 -39.01 69.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.843 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 27.4 mt -129.96 -53.52 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 322' ' ' THR . 66.3 m-85 -34.9 133.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -116.18 101.4 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.47 101.8 1.44 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.453 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.5 m -121.84 165.96 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 57.8 m -86.24 134.16 33.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -111.34 166.93 12.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 125.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.325 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -132.39 122.91 25.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -52.6 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.519 179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.9 m 52.03 46.63 26.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -88.41 129.51 35.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.825 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -144.3 -40.92 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 52.0 m -46.73 -49.48 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.877 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -136.64 173.45 11.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.04 34.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -80.77 122.42 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -91.37 168.44 11.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.93 157.91 31.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 251' ' ' ILE . 4.7 mp -95.81 137.86 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -41.89 -58.63 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -65.22 -46.71 79.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 65.82 42.67 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -120.59 40.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.577 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 2.3 m80 -102.84 154.44 19.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -89.81 166.66 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -131.64 127.42 36.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.774 HD13 HD13 ' A' ' 314' ' ' ILE . 9.4 mt -130.18 149.83 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -108.77 136.83 47.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.16 129.14 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.17 -28.67 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -145.52 143.9 21.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 154.16 68.14 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.468 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.0 t80 -147.88 127.55 13.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -94.8 109.13 42.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 172.82 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -124.08 -13.14 7.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -163.4 -178.14 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.3 t70 -64.4 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -37.66 -40.31 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.29 173.09 6.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.99 145.36 51.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 275' ' ' LEU . 60.9 tt0 -63.84 146.13 54.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 309' ' ' LEU . 6.5 mt -117.27 121.37 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 277' ' ' PRO . 99.4 t -117.64 134.33 23.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.713 . . . . 0.0 111.144 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.76 110.56 2.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.339 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.12 1.32 16.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -106.65 169.63 8.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.437 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.9 m-85 -116.03 155.16 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 300' ' ' SER . 40.6 mm -133.49 123.15 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 20.1 m-85 -87.39 119.11 27.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -102.72 141.14 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 23.9 p -134.86 139.35 31.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.684 0.754 . . . . 0.0 110.846 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.04 35.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 2.237 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 39.7 mtp -86.4 2.49 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.582 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 80.7 mm-40 -131.38 12.97 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.24 88.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.6 p -110.26 123.51 49.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.1 m 54.27 25.61 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 28.2 p -88.56 -43.45 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 m -45.0 -34.04 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -65.12 -42.03 94.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 169.37 -23.58 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -79.93 -179.72 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 110.899 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -155.93 128.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.5 t80 -89.75 113.43 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -137.03 176.37 20.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.2 m -128.4 126.3 40.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.65 ' HA ' HD13 ' A' ' 281' ' ' ILE . 43.7 t -62.13 155.99 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.6 tp -97.8 -33.55 11.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 99.2 m -75.05 -55.69 5.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 49.2 p -84.79 -39.57 18.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.02 10.33 62.75 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.467 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.05 153.41 26.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 59.9 p -122.5 140.7 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -176.76 179.15 47.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 11.3 mt -89.23 139.42 30.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -143.84 156.67 58.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.602 0.715 . . . . 0.0 110.923 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.75 121.08 7.78 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.352 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.68 -11.23 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.17 19.97 7.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -128.22 -3.03 5.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.07 -176.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 163.78 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 152.73 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.61 65.14 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.44 ' CG ' ' N ' ' A' ' 319' ' ' GLU . 3.9 p-10 -92.16 -54.0 4.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 320' ' ' CYS . 43.1 mp0 34.62 45.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 319' ' ' GLU . 5.6 t 34.26 51.04 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 322' ' ' THR . 2.9 m -82.41 -75.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.575 ' HB ' ' CD1' ' A' ' 325' ' ' PHE . 1.4 m -34.6 145.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.528 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.6 p-90 -63.03 -48.22 79.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.528 HG12 ' CE3' ' A' ' 323' ' ' TRP . 15.4 mm -135.0 94.26 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.575 ' CD1' ' HB ' ' A' ' 322' ' ' THR . 0.1 OUTLIER -164.23 163.35 22.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -144.44 169.96 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -166.78 37.17 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 37.6 m -44.15 130.2 6.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 13.8 m -63.2 -39.58 95.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -89.19 138.44 14.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -31.1 21.4 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.367 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 32.8 t -95.94 163.28 13.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.8 m -105.11 85.3 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.8 t -79.54 -46.12 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.4 t 45.64 41.62 7.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.04 1.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 80.8 p -99.04 126.06 44.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 92.5 p -80.46 132.5 35.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.13 127.1 5.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.5 t -70.61 164.15 25.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 151.3 49.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -134.07 104.3 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.733 HG22 ' H ' ' A' ' 253' ' ' PHE . 12.8 mm -52.9 -48.8 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.495 ' O ' ' CD ' ' A' ' 252' ' ' ARG . 1.0 OUTLIER 44.97 31.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.733 ' H ' HG22 ' A' ' 251' ' ' ILE . 1.1 m-85 55.25 45.78 25.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -166.12 174.78 8.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 43.62 38.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.596 ' CE1' ' HB2' ' A' ' 284' ' ' SER . 1.7 t60 -172.85 142.83 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.66 156.97 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.409 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.8 m -134.29 135.29 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 314' ' ' ILE . 7.4 mt -137.36 152.79 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.514 ' O ' HG22 ' A' ' 315' ' ' THR . 22.5 tm0? -108.66 129.93 55.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.41 134.13 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -109.14 -17.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.6 m-85 -158.55 143.89 12.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.655 0.741 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 152.57 69.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 2.269 . . . . 0.0 112.368 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 42.0 t80 -144.47 138.54 27.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.9 m -106.74 107.75 60.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.553 0.692 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG3' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.78 169.46 18.89 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -123.2 -14.2 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.432 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 0.3 OUTLIER -154.71 179.48 9.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.84 -35.49 80.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.498 ' OD1' HD12 ' A' ' 308' ' ' LEU . 26.0 t0 -40.59 -43.82 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 13.6 pm0 -100.28 177.66 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.6 tp -136.54 147.71 47.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.537 ' O ' HD23 ' A' ' 275' ' ' LEU . 19.8 tt0 -63.35 148.84 47.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -120.61 134.32 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.8 133.09 24.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.656 0.741 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 105.98 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.719 2.28 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.45 11.35 10.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -112.1 171.58 7.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -112.06 161.15 16.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.472 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 20.1 mm -140.08 123.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 41.2 m-85 -88.25 110.37 20.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.6 tmm? -98.88 132.24 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.596 ' HB2' ' CE1' ' A' ' 256' ' ' HIS . 1.3 t -126.06 144.15 47.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.752 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -31.61 20.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.714 2.276 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 28.7 mmm -76.33 4.27 9.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.585 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 19.5 mt-10 -133.13 18.41 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -77.74 82.39 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.5 p -103.11 134.92 45.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 41.79 25.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 289' ' ' THR . 32.2 p -85.68 -45.07 12.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 45.6 m -45.93 -31.89 2.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.45 -35.99 81.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.05 -25.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.441 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.5 m95 -79.98 -179.81 7.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.74 0.305 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.92 130.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 21.4 t80 -86.53 120.44 27.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -146.4 171.67 27.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.5 m -121.7 133.96 54.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.423 ' HA ' HD13 ' A' ' 281' ' ' ILE . 33.4 t -70.02 151.16 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.2 tp -96.08 -34.04 11.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -72.83 -43.06 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 68.8 p -96.78 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.13 8.68 14.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.3 m -83.95 155.23 22.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.6 p -124.12 132.92 53.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -170.5 -175.68 39.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.435 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 18.3 mt -87.78 151.28 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 308' ' ' LEU . 0.2 OUTLIER -155.25 157.32 31.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 110.946 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 116.07 4.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 2.248 . . . . 0.0 112.336 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.66 -14.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -90.06 20.52 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.545 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.9 m-85 -129.08 2.68 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -132.62 175.43 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 260' ' ' GLN . 12.8 t -149.64 154.38 38.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.463 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.2 OUTLIER -61.98 144.91 54.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.45 99.14 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.35 -43.99 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.438 ' OE2' ' N ' ' A' ' 320' ' ' CYS . 1.2 pp20? -53.77 -40.88 66.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.438 ' N ' ' OE2' ' A' ' 319' ' ' GLU . 4.7 t -44.13 161.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.7 m -135.77 -179.67 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 325' ' ' PHE . 4.1 p -108.94 138.59 45.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.462 ' CD2' HG12 ' A' ' 324' ' ' ILE . 2.6 p-90 -67.17 -41.27 86.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 323' ' ' TRP . 16.9 mm -126.89 -51.14 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 322' ' ' THR . 90.4 m-85 -41.49 156.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -117.63 -51.53 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 119.12 -106.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.464 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 11.3 m 41.33 53.43 3.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 3.6 m -95.74 140.8 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.826 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 168.37 -95.03 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.642 2.228 . . . . 0.0 112.378 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.2 m -80.5 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.3 p -42.32 141.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.816 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.499 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 23.1 t -87.31 103.1 15.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 m -146.0 137.02 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 123.19 -71.29 0.42 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 40.7 t -52.98 134.66 37.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 75.0 m -62.65 158.32 18.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -152.76 -145.07 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.8 t -79.04 131.09 36.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -64.1 123.8 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.23 139.03 57.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 253' ' ' PHE . 16.3 mt -69.02 128.4 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.447 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 8.8 tpt180 -94.96 35.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.579 ' H ' HG22 ' A' ' 251' ' ' ILE . 0.8 OUTLIER 56.45 44.12 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -91.81 -175.42 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.62 76.32 2.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 284' ' ' SER . 16.8 m-70 -100.16 154.28 18.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.41 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 12.9 pt-20 -128.65 152.75 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -112.69 138.56 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 314' ' ' ILE . 9.7 mt -135.54 150.93 49.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 17.3 tm0? -108.76 137.14 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.496 HG11 ' C ' ' A' ' 276' ' ' VAL . 49.8 t -66.44 137.22 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 4.5 pt -116.97 -14.39 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 91.2 m-85 -162.03 142.63 7.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.743 0.782 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 154.39 67.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.986 ' CB ' HD12 ' A' ' 275' ' ' LEU . 25.8 t80 -137.31 156.57 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 18.8 m -124.15 97.3 40.68 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.558 0.694 . . . . 0.0 111.108 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.75 171.17 14.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.318 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -125.24 -14.8 6.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.75 -178.5 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 271' ' ' ASP . 6.6 m-20 -65.49 -36.77 84.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -36.52 -42.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -107.64 175.46 5.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -131.61 141.24 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.52 154.28 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.986 HD12 ' CB ' ' A' ' 265' ' ' TYR . 23.7 mt -121.63 124.78 45.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.496 ' C ' HG11 ' A' ' 261' ' ' VAL . 71.2 t -113.83 130.23 24.01 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.687 0.756 . . . . 0.0 111.104 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.42 6.75 19.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -111.9 171.52 7.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.22 164.86 12.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 309' ' ' LEU . 12.1 mm -145.35 121.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HE2' HD13 ' A' ' 301' ' ' LEU . 84.6 m-85 -89.88 111.69 22.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.9 tmm? -99.52 136.14 39.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 256' ' ' HIS . 0.9 OUTLIER -128.43 136.98 29.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.669 0.747 . . . . 0.0 110.85 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -18.81 36.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 20.4 mmt -66.58 -37.54 85.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 4.9 mt-10 -120.21 44.94 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.488 ' CD ' ' O ' ' A' ' 288' ' ' GLN . 3.7 pp0? -96.94 52.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.424 ' O ' HD21 ' A' ' 308' ' ' LEU . 34.1 p -76.58 143.13 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 m 52.67 25.83 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 289' ' ' THR . 44.2 p -95.94 -49.24 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.183 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 t -46.68 -25.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.52 -35.95 70.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.26 -22.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.49 ' O ' HG23 ' A' ' 296' ' ' ILE . 68.7 m95 -86.31 178.96 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.97 122.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.431 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 19.5 t80 -78.81 110.09 13.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.18 175.78 19.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.4 m -126.47 127.48 45.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.559 ' HA ' HD13 ' A' ' 281' ' ' ILE . 36.4 t -66.1 153.03 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.722 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.2 tp -100.46 -43.17 6.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -62.79 -39.79 95.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 64.8 p -102.28 -55.3 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 112.94 1.57 25.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.2 t -71.84 166.18 22.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.6 m -137.9 143.81 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -174.81 47.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 289' ' ' THR . 12.1 mt -88.19 138.78 31.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.74 155.9 66.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.93 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.723 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.8 Cg_endo -69.77 125.34 12.02 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.32 -8.2 5.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.25 23.39 7.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 275' ' ' LEU . 11.6 m-85 -130.72 -3.92 4.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 259' ' ' LEU . 2.7 pp -131.0 -179.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 11.9 t -155.97 162.62 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.54 153.49 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -79.14 57.23 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.98 24.41 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -95.0 -43.06 8.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 62.2 m -88.74 155.93 19.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 24.3 p -110.96 166.17 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.645 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.5 OUTLIER -111.26 149.55 30.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.645 ' HD1' HG22 ' A' ' 322' ' ' THR . 5.9 p-90 -41.27 -43.37 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.578 HG12 ' CE3' ' A' ' 323' ' ' TRP . 10.6 mm -125.58 -64.92 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 324' ' ' ILE . 85.7 m-85 -34.24 140.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -113.52 -46.44 3.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 111.34 -125.46 7.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.2 t -165.75 127.11 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 11.6 t 56.45 46.28 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -100.03 -162.0 28.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.9 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 331' ' ' PRO . 29.2 t -34.75 115.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.1 m -100.97 120.03 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.48 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 24.7 m -78.66 134.6 37.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.818 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.1 p 40.2 42.14 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -132.01 -137.25 3.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.492 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -64.02 124.19 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 247' ' ' GLY . 89.1 p -136.89 118.59 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 246' ' ' SER . . . 36.85 72.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 p -107.44 127.76 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -71.08 112.21 7.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -100.92 145.42 28.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' ' 254' ' ' ALA . 5.3 mp -89.24 121.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -123.76 -51.34 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.41 37.37 4.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.742 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -107.52 177.29 4.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -57.09 -58.25 9.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.567 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 33.8 m80 -38.52 131.43 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 19.3 pt-20 -100.03 151.54 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 23.0 m -109.05 130.38 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.143 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 314' ' ' ILE . 11.7 mt -131.67 149.31 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 0.7 OUTLIER -108.63 132.42 53.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 54.6 t -64.74 132.3 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.6 -20.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -152.0 144.24 16.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.667 0.746 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.84 69.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 56.4 t80 -142.09 132.7 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.7 m -103.89 102.55 32.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.098 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 171.18 14.96 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -125.25 -15.15 6.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -152.29 -175.99 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.4 t70 -71.9 -37.64 70.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.4 OUTLIER -35.57 -39.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 pm0 -107.9 179.57 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 9.3 tp -133.92 145.48 49.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.53 141.52 58.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -114.98 130.7 56.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 277' ' ' PRO . 60.9 t -123.52 135.1 25.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.623 0.725 . . . . 0.0 111.124 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.77 117.05 4.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.22 1.08 29.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.39 175.95 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -115.34 165.4 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.478 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 25.8 mm -141.46 127.6 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.01 109.51 21.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.0 tmm? -99.93 133.27 44.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 8.9 t -132.04 137.48 30.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.758 . . . . 0.0 110.815 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.3 mmt -88.27 -11.69 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 1.8 pt-20 -129.55 26.57 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -85.59 84.76 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.442 ' O ' HD21 ' A' ' 308' ' ' LEU . 20.1 p -100.43 118.32 36.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 20.6 m 62.06 25.07 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 35.9 p -86.35 -53.35 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 291' ' ' THR . 65.6 m -37.85 -32.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 4.8 tp10 -66.32 -47.12 74.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 179.05 -28.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.529 ' O ' HG23 ' A' ' 296' ' ' ILE . 60.6 m95 -79.89 -179.79 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.302 . . . . 0.0 110.907 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -158.99 125.33 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 23.2 t80 -80.13 114.31 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.478 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -135.21 162.83 24.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 17.1 m -114.03 132.73 55.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 31.0 t -67.96 148.42 51.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.7 -31.02 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -78.09 -48.85 15.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 75.5 p -91.48 -42.46 10.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.48 4.72 57.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 87.1 m -73.55 168.84 18.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 110.844 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 10.5 m -138.63 139.22 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.68 -176.7 47.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -88.13 148.25 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -150.54 155.6 36.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.602 0.715 . . . . 0.0 110.927 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.1 Cg_endo -69.77 125.49 12.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.68 -8.76 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 312' ' ' ASN . 28.9 t-20 -96.14 22.01 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.574 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.1 m-85 -130.32 -3.27 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -129.85 175.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 260' ' ' GLN . 13.5 t -154.86 159.19 40.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.69 155.52 2.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -74.92 97.23 3.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.75 -34.43 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -42.65 -36.57 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 14.1 p -149.49 164.36 35.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' THR . 4.2 m -138.2 -176.71 4.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.508 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.4 OUTLIER -34.02 140.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.581 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.5 p-90 -41.24 -42.32 2.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.581 HG12 ' CE3' ' A' ' 323' ' ' TRP . 10.7 mm -119.54 -70.24 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.459 ' C ' ' O ' ' A' ' 324' ' ' ILE . 94.8 m-85 -33.76 119.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -110.26 -38.37 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.65 28.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.439 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 22.7 t -84.66 119.17 24.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 46.6 t -60.6 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -145.33 156.99 27.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 157.55 60.1 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 92.9 p -51.31 114.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.0 m 56.22 43.16 27.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.534 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 59.5 p -124.02 -45.72 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.834 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.7 p -69.16 157.7 36.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -167.33 106.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 t -98.4 149.62 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.7 p -169.15 177.56 4.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.4 11.6 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 53.2 m -38.55 107.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 110.836 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.543 ' HG2' HD11 ' A' ' 251' ' ' ILE . 15.2 ttm180 -98.77 -35.39 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 57.62 52.69 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.543 HD11 ' HG2' ' A' ' 249' ' ' ARG . 11.0 mm -82.13 -35.94 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.437 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 2.3 tpt180 39.2 35.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 1.2 m-85 57.76 54.13 6.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.64 -178.95 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.27 89.56 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.56 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 14.9 m80 -109.93 135.14 51.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.47 160.36 30.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.6 m -122.76 131.52 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.928 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -133.95 150.63 51.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -108.71 134.25 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.03 135.29 28.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -113.03 -12.5 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 92.3 m-85 -161.31 142.86 8.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.657 0.741 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.48 68.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 0.0 112.318 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.7 t80 -147.57 126.18 12.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.1 m -96.96 108.3 42.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.571 0.7 . . . . 0.0 111.125 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.0 Cg_endo -69.75 166.69 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -115.93 -21.3 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -153.72 -177.43 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 271' ' ' ASP . 25.6 t0 -65.33 -37.25 86.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.7 OUTLIER -37.83 -40.69 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.413 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.4 pm0 -105.83 175.34 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.9 tp -129.9 147.3 51.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.41 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.0 tt0 -67.52 145.67 54.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 309' ' ' LEU . 10.4 mt -116.06 132.58 56.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.25 129.77 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.688 0.756 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.71 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.49 10.6 9.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -113.26 178.21 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.42 159.88 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.1 mm -135.25 138.0 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -101.73 113.36 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.5 tmm? -99.04 140.55 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.56 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 6.0 t -133.81 141.78 41.16 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.893 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -37.42 9.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 36.8 mtp -74.14 1.34 11.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 37.8 mm-40 -128.36 17.15 6.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -77.98 86.14 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.739 ' O ' HD21 ' A' ' 308' ' ' LEU . 29.9 p -105.17 126.8 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.9 m 48.47 29.46 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 17.3 p -89.49 -50.0 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 59.1 p -39.9 -38.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.47 -46.36 89.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 175.03 -25.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 296' ' ' ILE . 59.6 m95 -80.58 -179.84 7.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.1 pt -156.52 125.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 38.5 t80 -80.13 111.2 16.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.56 169.33 22.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 305' ' ' CYS . 91.4 m -124.8 116.36 22.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.155 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 281' ' ' ILE . 4.9 t -54.48 153.43 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.81 -50.7 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 16.0 m -53.46 -52.79 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.4 p -87.22 -53.45 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.8 4.54 31.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.433 ' O ' HG23 ' A' ' 299' ' ' THR . 9.3 t -77.72 166.72 22.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 84.1 p -134.85 147.91 50.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 174.84 -176.84 47.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 289' ' ' THR . 12.3 mt -88.98 137.57 32.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.6 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.83 156.01 65.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.943 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 124.4 11.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.61 -8.81 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -95.62 21.93 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.559 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.6 m-85 -129.07 -1.5 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.85 -177.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.5 t -158.43 162.65 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -62.47 143.49 57.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.51 94.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -100.54 -45.3 5.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 319' ' ' GLU . 13.2 pt-20 -94.0 100.28 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 48.3 m -110.93 -48.72 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.3 p -54.21 -59.17 5.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.592 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.6 OUTLIER -114.86 145.18 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.154 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.592 ' HD1' HG22 ' A' ' 322' ' ' THR . 2.4 p-90 -47.58 -38.47 14.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 323' ' ' TRP . 8.2 mt -121.92 -67.12 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.146 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 324' ' ' ILE . 83.3 m-85 -36.67 148.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.13 163.58 13.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -106.96 50.03 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 26.3 m -87.88 114.22 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.844 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 4.3 t -70.02 -56.86 5.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 143.95 72.6 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.95 15.09 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.0 t -75.2 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.9 m -44.94 142.32 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 243' ' ' SER . 51.0 m -130.55 112.96 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 242' ' ' SER . 77.3 p -36.39 103.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -98.13 125.23 8.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.5 p -49.76 140.4 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.5 m -90.53 147.05 23.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 141.13 116.52 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.498 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.5 p -131.36 -175.82 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -77.87 149.35 34.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.58 92.7 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 251' ' ' ILE . 4.4 mp -40.86 120.72 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -99.43 52.62 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 54.23 44.86 28.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 255' ' ' ASN . . . -89.18 -178.65 5.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 256' ' ' HIS . 67.9 m-80 -36.44 -48.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 31.1 m80 -35.36 140.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -113.6 163.22 15.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.1 m -117.73 138.66 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.181 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 9.8 mt -135.56 149.53 49.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -109.16 131.5 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 80.6 t -66.02 128.39 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -103.89 -21.71 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -150.94 143.61 16.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.675 0.75 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.36 68.08 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.587 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 34.6 t80 -147.5 123.92 10.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.3 m -93.37 106.25 19.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.577 0.703 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.3 Cg_endo -69.75 171.6 14.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.624 2.216 . . . . 0.0 112.421 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.58 -14.94 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -158.9 -179.26 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 271' ' ' ASP . 38.7 t0 -64.77 -37.92 89.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -36.38 -39.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.9 pm0 -109.39 171.83 7.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 3.3 tp -125.73 142.38 51.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -64.44 135.59 56.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 313' ' ' TYR . 7.7 mt -106.05 128.32 53.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.31 130.76 24.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.65 0.738 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 112.73 3.15 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.651 2.234 . . . . 0.0 112.368 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.88 1.29 22.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.53 175.84 5.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.532 ' O ' HD13 ' A' ' 281' ' ' ILE . 8.9 m-85 -114.91 165.07 13.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 300' ' ' SER . 26.5 mm -143.34 140.85 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HE2' HD13 ' A' ' 301' ' ' LEU . 67.3 m-85 -109.16 116.04 31.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -101.76 136.93 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 13.4 p -125.55 138.68 32.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 0.0 110.883 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.491 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.78 -21.68 33.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 49.9 mmm -77.16 -24.15 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -118.03 29.51 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 15.1 pt20 -88.41 60.3 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 291' ' ' THR . 1.6 t -86.83 141.23 28.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.5 m 50.6 24.92 1.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 289' ' ' THR . 36.6 p -94.54 -41.55 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.6 m -51.41 -26.64 8.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.1 -30.99 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.8 m95 -81.21 179.51 7.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 314' ' ' ILE . 2.1 pt -160.02 119.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.83 111.44 10.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.455 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.4 167.41 23.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.522 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 305' ' ' CYS . 61.5 m -121.32 126.91 50.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 111.143 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.651 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.6 t -66.01 153.58 41.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.422 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.1 tp -92.75 -48.71 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -58.84 -57.68 11.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.7 p -78.61 -50.11 12.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.78 46.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.615 ' O ' HG23 ' A' ' 299' ' ' THR . 11.9 t -84.3 166.81 17.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 78.5 p -129.53 145.89 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.31 179.38 46.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -87.9 144.24 26.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.604 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -147.37 155.36 46.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.595 0.712 . . . . 0.0 110.897 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.78 128.73 16.43 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.22 -6.19 6.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -99.23 21.39 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.587 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 9.2 m-85 -129.73 -1.79 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.53 177.02 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.8 t -153.68 164.74 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -64.49 144.87 56.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.6 92.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.34 -34.87 16.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -45.34 -56.9 4.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 28.3 p -80.56 173.96 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.5 m -61.28 174.04 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 13.3 p -59.04 158.72 8.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.759 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -83.33 -39.4 20.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.759 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 21.8 mt -128.88 -49.45 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 324' ' ' ILE . 29.0 m-85 -34.61 135.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -121.8 156.3 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.88 -68.42 1.66 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 14.7 t -133.74 134.26 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.835 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 4.2 m -87.49 163.89 16.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -100.99 141.86 15.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.99 19.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.27 . . . . 0.0 112.377 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 52.4 m -76.98 -43.31 35.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.8 m -57.06 100.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.464 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.1 t -166.67 153.47 8.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.852 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.1 m -92.2 119.6 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -59.22 179.1 1.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.511 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 55.0 m -49.56 156.07 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.7 m -83.68 113.04 20.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -66.96 84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 99.8 p -120.05 141.17 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.24 131.48 48.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -103.6 170.96 7.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 253' ' ' PHE . 23.5 mt -87.59 122.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.417 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -89.7 32.38 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.587 ' H ' HG22 ' A' ' 251' ' ' ILE . 18.8 m-85 71.2 39.98 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.03 -178.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 256' ' ' HIS . 4.5 m120 -43.94 -43.58 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.493 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 31.7 m80 -35.82 131.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -90.26 167.14 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 317' ' ' ALA . 0.8 OUTLIER -131.92 130.34 41.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -130.99 150.18 52.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 22.4 tm0? -108.69 133.01 53.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 65.9 t -64.43 133.92 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 263' ' ' TYR . 2.4 pt -111.06 -19.59 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.442 ' CE2' HD12 ' A' ' 262' ' ' ILE . 80.6 m-85 -152.97 141.71 14.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 148.55 65.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 1.009 ' CB ' HD12 ' A' ' 275' ' ' LEU . 29.3 t80 -133.93 157.15 46.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.418 ' N ' ' CG ' ' A' ' 265' ' ' TYR . 6.4 m -126.28 101.05 28.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.72 169.73 18.17 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -124.57 -14.68 6.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -152.82 -175.57 5.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -28.9 61.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -42.97 7.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -101.45 178.8 4.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 6.9 tp -132.96 143.68 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.14 147.31 53.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 1.009 HD12 ' CB ' ' A' ' 265' ' ' TYR . 17.5 mt -115.9 124.67 51.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.4 t -115.61 130.59 24.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.634 0.731 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 111.43 2.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.63 2.64 19.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -111.19 175.16 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -115.38 164.63 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 309' ' ' LEU . 34.9 mm -138.77 121.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.504 ' CE2' HD13 ' A' ' 301' ' ' LEU . 20.6 m-85 -85.71 115.73 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -99.47 130.18 45.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 1.6 p -126.1 142.85 43.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -30.26 22.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.692 2.262 . . . . 0.0 112.364 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 65.2 mtp -76.6 -3.44 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.58 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 20.2 mm-40 -122.28 5.28 9.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.38 92.54 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.751 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.6 p -115.19 123.79 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.7 m 50.83 29.09 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 294' ' ' GLY . 16.7 p -86.52 -55.51 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 291' ' ' THR . 31.3 t -34.41 -37.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.27 -49.03 79.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.15 -26.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 296' ' ' ILE . 65.2 m95 -79.87 -179.77 7.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -158.38 119.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 19.9 t80 -78.44 112.77 15.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.46 175.25 21.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 305' ' ' CYS . 57.0 m -125.33 133.26 52.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 281' ' ' ILE . 28.3 t -71.14 150.62 45.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.9 tp -95.49 -40.29 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 93.3 m -69.88 -44.95 68.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -91.88 -53.06 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 105.58 8.73 34.55 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 299' ' ' THR . 8.9 t -78.34 166.55 22.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 54.0 p -139.17 133.88 32.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.2 -175.11 45.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.751 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -88.72 140.1 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.76 156.05 62.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.748 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.78 122.88 9.55 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.43 -10.4 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -94.6 22.77 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.688 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.9 m-85 -129.87 -2.83 4.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -132.14 -179.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.2 t -157.38 167.77 29.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 142.13 55.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 258' ' ' THR . . . -54.23 93.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -63.91 -44.1 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -48.75 101.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.4 t 69.98 42.46 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 8.2 t -85.0 124.01 31.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 22.1 p -95.32 -175.67 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.133 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.794 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.4 p-90 -130.49 -33.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.794 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 59.5 mt -128.16 -44.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -47.39 144.28 3.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -120.17 131.8 55.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.39 82.86 1.65 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 60.3 p -89.42 116.31 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.366 . . . . 0.0 110.851 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 40.6 m -118.67 170.99 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.09 163.36 24.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.6 Cg_endo -69.74 -30.39 22.46 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.722 2.282 . . . . 0.0 112.31 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 331' ' ' PRO . 9.9 t -37.57 102.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 68.9 m -86.65 42.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.863 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 29.7 t -87.19 149.32 24.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -61.86 110.31 1.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 115.54 45.79 0.6 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.1 p -142.24 159.42 42.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.5 t -151.39 116.5 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 141.32 55.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -126.15 89.19 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 57.4 46.83 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.21 92.0 7.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.607 HD12 ' CZ ' ' A' ' 282' ' ' PHE . 14.1 mt -94.93 116.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -84.6 29.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.474 ' H ' HG22 ' A' ' 251' ' ' ILE . 3.2 m-85 60.43 45.28 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.13 7.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -122.71 -44.16 2.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.576 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 6.2 m80 -90.97 142.67 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -92.36 166.75 12.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.424 ' O ' HD23 ' A' ' 259' ' ' LEU . 3.5 m -129.3 129.83 45.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 314' ' ' ILE . 11.9 mt -130.41 150.66 51.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 315' ' ' THR . 6.2 tt0 -110.19 128.35 55.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.4 133.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.36 -21.12 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -152.24 144.09 16.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.67 68.68 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.509 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 29.3 t80 -147.8 127.08 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.8 m -95.84 108.22 39.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 111.162 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.9 Cg_endo -69.73 172.04 13.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.234 . . . . 0.0 112.354 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -123.3 -13.38 7.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -162.44 -179.15 6.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.6 p-10 -63.63 -37.45 87.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.5 OUTLIER -37.3 -41.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.0 pm0 -107.63 174.62 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 4.5 tp -128.32 144.93 51.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.58 128.93 38.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 309' ' ' LEU . 7.7 mt -97.18 129.45 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.55 130.57 24.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.624 0.726 . . . . 0.0 111.134 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 103.74 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.34 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.47 5.37 7.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -111.29 169.97 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 281' ' ' ILE . 15.6 m-85 -113.32 145.44 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 300' ' ' SER . 32.1 mm -124.21 120.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 251' ' ' ILE . 17.9 m-85 -83.33 119.29 24.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -99.66 137.85 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.576 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 12.8 p -138.97 120.12 9.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.82 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 0.51 5.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -94.85 -24.12 17.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.538 ' O ' ' CD1' ' A' ' 297' ' ' TYR . 16.9 mm-40 -122.06 41.41 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 143.11 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.639 ' O ' HD11 ' A' ' 308' ' ' LEU . 24.9 p -147.79 116.51 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 23.4 m 64.4 25.4 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 294' ' ' GLY . 28.1 p -83.02 -52.3 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 291' ' ' THR . 12.5 m -36.66 -41.51 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -56.88 -45.37 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 172.53 -23.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -79.88 -179.9 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.736 0.303 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.36 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 287' ' ' GLU . 40.4 t80 -94.3 108.45 20.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -132.85 -177.29 14.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.0 m -132.48 126.29 32.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.613 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.0 OUTLIER -62.6 166.32 5.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.7 tp -107.08 -30.32 8.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -75.63 -54.17 7.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 9.3 p -90.28 -34.46 15.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.76 62.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 61.9 m -86.65 145.9 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.4 p -114.1 132.7 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.97 179.22 42.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 289' ' ' THR . 11.4 mt -89.5 142.64 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.77 156.42 48.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 120.89 7.6 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.718 2.279 . . . . 0.0 112.364 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.37 -11.57 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -92.86 19.9 7.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.8 m-85 -128.24 -1.6 5.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.981 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.44 174.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 260' ' ' GLN . 5.6 t -146.84 159.49 43.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 3.5 mptt -64.74 143.82 57.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.2 95.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.22 -43.62 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.65 -17.26 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 153.35 41.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 47.9 t -88.34 84.9 6.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 325' ' ' PHE . 8.2 p -51.75 127.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.53 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.2 p-90 -69.5 -32.23 70.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.53 HG12 ' CD2' ' A' ' 323' ' ' TRP . 20.8 mm -133.84 -54.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.465 ' HB2' ' CG2' ' A' ' 322' ' ' THR . 85.4 m-85 -35.18 135.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -85.22 84.09 7.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -143.75 33.29 1.77 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 92.2 p -40.21 131.27 2.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.837 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 2.5 t -81.67 -179.63 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.85 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.48 85.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -25.99 27.98 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 98.2 p -114.08 130.03 56.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.3 t -142.01 127.66 19.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.555 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 66.1 m -90.13 91.87 8.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.3 t -52.96 121.73 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.838 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 106.62 -112.5 3.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 57.7 m -150.73 160.15 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 110.85 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.2 t -69.52 86.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 134.81 148.74 5.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.5 m -85.54 90.46 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -51.89 -29.85 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.77 147.81 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.67 HD13 ' CG ' ' A' ' 256' ' ' HIS . 10.7 mt -94.22 117.78 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -120.78 -49.19 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -75.36 -45.0 42.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.588 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -73.11 172.13 11.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -129.76 94.63 3.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.67 ' CG ' HD13 ' A' ' 251' ' ' ILE . 20.9 m80 -99.55 136.13 39.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.15 168.65 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.9 m -131.21 129.49 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.775 HD13 HD13 ' A' ' 314' ' ' ILE . 10.5 mt -130.21 149.43 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -108.84 124.76 51.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.33 131.32 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -106.93 -12.08 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 75.3 m-85 -161.55 143.45 8.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.68 0.753 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.12 11.46 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 275' ' ' LEU . 3.1 t80 -171.77 118.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.2 m -83.75 113.4 47.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.579 0.704 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 171.95 13.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.395 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -119.89 -13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.405 ' OD1' ' CD ' ' A' ' 272' ' ' GLU . 2.5 p30 -167.63 -178.26 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.38 -29.67 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -45.33 -42.08 9.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.405 ' CD ' ' OD1' ' A' ' 269' ' ' ASN . 11.7 pm0 -106.82 177.28 4.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 12.7 tp -130.45 147.5 52.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.67 151.87 46.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.676 HD23 ' CD2' ' A' ' 265' ' ' TYR . 3.7 mm? -115.87 128.75 56.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.87 127.15 26.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.606 0.717 . . . . 0.0 111.139 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 104.55 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.65 2.233 . . . . 0.0 112.309 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.07 11.19 8.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -114.64 174.67 5.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -115.41 165.22 13.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.737 HD13 ' HA ' ' A' ' 300' ' ' SER . 15.1 mm -143.82 128.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -93.02 116.91 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -101.76 134.82 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.565 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 0.7 OUTLIER -125.66 141.46 39.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.684 0.754 . . . . 0.0 110.799 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.83 19.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 8.7 mtp -77.47 -2.07 33.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 12.4 mt-10 -121.77 8.09 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.98 85.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.658 ' O ' HD21 ' A' ' 308' ' ' LEU . 2.4 p -109.05 121.81 45.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.3 m 55.26 26.0 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 32.9 p -86.97 -44.15 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.2 t -43.15 -40.73 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.97 -40.43 80.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.81 -21.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.453 ' HB3' HD22 ' A' ' 308' ' ' LEU . 72.0 m95 -80.01 -179.78 7.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -156.74 122.04 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 36.5 t80 -84.59 111.71 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -137.19 -172.9 12.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 65.5 m -138.01 124.1 20.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.17 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.737 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -62.21 168.89 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.17 -41.07 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -67.23 -65.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.3 p -75.12 -31.92 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.03 63.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.496 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.68 152.59 18.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 33.5 p -121.34 136.85 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.1 -179.46 47.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.658 HD21 ' O ' ' A' ' 289' ' ' THR . 10.8 mt -87.93 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.76 156.68 65.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.603 0.716 . . . . 0.0 110.927 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 0.0 112.347 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -54.5 -14.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.26 19.14 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.546 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.68 -0.19 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.82 178.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.2 t -148.74 157.95 43.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -65.67 151.46 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.563 ' HB1' ' SG ' ' A' ' 320' ' ' CYS . . . -75.47 97.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -120.59 -53.75 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -54.16 -45.13 71.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.563 ' SG ' ' HB1' ' A' ' 317' ' ' ALA . 26.5 p -51.87 176.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 98.2 p -102.91 138.14 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.449 HG21 ' HB2' ' A' ' 325' ' ' PHE . 19.2 p -67.0 -179.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.57 ' CE3' HG12 ' A' ' 324' ' ' ILE . 6.1 p-90 -112.17 -40.39 4.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.57 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.8 mm -127.51 -34.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.449 ' HB2' HG21 ' A' ' 322' ' ' THR . 27.3 m-85 -45.39 142.73 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -116.98 150.5 38.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -126.26 -42.14 0.31 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 52.8 m -67.23 139.41 57.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 56.9 p -55.17 172.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 165.84 177.45 38.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.32 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.378 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m 37.6 42.19 0.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 334' ' ' GLY . 5.4 t -68.65 107.39 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 333' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.6 t -74.64 88.75 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 95.41 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 170.18 50.23 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.517 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.2 t -116.47 104.3 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 0.0 110.837 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.6 t -78.93 89.9 4.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 41.51 58.91 2.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 51.0 p -152.01 131.15 12.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.83 0.348 . . . . 0.0 110.839 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 5.3 ttp85 74.96 29.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -100.77 135.55 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.77 -41.32 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ARG . . . . . 0.416 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 1.5 tmt_? 45.65 34.78 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 1.5 m-85 58.12 47.23 14.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -88.31 -70.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -128.87 -38.58 1.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.562 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 8.2 m80 -70.36 139.43 51.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -77.53 151.89 34.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.61 132.04 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -135.03 150.97 50.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -108.74 131.74 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.52 126.48 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 2.2 pt -102.56 -18.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 70.1 m-85 -158.24 144.06 12.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 158.31 57.37 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.722 2.281 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -150.54 133.07 15.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.6 m -102.46 106.94 51.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.621 0.724 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.432 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.7 Cg_endo -69.75 170.89 15.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.725 2.283 . . . . 0.0 112.345 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.87 -15.37 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.404 ' H ' ' CD ' ' A' ' 272' ' ' GLU . 56.7 m-80 -150.66 -175.71 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.58 -40.76 69.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -38.59 -42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.3 pm0 -99.75 171.06 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 5.8 tp -131.9 150.96 52.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.3 tt0 -68.81 150.67 47.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 309' ' ' LEU . 10.9 mt -119.71 130.83 55.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.38 129.26 25.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.32 3.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.83 0.31 22.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 281' ' ' ILE . 26.9 m-85 -108.67 166.23 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 300' ' ' SER . 21.1 mm -142.35 124.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 22.7 m-85 -90.68 114.78 27.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.4 tmm? -100.3 141.61 32.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.562 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 1.1 t -141.27 138.72 17.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.664 0.745 . . . . 0.0 110.866 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.439 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.4 Cg_endo -69.78 -18.47 36.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 0.0 112.331 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 11.2 mtp -64.11 -31.61 72.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -123.0 41.74 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 8.3 pt20 -91.38 66.95 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 291' ' ' THR . 1.3 t -93.65 142.27 27.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.1 m 45.48 25.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 289' ' ' THR . 40.5 p -91.53 -58.32 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 291' ' ' THR . 26.8 m -36.2 -38.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.59 -46.69 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.52 -26.88 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.1 m95 -83.17 -179.98 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.752 0.31 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.33 136.53 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.493 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 38.6 t80 -89.48 111.72 22.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.475 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.46 167.66 22.98 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 92.6 m -126.14 116.49 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.601 ' HA ' HD13 ' A' ' 281' ' ' ILE . 7.2 t -55.28 147.66 16.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.575 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -89.24 -43.04 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.1 m -65.25 -60.95 2.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 30.4 p -75.2 -50.35 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.99 9.58 42.17 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.01 153.37 23.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.7 p -125.0 137.96 54.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -175.46 -173.42 41.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 20.5 mt -90.99 140.86 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.597 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -144.15 156.02 58.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 110.883 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.552 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.72 117.61 5.18 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.0 -14.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -90.44 21.21 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.552 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.18 -5.51 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -125.93 169.69 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.7 t -150.24 167.49 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.483 ' HD3' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -74.42 143.76 44.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.89 96.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.63 -33.91 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.34 72.04 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.49 -65.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 68.8 m -69.28 101.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.654 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.4 OUTLIER -74.59 143.94 44.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.654 ' HD1' HG22 ' A' ' 322' ' ' THR . 2.1 p-90 -46.74 -33.96 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.499 HG13 ' CD2' ' A' ' 323' ' ' TRP . 21.9 mt -121.81 -72.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 324' ' ' ILE . 82.3 m-85 -33.99 123.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -96.73 138.17 34.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.05 160.0 17.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 2.3 t -123.18 145.29 48.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 18.6 t -159.11 132.26 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -173.79 -158.71 18.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 119.05 6.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 17.6 m -132.04 134.86 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.2 p -82.91 152.38 25.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.487 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.6 m 41.63 42.03 1.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.9 m -97.04 -43.99 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 125.64 -162.81 19.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.523 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' SER . 12.2 m -125.8 94.92 4.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.861 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' SER . 46.0 m -36.7 -48.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.69 143.45 6.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.8 p -130.14 -44.05 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -97.17 -31.53 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.64 111.68 21.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 254' ' ' ALA . 27.6 mt -85.41 110.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -125.59 -47.48 1.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -114.96 40.33 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -134.22 153.45 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.0 82.32 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -111.44 132.16 54.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.12 168.03 11.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 1.7 m -129.2 127.24 40.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -127.54 150.03 49.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.11 127.21 53.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.89 138.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.468 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -114.89 -14.93 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 81.7 m-85 -159.2 146.7 13.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.686 0.755 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 165.34 31.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 44.2 t80 -160.75 123.4 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.8 m -90.29 110.07 38.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.584 0.706 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 52.9 Cg_endo -69.84 171.13 15.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.681 2.254 . . . . 0.0 112.269 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -119.7 -14.38 9.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -167.26 -178.67 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.43 -34.9 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -38.87 -44.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.435 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 2.6 pm0 -105.32 177.38 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.504 ' O ' ' CD2' ' A' ' 275' ' ' LEU . 4.0 tp -132.72 142.38 49.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.589 ' C ' HD22 ' A' ' 275' ' ' LEU . 34.4 tt0 -57.67 150.82 18.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.589 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.8 mm? -114.45 127.33 55.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.61 123.44 29.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 103.97 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.92 12.76 7.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.469 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -115.31 178.64 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -116.54 160.5 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.481 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 18.2 mm -138.98 133.28 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.8 m-85 -96.02 110.55 22.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -101.34 134.11 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 283' ' ' MET . 22.1 t -137.6 140.83 31.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.651 0.738 . . . . 0.0 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.434 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.73 -26.01 28.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -61.26 -33.61 73.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -117.45 41.39 2.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 288' ' ' GLN . 11.5 pt20 -96.08 95.91 8.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.45 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.6 p -115.11 137.31 52.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 9.5 m 48.49 25.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 43.5 p -88.53 -38.47 14.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.0 t -55.4 -24.84 32.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.94 -29.64 63.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 156.48 -18.57 0.44 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 55.9 m95 -86.99 179.6 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.14 124.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -80.19 111.15 16.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.84 175.09 19.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 70.3 m -131.7 132.46 43.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.2 t -65.58 150.56 48.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.56 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.6 tp -95.4 -35.42 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 48.4 m -77.18 -49.91 14.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 82.1 p -84.12 -52.46 6.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.05 3.16 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.462 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 82.9 m -77.44 147.89 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 89.6 p -120.73 140.37 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.28 -177.25 46.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.7 mt -88.18 149.56 23.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -153.06 155.54 32.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.553 0.692 . . . . 0.0 110.961 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.7 126.84 13.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.692 2.261 . . . . 0.0 112.369 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.22 -7.27 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -97.62 21.63 10.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.7 m-85 -129.35 -3.88 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.28 177.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.6 t -149.77 156.69 42.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -59.24 137.57 57.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -52.4 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -41.22 10.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.96 91.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 91.2 m -135.89 172.25 13.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 18.3 m -50.62 179.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.83 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.478 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.9 OUTLIER -83.9 147.46 27.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.154 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.533 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.2 p-90 -40.25 -35.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 323' ' ' TRP . 11.2 mm -132.26 -67.44 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 324' ' ' ILE . 87.9 m-85 -34.06 136.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.08 -53.42 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 117.61 73.5 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 40.0 p -173.7 148.83 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 39.7 m 58.52 41.32 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 156.85 70.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.523 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 100.88 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.7 t -57.95 149.48 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.8 m -86.81 -58.82 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.419 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.2 m -132.12 -47.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 m -81.34 162.85 23.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 144.81 85.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.8 t -150.99 173.11 14.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.6 t -109.17 147.94 31.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.87 110.6 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.507 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 p -80.39 -59.59 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 249' ' ' ARG . 13.8 mtp-105 -77.25 119.57 21.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -106.36 123.89 48.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.81 HG23 ' HB3' ' A' ' 254' ' ' ALA . 5.1 mp -87.27 115.65 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -123.66 -63.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -104.91 44.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.81 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -106.83 174.87 5.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -72.9 -48.98 32.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 17.7 m80 -37.91 134.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -87.5 160.92 18.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 5.6 m -123.54 125.24 44.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.997 HD13 HD13 ' A' ' 314' ' ' ILE . 11.8 mt -125.99 149.82 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -108.83 130.8 55.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.92 144.2 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -121.61 -14.6 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 71.4 m-85 -161.5 145.71 9.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.654 0.74 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 163.8 36.9 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.551 ' HD2' HD23 ' A' ' 275' ' ' LEU . 50.8 t80 -160.81 128.3 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.8 m -97.78 108.92 48.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.565 0.698 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.43 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.81 165.15 31.99 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.342 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -113.68 -21.9 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -154.02 -179.16 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.6 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -39.24 -45.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.8 pm0 -105.21 178.96 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.7 tp -132.24 151.94 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.748 ' C ' HD22 ' A' ' 275' ' ' LEU . 31.3 tt0 -64.9 155.85 32.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.3 mm? -121.31 131.54 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.91 126.26 25.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.666 0.746 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.01 2.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.649 2.233 . . . . 0.0 112.358 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.69 9.66 20.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -112.85 178.69 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -117.16 169.49 9.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.467 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 17.3 mm -146.14 125.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.557 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 24.7 m-85 -91.77 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -99.23 135.57 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.559 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 30.6 t -128.56 142.41 44.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.717 0.77 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -30.83 21.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.258 . . . . 0.0 112.345 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 47.7 mtp -77.26 4.39 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 66.9 mm-40 -127.41 -0.54 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -58.8 85.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.587 ' O ' HD21 ' A' ' 308' ' ' LEU . 1.4 p -109.32 107.92 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.0 m 66.82 28.02 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.9 p -88.24 -48.01 8.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.155 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 81.1 p -39.8 -39.57 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.18 -44.95 92.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 171.63 -23.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 62.9 m95 -79.73 -179.85 7.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.754 0.312 . . . . 0.0 110.916 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.643 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -157.93 121.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 32.0 t80 -79.92 113.7 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.77 175.52 20.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 305' ' ' CYS . 13.8 m -125.18 131.92 53.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.31 . . . . 0.0 111.133 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.4 t -66.1 148.74 51.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 12.3 tp -97.17 -37.18 10.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.8 m -73.55 -44.78 56.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -94.07 -46.47 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.86 3.36 49.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.551 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 299' ' ' THR . 56.2 m -71.65 176.9 4.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 6.7 m -149.07 140.26 23.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.19 48.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 289' ' ' THR . 12.2 mt -88.98 136.2 33.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -138.77 153.44 72.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 0.0 110.908 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.4 Cg_endo -69.85 123.9 10.52 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.339 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.73 -11.14 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -92.49 19.36 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 8.1 m-85 -128.91 -2.5 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.997 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.06 177.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.9 t -153.05 159.49 42.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -55.16 148.2 14.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -61.79 94.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.104 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.52 -40.55 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.29 103.02 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 7.7 m -153.19 161.52 42.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 35.1 m -90.03 -179.26 5.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.7 p -53.33 144.13 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.177 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.671 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.0 p-90 -75.14 -39.73 60.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.671 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 17.2 mt -127.21 -52.99 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.532 ' HB2' HG21 ' A' ' 322' ' ' THR . 96.5 m-85 -34.8 130.46 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -109.15 97.13 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 140.23 118.31 1.51 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 97.2 p -111.59 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.878 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 20.1 m -117.73 128.14 54.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 95.35 146.79 21.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 334' ' ' GLY . 53.8 Cg_endo -69.77 -2.08 9.58 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 331' ' ' PRO . 1.7 t -35.85 132.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.7 p 43.94 35.84 1.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 331' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 60.9 p -150.38 138.57 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.0 p -80.07 -45.74 17.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -141.27 137.75 8.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.528 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 50.2 m -113.41 -57.59 2.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.4 m -113.15 88.49 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 155.11 -51.8 0.45 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -47.23 123.32 5.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -140.8 141.89 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -163.7 169.74 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.52 122.29 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -81.47 41.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 59.79 40.59 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.52 -179.52 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -82.41 44.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 11.2 m80 -76.2 142.6 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -89.93 157.34 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 3.0 m -121.96 130.55 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 314' ' ' ILE . 11.6 mt -128.3 150.21 50.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 315' ' ' THR . 8.8 tt0 -108.57 131.09 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.18 133.17 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -103.48 -28.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -145.01 144.95 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 151.91 69.46 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.494 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 24.3 t80 -148.49 120.35 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.9 m -91.3 107.4 21.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.49 16.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -120.41 -14.66 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -157.81 176.63 12.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 271' ' ' ASP . 12.3 p-10 -62.92 -39.72 95.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.1 -39.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -105.82 175.14 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.633 HD11 ' SG ' ' A' ' 305' ' ' CYS . 5.5 tp -125.67 143.97 50.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.19 130.27 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.442 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -101.89 131.96 47.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.3 t -123.79 132.87 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.713 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.81 103.45 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.311 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.56 14.51 6.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -116.73 177.99 4.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.44 ' O ' HD13 ' A' ' 281' ' ' ILE . 9.8 m-85 -120.48 161.36 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 300' ' ' SER . 38.6 mm -142.51 139.39 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.3 m-85 -101.17 113.53 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -100.26 133.69 44.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 1.0 OUTLIER -133.76 136.94 27.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 0.0 110.869 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 54.0 Cg_endo -69.78 -20.36 34.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.29 -32.28 73.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -119.29 42.73 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 12.3 pt20 -94.21 81.78 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 291' ' ' THR . 35.9 p -94.83 137.5 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.7 m 39.45 31.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 289' ' ' THR . 34.6 p -88.33 -58.37 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 291' ' ' THR . 17.8 m -35.89 -43.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.35 -46.45 62.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.71 -26.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 296' ' ' ILE . 74.2 m95 -82.77 179.92 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.0 110.926 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -160.17 123.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -78.18 115.83 18.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.45 167.74 24.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 90.2 m -122.41 137.63 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.541 ' HA ' HD13 ' A' ' 281' ' ' ILE . 23.7 t -69.16 151.3 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.535 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 9.1 tp -100.02 -31.18 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 98.8 m -76.98 -36.76 56.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 20.2 p -102.12 -65.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.34 6.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 273' ' ' LEU . 28.5 p -72.09 155.07 40.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.1 p -124.52 154.57 40.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 173.92 179.52 44.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 309' ' ' LEU . 12.1 mt -87.56 147.52 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.585 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.3 OUTLIER -150.0 155.23 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.907 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.551 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 120.03 6.88 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.06 -12.43 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -92.67 21.9 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.551 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.45 -3.83 4.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.11 -179.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 260' ' ' GLN . 6.9 t -156.2 160.03 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -59.37 143.74 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -54.91 92.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -85.38 -41.95 14.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.81 43.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 31.4 p -80.32 160.89 25.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.3 t -121.08 170.36 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.571 HG21 ' CD2' ' A' ' 325' ' ' PHE . 5.9 p -75.54 163.96 26.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.533 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.4 p-90 -131.96 -41.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 323' ' ' TRP . 26.4 mm -125.04 -12.89 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 325' ' ' PHE . 0.1 OUTLIER -34.23 141.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -107.41 151.69 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -149.98 159.8 28.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.5 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 99.8 p -72.23 127.08 31.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 110.826 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 52.5 m -103.88 140.02 38.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 331' ' ' PRO . . . 79.07 -147.67 30.65 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.523 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 330' ' ' GLY . 53.4 Cg_endo -69.79 146.1 59.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 35.6 m -89.89 82.03 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.8 p -84.61 155.65 21.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.7 m -106.31 92.58 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 0.0 110.934 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 m 57.41 48.99 13.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -132.22 -53.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 78.0 p -119.85 -55.18 2.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.857 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -77.5 -68.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.54 -93.06 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 59.6 p -171.77 171.32 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 250' ' ' ASP . 33.3 mtm180 -95.97 85.66 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 249' ' ' ARG . 4.5 m-20 -162.3 127.09 3.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.25 116.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.183 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.84 47.51 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.74 44.14 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -76.0 -176.01 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.01 44.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 26.4 m80 -78.84 136.18 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 258' ' ' THR . 11.1 tp10 -95.92 159.04 15.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 8.3 m -123.72 123.11 39.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.746 HD13 HD13 ' A' ' 314' ' ' ILE . 6.9 mt -125.41 151.9 45.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -108.87 130.36 55.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.8 126.57 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -100.19 -17.01 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -156.27 145.63 15.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.671 0.748 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 162.79 40.72 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.675 2.25 . . . . 0.0 112.396 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 1.028 ' CB ' HD12 ' A' ' 275' ' ' LEU . 28.1 t80 -147.81 144.3 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.4 m -114.74 99.42 51.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.55 21.23 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.369 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -124.88 -14.01 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -147.64 -178.99 6.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.8 m-20 -71.87 -42.47 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 270' ' ' ASP . 29.4 t70 -37.34 -39.93 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.55 176.89 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.1 tp -137.8 153.6 49.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 21.9 tt0 -74.98 150.83 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 1.028 HD12 ' CB ' ' A' ' 265' ' ' TYR . 26.0 mt -117.71 133.66 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.23 130.87 24.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.634 0.731 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 105.65 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.24 . . . . 0.0 112.346 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.32 16.13 7.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -118.34 171.08 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.425 ' CD1' HG22 ' A' ' 258' ' ' THR . 9.0 m-85 -110.8 159.76 17.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.493 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 32.2 mm -136.76 133.95 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 301' ' ' LEU . 28.9 m-85 -99.33 111.64 23.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -100.41 138.92 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 7.7 t -137.74 134.22 18.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.731 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.417 ' HA ' ' CD ' ' A' ' 288' ' ' GLN . 53.2 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.247 . . . . 0.0 112.329 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.3 mmt -82.04 -27.95 32.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -126.1 42.14 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 285' ' ' PRO . 12.8 pt20 -98.14 75.04 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.558 ' O ' HD21 ' A' ' 308' ' ' LEU . 35.4 p -88.59 142.8 27.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 13.0 m 40.44 33.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.799 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 289' ' ' THR . 54.9 p -91.58 -57.46 2.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.8 t -38.59 -40.41 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -53.82 -44.42 70.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 175.37 -25.34 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.531 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.9 m95 -85.01 179.86 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -159.55 123.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 26.2 t80 -76.81 114.78 15.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLY . . . . . 0.493 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -134.55 163.82 24.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 93.1 m -116.26 129.08 56.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 111.131 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -65.62 151.64 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.819 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.9 tp -102.5 -29.5 11.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.7 m -81.87 -38.54 25.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 77.3 p -103.47 -38.96 6.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 -13.63 60.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 95.4 m -53.05 166.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.0 m -146.83 128.3 15.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.07 33.8 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.558 HD21 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -89.09 143.5 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.44 156.9 49.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.719 . . . . 0.0 110.886 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.655 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.7 117.01 4.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.248 . . . . 0.0 112.362 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.42 ' HA ' HD11 ' A' ' 296' ' ' ILE . 7.7 pt-20 -56.07 -13.21 1.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.26 23.45 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.612 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.3 m-85 -130.57 -3.1 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.746 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -126.1 177.2 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.7 t -151.97 159.35 43.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -61.78 151.08 35.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -77.32 46.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.69 23.06 11.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.37 99.23 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.2 m 53.38 36.61 23.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 54.5 p -161.01 125.83 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.618 HG21 ' CD2' ' A' ' 325' ' ' PHE . 8.3 p -77.35 166.97 22.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.575 ' CE3' HG12 ' A' ' 324' ' ' ILE . 3.4 p-90 -133.66 -45.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.575 HG12 ' CE3' ' A' ' 323' ' ' TRP . 20.4 mm -117.51 -16.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' A' ' 322' ' ' THR . 0.1 OUTLIER -34.2 138.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -101.61 165.82 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 114.09 115.64 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.8 m -115.0 174.53 5.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 0.0 110.824 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 90.5 p -134.57 121.02 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 147.54 -94.9 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.28 7.02 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.718 2.278 . . . . 0.0 112.332 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.8 p -86.62 141.74 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 90.4 p -103.85 42.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 11.4 m -123.13 169.66 11.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 244' ' ' GLY . 75.1 p -83.22 87.08 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 243' ' ' SER . . . 37.23 -146.66 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 19.8 m -98.45 110.28 22.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.6 t -72.97 154.74 40.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 248' ' ' SER . . . 79.86 -49.91 3.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' GLY . 14.6 m -35.15 136.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.08 147.92 25.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -106.21 156.49 18.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 1.024 HG23 ' HB3' ' A' ' 254' ' ' ALA . 5.0 mp -73.09 115.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -123.6 -49.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -116.52 34.35 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 1.024 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -110.46 174.44 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -108.81 43.96 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 22.2 m80 -98.97 136.7 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.72 163.65 12.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.1 m -125.89 126.56 44.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.974 HD13 HD13 ' A' ' 314' ' ' ILE . 14.3 mt -124.03 151.94 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -108.74 130.75 55.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.1 131.8 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.9 pt -107.93 -19.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.157 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -155.82 143.86 14.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.693 0.759 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 153.9 68.46 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.717 2.278 . . . . 0.0 112.314 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 35.9 t80 -150.69 125.65 9.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.947 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.14 109.43 44.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.569 0.7 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.406 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.73 166.79 26.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -115.69 -20.71 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -153.32 -179.2 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -64.87 -32.39 74.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -41.6 -44.09 2.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.2 pm0 -102.98 171.33 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.2 tp -124.59 147.05 48.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.433 ' C ' HD23 ' A' ' 275' ' ' LEU . 26.9 tt0 -66.56 140.26 57.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 309' ' ' LEU . 5.9 mt -112.13 127.68 55.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 277' ' ' PRO . 87.2 t -124.47 133.5 24.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.629 0.728 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.9 Cg_endo -69.71 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.56 2.94 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -111.18 162.6 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 281' ' ' ILE . 19.9 m-85 -106.06 159.19 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 300' ' ' SER . 20.0 mm -137.76 120.2 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.458 ' CE2' HD13 ' A' ' 301' ' ' LEU . 35.1 m-85 -81.98 114.76 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -99.47 138.03 37.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.496 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.1 p -137.66 125.73 14.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -10.71 29.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 40.5 mtp -83.04 -28.94 29.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 297' ' ' TYR . 50.5 mm-40 -117.65 40.41 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.448 ' CD ' ' O ' ' A' ' 288' ' ' GLN . 2.9 pp0? -96.15 123.68 39.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.481 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.5 p -129.06 126.92 40.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.0 m 55.1 25.18 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 294' ' ' GLY . 41.8 p -87.51 -54.53 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 291' ' ' THR . 28.0 t -36.35 -37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -61.57 -48.7 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -179.44 -27.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -79.82 -179.76 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.726 0.298 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.428 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.7 pt -152.34 134.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 287' ' ' GLU . 53.6 t80 -96.21 111.03 23.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -138.38 177.48 20.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 305' ' ' CYS . 58.6 m -127.37 119.55 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 111.16 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.854 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -55.26 168.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.458 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.8 tp -111.31 -28.65 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -74.38 -47.87 31.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.6 p -95.23 -28.95 14.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 80.7 16.04 76.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.753 ' O ' HG23 ' A' ' 299' ' ' THR . 5.9 t -88.55 169.04 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 79.6 p -131.34 142.78 50.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.95 48.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.643 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -92.25 151.45 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -157.54 157.5 30.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 110.958 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 123.76 10.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.757 2.305 . . . . 0.0 112.34 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.29 -8.97 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.21 19.18 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.506 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.0 m-85 -126.56 -1.18 6.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.974 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.25 175.94 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.4 t -149.71 165.4 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 4.7 mptt -67.16 143.8 56.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.07 95.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.58 -54.94 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.847 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 40.61 43.02 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 14.7 t -48.84 -45.09 40.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 74.7 m -113.74 102.25 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.3 p -99.95 156.43 17.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -80.94 -39.42 26.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 325' ' ' PHE . 4.0 mm -130.0 -53.64 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.424 ' HB2' HG21 ' A' ' 322' ' ' THR . 83.9 m-85 -36.23 146.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -131.17 135.55 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -166.99 -121.47 0.56 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.3 t -67.86 111.65 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 30.4 t -72.01 98.75 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 55.82 -158.21 8.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 85.44 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.362 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 m -81.62 143.14 32.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m 52.0 35.65 16.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.4 m -65.26 137.77 57.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 110.848 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 60.6 p -77.82 149.68 34.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.851 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.38 69.22 0.17 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 54.0 p -97.91 115.36 27.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 t -123.1 139.05 54.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.52 68.44 1.63 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.0 t -75.49 110.84 10.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 110.834 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -70.44 -29.48 66.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -104.05 161.66 13.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 256' ' ' HIS . 17.7 mt -86.76 116.27 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -126.58 -35.22 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.57 -40.95 22.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -82.79 158.89 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -99.59 40.48 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' HIS . . . . . 0.581 ' HB2' HD13 ' A' ' 251' ' ' ILE . 18.8 m80 -74.29 144.1 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -96.17 163.0 13.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.5 m -127.87 133.63 49.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 314' ' ' ILE . 9.2 mt -132.67 155.12 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -110.3 132.52 54.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.65 137.65 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.32 -18.69 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -155.02 142.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.75 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 158.17 57.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -153.3 125.33 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 m -95.62 109.99 48.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG2' ' A' ' 272' ' ' GLU . 54.1 Cg_endo -69.8 171.07 15.19 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -125.64 -13.69 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.431 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 23.3 m-80 -151.42 -175.39 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.18 -21.94 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 0.9 OUTLIER -104.76 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' A' ' 305' ' ' CYS . 6.7 tp -120.35 148.42 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.414 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 36.7 tt0 -72.48 145.56 47.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -115.73 135.51 53.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.492 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.5 t -127.54 134.81 26.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 111.16 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.492 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.3 Cg_endo -69.76 113.54 3.41 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 109.57 5.78 29.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.525 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -110.82 165.4 11.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.342 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.536 ' O ' HD13 ' A' ' 281' ' ' ILE . 28.2 m-85 -107.28 163.46 13.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 280' ' ' PHE . 15.1 mm -146.09 122.85 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.51 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 41.3 m-85 -81.93 128.83 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -98.96 129.39 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.476 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 0.4 OUTLIER -128.12 108.21 19.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.723 0.773 . . . . 0.0 110.901 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -3.11 11.34 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -88.88 -24.89 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 297' ' ' TYR . 55.3 mm-40 -122.97 40.85 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.34 109.12 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.452 ' O ' HD11 ' A' ' 308' ' ' LEU . 21.0 p -114.05 119.26 36.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.9 m 67.36 27.78 8.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.837 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 33.6 p -87.85 -41.22 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.8 t -49.28 -27.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 294' ' ' GLY . 4.9 pt-20 -70.9 -42.96 69.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 293' ' ' GLU . . . 173.77 -25.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 296' ' ' ILE . 73.5 m95 -80.54 179.28 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.717 0.294 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 311' ' ' GLU . 1.1 pt -156.83 126.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 287' ' ' GLU . 29.9 t80 -84.66 111.76 19.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -133.65 -173.56 13.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 91.8 m -133.21 141.03 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.7 t -74.74 149.6 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.51 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.1 tp -96.08 -39.36 9.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.5 m -71.35 -39.95 71.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.0 p -100.04 -63.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.84 10.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' A' ' 273' ' ' LEU . 2.3 p -79.53 153.77 29.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.4 p -120.25 147.86 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.79 -175.54 47.65 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -94.79 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.622 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.74 157.13 62.31 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.59 0.71 . . . . 0.0 110.913 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.654 2.236 . . . . 0.0 112.327 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.415 ' HA ' HD11 ' A' ' 296' ' ' ILE . 5.2 pt-20 -55.0 -15.52 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -88.74 19.69 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.544 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.69 -2.57 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.963 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -128.41 173.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.3 t -147.79 151.78 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -59.49 142.83 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.39 86.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -106.38 16.91 24.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.457 ' CD ' ' O ' ' A' ' 319' ' ' GLU . 2.5 pp20? -104.17 106.85 17.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 56.5 m 48.67 35.81 6.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -145.28 120.93 10.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.5 p -48.89 161.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' TRP . . . . . 0.801 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -90.17 -39.62 12.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.801 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 20.7 mt -130.16 -46.57 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.521 ' HB2' HG21 ' A' ' 322' ' ' THR . 61.9 m-85 -34.51 126.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -91.92 172.66 8.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -42.82 -39.99 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.518 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 1.5 t -153.04 136.31 15.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.818 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 53.2 m -101.66 149.94 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -159.87 -97.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.532 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.02 29.94 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.682 2.255 . . . . 0.0 112.382 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.3 m -114.19 107.71 15.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.7 t -58.45 -59.41 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.937 0.398 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.1 m -130.63 130.89 44.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 10.9 mt -129.73 150.45 51.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -108.68 131.53 54.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.37 128.69 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.9 pt -104.06 -16.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 79.2 m-85 -158.42 144.46 12.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.74 0.781 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 157.53 60.21 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.698 2.265 . . . . 0.0 112.332 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 15.6 t80 -148.83 127.67 12.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -96.53 107.0 33.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.549 0.69 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 170.92 15.44 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.335 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -125.81 -15.04 6.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.432 ' C ' ' OE1' ' A' ' 272' ' ' GLU . 65.9 m-80 -150.37 -175.71 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 9.0 t70 -72.76 -42.27 64.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 37.8 t70 -37.7 -38.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 269' ' ' ASN . 1.2 pm0 -102.54 168.22 9.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.8 tp -127.12 149.23 50.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.471 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 15.7 tt0 -69.72 143.9 52.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -113.36 141.28 47.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 277' ' ' PRO . 57.6 t -131.53 134.72 25.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.77 112.66 3.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.32 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.39 6.66 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -109.48 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -115.43 167.14 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 309' ' ' LEU . 29.2 mm -145.35 115.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.439 ' CE2' HD13 ' A' ' 301' ' ' LEU . 29.2 m-85 -85.02 118.7 24.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -102.31 137.95 39.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.49 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.2 p -134.66 140.26 34.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.67 0.748 . . . . 0.0 110.843 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -26.54 27.42 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.35 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.0 mtp -81.05 -1.72 45.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 71.8 mm-40 -126.91 18.52 7.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -77.14 127.8 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.815 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.4 p -148.93 113.4 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 63.78 25.15 14.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.4 p -88.59 -45.78 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.0 m -44.33 -24.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.31 -49.4 19.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 179.9 -26.55 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -80.23 -179.45 7.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.74 0.305 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 314' ' ' ILE . 1.0 OUTLIER -153.47 127.14 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 27.6 t80 -88.0 120.23 29.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -148.67 -173.71 19.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 38.8 m -130.42 139.06 50.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.333 . . . . 0.0 111.16 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.451 ' HA ' HD13 ' A' ' 281' ' ' ILE . 27.3 t -75.17 158.3 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.439 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.0 tp -100.14 -34.83 9.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 62.9 m -73.6 -61.29 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 67.5 p -78.62 -49.96 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.95 11.65 31.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.456 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.57 149.71 21.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.8 t -118.18 154.41 32.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 172.61 -173.29 45.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.815 HD21 ' O ' ' A' ' 289' ' ' THR . 20.6 mt -91.73 137.1 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.5 155.48 63.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.541 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.6 Cg_endo -69.8 119.99 6.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -57.06 -12.55 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.75 20.42 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.541 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.2 m-85 -129.04 -3.62 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -129.89 177.27 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 4.7 t -152.49 159.81 43.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -59.55 149.63 29.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.486 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 20.3 pt-20 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.895 0.378 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 18.2 m -116.02 137.08 52.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.929 HD13 HD13 ' A' ' 314' ' ' ILE . 9.1 mt -134.02 150.62 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -108.79 132.69 53.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.63 129.71 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 3.0 pt -107.38 -14.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.472 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 89.3 m-85 -159.28 143.26 11.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.654 0.74 . . . . 0.0 110.958 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 160.05 51.18 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -154.61 127.05 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.955 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.75 109.61 47.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.74 172.12 13.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -123.96 -14.28 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -162.49 -177.46 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -63.89 -36.67 84.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.42 -42.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.437 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.2 pm0 -105.23 175.11 5.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -130.58 143.11 50.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.63 144.01 56.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 309' ' ' LEU . 6.4 mt -112.51 142.51 44.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.37 128.21 19.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 104.31 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.277 . . . . 0.0 112.368 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.22 5.16 8.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -112.55 171.31 7.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.52 162.06 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 300' ' ' SER . 17.5 mm -135.09 132.38 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -99.49 106.21 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.7 tmm? -98.97 134.21 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.5 ' N ' ' SD ' ' A' ' 283' ' ' MET . 8.5 p -126.12 143.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.661 0.743 . . . . 0.0 110.875 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -24.47 29.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.351 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 44.2 mtp -81.53 -3.19 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 66.3 mm-40 -126.33 9.69 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -69.27 87.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 308' ' ' LEU . 19.9 p -104.99 128.9 53.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m 48.09 26.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 294' ' ' GLY . 29.4 p -86.05 -54.48 4.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.2 t -35.36 -36.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 18.4 tp10 -62.66 -47.72 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.15 -26.2 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.457 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.3 m95 -79.93 -179.78 7.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.903 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.519 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.89 125.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.7 t80 -84.2 111.14 19.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -134.29 -177.77 15.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 305' ' ' CYS . 97.2 m -133.18 129.6 38.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.123 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.407 ' HA ' HD13 ' A' ' 281' ' ' ILE . 2.4 t -66.17 154.77 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.3 tp -99.82 -29.94 12.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 5.2 m -72.65 -52.64 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.0 p -88.8 -55.37 3.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.93 23.36 6.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.555 ' O ' HG23 ' A' ' 299' ' ' THR . 11.6 t -96.15 166.28 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 81.1 p -129.02 143.39 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.85 47.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 289' ' ' THR . 10.9 mt -88.95 139.17 30.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 110.914 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.21 157.19 63.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.559 0.695 . . . . 0.0 110.946 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.3 Cg_endo -69.79 120.7 7.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.657 2.238 . . . . 0.0 112.344 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -58.68 -11.62 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -93.03 20.5 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.538 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.6 m-85 -128.74 -3.06 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -130.16 177.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.8 t -153.34 162.63 41.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -66.31 148.01 52.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.084 179.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.941 0.4 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.4 ' O ' HD23 ' A' ' 259' ' ' LEU . 1.8 m -133.03 126.78 32.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.95 151.41 50.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -108.77 133.72 52.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.5 142.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.447 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -119.99 -14.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.3 m-85 -158.33 143.78 12.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.68 0.752 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.49 69.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.977 ' HB2' HD12 ' A' ' 275' ' ' LEU . 41.3 t80 -138.46 144.82 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 11.8 m -115.45 97.66 49.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.69 171.52 14.24 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.341 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.59 -13.22 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -157.32 -179.54 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 271' ' ' ASP . 2.1 p30 -66.87 -38.71 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.67 -38.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -111.49 172.9 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 5.3 tp -129.02 143.62 50.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 275' ' ' LEU . 7.0 tt0 -65.44 150.13 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 265' ' ' TYR . 22.8 mt -117.48 127.12 53.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 277' ' ' PRO . 93.7 t -118.56 132.39 23.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.736 . . . . 0.0 111.129 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.76 110.75 2.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.726 2.284 . . . . 0.0 112.318 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.26 4.56 20.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -110.76 171.67 7.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 281' ' ' ILE . 32.1 m-85 -112.74 167.99 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 280' ' ' PHE . 12.3 mm -144.98 131.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 40.4 m-85 -91.68 120.2 32.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 284' ' ' SER . 1.9 tmm? -99.84 128.24 45.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.443 ' N ' ' SD ' ' A' ' 283' ' ' MET . 39.6 p -126.63 130.17 23.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.676 0.75 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.514 ' HA ' ' CG ' ' A' ' 288' ' ' GLN . 53.8 Cg_endo -69.7 -13.0 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 0.0 112.369 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.87 -22.45 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.599 ' OE1' ' CE2' ' A' ' 297' ' ' TYR . 13.7 mt-10 -112.27 36.0 3.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.514 ' CG ' ' HA ' ' A' ' 285' ' ' PRO . 9.3 mm100 -84.16 86.79 7.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.565 ' O ' HD11 ' A' ' 308' ' ' LEU . 15.9 p -110.74 108.63 18.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.3 m 61.62 30.73 18.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 293' ' ' GLU . 43.6 p -92.56 -59.67 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.9 m -34.06 -34.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . 9.9 tp10 -63.59 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -174.57 -30.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.524 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -80.13 -179.99 7.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.737 0.303 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.554 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.77 121.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.599 ' CE2' ' OE1' ' A' ' 287' ' ' GLU . 38.9 t80 -72.76 110.92 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -128.89 166.47 21.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 94.5 m -125.79 111.86 15.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.8 t -47.79 147.25 2.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.574 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -96.73 -45.47 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 97.8 m -63.25 -42.37 99.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 33.7 p -96.37 -53.28 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 110.82 0.2 28.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 99.6 m -69.97 151.67 45.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.6 p -124.19 138.14 54.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.65 -175.92 47.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 289' ' ' THR . 14.4 mt -88.38 144.98 26.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.1 156.49 50.76 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.677 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.5 Cg_endo -69.79 122.0 8.68 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.706 2.27 . . . . 0.0 112.309 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.36 -10.84 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -94.22 23.11 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.753 ' HB3' HD13 ' A' ' 275' ' ' LEU . 10.5 m-85 -130.95 -3.33 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.996 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -130.42 176.56 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.9 t -154.47 152.52 30.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -55.09 141.93 32.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.928 0.394 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -133.16 128.79 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.966 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.51 149.27 51.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 25.6 tm0? -108.78 124.59 50.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 85.2 t -58.32 138.45 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.5 pt -115.85 -11.86 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 84.6 m-85 -161.76 144.18 8.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.726 0.774 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.33 64.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.716 2.277 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 38.3 t80 -138.85 135.51 34.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -104.68 105.43 50.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.58 0.705 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 170.68 15.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -125.18 -16.82 5.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.452 ' CG ' ' OE2' ' A' ' 272' ' ' GLU . 0.2 OUTLIER -152.94 173.41 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 271' ' ' ASP . 3.9 t70 -59.62 -41.07 89.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -35.11 -44.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.452 ' OE2' ' CG ' ' A' ' 269' ' ' ASN . 11.6 pm0 -99.29 178.41 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.9 tp -135.37 148.81 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.78 140.68 55.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -111.98 141.17 45.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.513 HG13 ' HD2' ' A' ' 277' ' ' PRO . 96.1 t -129.08 135.24 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.643 0.735 . . . . 0.0 111.129 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.75 104.78 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.69 13.2 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.17 167.74 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.878 0.371 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.444 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.5 m-85 -107.3 166.0 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.703 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.5 mm -144.85 119.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 28.7 m-85 -87.41 115.86 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -98.88 141.38 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.5 ' N ' ' SD ' ' A' ' 283' ' ' MET . 5.3 t -133.94 142.33 43.05 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -32.63 17.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.638 2.225 . . . . 0.0 112.352 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 63.7 mtp -74.97 -0.55 19.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 15.7 mm-40 -125.43 15.04 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.19 87.59 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.664 ' O ' HD21 ' A' ' 308' ' ' LEU . 8.2 p -114.46 122.32 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.3 m 56.26 25.84 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 31.8 p -89.42 -42.22 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.3 t -48.31 -29.61 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.28 -36.26 76.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.75 -25.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 296' ' ' ILE . 66.2 m95 -80.01 -179.67 7.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.2 pt -157.2 128.41 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 25.1 t80 -86.19 112.47 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.43 ' HA3' HG22 ' A' ' 281' ' ' ILE . . . -135.35 172.42 22.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.472 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 74.0 m -125.96 113.56 17.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.703 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.9 t -50.08 174.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 11.7 tp -114.46 -26.96 7.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -81.46 -54.2 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.3 p -86.73 -27.54 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.07 82.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.2 m -84.63 148.97 26.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 91.0 p -120.3 130.72 54.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.77 -174.69 38.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 289' ' ' THR . 19.7 mt -87.71 149.39 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.64 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -154.95 157.03 31.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.903 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.2 Cg_endo -69.83 122.43 9.09 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.696 2.264 . . . . 0.0 112.289 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.92 -10.07 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -95.48 22.77 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.549 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.4 m-85 -130.47 -2.03 4.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -133.23 172.15 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.5 t -147.17 164.46 33.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.61 151.31 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.117 179.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.944 0.402 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -131.64 127.42 36.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.774 HD13 HD13 ' A' ' 314' ' ' ILE . 9.4 mt -130.18 149.83 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -108.77 136.83 47.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.16 129.14 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.17 -28.67 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -145.52 143.9 21.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 154.16 68.14 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.468 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.0 t80 -147.88 127.55 13.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -94.8 109.13 42.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 172.82 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -124.08 -13.14 7.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -163.4 -178.14 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.3 t70 -64.4 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -37.66 -40.31 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.29 173.09 6.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.99 145.36 51.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 275' ' ' LEU . 60.9 tt0 -63.84 146.13 54.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 309' ' ' LEU . 6.5 mt -117.27 121.37 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 277' ' ' PRO . 99.4 t -117.64 134.33 23.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.713 . . . . 0.0 111.144 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.76 110.56 2.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.339 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.12 1.32 16.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -106.65 169.63 8.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.437 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.9 m-85 -116.03 155.16 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 300' ' ' SER . 40.6 mm -133.49 123.15 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 20.1 m-85 -87.39 119.11 27.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -102.72 141.14 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.499 ' N ' ' SD ' ' A' ' 283' ' ' MET . 23.9 p -134.86 139.35 31.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.684 0.754 . . . . 0.0 110.846 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.04 35.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 2.237 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 39.7 mtp -86.4 2.49 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.582 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 80.7 mm-40 -131.38 12.97 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.24 88.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.6 p -110.26 123.51 49.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.1 m 54.27 25.61 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 28.2 p -88.56 -43.45 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 m -45.0 -34.04 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -65.12 -42.03 94.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 169.37 -23.58 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -79.93 -179.72 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 110.899 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -155.93 128.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.5 t80 -89.75 113.43 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -137.03 176.37 20.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.2 m -128.4 126.3 40.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.65 ' HA ' HD13 ' A' ' 281' ' ' ILE . 43.7 t -62.13 155.99 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.6 tp -97.8 -33.55 11.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 99.2 m -75.05 -55.69 5.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 49.2 p -84.79 -39.57 18.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.02 10.33 62.75 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.467 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.05 153.41 26.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 59.9 p -122.5 140.7 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -176.76 179.15 47.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 11.3 mt -89.23 139.42 30.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -143.84 156.67 58.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.602 0.715 . . . . 0.0 110.923 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.75 121.08 7.78 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.352 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.68 -11.23 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.17 19.97 7.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -128.22 -3.03 5.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.07 -176.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 163.78 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 152.73 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.902 0.382 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.409 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.8 m -134.29 135.29 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 314' ' ' ILE . 7.4 mt -137.36 152.79 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.514 ' O ' HG22 ' A' ' 315' ' ' THR . 22.5 tm0? -108.66 129.93 55.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.41 134.13 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -109.14 -17.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.6 m-85 -158.55 143.89 12.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.655 0.741 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 152.57 69.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 2.269 . . . . 0.0 112.368 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 42.0 t80 -144.47 138.54 27.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.9 m -106.74 107.75 60.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.553 0.692 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG3' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.78 169.46 18.89 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -123.2 -14.2 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.432 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 0.3 OUTLIER -154.71 179.48 9.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.84 -35.49 80.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.498 ' OD1' HD12 ' A' ' 308' ' ' LEU . 26.0 t0 -40.59 -43.82 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 13.6 pm0 -100.28 177.66 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.6 tp -136.54 147.71 47.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.537 ' O ' HD23 ' A' ' 275' ' ' LEU . 19.8 tt0 -63.35 148.84 47.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -120.61 134.32 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.8 133.09 24.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.656 0.741 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 105.98 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.719 2.28 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.45 11.35 10.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -112.1 171.58 7.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -112.06 161.15 16.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.472 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 20.1 mm -140.08 123.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -88.25 110.37 20.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.6 tmm? -98.88 132.24 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.474 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.3 t -126.06 144.15 47.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.752 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -31.61 20.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.714 2.276 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 28.7 mmm -76.33 4.27 9.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.585 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 19.5 mt-10 -133.13 18.41 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -77.74 82.39 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.5 p -103.11 134.92 45.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 41.79 25.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 289' ' ' THR . 32.2 p -85.68 -45.07 12.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 45.6 m -45.93 -31.89 2.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.45 -35.99 81.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.05 -25.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.441 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.5 m95 -79.98 -179.81 7.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.74 0.305 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.92 130.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 21.4 t80 -86.53 120.44 27.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -146.4 171.67 27.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.5 m -121.7 133.96 54.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.423 ' HA ' HD13 ' A' ' 281' ' ' ILE . 33.4 t -70.02 151.16 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.2 tp -96.08 -34.04 11.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -72.83 -43.06 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 68.8 p -96.78 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.13 8.68 14.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.3 m -83.95 155.23 22.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.6 p -124.12 132.92 53.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -170.5 -175.68 39.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.435 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 18.3 mt -87.78 151.28 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 308' ' ' LEU . 0.2 OUTLIER -155.25 157.32 31.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 110.946 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 116.07 4.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 2.248 . . . . 0.0 112.336 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.66 -14.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -90.06 20.52 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.545 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.9 m-85 -129.08 2.68 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -132.62 175.43 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 260' ' ' GLN . 12.8 t -149.64 154.38 38.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.463 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.2 OUTLIER -61.98 144.91 54.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.41 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 12.9 pt-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.914 0.388 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -112.69 138.56 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 314' ' ' ILE . 9.7 mt -135.54 150.93 49.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 17.3 tm0? -108.76 137.14 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.496 HG11 ' C ' ' A' ' 276' ' ' VAL . 49.8 t -66.44 137.22 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 4.5 pt -116.97 -14.39 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 91.2 m-85 -162.03 142.63 7.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.743 0.782 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 154.39 67.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.986 ' CB ' HD12 ' A' ' 275' ' ' LEU . 25.8 t80 -137.31 156.57 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 18.8 m -124.15 97.3 40.68 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.558 0.694 . . . . 0.0 111.108 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.75 171.17 14.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.318 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -125.24 -14.8 6.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.75 -178.5 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 271' ' ' ASP . 6.6 m-20 -65.49 -36.77 84.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -36.52 -42.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -107.64 175.46 5.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -131.61 141.24 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.52 154.28 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.986 HD12 ' CB ' ' A' ' 265' ' ' TYR . 23.7 mt -121.63 124.78 45.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.496 ' C ' HG11 ' A' ' 261' ' ' VAL . 71.2 t -113.83 130.23 24.01 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.687 0.756 . . . . 0.0 111.104 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.42 6.75 19.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -111.9 171.52 7.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.22 164.86 12.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 309' ' ' LEU . 12.1 mm -145.35 121.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HE2' HD13 ' A' ' 301' ' ' LEU . 84.6 m-85 -89.88 111.69 22.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.9 tmm? -99.52 136.14 39.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.499 ' N ' ' SD ' ' A' ' 283' ' ' MET . 0.9 OUTLIER -128.43 136.98 29.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.669 0.747 . . . . 0.0 110.85 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -18.81 36.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 20.4 mmt -66.58 -37.54 85.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 4.9 mt-10 -120.21 44.94 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.488 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 3.7 pp0? -96.94 52.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.424 ' O ' HD21 ' A' ' 308' ' ' LEU . 34.1 p -76.58 143.13 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 m 52.67 25.83 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 289' ' ' THR . 44.2 p -95.94 -49.24 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.183 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 t -46.68 -25.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.52 -35.95 70.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.26 -22.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.49 ' O ' HG23 ' A' ' 296' ' ' ILE . 68.7 m95 -86.31 178.96 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.97 122.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.431 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 19.5 t80 -78.81 110.09 13.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.18 175.78 19.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.4 m -126.47 127.48 45.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.559 ' HA ' HD13 ' A' ' 281' ' ' ILE . 36.4 t -66.1 153.03 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.722 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.2 tp -100.46 -43.17 6.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -62.79 -39.79 95.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 64.8 p -102.28 -55.3 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 112.94 1.57 25.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.2 t -71.84 166.18 22.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.6 m -137.9 143.81 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -174.81 47.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 289' ' ' THR . 12.1 mt -88.19 138.78 31.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.74 155.9 66.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.93 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.723 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.8 Cg_endo -69.77 125.34 12.02 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.32 -8.2 5.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.25 23.39 7.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 275' ' ' LEU . 11.6 m-85 -130.72 -3.92 4.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 259' ' ' LEU . 2.7 pp -131.0 -179.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 11.9 t -155.97 162.62 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.54 153.49 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 19.3 pt-20 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 23.0 m -109.05 130.38 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.143 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 314' ' ' ILE . 11.7 mt -131.67 149.31 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 0.7 OUTLIER -108.63 132.42 53.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 54.6 t -64.74 132.3 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.6 -20.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -152.0 144.24 16.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.667 0.746 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.84 69.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 56.4 t80 -142.09 132.7 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.7 m -103.89 102.55 32.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.098 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 171.18 14.96 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -125.25 -15.15 6.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -152.29 -175.99 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.4 t70 -71.9 -37.64 70.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.4 OUTLIER -35.57 -39.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 pm0 -107.9 179.57 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 9.3 tp -133.92 145.48 49.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.53 141.52 58.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -114.98 130.7 56.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 277' ' ' PRO . 60.9 t -123.52 135.1 25.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.623 0.725 . . . . 0.0 111.124 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.77 117.05 4.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.22 1.08 29.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.39 175.95 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -115.34 165.4 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.478 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 25.8 mm -141.46 127.6 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.01 109.51 21.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.0 tmm? -99.93 133.27 44.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.488 ' N ' ' SD ' ' A' ' 283' ' ' MET . 8.9 t -132.04 137.48 30.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.758 . . . . 0.0 110.815 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.3 mmt -88.27 -11.69 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 1.8 pt-20 -129.55 26.57 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -85.59 84.76 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.442 ' O ' HD21 ' A' ' 308' ' ' LEU . 20.1 p -100.43 118.32 36.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 20.6 m 62.06 25.07 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 35.9 p -86.35 -53.35 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 291' ' ' THR . 65.6 m -37.85 -32.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 4.8 tp10 -66.32 -47.12 74.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 179.05 -28.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.529 ' O ' HG23 ' A' ' 296' ' ' ILE . 60.6 m95 -79.89 -179.79 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.302 . . . . 0.0 110.907 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -158.99 125.33 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 23.2 t80 -80.13 114.31 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.478 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -135.21 162.83 24.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 17.1 m -114.03 132.73 55.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 31.0 t -67.96 148.42 51.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.7 -31.02 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -78.09 -48.85 15.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 75.5 p -91.48 -42.46 10.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.48 4.72 57.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 87.1 m -73.55 168.84 18.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 110.844 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 10.5 m -138.63 139.22 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.68 -176.7 47.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -88.13 148.25 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -150.54 155.6 36.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.602 0.715 . . . . 0.0 110.927 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.1 Cg_endo -69.77 125.49 12.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.68 -8.76 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 312' ' ' ASN . 28.9 t-20 -96.14 22.01 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.574 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.1 m-85 -130.32 -3.27 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -129.85 175.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 260' ' ' GLN . 13.5 t -154.86 159.19 40.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.69 155.52 2.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.945 0.402 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.6 m -122.76 131.52 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.928 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -133.95 150.63 51.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -108.71 134.25 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.03 135.29 28.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -113.03 -12.5 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 92.3 m-85 -161.31 142.86 8.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.657 0.741 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.48 68.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 0.0 112.318 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.7 t80 -147.57 126.18 12.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.1 m -96.96 108.3 42.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.571 0.7 . . . . 0.0 111.125 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.0 Cg_endo -69.75 166.69 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -115.93 -21.3 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -153.72 -177.43 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 271' ' ' ASP . 25.6 t0 -65.33 -37.25 86.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.7 OUTLIER -37.83 -40.69 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.413 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.4 pm0 -105.83 175.34 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.9 tp -129.9 147.3 51.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.41 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.0 tt0 -67.52 145.67 54.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 309' ' ' LEU . 10.4 mt -116.06 132.58 56.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.25 129.77 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.688 0.756 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.71 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.49 10.6 9.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -113.26 178.21 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.42 159.88 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.1 mm -135.25 138.0 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -101.73 113.36 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.5 tmm? -99.04 140.55 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.497 ' N ' ' SD ' ' A' ' 283' ' ' MET . 6.0 t -133.81 141.78 41.16 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.893 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -37.42 9.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 36.8 mtp -74.14 1.34 11.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 37.8 mm-40 -128.36 17.15 6.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -77.98 86.14 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.739 ' O ' HD21 ' A' ' 308' ' ' LEU . 29.9 p -105.17 126.8 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.9 m 48.47 29.46 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 17.3 p -89.49 -50.0 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 59.1 p -39.9 -38.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.47 -46.36 89.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 175.03 -25.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 296' ' ' ILE . 59.6 m95 -80.58 -179.84 7.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.1 pt -156.52 125.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 38.5 t80 -80.13 111.2 16.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.56 169.33 22.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 305' ' ' CYS . 91.4 m -124.8 116.36 22.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.155 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 281' ' ' ILE . 4.9 t -54.48 153.43 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.81 -50.7 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 16.0 m -53.46 -52.79 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.4 p -87.22 -53.45 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.8 4.54 31.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.433 ' O ' HG23 ' A' ' 299' ' ' THR . 9.3 t -77.72 166.72 22.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 84.1 p -134.85 147.91 50.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 174.84 -176.84 47.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 289' ' ' THR . 12.3 mt -88.98 137.57 32.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.83 156.01 65.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.943 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 124.4 11.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.61 -8.81 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -95.62 21.93 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.559 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.6 m-85 -129.07 -1.5 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.85 -177.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.5 t -158.43 162.65 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -62.47 143.49 57.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.112 179.815 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.1 m -117.73 138.66 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.181 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 9.8 mt -135.56 149.53 49.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -109.16 131.5 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 80.6 t -66.02 128.39 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -103.89 -21.71 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -150.94 143.61 16.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.675 0.75 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.36 68.08 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.587 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 34.6 t80 -147.5 123.92 10.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.3 m -93.37 106.25 19.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.577 0.703 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.3 Cg_endo -69.75 171.6 14.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.624 2.216 . . . . 0.0 112.421 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.58 -14.94 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -158.9 -179.26 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 271' ' ' ASP . 38.7 t0 -64.77 -37.92 89.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -36.38 -39.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.9 pm0 -109.39 171.83 7.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 3.3 tp -125.73 142.38 51.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -64.44 135.59 56.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 313' ' ' TYR . 7.7 mt -106.05 128.32 53.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.31 130.76 24.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.65 0.738 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 112.73 3.15 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.651 2.234 . . . . 0.0 112.368 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.88 1.29 22.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.53 175.84 5.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.532 ' O ' HD13 ' A' ' 281' ' ' ILE . 8.9 m-85 -114.91 165.07 13.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 300' ' ' SER . 26.5 mm -143.34 140.85 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HE2' HD13 ' A' ' 301' ' ' LEU . 67.3 m-85 -109.16 116.04 31.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -101.76 136.93 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.428 ' N ' ' SD ' ' A' ' 283' ' ' MET . 13.4 p -125.55 138.68 32.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 0.0 110.883 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.491 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.78 -21.68 33.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 49.9 mmm -77.16 -24.15 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -118.03 29.51 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 15.1 pt20 -88.41 60.3 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 291' ' ' THR . 1.6 t -86.83 141.23 28.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.5 m 50.6 24.92 1.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 289' ' ' THR . 36.6 p -94.54 -41.55 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.6 m -51.41 -26.64 8.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.1 -30.99 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.8 m95 -81.21 179.51 7.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 314' ' ' ILE . 2.1 pt -160.02 119.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.83 111.44 10.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.455 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.4 167.41 23.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.522 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 305' ' ' CYS . 61.5 m -121.32 126.91 50.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 111.143 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.651 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.6 t -66.01 153.58 41.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.422 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.1 tp -92.75 -48.71 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -58.84 -57.68 11.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.7 p -78.61 -50.11 12.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.78 46.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.615 ' O ' HG23 ' A' ' 299' ' ' THR . 11.9 t -84.3 166.81 17.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 78.5 p -129.53 145.89 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.31 179.38 46.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -87.9 144.24 26.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -147.37 155.36 46.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.595 0.712 . . . . 0.0 110.897 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.78 128.73 16.43 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.22 -6.19 6.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -99.23 21.39 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.587 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 9.2 m-85 -129.73 -1.79 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.53 177.02 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.8 t -153.68 164.74 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -64.49 144.87 56.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 317' ' ' ALA . 0.8 OUTLIER -131.92 130.34 41.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -130.99 150.18 52.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 22.4 tm0? -108.69 133.01 53.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 65.9 t -64.43 133.92 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 263' ' ' TYR . 2.4 pt -111.06 -19.59 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.442 ' CE2' HD12 ' A' ' 262' ' ' ILE . 80.6 m-85 -152.97 141.71 14.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 148.55 65.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 1.009 ' CB ' HD12 ' A' ' 275' ' ' LEU . 29.3 t80 -133.93 157.15 46.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.418 ' N ' ' CG ' ' A' ' 265' ' ' TYR . 6.4 m -126.28 101.05 28.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.72 169.73 18.17 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -124.57 -14.68 6.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -152.82 -175.57 5.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -28.9 61.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -42.97 7.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -101.45 178.8 4.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 6.9 tp -132.96 143.68 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.14 147.31 53.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 1.009 HD12 ' CB ' ' A' ' 265' ' ' TYR . 17.5 mt -115.9 124.67 51.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.4 t -115.61 130.59 24.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.634 0.731 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 111.43 2.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.63 2.64 19.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -111.19 175.16 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -115.38 164.63 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 309' ' ' LEU . 34.9 mm -138.77 121.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.504 ' CE2' HD13 ' A' ' 301' ' ' LEU . 20.6 m-85 -85.71 115.73 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -99.47 130.18 45.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.447 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.6 p -126.1 142.85 43.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -30.26 22.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.692 2.262 . . . . 0.0 112.364 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 65.2 mtp -76.6 -3.44 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.58 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 20.2 mm-40 -122.28 5.28 9.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.38 92.54 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.751 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.6 p -115.19 123.79 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.7 m 50.83 29.09 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 294' ' ' GLY . 16.7 p -86.52 -55.51 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 291' ' ' THR . 31.3 t -34.41 -37.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.27 -49.03 79.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.15 -26.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 296' ' ' ILE . 65.2 m95 -79.87 -179.77 7.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -158.38 119.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 19.9 t80 -78.44 112.77 15.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.46 175.25 21.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 305' ' ' CYS . 57.0 m -125.33 133.26 52.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 281' ' ' ILE . 28.3 t -71.14 150.62 45.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.9 tp -95.49 -40.29 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 93.3 m -69.88 -44.95 68.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -91.88 -53.06 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 105.58 8.73 34.55 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 299' ' ' THR . 8.9 t -78.34 166.55 22.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 54.0 p -139.17 133.88 32.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.2 -175.11 45.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.751 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -88.72 140.1 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.76 156.05 62.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.748 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.78 122.88 9.55 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.43 -10.4 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -94.6 22.77 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.688 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.9 m-85 -129.87 -2.83 4.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -132.14 -179.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.2 t -157.38 167.77 29.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 142.13 55.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.915 0.388 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.424 ' O ' HD23 ' A' ' 259' ' ' LEU . 3.5 m -129.3 129.83 45.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 314' ' ' ILE . 11.9 mt -130.41 150.66 51.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 315' ' ' THR . 6.2 tt0 -110.19 128.35 55.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.4 133.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.36 -21.12 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -152.24 144.09 16.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.67 68.68 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.509 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 29.3 t80 -147.8 127.08 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.8 m -95.84 108.22 39.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 111.162 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.9 Cg_endo -69.73 172.04 13.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.234 . . . . 0.0 112.354 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -123.3 -13.38 7.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -162.44 -179.15 6.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.6 p-10 -63.63 -37.45 87.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.5 OUTLIER -37.3 -41.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.0 pm0 -107.63 174.62 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 4.5 tp -128.32 144.93 51.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.58 128.93 38.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 309' ' ' LEU . 7.7 mt -97.18 129.45 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.55 130.57 24.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.624 0.726 . . . . 0.0 111.134 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 103.74 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.34 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.47 5.37 7.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -111.29 169.97 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 281' ' ' ILE . 15.6 m-85 -113.32 145.44 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 300' ' ' SER . 32.1 mm -124.21 120.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.541 ' CE2' HD13 ' A' ' 301' ' ' LEU . 17.9 m-85 -83.33 119.29 24.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -99.66 137.85 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.497 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.8 p -138.97 120.12 9.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.82 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 0.51 5.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -94.85 -24.12 17.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.538 ' O ' ' CD1' ' A' ' 297' ' ' TYR . 16.9 mm-40 -122.06 41.41 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 143.11 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.639 ' O ' HD11 ' A' ' 308' ' ' LEU . 24.9 p -147.79 116.51 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 23.4 m 64.4 25.4 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 294' ' ' GLY . 28.1 p -83.02 -52.3 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 291' ' ' THR . 12.5 m -36.66 -41.51 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -56.88 -45.37 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 172.53 -23.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -79.88 -179.9 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.736 0.303 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.36 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 287' ' ' GLU . 40.4 t80 -94.3 108.45 20.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -132.85 -177.29 14.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.0 m -132.48 126.29 32.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.613 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.0 OUTLIER -62.6 166.32 5.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.7 tp -107.08 -30.32 8.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -75.63 -54.17 7.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 9.3 p -90.28 -34.46 15.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.76 62.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 61.9 m -86.65 145.9 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.4 p -114.1 132.7 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.97 179.22 42.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 289' ' ' THR . 11.4 mt -89.5 142.64 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.77 156.42 48.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 120.89 7.6 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.718 2.279 . . . . 0.0 112.364 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.37 -11.57 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -92.86 19.9 7.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.8 m-85 -128.24 -1.6 5.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.981 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.44 174.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 260' ' ' GLN . 5.6 t -146.84 159.49 43.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 3.5 mptt -64.74 143.82 57.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.913 0.387 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.9 m -131.21 129.49 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.775 HD13 HD13 ' A' ' 314' ' ' ILE . 10.5 mt -130.21 149.43 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -108.84 124.76 51.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.33 131.32 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -106.93 -12.08 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 75.3 m-85 -161.55 143.45 8.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.68 0.753 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.12 11.46 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 275' ' ' LEU . 3.1 t80 -171.77 118.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.2 m -83.75 113.4 47.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.579 0.704 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 171.95 13.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.395 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -119.89 -13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.405 ' OD1' ' CD ' ' A' ' 272' ' ' GLU . 2.5 p30 -167.63 -178.26 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.38 -29.67 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -45.33 -42.08 9.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.405 ' CD ' ' OD1' ' A' ' 269' ' ' ASN . 11.7 pm0 -106.82 177.28 4.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 12.7 tp -130.45 147.5 52.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.67 151.87 46.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.676 HD23 ' CD2' ' A' ' 265' ' ' TYR . 3.7 mm? -115.87 128.75 56.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.87 127.15 26.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.606 0.717 . . . . 0.0 111.139 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 104.55 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.65 2.233 . . . . 0.0 112.309 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.07 11.19 8.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -114.64 174.67 5.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -115.41 165.22 13.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.737 HD13 ' HA ' ' A' ' 300' ' ' SER . 15.1 mm -143.82 128.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -93.02 116.91 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -101.76 134.82 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.435 ' N ' ' SD ' ' A' ' 283' ' ' MET . 0.7 OUTLIER -125.66 141.46 39.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.684 0.754 . . . . 0.0 110.799 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.83 19.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 8.7 mtp -77.47 -2.07 33.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 12.4 mt-10 -121.77 8.09 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -67.98 85.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.658 ' O ' HD21 ' A' ' 308' ' ' LEU . 2.4 p -109.05 121.81 45.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.3 m 55.26 26.0 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 32.9 p -86.97 -44.15 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.2 t -43.15 -40.73 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.97 -40.43 80.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.81 -21.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.453 ' HB3' HD22 ' A' ' 308' ' ' LEU . 72.0 m95 -80.01 -179.78 7.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -156.74 122.04 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 36.5 t80 -84.59 111.71 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -137.19 -172.9 12.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 65.5 m -138.01 124.1 20.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.17 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.737 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -62.21 168.89 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.17 -41.07 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -67.23 -65.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.3 p -75.12 -31.92 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.03 63.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.496 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.68 152.59 18.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 33.5 p -121.34 136.85 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.1 -179.46 47.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.658 HD21 ' O ' ' A' ' 289' ' ' THR . 10.8 mt -87.93 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.76 156.68 65.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.603 0.716 . . . . 0.0 110.927 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 0.0 112.347 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -54.5 -14.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.26 19.14 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.546 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.68 -0.19 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.82 178.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.2 t -148.74 157.95 43.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -65.67 151.46 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.834 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.901 0.381 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.61 132.04 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -135.03 150.97 50.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -108.74 131.74 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.52 126.48 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 2.2 pt -102.56 -18.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 70.1 m-85 -158.24 144.06 12.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 158.31 57.37 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.722 2.281 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -150.54 133.07 15.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.6 m -102.46 106.94 51.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.621 0.724 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.432 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.7 Cg_endo -69.75 170.89 15.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.725 2.283 . . . . 0.0 112.345 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.87 -15.37 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.404 ' H ' ' CD ' ' A' ' 272' ' ' GLU . 56.7 m-80 -150.66 -175.71 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.58 -40.76 69.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -38.59 -42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.3 pm0 -99.75 171.06 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 5.8 tp -131.9 150.96 52.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.3 tt0 -68.81 150.67 47.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 309' ' ' LEU . 10.9 mt -119.71 130.83 55.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.38 129.26 25.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.32 3.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.83 0.31 22.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 281' ' ' ILE . 26.9 m-85 -108.67 166.23 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 300' ' ' SER . 21.1 mm -142.35 124.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 22.7 m-85 -90.68 114.78 27.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.4 tmm? -100.3 141.61 32.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.491 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.1 t -141.27 138.72 17.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.664 0.745 . . . . 0.0 110.866 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.439 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.4 Cg_endo -69.78 -18.47 36.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 0.0 112.331 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 11.2 mtp -64.11 -31.61 72.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -123.0 41.74 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 8.3 pt20 -91.38 66.95 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 291' ' ' THR . 1.3 t -93.65 142.27 27.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.1 m 45.48 25.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 289' ' ' THR . 40.5 p -91.53 -58.32 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 291' ' ' THR . 26.8 m -36.2 -38.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.59 -46.69 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.52 -26.88 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.1 m95 -83.17 -179.98 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.752 0.31 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.33 136.53 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.493 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 38.6 t80 -89.48 111.72 22.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.475 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.46 167.66 22.98 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 92.6 m -126.14 116.49 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.601 ' HA ' HD13 ' A' ' 281' ' ' ILE . 7.2 t -55.28 147.66 16.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.575 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -89.24 -43.04 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.1 m -65.25 -60.95 2.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 30.4 p -75.2 -50.35 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.99 9.58 42.17 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.01 153.37 23.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.7 p -125.0 137.96 54.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -175.46 -173.42 41.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 20.5 mt -90.99 140.86 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -144.15 156.02 58.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 110.883 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.552 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.72 117.61 5.18 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.0 -14.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -90.44 21.21 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.552 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.18 -5.51 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -125.93 169.69 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.7 t -150.24 167.49 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.483 ' HD3' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -74.42 143.76 44.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 1.7 m -129.2 127.24 40.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -127.54 150.03 49.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.11 127.21 53.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.89 138.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.468 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -114.89 -14.93 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 81.7 m-85 -159.2 146.7 13.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.686 0.755 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 165.34 31.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 44.2 t80 -160.75 123.4 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.8 m -90.29 110.07 38.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.584 0.706 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 52.9 Cg_endo -69.84 171.13 15.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.681 2.254 . . . . 0.0 112.269 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -119.7 -14.38 9.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -167.26 -178.67 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.43 -34.9 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -38.87 -44.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.435 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 2.6 pm0 -105.32 177.38 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.504 ' O ' ' CD2' ' A' ' 275' ' ' LEU . 4.0 tp -132.72 142.38 49.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.589 ' C ' HD22 ' A' ' 275' ' ' LEU . 34.4 tt0 -57.67 150.82 18.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.589 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.8 mm? -114.45 127.33 55.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.61 123.44 29.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 103.97 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.92 12.76 7.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.469 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -115.31 178.64 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -116.54 160.5 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.481 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 18.2 mm -138.98 133.28 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.8 m-85 -96.02 110.55 22.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -101.34 134.11 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 283' ' ' MET . 22.1 t -137.6 140.83 31.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.651 0.738 . . . . 0.0 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.434 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.73 -26.01 28.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -61.26 -33.61 73.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -117.45 41.39 2.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 288' ' ' GLN . 11.5 pt20 -96.08 95.91 8.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.45 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.6 p -115.11 137.31 52.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 9.5 m 48.49 25.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 43.5 p -88.53 -38.47 14.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.0 t -55.4 -24.84 32.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.94 -29.64 63.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 156.48 -18.57 0.44 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 55.9 m95 -86.99 179.6 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.14 124.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -80.19 111.15 16.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.84 175.09 19.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 70.3 m -131.7 132.46 43.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.2 t -65.58 150.56 48.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.56 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.6 tp -95.4 -35.42 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 48.4 m -77.18 -49.91 14.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 82.1 p -84.12 -52.46 6.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.05 3.16 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.462 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 82.9 m -77.44 147.89 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 89.6 p -120.73 140.37 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.28 -177.25 46.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.7 mt -88.18 149.56 23.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -153.06 155.54 32.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.553 0.692 . . . . 0.0 110.961 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.7 126.84 13.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.692 2.261 . . . . 0.0 112.369 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.22 -7.27 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -97.62 21.63 10.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.7 m-85 -129.35 -3.88 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.28 177.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.6 t -149.77 156.69 42.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -59.24 137.57 57.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.915 0.388 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 5.6 m -123.54 125.24 44.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.997 HD13 HD13 ' A' ' 314' ' ' ILE . 11.8 mt -125.99 149.82 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -108.83 130.8 55.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.92 144.2 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -121.61 -14.6 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 71.4 m-85 -161.5 145.71 9.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.654 0.74 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 163.8 36.9 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.551 ' HD2' HD23 ' A' ' 275' ' ' LEU . 50.8 t80 -160.81 128.3 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.8 m -97.78 108.92 48.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.565 0.698 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.43 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.81 165.15 31.99 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.342 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -113.68 -21.9 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -154.02 -179.16 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.6 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -39.24 -45.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.8 pm0 -105.21 178.96 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.7 tp -132.24 151.94 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.748 ' C ' HD22 ' A' ' 275' ' ' LEU . 31.3 tt0 -64.9 155.85 32.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.3 mm? -121.31 131.54 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.91 126.26 25.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.666 0.746 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.01 2.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.649 2.233 . . . . 0.0 112.358 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.69 9.66 20.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -112.85 178.69 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -117.16 169.49 9.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.467 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 17.3 mm -146.14 125.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.557 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 24.7 m-85 -91.77 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -99.23 135.57 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.474 ' N ' ' SD ' ' A' ' 283' ' ' MET . 30.6 t -128.56 142.41 44.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.717 0.77 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -30.83 21.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.258 . . . . 0.0 112.345 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 47.7 mtp -77.26 4.39 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 66.9 mm-40 -127.41 -0.54 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -58.8 85.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.587 ' O ' HD21 ' A' ' 308' ' ' LEU . 1.4 p -109.32 107.92 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.0 m 66.82 28.02 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.9 p -88.24 -48.01 8.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.155 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 81.1 p -39.8 -39.57 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.18 -44.95 92.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 171.63 -23.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 62.9 m95 -79.73 -179.85 7.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.754 0.312 . . . . 0.0 110.916 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.643 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -157.93 121.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 32.0 t80 -79.92 113.7 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.77 175.52 20.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 305' ' ' CYS . 13.8 m -125.18 131.92 53.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.31 . . . . 0.0 111.133 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.4 t -66.1 148.74 51.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 12.3 tp -97.17 -37.18 10.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.8 m -73.55 -44.78 56.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -94.07 -46.47 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.86 3.36 49.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.551 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 299' ' ' THR . 56.2 m -71.65 176.9 4.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 6.7 m -149.07 140.26 23.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.19 48.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 289' ' ' THR . 12.2 mt -88.98 136.2 33.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -138.77 153.44 72.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 0.0 110.908 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.4 Cg_endo -69.85 123.9 10.52 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.339 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.73 -11.14 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -92.49 19.36 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 8.1 m-85 -128.91 -2.5 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.997 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.06 177.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.9 t -153.05 159.49 42.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -55.16 148.2 14.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.104 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.917 0.389 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 3.0 m -121.96 130.55 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 314' ' ' ILE . 11.6 mt -128.3 150.21 50.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 315' ' ' THR . 8.8 tt0 -108.57 131.09 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.18 133.17 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -103.48 -28.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -145.01 144.95 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 151.91 69.46 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.494 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 24.3 t80 -148.49 120.35 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.9 m -91.3 107.4 21.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.49 16.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -120.41 -14.66 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -157.81 176.63 12.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 271' ' ' ASP . 12.3 p-10 -62.92 -39.72 95.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.1 -39.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -105.82 175.14 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.633 HD11 ' SG ' ' A' ' 305' ' ' CYS . 5.5 tp -125.67 143.97 50.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.19 130.27 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.442 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -101.89 131.96 47.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.3 t -123.79 132.87 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.713 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.81 103.45 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.311 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.56 14.51 6.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -116.73 177.99 4.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.44 ' O ' HD13 ' A' ' 281' ' ' ILE . 9.8 m-85 -120.48 161.36 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 300' ' ' SER . 38.6 mm -142.51 139.39 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.3 m-85 -101.17 113.53 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -100.26 133.69 44.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.456 ' N ' ' SD ' ' A' ' 283' ' ' MET . 1.0 OUTLIER -133.76 136.94 27.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 0.0 110.869 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 54.0 Cg_endo -69.78 -20.36 34.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.29 -32.28 73.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -119.29 42.73 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 12.3 pt20 -94.21 81.78 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 291' ' ' THR . 35.9 p -94.83 137.5 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.7 m 39.45 31.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 289' ' ' THR . 34.6 p -88.33 -58.37 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 291' ' ' THR . 17.8 m -35.89 -43.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.35 -46.45 62.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.71 -26.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 296' ' ' ILE . 74.2 m95 -82.77 179.92 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.0 110.926 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -160.17 123.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -78.18 115.83 18.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.45 167.74 24.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 90.2 m -122.41 137.63 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.541 ' HA ' HD13 ' A' ' 281' ' ' ILE . 23.7 t -69.16 151.3 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.535 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 9.1 tp -100.02 -31.18 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 98.8 m -76.98 -36.76 56.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 20.2 p -102.12 -65.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.34 6.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 273' ' ' LEU . 28.5 p -72.09 155.07 40.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.1 p -124.52 154.57 40.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 173.92 179.52 44.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 309' ' ' LEU . 12.1 mt -87.56 147.52 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.3 OUTLIER -150.0 155.23 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.907 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.551 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 120.03 6.88 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.06 -12.43 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -92.67 21.9 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.551 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.45 -3.83 4.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.11 -179.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 260' ' ' GLN . 6.9 t -156.2 160.03 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -59.37 143.74 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 258' ' ' THR . 11.1 tp10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.968 0.413 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 8.3 m -123.72 123.11 39.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.746 HD13 HD13 ' A' ' 314' ' ' ILE . 6.9 mt -125.41 151.9 45.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -108.87 130.36 55.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.8 126.57 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -100.19 -17.01 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -156.27 145.63 15.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.671 0.748 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 162.79 40.72 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.675 2.25 . . . . 0.0 112.396 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 1.028 ' CB ' HD12 ' A' ' 275' ' ' LEU . 28.1 t80 -147.81 144.3 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.4 m -114.74 99.42 51.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.55 21.23 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.369 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -124.88 -14.01 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -147.64 -178.99 6.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.8 m-20 -71.87 -42.47 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 270' ' ' ASP . 29.4 t70 -37.34 -39.93 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.55 176.89 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.1 tp -137.8 153.6 49.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 21.9 tt0 -74.98 150.83 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 1.028 HD12 ' CB ' ' A' ' 265' ' ' TYR . 26.0 mt -117.71 133.66 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.23 130.87 24.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.634 0.731 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 105.65 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.24 . . . . 0.0 112.346 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.32 16.13 7.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -118.34 171.08 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.425 ' CD1' HG22 ' A' ' 258' ' ' THR . 9.0 m-85 -110.8 159.76 17.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.493 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 32.2 mm -136.76 133.95 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 301' ' ' LEU . 28.9 m-85 -99.33 111.64 23.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -100.41 138.92 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.491 ' N ' ' SD ' ' A' ' 283' ' ' MET . 7.7 t -137.74 134.22 18.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.731 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.417 ' HA ' ' CD ' ' A' ' 288' ' ' GLN . 53.2 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.247 . . . . 0.0 112.329 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.3 mmt -82.04 -27.95 32.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -126.1 42.14 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 285' ' ' PRO . 12.8 pt20 -98.14 75.04 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.558 ' O ' HD21 ' A' ' 308' ' ' LEU . 35.4 p -88.59 142.8 27.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 13.0 m 40.44 33.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.799 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 289' ' ' THR . 54.9 p -91.58 -57.46 2.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.8 t -38.59 -40.41 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -53.82 -44.42 70.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 175.37 -25.34 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.531 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.9 m95 -85.01 179.86 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -159.55 123.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 26.2 t80 -76.81 114.78 15.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . 0.493 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -134.55 163.82 24.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 93.1 m -116.26 129.08 56.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 111.131 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -65.62 151.64 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.819 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.9 tp -102.5 -29.5 11.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.7 m -81.87 -38.54 25.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 77.3 p -103.47 -38.96 6.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 -13.63 60.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 95.4 m -53.05 166.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.0 m -146.83 128.3 15.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.07 33.8 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.558 HD21 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -89.09 143.5 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.44 156.9 49.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.719 . . . . 0.0 110.886 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.655 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.7 117.01 4.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.248 . . . . 0.0 112.362 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.42 ' HA ' HD11 ' A' ' 296' ' ' ILE . 7.7 pt-20 -56.07 -13.21 1.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.26 23.45 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.612 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.3 m-85 -130.57 -3.1 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.746 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -126.1 177.2 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.7 t -151.97 159.35 43.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -61.78 151.08 35.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.963 0.411 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.1 m -125.89 126.56 44.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.974 HD13 HD13 ' A' ' 314' ' ' ILE . 14.3 mt -124.03 151.94 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -108.74 130.75 55.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.1 131.8 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.9 pt -107.93 -19.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.157 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -155.82 143.86 14.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.693 0.759 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 153.9 68.46 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.717 2.278 . . . . 0.0 112.314 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 35.9 t80 -150.69 125.65 9.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.947 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.14 109.43 44.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.569 0.7 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.406 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.73 166.79 26.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -115.69 -20.71 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -153.32 -179.2 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -64.87 -32.39 74.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -41.6 -44.09 2.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.2 pm0 -102.98 171.33 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.2 tp -124.59 147.05 48.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.433 ' C ' HD23 ' A' ' 275' ' ' LEU . 26.9 tt0 -66.56 140.26 57.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 309' ' ' LEU . 5.9 mt -112.13 127.68 55.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 277' ' ' PRO . 87.2 t -124.47 133.5 24.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.629 0.728 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.9 Cg_endo -69.71 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.56 2.94 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -111.18 162.6 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 281' ' ' ILE . 19.9 m-85 -106.06 159.19 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 300' ' ' SER . 20.0 mm -137.76 120.2 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.458 ' CE2' HD13 ' A' ' 301' ' ' LEU . 35.1 m-85 -81.98 114.76 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -99.47 138.03 37.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.496 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.1 p -137.66 125.73 14.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -10.71 29.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 40.5 mtp -83.04 -28.94 29.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 297' ' ' TYR . 50.5 mm-40 -117.65 40.41 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.448 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 2.9 pp0? -96.15 123.68 39.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.481 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.5 p -129.06 126.92 40.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.0 m 55.1 25.18 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 294' ' ' GLY . 41.8 p -87.51 -54.53 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 291' ' ' THR . 28.0 t -36.35 -37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -61.57 -48.7 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -179.44 -27.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -79.82 -179.76 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.726 0.298 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.428 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.7 pt -152.34 134.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 287' ' ' GLU . 53.6 t80 -96.21 111.03 23.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -138.38 177.48 20.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 305' ' ' CYS . 58.6 m -127.37 119.55 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 111.16 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.854 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -55.26 168.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.458 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.8 tp -111.31 -28.65 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -74.38 -47.87 31.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.6 p -95.23 -28.95 14.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 80.7 16.04 76.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.753 ' O ' HG23 ' A' ' 299' ' ' THR . 5.9 t -88.55 169.04 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 79.6 p -131.34 142.78 50.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.95 48.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.643 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -92.25 151.45 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -157.54 157.5 30.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 110.958 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 123.76 10.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.757 2.305 . . . . 0.0 112.34 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.29 -8.97 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.21 19.18 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.506 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.0 m-85 -126.56 -1.18 6.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.974 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.25 175.94 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.4 t -149.71 165.4 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 4.7 mptt -67.16 143.8 56.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.854 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.5 m -127.87 133.63 49.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 314' ' ' ILE . 9.2 mt -132.67 155.12 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -110.3 132.52 54.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.65 137.65 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.32 -18.69 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -155.02 142.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.75 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 158.17 57.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -153.3 125.33 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 m -95.62 109.99 48.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG2' ' A' ' 272' ' ' GLU . 54.1 Cg_endo -69.8 171.07 15.19 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -125.64 -13.69 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ASN . . . . . 0.431 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 23.3 m-80 -151.42 -175.39 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.18 -21.94 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 0.9 OUTLIER -104.76 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' A' ' 305' ' ' CYS . 6.7 tp -120.35 148.42 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.414 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 36.7 tt0 -72.48 145.56 47.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -115.73 135.51 53.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.492 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.5 t -127.54 134.81 26.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 111.16 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.492 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.3 Cg_endo -69.76 113.54 3.41 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 109.57 5.78 29.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.525 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -110.82 165.4 11.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.342 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.536 ' O ' HD13 ' A' ' 281' ' ' ILE . 28.2 m-85 -107.28 163.46 13.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 280' ' ' PHE . 15.1 mm -146.09 122.85 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.51 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 41.3 m-85 -81.93 128.83 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -98.96 129.39 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 108.21 19.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.723 0.773 . . . . 0.0 110.901 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -3.11 11.34 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -88.88 -24.89 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 297' ' ' TYR . 55.3 mm-40 -122.97 40.85 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.34 109.12 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.452 ' O ' HD11 ' A' ' 308' ' ' LEU . 21.0 p -114.05 119.26 36.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.9 m 67.36 27.78 8.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.837 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 33.6 p -87.85 -41.22 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.8 t -49.28 -27.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 294' ' ' GLY . 4.9 pt-20 -70.9 -42.96 69.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 293' ' ' GLU . . . 173.77 -25.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 296' ' ' ILE . 73.5 m95 -80.54 179.28 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.717 0.294 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 311' ' ' GLU . 1.1 pt -156.83 126.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 287' ' ' GLU . 29.9 t80 -84.66 111.76 19.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -133.65 -173.56 13.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 91.8 m -133.21 141.03 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.7 t -74.74 149.6 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.51 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.1 tp -96.08 -39.36 9.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.5 m -71.35 -39.95 71.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.0 p -100.04 -63.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.84 10.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' A' ' 273' ' ' LEU . 2.3 p -79.53 153.77 29.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.4 p -120.25 147.86 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.79 -175.54 47.65 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -94.79 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.622 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.74 157.13 62.31 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.59 0.71 . . . . 0.0 110.913 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.654 2.236 . . . . 0.0 112.327 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.415 ' HA ' HD11 ' A' ' 296' ' ' ILE . 5.2 pt-20 -55.0 -15.52 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -88.74 19.69 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.544 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.69 -2.57 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.963 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -128.41 173.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.3 t -147.79 151.78 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -59.49 142.83 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.882 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 47.9 t -109.85 132.21 54.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.923 0.392 . . . . 0.0 110.822 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 53.7 m -93.03 87.03 5.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.838 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.27 108.34 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.4 t -56.29 176.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 41.0 t -52.69 -55.66 21.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.05 179.23 53.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.1 t -162.73 158.56 23.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.911 0.386 . . . . 0.0 110.795 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 53.7 mtt85 -62.62 -31.01 71.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -128.43 153.41 47.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 254' ' ' ALA . 4.4 mp -89.38 106.5 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.516 ' HB3' ' CD1' ' A' ' 253' ' ' PHE . 6.2 ttm180 -124.55 -48.14 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 252' ' ' ARG . 6.7 m-85 -111.44 12.52 21.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.553 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -106.0 157.48 17.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -106.03 46.12 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.571 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 19.2 m80 -74.59 136.73 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -85.21 162.77 19.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.944 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.1 m -130.63 130.89 44.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 10.9 mt -129.73 150.45 51.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -108.68 131.53 54.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.37 128.69 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.443 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.9 pt -104.06 -16.88 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 79.2 m-85 -158.42 144.46 12.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.74 0.781 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 157.53 60.21 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.698 2.265 . . . . 0.0 112.332 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 15.6 t80 -148.83 127.67 12.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -96.53 107.0 33.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.549 0.69 . . . . 0.0 111.138 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 170.92 15.44 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 0.0 112.335 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -125.81 -15.04 6.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.432 ' C ' ' OE1' ' A' ' 272' ' ' GLU . 65.9 m-80 -150.37 -175.71 5.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 9.0 t70 -72.76 -42.27 64.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 37.8 t70 -37.7 -38.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 269' ' ' ASN . 1.2 pm0 -102.54 168.22 9.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.8 tp -127.12 149.23 50.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.471 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 15.7 tt0 -69.72 143.9 52.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.573 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -113.36 141.28 47.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 277' ' ' PRO . 57.6 t -131.53 134.72 25.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.639 0.733 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.77 112.66 3.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.32 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.39 6.66 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -109.48 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -115.43 167.14 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 309' ' ' LEU . 29.2 mm -145.35 115.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.439 ' CE2' HD13 ' A' ' 301' ' ' LEU . 29.2 m-85 -85.02 118.7 24.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -102.31 137.95 39.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.571 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 1.2 p -134.66 140.26 34.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.67 0.748 . . . . 0.0 110.843 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -26.54 27.42 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.267 . . . . 0.0 112.35 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.0 mtp -81.05 -1.72 45.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 71.8 mm-40 -126.91 18.52 7.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -77.14 127.8 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.815 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.4 p -148.93 113.4 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 63.78 25.15 14.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.4 p -88.59 -45.78 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.115 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.0 m -44.33 -24.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.835 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.31 -49.4 19.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 179.9 -26.55 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -80.23 -179.45 7.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.74 0.305 . . . . 0.0 110.933 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 314' ' ' ILE . 1.0 OUTLIER -153.47 127.14 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 27.6 t80 -88.0 120.23 29.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -148.67 -173.71 19.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 38.8 m -130.42 139.06 50.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.333 . . . . 0.0 111.16 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.451 ' HA ' HD13 ' A' ' 281' ' ' ILE . 27.3 t -75.17 158.3 33.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.439 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.0 tp -100.14 -34.83 9.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 62.9 m -73.6 -61.29 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 67.5 p -78.62 -49.96 12.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 103.95 11.65 31.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.456 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.2 m -91.57 149.71 21.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.8 t -118.18 154.41 32.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 172.61 -173.29 45.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.815 HD21 ' O ' ' A' ' 289' ' ' THR . 20.6 mt -91.73 137.1 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.5 155.48 63.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 0.0 110.957 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.541 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.6 Cg_endo -69.8 119.99 6.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -57.06 -12.55 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.75 20.42 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.541 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.2 m-85 -129.04 -3.62 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -129.89 177.27 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 4.7 t -152.49 159.81 43.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -59.55 149.63 29.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -84.16 108.37 17.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.56 24.26 12.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -97.05 -39.26 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.62 140.93 32.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 83.0 p -128.79 142.69 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.856 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.518 HG21 ' HB2' ' A' ' 325' ' ' PHE . 3.1 p -72.74 -177.05 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.469 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.4 p-90 -108.48 -41.28 4.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.469 HG12 ' CE3' ' A' ' 323' ' ' TRP . 6.2 mm -130.09 -31.26 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.152 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.518 ' HB2' HG21 ' A' ' 322' ' ' THR . 30.8 m-85 -47.6 116.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -89.55 -53.78 4.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 82.72 -80.28 1.82 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.535 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 82.7 p -174.13 141.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.879 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 95.9 p -157.18 153.58 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 145.97 -93.8 0.16 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.7 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 0.0 112.31 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 331' ' ' PRO . 4.1 t 37.27 41.77 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 40.6 m -111.82 138.88 47.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 89.5 p -74.27 -44.08 54.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 110.857 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.7 t -77.11 96.79 4.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.13 135.88 12.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 19.3 t -88.66 117.88 27.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.6 m -60.97 151.13 31.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -172.52 102.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 88.4 p -141.59 166.11 25.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.88 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -73.82 121.58 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -48.92 141.87 7.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 252' ' ' ARG . 86.1 mt -71.29 -37.43 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 251' ' ' ILE . 13.6 mmt180 38.33 44.85 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 47.95 53.48 11.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -86.06 -179.32 6.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 255' ' ' ASN . 2.4 p30 -77.96 47.28 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.571 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 9.5 m80 -98.75 141.27 31.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.486 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 20.3 pt-20 -98.35 155.0 17.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 18.2 m -116.02 137.08 52.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.929 HD13 HD13 ' A' ' 314' ' ' ILE . 9.1 mt -134.02 150.62 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -108.79 132.69 53.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.63 129.71 31.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 3.0 pt -107.38 -14.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.472 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 89.3 m-85 -159.28 143.26 11.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.654 0.74 . . . . 0.0 110.958 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 160.05 51.18 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -154.61 127.05 7.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.955 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.75 109.61 47.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.74 172.12 13.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.713 2.275 . . . . 0.0 112.34 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -123.96 -14.28 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -162.49 -177.46 5.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -63.89 -36.67 84.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.42 -42.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.437 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.2 pm0 -105.23 175.11 5.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -130.58 143.11 50.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.63 144.01 56.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 309' ' ' LEU . 6.4 mt -112.51 142.51 44.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.37 128.21 19.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.619 0.723 . . . . 0.0 111.139 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 104.31 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.715 2.277 . . . . 0.0 112.368 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.22 5.16 8.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -112.55 171.31 7.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.52 162.06 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 300' ' ' SER . 17.5 mm -135.09 132.38 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -99.49 106.21 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.7 tmm? -98.97 134.21 42.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.876 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.571 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 8.5 p -126.12 143.19 44.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.661 0.743 . . . . 0.0 110.875 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -24.47 29.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.659 2.239 . . . . 0.0 112.351 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 44.2 mtp -81.53 -3.19 52.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 66.3 mm-40 -126.33 9.69 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -69.27 87.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 308' ' ' LEU . 19.9 p -104.99 128.9 53.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.9 m 48.09 26.33 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 294' ' ' GLY . 29.4 p -86.05 -54.48 4.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.2 t -35.36 -36.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 18.4 tp10 -62.66 -47.72 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.15 -26.2 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.457 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.3 m95 -79.93 -179.78 7.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.903 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.519 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.89 125.24 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.116 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.7 t80 -84.2 111.14 19.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -134.29 -177.77 15.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 305' ' ' CYS . 97.2 m -133.18 129.6 38.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.123 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.407 ' HA ' HD13 ' A' ' 281' ' ' ILE . 2.4 t -66.17 154.77 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.3 tp -99.82 -29.94 12.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 5.2 m -72.65 -52.64 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.0 p -88.8 -55.37 3.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.93 23.36 6.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.555 ' O ' HG23 ' A' ' 299' ' ' THR . 11.6 t -96.15 166.28 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 81.1 p -129.02 143.39 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.85 47.82 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.467 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 289' ' ' THR . 10.9 mt -88.95 139.17 30.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 0.0 110.914 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.21 157.19 63.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.559 0.695 . . . . 0.0 110.946 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.3 Cg_endo -69.79 120.7 7.44 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.657 2.238 . . . . 0.0 112.344 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -58.68 -11.62 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -93.03 20.5 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.538 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.6 m-85 -128.74 -3.06 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -130.16 177.98 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.8 t -153.34 162.63 41.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -66.31 148.01 52.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.54 92.06 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.084 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -108.86 22.18 16.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -108.71 -55.9 2.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.96 118.21 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 34.6 t -144.96 157.54 44.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 15.1 p -66.6 -176.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.568 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.0 p-90 -119.5 -46.94 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.568 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.1 mm -124.15 -48.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 324' ' ' ILE . 12.5 m-30 -34.32 143.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -111.66 97.65 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 94.84 113.49 2.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 329' ' ' SER . 46.6 m -88.39 112.78 23.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.0 110.842 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 328' ' ' SER . 18.9 p 37.58 43.84 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -130.36 82.81 0.32 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -7.82 22.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.72 2.28 . . . . 0.0 112.361 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 16.2 t -56.71 -50.76 71.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 57.6 m -78.38 -44.67 24.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.46 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.2 t -125.33 132.47 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.864 0.364 . . . . 0.0 110.854 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.2 p -52.63 129.88 30.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.23 111.82 0.34 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 92.7 p -87.08 145.34 26.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.901 0.381 . . . . 0.0 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 94.9 p -61.34 -50.81 71.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.814 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.78 -172.38 43.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.505 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.6 t -96.4 110.08 22.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.876 0.37 . . . . 0.0 110.864 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -132.29 140.95 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -172.56 143.21 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 256' ' ' HIS . 75.7 mt -83.13 -41.89 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 253' ' ' PHE . 5.6 mmm180 39.3 44.58 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 252' ' ' ARG . 5.5 m-85 35.69 47.41 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -104.19 -43.27 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -132.54 -53.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.582 ' HB2' HG23 ' A' ' 251' ' ' ILE . 33.8 m80 -74.36 138.41 43.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -101.88 175.54 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.4 ' O ' HD23 ' A' ' 259' ' ' LEU . 1.8 m -133.03 126.78 32.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.996 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.95 151.41 50.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -108.77 133.72 52.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.5 142.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.447 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -119.99 -14.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.3 m-85 -158.33 143.78 12.19 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.68 0.752 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.49 69.47 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.977 ' HB2' HD12 ' A' ' 275' ' ' LEU . 41.3 t80 -138.46 144.82 40.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 11.8 m -115.45 97.66 49.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 111.18 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.69 171.52 14.24 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.341 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.59 -13.22 6.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -157.32 -179.54 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 271' ' ' ASP . 2.1 p30 -66.87 -38.71 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.67 -38.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -111.49 172.9 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 5.3 tp -129.02 143.62 50.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 275' ' ' LEU . 7.0 tt0 -65.44 150.13 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 265' ' ' TYR . 22.8 mt -117.48 127.12 53.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 277' ' ' PRO . 93.7 t -118.56 132.39 23.86 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.736 . . . . 0.0 111.129 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.76 110.75 2.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.726 2.284 . . . . 0.0 112.318 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.26 4.56 20.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -110.76 171.67 7.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.817 ' O ' HD13 ' A' ' 281' ' ' ILE . 32.1 m-85 -112.74 167.99 10.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 280' ' ' PHE . 12.3 mm -144.98 131.17 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 40.4 m-85 -91.68 120.2 32.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 284' ' ' SER . 1.9 tmm? -99.84 128.24 45.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.58 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 39.6 p -126.63 130.17 23.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.676 0.75 . . . . 0.0 110.852 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.514 ' HA ' ' CG ' ' A' ' 288' ' ' GLN . 53.8 Cg_endo -69.7 -13.0 34.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 0.0 112.369 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 32.8 mmt -81.87 -22.45 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.599 ' OE1' ' CE2' ' A' ' 297' ' ' TYR . 13.7 mt-10 -112.27 36.0 3.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.514 ' CG ' ' HA ' ' A' ' 285' ' ' PRO . 9.3 mm100 -84.16 86.79 7.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.565 ' O ' HD11 ' A' ' 308' ' ' LEU . 15.9 p -110.74 108.63 18.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 7.3 m 61.62 30.73 18.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 293' ' ' GLU . 43.6 p -92.56 -59.67 2.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.155 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 291' ' ' THR . 2.9 m -34.06 -34.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . 9.9 tp10 -63.59 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -174.57 -30.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.524 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -80.13 -179.99 7.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.737 0.303 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.554 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.77 121.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.599 ' CE2' ' OE1' ' A' ' 287' ' ' GLU . 38.9 t80 -72.76 110.92 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -128.89 166.47 21.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 94.5 m -125.79 111.86 15.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.8 t -47.79 147.25 2.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.574 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -96.73 -45.47 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 97.8 m -63.25 -42.37 99.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 33.7 p -96.37 -53.28 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.114 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 110.82 0.2 28.84 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.513 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 99.6 m -69.97 151.67 45.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.6 p -124.19 138.14 54.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 178.65 -175.92 47.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 289' ' ' THR . 14.4 mt -88.38 144.98 26.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.93 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.1 156.49 50.76 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.621 0.724 . . . . 0.0 110.918 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.677 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.5 Cg_endo -69.79 122.0 8.68 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.706 2.27 . . . . 0.0 112.309 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.36 -10.84 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.913 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -94.22 23.11 5.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.753 ' HB3' HD13 ' A' ' 275' ' ' LEU . 10.5 m-85 -130.95 -3.33 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.996 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -130.42 176.56 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.111 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.9 t -154.47 152.52 30.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -55.09 141.93 32.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.21 89.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -105.92 -38.4 6.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -64.9 -63.72 1.04 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 3.1 t 48.96 44.96 22.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 79.6 p -120.73 92.24 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 325' ' ' PHE . 0.9 OUTLIER -96.64 140.96 30.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.584 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.4 p-90 -72.58 -41.95 65.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.584 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.6 mm -125.36 -55.97 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.171 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.505 ' HB2' HG21 ' A' ' 322' ' ' THR . 96.5 m-85 -34.36 139.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -91.89 -49.76 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 137.1 151.83 6.04 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.524 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.5 m -81.4 52.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.866 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 60.4 p -167.51 174.16 8.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -175.03 84.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 172.24 13.06 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.644 2.229 . . . . 0.0 112.34 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.4 t -82.98 104.65 13.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 67.7 p -38.99 -42.25 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.492 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 12.8 m -86.78 104.08 15.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 0.0 110.857 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.1 p -131.27 145.77 52.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 143.23 -120.92 1.6 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 82.8 p -130.28 169.0 16.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.8 m -90.42 109.5 20.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -58.38 123.94 34.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.5 m -64.58 115.86 5.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 0.0 110.867 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -135.52 163.45 30.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.821 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.45 148.3 33.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.85 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.1 121.64 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.417 ' HD3' ' C ' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -123.52 -36.44 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -66.29 -53.69 33.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -83.52 176.67 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.12 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -125.85 83.21 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.543 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 9.9 m80 -100.0 140.18 34.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -86.73 171.05 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.8 m -133.16 128.79 36.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.966 HD13 HD13 ' A' ' 314' ' ' ILE . 11.4 mt -129.51 149.27 51.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 25.6 tm0? -108.78 124.59 50.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 85.2 t -58.32 138.45 19.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.542 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.5 pt -115.85 -11.86 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 84.6 m-85 -161.76 144.18 8.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.726 0.774 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.33 64.98 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.716 2.277 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 38.3 t80 -138.85 135.51 34.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 110.91 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -104.68 105.43 50.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.58 0.705 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 170.68 15.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -125.18 -16.82 5.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.452 ' CG ' ' OE2' ' A' ' 272' ' ' GLU . 0.2 OUTLIER -152.94 173.41 15.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.881 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 271' ' ' ASP . 3.9 t70 -59.62 -41.07 89.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 271' ' ' ASP . 0.0 OUTLIER -35.11 -44.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.452 ' OE2' ' CG ' ' A' ' 269' ' ' ASN . 11.6 pm0 -99.29 178.41 4.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 5.9 tp -135.37 148.81 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.78 140.68 55.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.64 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -111.98 141.17 45.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.513 HG13 ' HD2' ' A' ' 277' ' ' PRO . 96.1 t -129.08 135.24 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.643 0.735 . . . . 0.0 111.129 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.75 104.78 1.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.69 13.2 8.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.17 167.74 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.878 0.371 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.444 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.5 m-85 -107.3 166.0 10.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.703 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.5 mm -144.85 119.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 28.7 m-85 -87.41 115.86 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -98.88 141.38 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.543 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 5.3 t -133.94 142.33 43.05 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -32.63 17.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.638 2.225 . . . . 0.0 112.352 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 63.7 mtp -74.97 -0.55 19.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 15.7 mm-40 -125.43 15.04 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -75.19 87.59 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.664 ' O ' HD21 ' A' ' 308' ' ' LEU . 8.2 p -114.46 122.32 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.3 m 56.26 25.84 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.422 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 31.8 p -89.42 -42.22 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 14.3 t -48.31 -29.61 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.28 -36.26 76.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.75 -25.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 296' ' ' ILE . 66.2 m95 -80.01 -179.67 7.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.761 0.315 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.2 pt -157.2 128.41 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 25.1 t80 -86.19 112.47 21.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.43 ' HA3' HG22 ' A' ' 281' ' ' ILE . . . -135.35 172.42 22.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.472 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 74.0 m -125.96 113.56 17.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.16 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.703 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.9 t -50.08 174.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.837 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 11.7 tp -114.46 -26.96 7.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -81.46 -54.2 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.3 p -86.73 -27.54 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.75 14.07 82.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.473 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.2 m -84.63 148.97 26.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 91.0 p -120.3 130.72 54.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.77 -174.69 38.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 289' ' ' THR . 19.7 mt -87.71 149.39 24.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.64 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -154.95 157.03 31.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.903 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.2 Cg_endo -69.83 122.43 9.09 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.696 2.264 . . . . 0.0 112.289 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.92 -10.07 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -95.48 22.77 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.549 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.4 m-85 -130.47 -2.03 4.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -133.23 172.15 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.5 t -147.17 164.46 33.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -68.61 151.31 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.22 90.19 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.117 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.52 24.93 11.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -89.59 84.17 6.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 58.3 m -69.54 127.58 33.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 29.7 m -92.13 -59.0 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.832 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.3 p -118.68 149.54 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.185 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.843 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -72.09 -39.01 69.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.843 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 27.4 mt -129.96 -53.52 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 322' ' ' THR . 66.3 m-85 -34.9 133.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.881 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -116.18 101.4 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.47 101.8 1.44 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.453 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 3.5 m -121.84 165.96 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 57.8 m -86.24 134.16 33.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -111.34 166.93 12.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 125.67 12.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.325 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.4 m -132.39 122.91 25.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -52.6 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.519 179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.9 m 52.03 46.63 26.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 110.839 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 t -88.41 129.51 35.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.825 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -144.3 -40.92 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 52.0 m -46.73 -49.48 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 110.877 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.6 t -136.64 173.45 11.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.869 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 95.01 162.04 34.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.6 t -80.77 122.42 27.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -91.37 168.44 11.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.93 157.91 31.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 251' ' ' ILE . 4.7 mp -95.81 137.86 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -41.89 -58.63 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -65.22 -46.71 79.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 65.82 42.67 3.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -120.59 40.22 3.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.577 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 2.3 m80 -102.84 154.44 19.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -89.81 166.66 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -131.64 127.42 36.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.118 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.774 HD13 HD13 ' A' ' 314' ' ' ILE . 9.4 mt -130.18 149.83 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -108.77 136.83 47.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.16 129.14 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.17 -28.67 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -145.52 143.9 21.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 154.16 68.14 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.302 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.468 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.0 t80 -147.88 127.55 13.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -94.8 109.13 42.1 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 172.82 11.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -124.08 -13.14 7.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -163.4 -178.14 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.3 t70 -64.4 -37.96 89.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -37.66 -40.31 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.29 173.09 6.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.99 145.36 51.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 275' ' ' LEU . 60.9 tt0 -63.84 146.13 54.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 309' ' ' LEU . 6.5 mt -117.27 121.37 40.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 277' ' ' PRO . 99.4 t -117.64 134.33 23.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.598 0.713 . . . . 0.0 111.144 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.6 Cg_endo -69.76 110.56 2.58 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.339 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.12 1.32 16.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.482 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -106.65 169.63 8.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.437 ' O ' HD13 ' A' ' 281' ' ' ILE . 17.9 m-85 -116.03 155.16 28.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 300' ' ' SER . 40.6 mm -133.49 123.15 45.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 20.1 m-85 -87.39 119.11 27.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -102.72 141.14 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 23.9 p -134.86 139.35 31.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.684 0.754 . . . . 0.0 110.846 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -20.04 35.31 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 2.237 . . . . 0.0 112.321 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 39.7 mtp -86.4 2.49 47.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.582 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 80.7 mm-40 -131.38 12.97 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -71.24 88.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 22.6 p -110.26 123.51 49.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.1 m 54.27 25.61 6.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 28.2 p -88.56 -43.45 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 m -45.0 -34.04 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -65.12 -42.03 94.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 169.37 -23.58 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 296' ' ' ILE . 69.7 m95 -79.93 -179.72 7.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 110.899 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -155.93 128.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 34.5 t80 -89.75 113.43 24.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -137.03 176.37 20.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.495 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.2 m -128.4 126.3 40.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.65 ' HA ' HD13 ' A' ' 281' ' ' ILE . 43.7 t -62.13 155.99 22.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.6 tp -97.8 -33.55 11.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 99.2 m -75.05 -55.69 5.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 49.2 p -84.79 -39.57 18.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.02 10.33 62.75 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.467 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 66.2 m -82.05 153.41 26.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 59.9 p -122.5 140.7 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -176.76 179.15 47.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 11.3 mt -89.23 139.42 30.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -143.84 156.67 58.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.602 0.715 . . . . 0.0 110.923 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.75 121.08 7.78 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.352 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.68 -11.23 2.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.17 19.97 7.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 10.5 m-85 -128.22 -3.03 5.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.774 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.07 -176.08 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 163.78 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 152.73 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.61 65.14 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.44 ' CG ' ' N ' ' A' ' 319' ' ' GLU . 3.9 p-10 -92.16 -54.0 4.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' ' 320' ' ' CYS . 43.1 mp0 34.62 45.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 319' ' ' GLU . 5.6 t 34.26 51.04 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 322' ' ' THR . 2.9 m -82.41 -75.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.575 ' HB ' ' CD1' ' A' ' 325' ' ' PHE . 1.4 m -34.6 145.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.528 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.6 p-90 -63.03 -48.22 79.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.528 HG12 ' CE3' ' A' ' 323' ' ' TRP . 15.4 mm -135.0 94.26 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.575 ' CD1' ' HB ' ' A' ' 322' ' ' THR . 0.1 OUTLIER -164.23 163.35 22.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -144.44 169.96 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -166.78 37.17 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 37.6 m -44.15 130.2 6.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 13.8 m -63.2 -39.58 95.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -89.19 138.44 14.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -31.1 21.4 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.367 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 32.8 t -95.94 163.28 13.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.8 m -105.11 85.3 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.461 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.8 t -79.54 -46.12 17.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.389 . . . . 0.0 110.863 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.4 t 45.64 41.62 7.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -89.29 -59.04 1.59 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 80.8 p -99.04 126.06 44.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 92.5 p -80.46 132.5 35.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.884 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 111.13 127.1 5.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.5 t -70.61 164.15 25.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 151.3 49.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -134.07 104.3 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.733 HG22 ' H ' ' A' ' 253' ' ' PHE . 12.8 mm -52.9 -48.8 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.495 ' CD ' ' O ' ' A' ' 252' ' ' ARG . 1.0 OUTLIER 44.97 31.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.733 ' H ' HG22 ' A' ' 251' ' ' ILE . 1.1 m-85 55.25 45.78 25.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -166.12 174.78 8.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.083 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 43.62 38.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.596 ' CE1' ' HB2' ' A' ' 284' ' ' SER . 1.7 t60 -172.85 142.83 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.66 156.97 23.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.409 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.8 m -134.29 135.29 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 314' ' ' ILE . 7.4 mt -137.36 152.79 50.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.514 ' O ' HG22 ' A' ' 315' ' ' THR . 22.5 tm0? -108.66 129.93 55.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.7 t -62.41 134.13 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -109.14 -17.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.449 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 74.6 m-85 -158.55 143.89 12.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.655 0.741 . . . . 0.0 110.911 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 152.57 69.49 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.704 2.269 . . . . 0.0 112.368 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 42.0 t80 -144.47 138.54 27.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.9 m -106.74 107.75 60.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.553 0.692 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG3' ' A' ' 272' ' ' GLU . 53.6 Cg_endo -69.78 169.46 18.89 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.656 2.238 . . . . 0.0 112.345 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -123.2 -14.2 7.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.432 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 0.3 OUTLIER -154.71 179.48 9.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.84 -35.49 80.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.498 ' OD1' HD12 ' A' ' 308' ' ' LEU . 26.0 t0 -40.59 -43.82 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 13.6 pm0 -100.28 177.66 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.443 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 3.6 tp -136.54 147.71 47.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.537 ' O ' HD23 ' A' ' 275' ' ' LEU . 19.8 tt0 -63.35 148.84 47.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 309' ' ' LEU . 11.3 mt -120.61 134.32 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 42.8 t -122.8 133.09 24.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.656 0.741 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 105.98 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.719 2.28 . . . . 0.0 112.308 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 115.45 11.35 10.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -112.1 171.58 7.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -112.06 161.15 16.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.472 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 20.1 mm -140.08 123.91 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.083 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 41.2 m-85 -88.25 110.37 20.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.6 tmm? -98.88 132.24 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.596 ' HB2' ' CE1' ' A' ' 256' ' ' HIS . 1.3 t -126.06 144.15 47.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.752 . . . . 0.0 110.874 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -31.61 20.52 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.714 2.276 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 28.7 mmm -76.33 4.27 9.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.585 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 19.5 mt-10 -133.13 18.41 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -77.74 82.39 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.63 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.5 p -103.11 134.92 45.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 16.4 m 41.79 25.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 289' ' ' THR . 32.2 p -85.68 -45.07 12.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 45.6 m -45.93 -31.89 2.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -66.45 -35.99 81.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 164.05 -25.89 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.441 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.5 m95 -79.98 -179.81 7.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.74 0.305 . . . . 0.0 110.917 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.3 pt -156.92 130.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 21.4 t80 -86.53 120.44 27.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -146.4 171.67 27.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.5 m -121.7 133.96 54.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.776 0.322 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.423 ' HA ' HD13 ' A' ' 281' ' ' ILE . 33.4 t -70.02 151.16 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 9.2 tp -96.08 -34.04 11.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -72.83 -43.06 63.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 68.8 p -96.78 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.13 8.68 14.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 72.3 m -83.95 155.23 22.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.837 0.351 . . . . 0.0 110.847 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.6 p -124.12 132.92 53.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -170.5 -175.68 39.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.435 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.63 HD21 ' O ' ' A' ' 289' ' ' THR . 18.3 mt -87.78 151.28 23.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 308' ' ' LEU . 0.2 OUTLIER -155.25 157.32 31.73 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 110.946 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.7 Cg_endo -69.78 116.07 4.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.673 2.248 . . . . 0.0 112.336 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -54.66 -14.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -90.06 20.52 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.545 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 8.9 m-85 -129.08 2.68 5.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -132.62 175.43 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 260' ' ' GLN . 12.8 t -149.64 154.38 38.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.463 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.2 OUTLIER -61.98 144.91 54.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -73.45 99.14 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.35 -43.99 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.438 ' OE2' ' N ' ' A' ' 320' ' ' CYS . 1.2 pp20? -53.77 -40.88 66.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.438 ' N ' ' OE2' ' A' ' 319' ' ' GLU . 4.7 t -44.13 161.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.7 m -135.77 -179.67 5.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 325' ' ' PHE . 4.1 p -108.94 138.59 45.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.462 ' CD2' HG12 ' A' ' 324' ' ' ILE . 2.6 p-90 -67.17 -41.27 86.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 323' ' ' TRP . 16.9 mm -126.89 -51.14 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 322' ' ' THR . 90.4 m-85 -41.49 156.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -117.63 -51.53 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.809 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 119.12 -106.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.464 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 11.3 m 41.33 53.43 3.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.867 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 3.6 m -95.74 140.8 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.826 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 168.37 -95.03 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -5.33 15.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.642 2.228 . . . . 0.0 112.378 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 11.2 m -80.5 -62.27 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 46.3 p -42.32 141.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.816 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.499 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 23.1 t -87.31 103.1 15.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 m -146.0 137.02 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 123.19 -71.29 0.42 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 40.7 t -52.98 134.66 37.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 75.0 m -62.65 158.32 18.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -152.76 -145.07 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.8 t -79.04 131.09 36.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -64.1 123.8 19.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.23 139.03 57.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 253' ' ' PHE . 16.3 mt -69.02 128.4 32.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.147 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.447 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 8.8 tpt180 -94.96 35.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.579 ' H ' HG22 ' A' ' 251' ' ' ILE . 0.8 OUTLIER 56.45 44.12 24.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -91.81 -175.42 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.62 76.32 2.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.533 ' CD2' ' OG ' ' A' ' 284' ' ' SER . 29.5 m80 -100.16 154.28 18.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.41 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 12.9 pt-20 -128.65 152.75 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.7 m -112.69 138.56 49.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.024 HD13 HD13 ' A' ' 314' ' ' ILE . 9.7 mt -135.54 150.93 49.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 17.3 tm0? -108.76 137.14 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.496 HG11 ' C ' ' A' ' 276' ' ' VAL . 49.8 t -66.44 137.22 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.549 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 4.5 pt -116.97 -14.39 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 91.2 m-85 -162.03 142.63 7.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.743 0.782 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 154.39 67.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.278 . . . . 0.0 112.325 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.986 ' CB ' HD12 ' A' ' 275' ' ' LEU . 25.8 t80 -137.31 156.57 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 267' ' ' PRO . 18.8 m -124.15 97.3 40.68 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.558 0.694 . . . . 0.0 111.108 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.75 171.17 14.95 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.239 . . . . 0.0 112.318 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -125.24 -14.8 6.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.75 -178.5 7.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 271' ' ' ASP . 6.6 m-20 -65.49 -36.77 84.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -36.52 -42.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -107.64 175.46 5.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.3 tp -131.61 141.24 49.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.52 154.28 25.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.986 HD12 ' CB ' ' A' ' 265' ' ' TYR . 23.7 mt -121.63 124.78 45.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.496 ' C ' HG11 ' A' ' 261' ' ' VAL . 71.2 t -113.83 130.23 24.01 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.687 0.756 . . . . 0.0 111.104 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 109.79 2.4 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.42 6.75 19.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -111.9 171.52 7.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.22 164.86 12.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 309' ' ' LEU . 12.1 mm -145.35 121.39 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.135 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.722 ' HE2' HD13 ' A' ' 301' ' ' LEU . 84.6 m-85 -89.88 111.69 22.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.499 ' SD ' ' N ' ' A' ' 284' ' ' SER . 2.9 tmm? -99.52 136.14 39.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 256' ' ' HIS . 0.9 OUTLIER -128.43 136.98 29.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.669 0.747 . . . . 0.0 110.85 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -18.81 36.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 20.4 mmt -66.58 -37.54 85.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.913 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 4.9 mt-10 -120.21 44.94 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.488 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 3.7 pp0? -96.94 52.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.424 ' O ' HD21 ' A' ' 308' ' ' LEU . 34.1 p -76.58 143.13 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.4 m 52.67 25.83 4.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 289' ' ' THR . 44.2 p -95.94 -49.24 5.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.183 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 t -46.68 -25.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.52 -35.95 70.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.26 -22.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.49 ' O ' HG23 ' A' ' 296' ' ' ILE . 68.7 m95 -86.31 178.96 6.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.97 122.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.431 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 19.5 t80 -78.81 110.09 13.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.18 175.78 19.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.458 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.4 m -126.47 127.48 45.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.763 0.316 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.559 ' HA ' HD13 ' A' ' 281' ' ' ILE . 36.4 t -66.1 153.03 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.722 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.2 tp -100.46 -43.17 6.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -62.79 -39.79 95.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 64.8 p -102.28 -55.3 2.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 112.94 1.57 25.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 273' ' ' LEU . 11.2 t -71.84 166.18 22.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.801 0.334 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 11.6 m -137.9 143.81 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 175.87 -174.81 47.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 289' ' ' THR . 12.1 mt -88.19 138.78 31.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.872 0.368 . . . . 0.0 110.929 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.74 155.9 66.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.93 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.723 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.8 Cg_endo -69.77 125.34 12.02 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.682 2.255 . . . . 0.0 112.297 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.32 -8.2 5.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.25 23.39 7.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.698 ' HB3' HD13 ' A' ' 275' ' ' LEU . 11.6 m-85 -130.72 -3.92 4.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 1.024 HD13 HD13 ' A' ' 259' ' ' LEU . 2.7 pp -131.0 -179.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.142 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 11.9 t -155.97 162.62 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.54 153.49 16.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -79.14 57.23 2.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.98 24.41 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -95.0 -43.06 8.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 62.2 m -88.74 155.93 19.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.871 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 24.3 p -110.96 166.17 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.645 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.5 OUTLIER -111.26 149.55 30.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.645 ' HD1' HG22 ' A' ' 322' ' ' THR . 5.9 p-90 -41.27 -43.37 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.578 HG12 ' CE3' ' A' ' 323' ' ' TRP . 10.6 mm -125.58 -64.92 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 324' ' ' ILE . 85.7 m-85 -34.24 140.37 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -113.52 -46.44 3.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 111.34 -125.46 7.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 19.2 t -165.75 127.11 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 11.6 t 56.45 46.28 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -100.03 -162.0 28.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.9 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 331' ' ' PRO . 29.2 t -34.75 115.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 47.1 m -100.97 120.03 39.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.48 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 24.7 m -78.66 134.6 37.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.928 0.394 . . . . 0.0 110.818 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.1 p 40.2 42.14 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -132.01 -137.25 3.96 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.492 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -64.02 124.19 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 247' ' ' GLY . 89.1 p -136.89 118.59 15.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 246' ' ' SER . . . 36.85 72.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.484 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 p -107.44 127.76 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -71.08 112.21 7.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -100.92 145.42 28.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.742 HG23 ' HB3' ' A' ' 254' ' ' ALA . 5.3 mp -89.24 121.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -123.76 -51.34 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.41 37.37 4.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.742 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -107.52 177.29 4.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -57.09 -58.25 9.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.567 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 33.8 m80 -38.52 131.43 1.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.479 ' CG ' ' HB3' ' A' ' 283' ' ' MET . 19.3 pt-20 -100.03 151.54 21.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 23.0 m -109.05 130.38 55.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.143 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 314' ' ' ILE . 11.7 mt -131.67 149.31 52.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 0.7 OUTLIER -108.63 132.42 53.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.497 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 54.6 t -64.74 132.3 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.6 -20.89 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.188 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -152.0 144.24 16.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.667 0.746 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.84 69.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 56.4 t80 -142.09 132.7 25.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.7 m -103.89 102.55 32.03 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.098 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 171.18 14.96 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -125.25 -15.15 6.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -152.29 -175.99 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.4 t70 -71.9 -37.64 70.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.4 OUTLIER -35.57 -39.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.836 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 pm0 -107.9 179.57 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 9.3 tp -133.92 145.48 49.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.53 141.52 58.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.561 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -114.98 130.7 56.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 277' ' ' PRO . 60.9 t -123.52 135.1 25.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.623 0.725 . . . . 0.0 111.124 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.5 Cg_endo -69.77 117.05 4.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.351 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.22 1.08 29.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -105.39 175.95 5.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -115.34 165.4 13.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.478 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 25.8 mm -141.46 127.6 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -95.01 109.51 21.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.0 tmm? -99.93 133.27 44.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 8.9 t -132.04 137.48 30.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.758 . . . . 0.0 110.815 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.5 23.77 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.3 mmt -88.27 -11.69 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 1.8 pt-20 -129.55 26.57 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -85.59 84.76 7.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.442 ' O ' HD21 ' A' ' 308' ' ' LEU . 20.1 p -100.43 118.32 36.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 20.6 m 62.06 25.07 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.458 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 35.9 p -86.35 -53.35 5.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 291' ' ' THR . 65.6 m -37.85 -32.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' THR . 4.8 tp10 -66.32 -47.12 74.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 179.05 -28.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.529 ' O ' HG23 ' A' ' 296' ' ' ILE . 60.6 m95 -79.89 -179.79 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.302 . . . . 0.0 110.907 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -158.99 125.33 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.157 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 23.2 t80 -80.13 114.31 18.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.478 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -135.21 162.83 24.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 17.1 m -114.03 132.73 55.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 31.0 t -67.96 148.42 51.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.7 -31.02 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -78.09 -48.85 15.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 75.5 p -91.48 -42.46 10.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.48 4.72 57.14 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 87.1 m -73.55 168.84 18.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 110.844 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 10.5 m -138.63 139.22 38.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.68 -176.7 47.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -88.13 148.25 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.914 0.388 . . . . 0.0 110.907 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -150.54 155.6 36.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.602 0.715 . . . . 0.0 110.927 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.1 Cg_endo -69.77 125.49 12.2 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -61.68 -8.76 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 312' ' ' ASN . 28.9 t-20 -96.14 22.01 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.574 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 11.1 m-85 -130.32 -3.27 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -129.85 175.22 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 260' ' ' GLN . 13.5 t -154.86 159.19 40.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.69 155.52 2.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -74.92 97.23 3.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.079 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.75 -34.43 3.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -42.65 -36.57 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 14.1 p -149.49 164.36 35.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 322' ' ' THR . 4.2 m -138.2 -176.71 4.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.508 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.4 OUTLIER -34.02 140.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.581 ' CE3' HG12 ' A' ' 324' ' ' ILE . 5.5 p-90 -41.24 -42.32 2.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.581 HG12 ' CE3' ' A' ' 323' ' ' TRP . 10.7 mm -119.54 -70.24 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.115 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.459 ' C ' ' O ' ' A' ' 324' ' ' ILE . 94.8 m-85 -33.76 119.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -110.26 -38.37 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.65 28.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.439 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 22.7 t -84.66 119.17 24.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 46.6 t -60.6 -57.38 12.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -145.33 156.99 27.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 157.55 60.1 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.681 2.254 . . . . 0.0 112.358 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 92.9 p -51.31 114.13 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.0 m 56.22 43.16 27.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.534 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 59.5 p -124.02 -45.72 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.834 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.7 p -69.16 157.7 36.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -167.33 106.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.478 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 t -98.4 149.62 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.7 p -169.15 177.56 4.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.83 36.4 11.6 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 53.2 m -38.55 107.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 110.836 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.543 ' HG2' HD11 ' A' ' 251' ' ' ILE . 15.2 ttm180 -98.77 -35.39 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 57.62 52.69 8.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.543 HD11 ' HG2' ' A' ' 249' ' ' ARG . 11.0 mm -82.13 -35.94 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.437 ' C ' ' CD1' ' A' ' 253' ' ' PHE . 2.3 tpt180 39.2 35.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 1.2 m-85 57.76 54.13 6.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.64 -178.95 3.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.27 89.56 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.56 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 14.9 m80 -109.93 135.14 51.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.47 160.36 30.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.6 m -122.76 131.52 53.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.928 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -133.95 150.63 51.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -108.71 134.25 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.1 t -67.03 135.29 28.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -113.03 -12.5 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 92.3 m-85 -161.31 142.86 8.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.657 0.741 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.48 68.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 0.0 112.318 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 21.7 t80 -147.57 126.18 12.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.1 m -96.96 108.3 42.74 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.571 0.7 . . . . 0.0 111.125 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.0 Cg_endo -69.75 166.69 26.75 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -115.93 -21.3 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -153.72 -177.43 6.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 271' ' ' ASP . 25.6 t0 -65.33 -37.25 86.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.7 OUTLIER -37.83 -40.69 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.413 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.4 pm0 -105.83 175.34 5.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 5.9 tp -129.9 147.3 51.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.41 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.0 tt0 -67.52 145.67 54.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 309' ' ' LEU . 10.4 mt -116.06 132.58 56.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.25 129.77 25.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.688 0.756 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.71 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.49 10.6 9.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -113.26 178.21 4.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.866 0.365 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -118.42 159.88 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 300' ' ' SER . 12.1 mm -135.25 138.0 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -101.73 113.36 26.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.5 tmm? -99.04 140.55 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.56 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 6.0 t -133.81 141.78 41.16 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.645 0.736 . . . . 0.0 110.893 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -37.42 9.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 36.8 mtp -74.14 1.34 11.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.575 ' HB3' ' CD2' ' A' ' 297' ' ' TYR . 37.8 mm-40 -128.36 17.15 6.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -77.98 86.14 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.954 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.739 ' O ' HD21 ' A' ' 308' ' ' LEU . 29.9 p -105.17 126.8 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.9 m 48.47 29.46 2.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 17.3 p -89.49 -50.0 6.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.174 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 59.1 p -39.9 -38.07 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -59.47 -46.36 89.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 175.03 -25.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 296' ' ' ILE . 59.6 m95 -80.58 -179.84 7.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.1 pt -156.52 125.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 287' ' ' GLU . 38.5 t80 -80.13 111.2 16.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.56 169.33 22.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 305' ' ' CYS . 91.4 m -124.8 116.36 22.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.155 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 281' ' ' ILE . 4.9 t -54.48 153.43 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.81 -50.7 4.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 16.0 m -53.46 -52.79 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 32.4 p -87.22 -53.45 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 108.8 4.54 31.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.433 ' O ' HG23 ' A' ' 299' ' ' THR . 9.3 t -77.72 166.72 22.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 84.1 p -134.85 147.91 50.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 174.84 -176.84 47.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.518 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 289' ' ' THR . 12.3 mt -88.98 137.57 32.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.897 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.83 156.01 65.9 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.73 . . . . 0.0 110.943 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 124.4 11.04 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.61 -8.81 4.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -95.62 21.93 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.559 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.6 m-85 -129.07 -1.5 5.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.85 -177.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.5 t -158.43 162.65 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -62.47 143.49 57.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.51 94.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -100.54 -45.3 5.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 319' ' ' GLU . 13.2 pt-20 -94.0 100.28 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 48.3 m -110.93 -48.72 3.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 30.3 p -54.21 -59.17 5.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.592 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.6 OUTLIER -114.86 145.18 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.154 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.592 ' HD1' HG22 ' A' ' 322' ' ' THR . 2.4 p-90 -47.58 -38.47 14.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 323' ' ' TRP . 8.2 mt -121.92 -67.12 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.146 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 324' ' ' ILE . 83.3 m-85 -36.67 148.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -95.13 163.58 13.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -106.96 50.03 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 26.3 m -87.88 114.22 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 0.0 110.844 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 4.3 t -70.02 -56.86 5.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 143.95 72.6 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.442 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.95 15.09 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.0 t -75.2 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.9 m -44.94 142.32 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.508 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 243' ' ' SER . 51.0 m -130.55 112.96 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 242' ' ' SER . 77.3 p -36.39 103.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -98.13 125.23 8.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 74.5 p -49.76 140.4 11.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.5 m -90.53 147.05 23.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 141.13 116.52 1.28 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.498 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.5 p -131.36 -175.82 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -77.87 149.35 34.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.58 92.7 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 251' ' ' ILE . 4.4 mp -40.86 120.72 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -99.43 52.62 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 54.23 44.86 28.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.407 ' O ' ' C ' ' A' ' 255' ' ' ASN . . . -89.18 -178.65 5.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 256' ' ' HIS . 67.9 m-80 -36.44 -48.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 31.1 m80 -35.36 140.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -113.6 163.22 15.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 259' ' ' LEU . 2.1 m -117.73 138.66 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.181 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 314' ' ' ILE . 9.8 mt -135.56 149.53 49.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -109.16 131.5 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 80.6 t -66.02 128.39 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.15 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -103.89 -21.71 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -150.94 143.61 16.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.675 0.75 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 154.36 68.08 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.382 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.587 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 34.6 t80 -147.5 123.92 10.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.3 m -93.37 106.25 19.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.577 0.703 . . . . 0.0 111.118 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 54.3 Cg_endo -69.75 171.6 14.15 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.624 2.216 . . . . 0.0 112.421 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.58 -14.94 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -158.9 -179.26 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 271' ' ' ASP . 38.7 t0 -64.77 -37.92 89.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.3 OUTLIER -36.38 -39.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.9 pm0 -109.39 171.83 7.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 3.3 tp -125.73 142.38 51.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -64.44 135.59 56.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 313' ' ' TYR . 7.7 mt -106.05 128.32 53.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 89.5 t -119.31 130.76 24.67 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.65 0.738 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 112.73 3.15 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.651 2.234 . . . . 0.0 112.368 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.88 1.29 22.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -107.53 175.84 5.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.532 ' O ' HD13 ' A' ' 281' ' ' ILE . 8.9 m-85 -114.91 165.07 13.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.651 HD13 ' HA ' ' A' ' 300' ' ' SER . 26.5 mm -143.34 140.85 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.422 ' HE2' HD13 ' A' ' 301' ' ' LEU . 67.3 m-85 -109.16 116.04 31.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.7 tmm? -101.76 136.93 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 13.4 p -125.55 138.68 32.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 0.0 110.883 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.491 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.78 -21.68 33.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.306 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 49.9 mmm -77.16 -24.15 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -118.03 29.51 7.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 15.1 pt20 -88.41 60.3 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.911 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 291' ' ' THR . 1.6 t -86.83 141.23 28.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.5 m 50.6 24.92 1.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 289' ' ' THR . 36.6 p -94.54 -41.55 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.18 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.6 m -51.41 -26.64 8.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -72.1 -30.99 65.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.576 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.8 m95 -81.21 179.51 7.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 314' ' ' ILE . 2.1 pt -160.02 119.36 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.83 111.44 10.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.455 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.4 167.41 23.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.522 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 305' ' ' CYS . 61.5 m -121.32 126.91 50.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 111.143 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.651 ' HA ' HD13 ' A' ' 281' ' ' ILE . 3.6 t -66.01 153.58 41.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.422 HD13 ' HE2' ' A' ' 282' ' ' PHE . 14.1 tp -92.75 -48.71 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.3 m -58.84 -57.68 11.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 58.7 p -78.61 -50.11 12.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.78 46.17 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.615 ' O ' HG23 ' A' ' 299' ' ' THR . 11.9 t -84.3 166.81 17.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 78.5 p -129.53 145.89 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.31 179.38 46.73 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -87.9 144.24 26.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 0.0 110.876 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.604 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -147.37 155.36 46.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.595 0.712 . . . . 0.0 110.897 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.78 128.73 16.43 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.368 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.22 -6.19 6.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -99.23 21.39 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.587 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 9.2 m-85 -129.73 -1.79 4.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.92 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.53 177.02 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.8 t -153.68 164.74 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.153 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -64.49 144.87 56.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.6 92.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.34 -34.87 16.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -45.34 -56.9 4.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 28.3 p -80.56 173.96 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 25.5 m -61.28 174.04 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 13.3 p -59.04 158.72 8.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.168 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.759 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -83.33 -39.4 20.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.759 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 21.8 mt -128.88 -49.45 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 324' ' ' ILE . 29.0 m-85 -34.61 135.96 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -121.8 156.3 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.88 -68.42 1.66 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 14.7 t -133.74 134.26 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.835 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 4.2 m -87.49 163.89 16.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -100.99 141.86 15.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.99 19.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.27 . . . . 0.0 112.377 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 52.4 m -76.98 -43.31 35.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.8 m -57.06 100.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.464 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 15.1 t -166.67 153.47 8.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.852 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.1 m -92.2 119.6 31.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -59.22 179.1 1.8 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.511 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 55.0 m -49.56 156.07 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.7 m -83.68 113.04 20.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -66.96 84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 99.8 p -120.05 141.17 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.24 131.48 48.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -103.6 170.96 7.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 253' ' ' PHE . 23.5 mt -87.59 122.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.417 ' HB2' ' NH1' ' A' ' 252' ' ' ARG . 0.0 OUTLIER -89.7 32.38 0.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.587 ' H ' HG22 ' A' ' 251' ' ' ILE . 18.8 m-85 71.2 39.98 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.03 -178.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 256' ' ' HIS . 4.5 m120 -43.94 -43.58 6.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.493 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 31.7 m80 -35.82 131.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -90.26 167.14 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 317' ' ' ALA . 0.8 OUTLIER -131.92 130.34 41.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 314' ' ' ILE . 12.6 mt -130.99 150.18 52.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 261' ' ' VAL . 22.4 tm0? -108.69 133.01 53.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.489 ' O ' ' NE2' ' A' ' 260' ' ' GLN . 65.9 t -64.43 133.92 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 263' ' ' TYR . 2.4 pt -111.06 -19.59 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.442 ' CE2' HD12 ' A' ' 262' ' ' ILE . 80.6 m-85 -152.97 141.71 14.22 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.673 0.749 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 148.55 65.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 1.009 ' CB ' HD12 ' A' ' 275' ' ' LEU . 29.3 t80 -133.93 157.15 46.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.418 ' N ' ' CG ' ' A' ' 265' ' ' TYR . 6.4 m -126.28 101.05 28.7 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 0.0 111.152 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 266' ' ' THR . 54.0 Cg_endo -69.72 169.73 18.17 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -124.57 -14.68 6.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -152.82 -175.57 5.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.67 -28.9 61.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -42.97 7.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -101.45 178.8 4.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 305' ' ' CYS . 6.9 tp -132.96 143.68 49.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.14 147.31 53.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 1.009 HD12 ' CB ' ' A' ' 265' ' ' TYR . 17.5 mt -115.9 124.67 51.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 95.4 t -115.61 130.59 24.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.634 0.731 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 111.43 2.82 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.31 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 116.63 2.64 19.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.466 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -111.19 175.16 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.836 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -115.38 164.63 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 309' ' ' LEU . 34.9 mm -138.77 121.09 17.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.504 ' CE2' HD13 ' A' ' 301' ' ' LEU . 20.6 m-85 -85.71 115.73 23.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -99.47 130.18 45.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 1.6 p -126.1 142.85 43.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -30.26 22.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.692 2.262 . . . . 0.0 112.364 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 65.2 mtp -76.6 -3.44 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.58 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 20.2 mm-40 -122.28 5.28 9.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.38 92.54 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.751 ' O ' HD21 ' A' ' 308' ' ' LEU . 40.6 p -115.19 123.79 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.7 m 50.83 29.09 4.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.807 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 294' ' ' GLY . 16.7 p -86.52 -55.51 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.133 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 291' ' ' THR . 31.3 t -34.41 -37.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.27 -49.03 79.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.15 -26.48 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.516 ' O ' HG23 ' A' ' 296' ' ' ILE . 65.2 m95 -79.87 -179.77 7.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.765 0.317 . . . . 0.0 110.898 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -158.38 119.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 19.9 t80 -78.44 112.77 15.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.454 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.46 175.25 21.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 305' ' ' CYS . 57.0 m -125.33 133.26 52.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.107 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 281' ' ' ILE . 28.3 t -71.14 150.62 45.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 282' ' ' PHE . 13.9 tp -95.49 -40.29 9.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 93.3 m -69.88 -44.95 68.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -91.88 -53.06 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 105.58 8.73 34.55 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 299' ' ' THR . 8.9 t -78.34 166.55 22.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 54.0 p -139.17 133.88 32.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.2 -175.11 45.07 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.751 HD21 ' O ' ' A' ' 289' ' ' THR . 11.1 mt -88.72 140.1 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -142.76 156.05 62.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.593 0.711 . . . . 0.0 110.907 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.748 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.78 122.88 9.55 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -60.43 -10.4 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -94.6 22.77 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.688 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.9 m-85 -129.87 -2.83 4.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -132.14 -179.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.1 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.2 t -157.38 167.77 29.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 142.13 55.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 258' ' ' THR . . . -54.23 93.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.076 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -63.91 -44.1 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -48.75 101.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.4 t 69.98 42.46 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 8.2 t -85.0 124.01 31.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . . . . . . . . . 22.1 p -95.32 -175.67 3.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.133 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.794 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.4 p-90 -130.49 -33.99 1.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.794 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 59.5 mt -128.16 -44.69 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -47.39 144.28 3.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -120.17 131.8 55.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.39 82.86 1.65 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 60.3 p -89.42 116.31 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.366 . . . . 0.0 110.851 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 40.6 m -118.67 170.99 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.09 163.36 24.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 332' ' ' SER . 53.6 Cg_endo -69.74 -30.39 22.46 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.722 2.282 . . . . 0.0 112.31 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 331' ' ' PRO . 9.9 t -37.57 102.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 68.9 m -86.65 42.21 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.863 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 29.7 t -87.19 149.32 24.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 m -61.86 110.31 1.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 115.54 45.79 0.6 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.1 p -142.24 159.42 42.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 110.877 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.5 t -151.39 116.5 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 141.32 55.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.2 t -126.15 89.19 2.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 57.4 46.83 17.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.21 92.0 7.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.607 HD12 ' CZ ' ' A' ' 282' ' ' PHE . 14.1 mt -94.93 116.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -84.6 29.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.474 ' H ' HG22 ' A' ' 251' ' ' ILE . 3.2 m-85 60.43 45.28 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.13 7.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.106 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -122.71 -44.16 2.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.576 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 6.2 m80 -90.97 142.67 27.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -92.36 166.75 12.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.424 ' O ' HD23 ' A' ' 259' ' ' LEU . 3.5 m -129.3 129.83 45.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.981 HD13 HD13 ' A' ' 314' ' ' ILE . 11.9 mt -130.41 150.66 51.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 315' ' ' THR . 6.2 tt0 -110.19 128.35 55.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.4 133.57 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.5 pt -109.36 -21.12 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -152.24 144.09 16.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.646 0.736 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.67 68.68 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 0.0 112.373 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.509 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 29.3 t80 -147.8 127.08 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.959 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.8 m -95.84 108.22 39.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 111.162 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.9 Cg_endo -69.73 172.04 13.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.234 . . . . 0.0 112.354 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -123.3 -13.38 7.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.941 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -162.44 -179.15 6.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 271' ' ' ASP . 21.6 p-10 -63.63 -37.45 87.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.5 OUTLIER -37.3 -41.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.0 pm0 -107.63 174.62 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 305' ' ' CYS . 4.5 tp -128.32 144.93 51.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.58 128.93 38.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 309' ' ' LEU . 7.7 mt -97.18 129.45 44.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.55 130.57 24.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.624 0.726 . . . . 0.0 111.134 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 103.74 1.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.709 2.273 . . . . 0.0 112.34 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.47 5.37 7.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.44 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -111.29 169.97 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 281' ' ' ILE . 15.6 m-85 -113.32 145.44 41.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 300' ' ' SER . 32.1 mm -124.21 120.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 251' ' ' ILE . 17.9 m-85 -83.33 119.29 24.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -99.66 137.85 37.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.576 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 12.8 p -138.97 120.12 9.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.82 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 0.51 5.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.668 2.245 . . . . 0.0 112.366 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 10.4 mmt -94.85 -24.12 17.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.538 ' O ' ' CD1' ' A' ' 297' ' ' TYR . 16.9 mm-40 -122.06 41.41 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.0 143.11 27.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.639 ' O ' HD11 ' A' ' 308' ' ' LEU . 24.9 p -147.79 116.51 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 23.4 m 64.4 25.4 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 294' ' ' GLY . 28.1 p -83.02 -52.3 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 291' ' ' THR . 12.5 m -36.66 -41.51 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -56.88 -45.37 82.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 172.53 -23.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.494 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -79.88 -179.9 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.736 0.303 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.36 131.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 287' ' ' GLU . 40.4 t80 -94.3 108.45 20.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -132.85 -177.29 14.83 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 89.0 m -132.48 126.29 32.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.613 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.0 OUTLIER -62.6 166.32 5.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.7 tp -107.08 -30.32 8.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.4 m -75.63 -54.17 7.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 9.3 p -90.28 -34.46 15.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 84.97 17.76 62.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.477 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 61.9 m -86.65 145.9 26.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.782 0.325 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 95.4 p -114.1 132.7 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.852 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -169.97 179.22 42.41 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 289' ' ' THR . 11.4 mt -89.5 142.64 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.77 156.42 48.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 120.89 7.6 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.718 2.279 . . . . 0.0 112.364 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -58.37 -11.57 2.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -92.86 19.9 7.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.8 m-85 -128.24 -1.6 5.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.981 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.44 174.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 260' ' ' GLN . 5.6 t -146.84 159.49 43.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 3.5 mptt -64.74 143.82 57.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.2 95.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -101.22 -43.62 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -57.65 -17.26 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 36.4 m -71.84 153.35 41.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 47.9 t -88.34 84.9 6.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.87 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 325' ' ' PHE . 8.2 p -51.75 127.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.53 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.2 p-90 -69.5 -32.23 70.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.53 HG12 ' CD2' ' A' ' 323' ' ' TRP . 20.8 mm -133.84 -54.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.465 ' HB2' ' CG2' ' A' ' 322' ' ' THR . 85.4 m-85 -35.18 135.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -85.22 84.09 7.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -143.75 33.29 1.77 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 92.2 p -40.21 131.27 2.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.892 0.377 . . . . 0.0 110.837 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 2.5 t -81.67 -179.63 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.85 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.48 85.95 0.24 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -25.99 27.98 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 98.2 p -114.08 130.03 56.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.3 t -142.01 127.66 19.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.555 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 66.1 m -90.13 91.87 8.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.3 t -52.96 121.73 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.838 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 106.62 -112.5 3.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 57.7 m -150.73 160.15 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 110.85 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 14.2 t -69.52 86.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 134.81 148.74 5.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.5 m -85.54 90.46 7.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -51.89 -29.85 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.77 147.81 30.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.67 HD13 ' CG ' ' A' ' 256' ' ' HIS . 10.7 mt -94.22 117.78 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -120.78 -49.19 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -75.36 -45.0 42.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.588 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -73.11 172.13 11.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -129.76 94.63 3.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.67 ' CG ' HD13 ' A' ' 251' ' ' ILE . 20.9 m80 -99.55 136.13 39.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -83.15 168.65 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 5.9 m -131.21 129.49 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.141 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.775 HD13 HD13 ' A' ' 314' ' ' ILE . 10.5 mt -130.21 149.43 51.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -108.84 124.76 51.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.33 131.32 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.143 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -106.93 -12.08 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 75.3 m-85 -161.55 143.45 8.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.68 0.753 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.12 11.46 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.642 2.228 . . . . 0.0 112.338 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 275' ' ' LEU . 3.1 t80 -171.77 118.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.2 m -83.75 113.4 47.06 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.579 0.704 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 171.95 13.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 0.0 112.395 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -119.89 -13.39 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.405 ' OD1' ' CD ' ' A' ' 272' ' ' GLU . 2.5 p30 -167.63 -178.26 3.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.38 -29.67 70.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 271' ' ' ASP . 0.2 OUTLIER -45.33 -42.08 9.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.405 ' CD ' ' OD1' ' A' ' 269' ' ' ASN . 11.7 pm0 -106.82 177.28 4.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 12.7 tp -130.45 147.5 52.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -67.67 151.87 46.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.676 HD23 ' CD2' ' A' ' 265' ' ' TYR . 3.7 mm? -115.87 128.75 56.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.87 127.15 26.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.606 0.717 . . . . 0.0 111.139 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 104.55 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.65 2.233 . . . . 0.0 112.309 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.07 11.19 8.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -114.64 174.67 5.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -115.41 165.22 13.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.737 HD13 ' HA ' ' A' ' 300' ' ' SER . 15.1 mm -143.82 128.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -93.02 116.91 29.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.824 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.9 tmm? -101.76 134.82 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.565 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 0.7 OUTLIER -125.66 141.46 39.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.684 0.754 . . . . 0.0 110.799 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -31.83 19.73 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 8.7 mtp -77.47 -2.07 33.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.576 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 12.4 mt-10 -121.77 8.09 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -67.98 85.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.658 ' O ' HD21 ' A' ' 308' ' ' LEU . 2.4 p -109.05 121.81 45.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 10.3 m 55.26 26.0 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 296' ' ' ILE . 32.9 p -86.97 -44.15 11.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.2 t -43.15 -40.73 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -57.97 -40.43 80.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 165.81 -21.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.453 ' HB3' HD22 ' A' ' 308' ' ' LEU . 72.0 m95 -80.01 -179.78 7.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.6 pt -156.74 122.04 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.181 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 36.5 t80 -84.59 111.71 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -137.19 -172.9 12.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 65.5 m -138.01 124.1 20.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.17 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.737 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -62.21 168.89 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.862 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.17 -41.07 5.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.4 m -67.23 -65.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.086 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.3 p -75.12 -31.92 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.9 25.03 63.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.496 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.68 152.59 18.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.914 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 33.5 p -121.34 136.85 54.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -177.1 -179.46 47.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.513 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.658 HD21 ' O ' ' A' ' 289' ' ' THR . 10.8 mt -87.93 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -141.76 156.68 65.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.603 0.716 . . . . 0.0 110.927 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.8 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 0.0 112.347 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -54.5 -14.72 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -89.26 19.14 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.546 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.68 -0.19 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.82 178.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.112 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.2 t -148.74 157.95 43.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -65.67 151.46 46.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.563 ' HB1' ' SG ' ' A' ' 320' ' ' CYS . . . -75.47 97.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.099 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -120.59 -53.75 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -54.16 -45.13 71.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.563 ' SG ' ' HB1' ' A' ' 317' ' ' ALA . 26.5 p -51.87 176.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 98.2 p -102.91 138.14 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.449 HG21 ' HB2' ' A' ' 325' ' ' PHE . 19.2 p -67.0 -179.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.57 ' CE3' HG12 ' A' ' 324' ' ' ILE . 6.1 p-90 -112.17 -40.39 4.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.916 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.57 HG12 ' CE3' ' A' ' 323' ' ' TRP . 13.8 mm -127.51 -34.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.135 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.449 ' HB2' HG21 ' A' ' 322' ' ' THR . 27.3 m-85 -45.39 142.73 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -116.98 150.5 38.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -126.26 -42.14 0.31 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 52.8 m -67.23 139.41 57.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 56.9 p -55.17 172.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.846 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 165.84 177.45 38.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.32 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.669 2.246 . . . . 0.0 112.378 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m 37.6 42.19 0.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 334' ' ' GLY . 5.4 t -68.65 107.39 2.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 333' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 26.6 t -74.64 88.75 2.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.3 t -116.98 95.41 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 170.18 50.23 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.517 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.2 t -116.47 104.3 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.888 0.375 . . . . 0.0 110.837 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 3.6 t -78.93 89.9 4.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 41.51 58.91 2.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.5 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 51.0 p -152.01 131.15 12.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.83 0.348 . . . . 0.0 110.839 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 5.3 ttp85 74.96 29.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.813 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -100.77 135.55 42.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.0 mm -63.77 -41.32 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . 0.416 ' CD ' ' O ' ' A' ' 252' ' ' ARG . 1.5 tmt_? 45.65 34.78 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 252' ' ' ARG . 1.5 m-85 58.12 47.23 14.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -88.31 -70.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -128.87 -38.58 1.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.562 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 8.2 m80 -70.36 139.43 51.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -77.53 151.89 34.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 2.1 m -117.61 132.04 56.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 1.092 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -135.03 150.97 50.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -108.74 131.74 54.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.52 126.48 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 2.2 pt -102.56 -18.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 70.1 m-85 -158.24 144.06 12.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.641 0.734 . . . . 0.0 110.918 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 158.31 57.37 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.722 2.281 . . . . 0.0 112.333 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -150.54 133.07 15.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.6 m -102.46 106.94 51.73 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.621 0.724 . . . . 0.0 111.115 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.432 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 53.7 Cg_endo -69.75 170.89 15.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.725 2.283 . . . . 0.0 112.345 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -124.87 -15.37 6.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.404 ' H ' ' CD ' ' A' ' 272' ' ' GLU . 56.7 m-80 -150.66 -175.71 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -71.58 -40.76 69.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -38.59 -42.16 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.432 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 1.3 pm0 -99.75 171.06 8.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 5.8 tp -131.9 150.96 52.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 275' ' ' LEU . 35.3 tt0 -68.81 150.67 47.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 309' ' ' LEU . 10.9 mt -119.71 130.83 55.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 86.3 t -122.38 129.26 25.14 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 114.32 3.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.83 0.31 22.93 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.501 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -110.42 169.49 8.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.436 ' O ' HD13 ' A' ' 281' ' ' ILE . 26.9 m-85 -108.67 166.23 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 300' ' ' SER . 21.1 mm -142.35 124.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.575 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 22.7 m-85 -90.68 114.78 27.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.4 tmm? -100.3 141.61 32.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.562 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 1.1 t -141.27 138.72 17.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.664 0.745 . . . . 0.0 110.866 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.439 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.4 Cg_endo -69.78 -18.47 36.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 0.0 112.331 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 11.2 mtp -64.11 -31.61 72.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -123.0 41.74 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 8.3 pt20 -91.38 66.95 5.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 291' ' ' THR . 1.3 t -93.65 142.27 27.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.1 m 45.48 25.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 289' ' ' THR . 40.5 p -91.53 -58.32 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.138 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 291' ' ' THR . 26.8 m -36.2 -38.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.59 -46.69 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 178.52 -26.88 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.52 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 296' ' ' ILE . 67.1 m95 -83.17 -179.98 7.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.752 0.31 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.561 HD11 HG12 ' A' ' 314' ' ' ILE . 1.2 pt -157.33 136.53 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.493 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 38.6 t80 -89.48 111.72 22.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.475 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -132.46 167.66 22.98 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 92.6 m -126.14 116.49 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.75 0.31 . . . . 0.0 111.16 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.601 ' HA ' HD13 ' A' ' 281' ' ' ILE . 7.2 t -55.28 147.66 16.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.575 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 10.0 tp -89.24 -43.04 11.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.1 m -65.25 -60.95 2.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 30.4 p -75.2 -50.35 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 101.99 9.58 42.17 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.01 153.37 23.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 80.7 p -125.0 137.96 54.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -175.46 -173.42 41.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 20.5 mt -90.99 140.86 29.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.895 0.378 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -144.15 156.02 58.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.654 0.74 . . . . 0.0 110.883 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.552 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.72 117.61 5.18 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.0 -14.29 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -90.44 21.21 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.552 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.18 -5.51 4.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 1.092 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -125.93 169.69 16.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 13.7 t -150.24 167.49 26.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.483 ' HD3' HD22 ' A' ' 259' ' ' LEU . 0.2 OUTLIER -74.42 143.76 44.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.924 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.89 96.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.077 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.63 -33.91 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.34 72.04 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 71.9 m -64.49 -65.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 68.8 m -69.28 101.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.654 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.4 OUTLIER -74.59 143.94 44.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.654 ' HD1' HG22 ' A' ' 322' ' ' THR . 2.1 p-90 -46.74 -33.96 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.499 HG13 ' CD2' ' A' ' 323' ' ' TRP . 21.9 mt -121.81 -72.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.457 ' N ' HG22 ' A' ' 324' ' ' ILE . 82.3 m-85 -33.99 123.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -96.73 138.17 34.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.05 160.0 17.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 2.3 t -123.18 145.29 48.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 18.6 t -159.11 132.26 7.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -173.79 -158.71 18.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 119.05 6.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 17.6 m -132.04 134.86 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.832 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.2 p -82.91 152.38 25.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.487 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.6 m 41.63 42.03 1.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.9 m -97.04 -43.99 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 125.64 -162.81 19.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.523 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' SER . 12.2 m -125.8 94.92 4.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.861 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' SER . 46.0 m -36.7 -48.58 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.69 143.45 6.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.8 p -130.14 -44.05 1.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -97.17 -31.53 12.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.64 111.68 21.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 254' ' ' ALA . 27.6 mt -85.41 110.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 43.2 mtt-85 -125.59 -47.48 1.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -114.96 40.33 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -134.22 153.45 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.0 82.32 2.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.571 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 39.1 m80 -111.44 132.16 54.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.12 168.03 11.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.705 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 1.7 m -129.2 127.24 40.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.947 HD13 HD13 ' A' ' 314' ' ' ILE . 11.2 mt -127.54 150.03 49.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -109.11 127.21 53.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.89 138.89 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.145 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.468 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.4 pt -114.89 -14.93 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 81.7 m-85 -159.2 146.7 13.15 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.686 0.755 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 165.34 31.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.259 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 44.2 t80 -160.75 123.4 3.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.8 m -90.29 110.07 38.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.584 0.706 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' CB ' ' CG ' ' A' ' 272' ' ' GLU . 52.9 Cg_endo -69.84 171.13 15.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.681 2.254 . . . . 0.0 112.269 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -119.7 -14.38 9.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -167.26 -178.67 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.43 -34.9 74.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -38.87 -44.28 1.03 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.435 ' CG ' ' CB ' ' A' ' 267' ' ' PRO . 2.6 pm0 -105.32 177.38 4.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.504 ' O ' ' CD2' ' A' ' 275' ' ' LEU . 4.0 tp -132.72 142.38 49.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.589 ' C ' HD22 ' A' ' 275' ' ' LEU . 34.4 tt0 -57.67 150.82 18.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.589 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.8 mm? -114.45 127.33 55.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 75.5 t -117.61 123.44 29.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 103.97 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.92 12.76 7.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.469 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -115.31 178.64 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -116.54 160.5 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.481 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 18.2 mm -138.98 133.28 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.8 m-85 -96.02 110.55 22.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -101.34 134.11 44.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.571 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 22.1 t -137.6 140.83 31.29 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.651 0.738 . . . . 0.0 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.434 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 53.9 Cg_endo -69.73 -26.01 28.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 7.2 mmt -61.26 -33.61 73.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -117.45 41.39 2.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 288' ' ' GLN . 11.5 pt20 -96.08 95.91 8.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.45 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.6 p -115.11 137.31 52.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.115 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 9.5 m 48.49 25.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 43.5 p -88.53 -38.47 14.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.0 t -55.4 -24.84 32.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.869 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.94 -29.64 63.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 156.48 -18.57 0.44 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 55.9 m95 -86.99 179.6 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 110.899 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 314' ' ' ILE . 1.3 pt -158.14 124.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -80.19 111.15 16.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -130.84 175.09 19.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 70.3 m -131.7 132.46 43.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 111.123 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 17.2 t -65.58 150.56 48.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.56 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.6 tp -95.4 -35.42 11.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.944 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 48.4 m -77.18 -49.91 14.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 82.1 p -84.12 -52.46 6.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 106.05 3.16 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.462 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 273' ' ' LEU . 82.9 m -77.44 147.89 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.88 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 89.6 p -120.73 140.37 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -178.28 -177.25 46.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.7 mt -88.18 149.56 23.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 110.927 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -153.06 155.54 32.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.553 0.692 . . . . 0.0 110.961 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.3 Cg_endo -69.7 126.84 13.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.692 2.261 . . . . 0.0 112.369 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.22 -7.27 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -97.62 21.63 10.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 265' ' ' TYR . 8.7 m-85 -129.35 -3.88 4.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.947 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.28 177.96 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 1.6 t -149.77 156.69 42.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -59.24 137.57 57.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -52.4 95.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -41.22 10.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.96 91.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 91.2 m -135.89 172.25 13.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 18.3 m -50.62 179.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.83 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.478 HG22 ' HD1' ' A' ' 323' ' ' TRP . 0.9 OUTLIER -83.9 147.46 27.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.154 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.533 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.2 p-90 -40.25 -35.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 323' ' ' TRP . 11.2 mm -132.26 -67.44 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.455 ' C ' ' O ' ' A' ' 324' ' ' ILE . 87.9 m-85 -34.06 136.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -113.08 -53.42 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 117.61 73.5 0.47 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 40.0 p -173.7 148.83 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 39.7 m 58.52 41.32 22.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 156.85 70.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.523 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 100.88 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.363 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.7 t -57.95 149.48 22.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.8 m -86.81 -58.82 2.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.419 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.2 m -132.12 -47.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 m -81.34 162.85 23.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.811 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 144.81 85.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.517 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.8 t -150.99 173.11 14.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.6 t -109.17 147.94 31.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 82.87 110.6 0.48 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.507 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 p -80.39 -59.59 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 249' ' ' ARG . 13.8 mtp-105 -77.25 119.57 21.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -106.36 123.89 48.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.81 HG23 ' HB3' ' A' ' 254' ' ' ALA . 5.1 mp -87.27 115.65 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -123.66 -63.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -104.91 44.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.81 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -106.83 174.87 5.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -72.9 -48.98 32.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 17.7 m80 -37.91 134.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -87.5 160.92 18.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 5.6 m -123.54 125.24 44.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.997 HD13 HD13 ' A' ' 314' ' ' ILE . 11.8 mt -125.99 149.82 48.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -108.83 130.8 55.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.92 144.2 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.539 ' O ' ' CG ' ' A' ' 263' ' ' TYR . 1.8 pt -121.61 -14.6 7.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' A' ' 262' ' ' ILE . 71.4 m-85 -161.5 145.71 9.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.654 0.74 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 163.8 36.9 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.332 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.551 ' HD2' HD23 ' A' ' 275' ' ' LEU . 50.8 t80 -160.81 128.3 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 9.8 m -97.78 108.92 48.65 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.565 0.698 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.43 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.81 165.15 31.99 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.342 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -113.68 -21.9 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -154.02 -179.16 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.6 -32.98 74.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -39.24 -45.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.43 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 2.8 pm0 -105.21 178.96 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.7 tp -132.24 151.94 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.748 ' C ' HD22 ' A' ' 275' ' ' LEU . 31.3 tt0 -64.9 155.85 32.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.748 HD22 ' C ' ' A' ' 274' ' ' GLU . 1.3 mm? -121.31 131.54 54.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.905 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.91 126.26 25.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.666 0.746 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.01 2.96 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.649 2.233 . . . . 0.0 112.358 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 111.69 9.66 20.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -112.85 178.69 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -117.16 169.49 9.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.467 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 17.3 mm -146.14 125.58 5.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.557 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 24.7 m-85 -91.77 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.5 tmm? -99.23 135.57 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.559 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 30.6 t -128.56 142.41 44.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.717 0.77 . . . . 0.0 110.855 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -30.83 21.56 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.258 . . . . 0.0 112.345 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 47.7 mtp -77.26 4.39 10.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 297' ' ' TYR . 66.9 mm-40 -127.41 -0.54 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -58.8 85.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.587 ' O ' HD21 ' A' ' 308' ' ' LEU . 1.4 p -109.32 107.92 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.0 m 66.82 28.02 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.9 p -88.24 -48.01 8.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.155 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 81.1 p -39.8 -39.57 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -59.18 -44.95 92.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 171.63 -23.24 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 296' ' ' ILE . 62.9 m95 -79.73 -179.85 7.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.754 0.312 . . . . 0.0 110.916 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.643 HD11 HG12 ' A' ' 314' ' ' ILE . 1.8 pt -157.93 121.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 287' ' ' GLU . 32.0 t80 -79.92 113.7 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -133.77 175.52 20.24 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 305' ' ' CYS . 13.8 m -125.18 131.92 53.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.75 0.31 . . . . 0.0 111.133 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 22.4 t -66.1 148.74 51.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 12.3 tp -97.17 -37.18 10.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.8 m -73.55 -44.78 56.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 53.4 p -94.07 -46.47 7.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 102.86 3.36 49.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.551 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 299' ' ' THR . 56.2 m -71.65 176.9 4.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 6.7 m -149.07 140.26 23.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 179.76 -177.19 48.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 289' ' ' THR . 12.2 mt -88.98 136.2 33.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -138.77 153.44 72.1 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 0.0 110.908 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 313' ' ' TYR . 53.4 Cg_endo -69.85 123.9 10.52 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.653 2.235 . . . . 0.0 112.339 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.73 -11.14 2.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -92.49 19.36 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 310' ' ' PRO . 8.1 m-85 -128.91 -2.5 5.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.997 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -134.06 177.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 2.9 t -153.05 159.49 42.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -55.16 148.2 14.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -61.79 94.03 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.104 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -80.52 -40.55 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.29 103.02 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 7.7 m -153.19 161.52 42.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 35.1 m -90.03 -179.26 5.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.532 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.7 p -53.33 144.13 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.177 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.671 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.0 p-90 -75.14 -39.73 60.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.671 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 17.2 mt -127.21 -52.99 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.118 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.532 ' HB2' HG21 ' A' ' 322' ' ' THR . 96.5 m-85 -34.8 130.46 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -109.15 97.13 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 140.23 118.31 1.51 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.496 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 97.2 p -111.59 52.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.878 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 20.1 m -117.73 128.14 54.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 95.35 146.79 21.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.506 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 334' ' ' GLY . 53.8 Cg_endo -69.77 -2.08 9.58 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 331' ' ' PRO . 1.7 t -35.85 132.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 4.7 p 43.94 35.84 1.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 331' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 60.9 p -150.38 138.57 20.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.0 p -80.07 -45.74 17.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -141.27 137.75 8.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.528 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 50.2 m -113.41 -57.59 2.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.378 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.4 m -113.15 88.49 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 155.11 -51.8 0.45 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -47.23 123.32 5.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -140.8 141.89 34.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -163.7 169.74 18.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.52 122.29 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -81.47 41.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 59.79 40.59 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -73.52 -179.52 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -82.41 44.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 11.2 m80 -76.2 142.6 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -89.93 157.34 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 3.0 m -121.96 130.55 53.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 314' ' ' ILE . 11.6 mt -128.3 150.21 50.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 315' ' ' THR . 8.8 tt0 -108.57 131.09 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.18 133.17 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -103.48 -28.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -145.01 144.95 25.48 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.697 0.76 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 151.91 69.46 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.709 2.272 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.494 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 24.3 t80 -148.49 120.35 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 11.9 m -91.3 107.4 21.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.561 0.696 . . . . 0.0 111.154 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.49 16.5 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.316 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -120.41 -14.66 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -157.81 176.63 12.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 271' ' ' ASP . 12.3 p-10 -62.92 -39.72 95.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 270' ' ' ASP . 0.6 OUTLIER -35.1 -39.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -105.82 175.14 5.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.633 HD11 ' SG ' ' A' ' 305' ' ' CYS . 5.5 tp -125.67 143.97 50.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -70.19 130.27 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.442 HD21 HD13 ' A' ' 309' ' ' LEU . 10.2 mt -101.89 131.96 47.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.3 t -123.79 132.87 24.31 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.598 0.713 . . . . 0.0 111.124 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.4 Cg_endo -69.81 103.45 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.311 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.56 14.51 6.84 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.426 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -116.73 177.99 4.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.44 ' O ' HD13 ' A' ' 281' ' ' ILE . 9.8 m-85 -120.48 161.36 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 300' ' ' SER . 38.6 mm -142.51 139.39 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 25.3 m-85 -101.17 113.53 26.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.1 tmm? -100.26 133.69 44.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 1.0 OUTLIER -133.76 136.94 27.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.707 0.765 . . . . 0.0 110.869 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 288' ' ' GLN . 54.0 Cg_endo -69.78 -20.36 34.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.29 -32.28 73.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -119.29 42.73 2.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 285' ' ' PRO . 12.3 pt20 -94.21 81.78 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 291' ' ' THR . 35.9 p -94.83 137.5 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 14.7 m 39.45 31.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 289' ' ' THR . 34.6 p -88.33 -58.37 2.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 291' ' ' THR . 17.8 m -35.89 -43.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -51.35 -46.45 62.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 177.71 -26.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.498 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 296' ' ' ILE . 74.2 m95 -82.77 179.92 7.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.0 110.926 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -160.17 123.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.106 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -78.18 115.83 18.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -136.45 167.74 24.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.51 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 90.2 m -122.41 137.63 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.541 ' HA ' HD13 ' A' ' 281' ' ' ILE . 23.7 t -69.16 151.3 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.535 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 9.1 tp -100.02 -31.18 11.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 98.8 m -76.98 -36.76 56.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 20.2 p -102.12 -65.7 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.34 6.86 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.633 ' SG ' HD11 ' A' ' 273' ' ' LEU . 28.5 p -72.09 155.07 40.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 30.1 p -124.52 154.57 40.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 173.92 179.52 44.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 309' ' ' LEU . 12.1 mt -87.56 147.52 25.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.3 OUTLIER -150.0 155.23 37.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 0.0 110.907 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.551 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.77 120.03 6.88 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.06 -12.43 2.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -92.67 21.9 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.849 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.551 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 9.2 m-85 -130.45 -3.83 4.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -127.11 -179.4 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 260' ' ' GLN . 6.9 t -156.2 160.03 39.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -59.37 143.74 48.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -54.91 92.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -85.38 -41.95 14.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.847 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.81 43.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 31.4 p -80.32 160.89 25.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.3 t -121.08 170.36 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.571 HG21 ' CD2' ' A' ' 325' ' ' PHE . 5.9 p -75.54 163.96 26.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.533 ' CD2' HG12 ' A' ' 324' ' ' ILE . 3.4 p-90 -131.96 -41.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.533 HG12 ' CD2' ' A' ' 323' ' ' TRP . 26.4 mm -125.04 -12.89 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 325' ' ' PHE . 0.1 OUTLIER -34.23 141.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -107.41 151.69 25.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -149.98 159.8 28.25 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.5 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 99.8 p -72.23 127.08 31.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 110.826 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 52.5 m -103.88 140.02 38.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 331' ' ' PRO . . . 79.07 -147.67 30.65 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.523 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 330' ' ' GLY . 53.4 Cg_endo -69.79 146.1 59.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.326 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 35.6 m -89.89 82.03 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.834 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.8 p -84.61 155.65 21.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.436 -0.266 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 58.7 m -106.31 92.58 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 0.0 110.934 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 30.2 m 57.41 48.99 13.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -132.22 -53.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 78.0 p -119.85 -55.18 2.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.857 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.6 m -77.5 -68.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.54 -93.06 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.497 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 59.6 p -171.77 171.32 5.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.445 ' O ' ' CG ' ' A' ' 250' ' ' ASP . 33.3 mtm180 -95.97 85.66 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 249' ' ' ARG . 4.5 m-20 -162.3 127.09 3.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.25 116.4 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.183 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -97.84 47.51 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 58.74 44.14 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -76.0 -176.01 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.105 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.01 44.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 284' ' ' SER . 26.4 m80 -78.84 136.18 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 258' ' ' THR . 11.1 tp10 -95.92 159.04 15.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 317' ' ' ALA . 8.3 m -123.72 123.11 39.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.746 HD13 HD13 ' A' ' 314' ' ' ILE . 6.9 mt -125.41 151.9 45.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -108.87 130.36 55.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.8 126.57 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 2.7 pt -100.19 -17.01 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -156.27 145.63 15.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.671 0.748 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 162.79 40.72 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.675 2.25 . . . . 0.0 112.396 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 1.028 ' CB ' HD12 ' A' ' 275' ' ' LEU . 28.1 t80 -147.81 144.3 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 16.4 m -114.74 99.42 51.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.581 0.705 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.55 21.23 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.685 2.257 . . . . 0.0 112.369 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -124.88 -14.01 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -147.64 -178.99 6.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.867 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 271' ' ' ASP . 1.8 m-20 -71.87 -42.47 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 270' ' ' ASP . 29.4 t70 -37.34 -39.93 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -100.55 176.89 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 274' ' ' GLU . 7.1 tp -137.8 153.6 49.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 21.9 tt0 -74.98 150.83 38.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 1.028 HD12 ' CB ' ' A' ' 265' ' ' TYR . 26.0 mt -117.71 133.66 55.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.23 130.87 24.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.634 0.731 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 105.65 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.24 . . . . 0.0 112.346 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 114.32 16.13 7.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -118.34 171.08 8.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.425 ' CD1' HG22 ' A' ' 258' ' ' THR . 9.0 m-85 -110.8 159.76 17.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.493 ' CG2' ' HA3' ' A' ' 298' ' ' GLY . 32.2 mm -136.76 133.95 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 301' ' ' LEU . 28.9 m-85 -99.33 111.64 23.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 284' ' ' SER . 4.0 tmm? -100.41 138.92 36.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 256' ' ' HIS . 7.7 t -137.74 134.22 18.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.636 0.731 . . . . 0.0 110.871 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.417 ' HA ' ' CD ' ' A' ' 288' ' ' GLN . 53.2 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.247 . . . . 0.0 112.329 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 33.3 mmt -82.04 -27.95 32.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 297' ' ' TYR . 10.9 mt-10 -126.1 42.14 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.417 ' CD ' ' HA ' ' A' ' 285' ' ' PRO . 12.8 pt20 -98.14 75.04 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.558 ' O ' HD21 ' A' ' 308' ' ' LEU . 35.4 p -88.59 142.8 27.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 13.0 m 40.44 33.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.799 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 289' ' ' THR . 54.9 p -91.58 -57.46 2.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.8 t -38.59 -40.41 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -53.82 -44.42 70.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' THR . . . 175.37 -25.34 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.531 ' O ' HG23 ' A' ' 296' ' ' ILE . 71.9 m95 -85.01 179.86 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.747 0.308 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 295' ' ' TRP . 1.3 pt -159.55 123.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 287' ' ' GLU . 26.2 t80 -76.81 114.78 15.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . 0.493 ' HA3' ' CG2' ' A' ' 281' ' ' ILE . . . -134.55 163.82 24.66 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.498 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 93.1 m -116.26 129.08 56.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 111.131 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 32.6 t -65.62 151.64 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.819 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.9 tp -102.5 -29.5 11.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.7 m -81.87 -38.54 25.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.155 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 77.3 p -103.47 -38.96 6.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 100.24 -13.63 60.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.495 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . . . . . . . . . 95.4 m -53.05 166.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.0 m -146.83 128.3 15.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.07 33.8 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.558 HD21 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -89.09 143.5 26.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -146.44 156.9 49.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.719 . . . . 0.0 110.886 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.655 ' HD2' HD11 ' A' ' 275' ' ' LEU . 53.7 Cg_endo -69.7 117.01 4.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.248 . . . . 0.0 112.362 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.42 ' HA ' HD11 ' A' ' 296' ' ' ILE . 7.7 pt-20 -56.07 -13.21 1.82 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -92.26 23.45 3.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.612 ' HB3' HD13 ' A' ' 275' ' ' LEU . 9.3 m-85 -130.57 -3.1 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.746 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -126.1 177.2 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.105 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 6.7 t -151.97 159.35 43.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -61.78 151.08 35.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 258' ' ' THR . . . -77.32 46.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.054 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.69 23.06 11.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -93.37 99.23 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 2.2 m 53.38 36.61 23.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 54.5 p -161.01 125.83 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.618 HG21 ' CD2' ' A' ' 325' ' ' PHE . 8.3 p -77.35 166.97 22.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.575 ' CE3' HG12 ' A' ' 324' ' ' ILE . 3.4 p-90 -133.66 -45.51 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.575 HG12 ' CE3' ' A' ' 323' ' ' TRP . 20.4 mm -117.51 -16.09 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.097 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' A' ' 322' ' ' THR . 0.1 OUTLIER -34.2 138.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -101.61 165.82 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 114.09 115.64 3.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.8 m -115.0 174.53 5.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 0.0 110.824 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 90.5 p -134.57 121.02 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 147.54 -94.9 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.28 7.02 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.718 2.278 . . . . 0.0 112.332 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.8 p -86.62 141.74 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 90.4 p -103.85 42.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 11.4 m -123.13 169.66 11.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 244' ' ' GLY . 75.1 p -83.22 87.08 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 243' ' ' SER . . . 37.23 -146.66 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 19.8 m -98.45 110.28 22.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.881 0.372 . . . . 0.0 110.852 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.6 t -72.97 154.74 40.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 248' ' ' SER . . . 79.86 -49.91 3.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' GLY . 14.6 m -35.15 136.02 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 0.0 110.864 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.08 147.92 25.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -106.21 156.49 18.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 1.024 HG23 ' HB3' ' A' ' 254' ' ' ALA . 5.0 mp -73.09 115.83 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -123.6 -49.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -116.52 34.35 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 1.024 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -110.46 174.44 5.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.073 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -108.81 43.96 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 284' ' ' SER . 22.2 m80 -98.97 136.7 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -98.72 163.65 12.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 3.1 m -125.89 126.56 44.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.974 HD13 HD13 ' A' ' 314' ' ' ILE . 14.3 mt -124.03 151.94 43.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -108.74 130.75 55.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.1 131.8 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.9 pt -107.93 -19.11 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.157 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -155.82 143.86 14.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.693 0.759 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 153.9 68.46 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.717 2.278 . . . . 0.0 112.314 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 313' ' ' TYR . 35.9 t80 -150.69 125.65 9.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.947 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.9 m -95.14 109.43 44.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.569 0.7 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.406 ' HB3' ' CG ' ' A' ' 272' ' ' GLU . 53.5 Cg_endo -69.73 166.79 26.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.323 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -115.69 -20.71 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -153.32 -179.2 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -64.87 -32.39 74.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -41.6 -44.09 2.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 267' ' ' PRO . 1.2 pm0 -102.98 171.33 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 6.2 tp -124.59 147.05 48.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.433 ' C ' HD23 ' A' ' 275' ' ' LEU . 26.9 tt0 -66.56 140.26 57.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 309' ' ' LEU . 5.9 mt -112.13 127.68 55.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 277' ' ' PRO . 87.2 t -124.47 133.5 24.78 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.629 0.728 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.9 Cg_endo -69.71 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.335 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.56 2.94 9.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -111.18 162.6 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.456 ' O ' HD13 ' A' ' 281' ' ' ILE . 19.9 m-85 -106.06 159.19 16.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.854 HD13 ' HA ' ' A' ' 300' ' ' SER . 20.0 mm -137.76 120.2 19.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.458 ' CE2' HD13 ' A' ' 301' ' ' LEU . 35.1 m-85 -81.98 114.76 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 284' ' ' SER . 3.3 tmm? -99.47 138.03 37.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.496 ' N ' ' SD ' ' A' ' 283' ' ' MET . 12.1 p -137.66 125.73 14.28 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.862 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -10.71 29.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 0.0 112.345 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 40.5 mtp -83.04 -28.94 29.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 297' ' ' TYR . 50.5 mm-40 -117.65 40.41 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.448 ' O ' ' CD ' ' A' ' 288' ' ' GLN . 2.9 pp0? -96.15 123.68 39.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.481 ' O ' HD21 ' A' ' 308' ' ' LEU . 17.5 p -129.06 126.92 40.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 19.0 m 55.1 25.18 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 294' ' ' GLY . 41.8 p -87.51 -54.53 4.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.116 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 291' ' ' THR . 28.0 t -36.35 -37.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -61.57 -48.7 79.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 291' ' ' THR . . . -179.44 -27.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -79.82 -179.76 7.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.726 0.298 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.428 ' CD1' HG12 ' A' ' 314' ' ' ILE . 1.7 pt -152.34 134.58 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 287' ' ' GLU . 53.6 t80 -96.21 111.03 23.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -138.38 177.48 20.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 305' ' ' CYS . 58.6 m -127.37 119.55 26.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.759 0.314 . . . . 0.0 111.16 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.854 ' HA ' HD13 ' A' ' 281' ' ' ILE . 1.1 t -55.26 168.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.458 HD13 ' CE2' ' A' ' 282' ' ' PHE . 12.8 tp -111.31 -28.65 8.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.6 m -74.38 -47.87 31.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.6 p -95.23 -28.95 14.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 80.7 16.04 76.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.753 ' O ' HG23 ' A' ' 299' ' ' THR . 5.9 t -88.55 169.04 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 79.6 p -131.34 142.78 50.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.95 48.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.493 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.643 ' C ' HD23 ' A' ' 309' ' ' LEU . 11.4 mt -92.25 151.45 20.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.914 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -157.54 157.5 30.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.582 0.706 . . . . 0.0 110.958 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.506 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 54.2 Cg_endo -69.74 123.76 10.43 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.757 2.305 . . . . 0.0 112.34 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -61.29 -8.97 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -94.21 19.18 9.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.506 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.0 m-85 -126.56 -1.18 6.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.974 HD13 HD13 ' A' ' 259' ' ' LEU . 2.8 pp -131.25 175.94 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 7.4 t -149.71 165.4 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 316' ' ' LYS . 4.7 mptt -67.16 143.8 56.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -66.07 95.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.092 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.58 -54.94 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.847 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 40.61 43.02 1.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 14.7 t -48.84 -45.09 40.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 74.7 m -113.74 102.25 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.3 p -99.95 156.43 17.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -80.94 -39.42 26.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 325' ' ' PHE . 4.0 mm -130.0 -53.64 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.424 ' HB2' HG21 ' A' ' 322' ' ' THR . 83.9 m-85 -36.23 146.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -131.17 135.55 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -166.99 -121.47 0.56 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 5.3 t -67.86 111.65 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 30.4 t -72.01 98.75 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 55.82 -158.21 8.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.471 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 85.44 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.362 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 m -81.62 143.14 32.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.3 m 52.0 35.65 16.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 45.4 m -65.26 137.77 57.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.378 . . . . 0.0 110.848 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 60.6 p -77.82 149.68 34.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.851 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.38 69.22 0.17 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 54.0 p -97.91 115.36 27.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.3 t -123.1 139.05 54.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.52 68.44 1.63 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.0 t -75.49 110.84 10.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 110.834 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -70.44 -29.48 66.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.828 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -104.05 161.66 13.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 256' ' ' HIS . 17.7 mt -86.76 116.27 29.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -126.58 -35.22 2.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.57 -40.95 22.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.406 ' HB3' HG23 ' A' ' 251' ' ' ILE . . . -82.79 158.89 22.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -99.59 40.48 1.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . 0.581 ' HB2' HD13 ' A' ' 251' ' ' ILE . 18.8 m80 -74.29 144.1 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -96.17 163.0 13.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 7.5 m -127.87 133.63 49.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 314' ' ' ILE . 9.2 mt -132.67 155.12 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -110.3 132.52 54.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 40.5 t -65.65 137.65 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.32 -18.69 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -155.02 142.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.75 . . . . 0.0 110.918 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 158.17 57.95 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -153.3 125.33 7.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 m -95.62 109.99 48.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.578 0.704 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.419 ' CB ' ' HG2' ' A' ' 272' ' ' GLU . 54.1 Cg_endo -69.8 171.07 15.19 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.356 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -125.64 -13.69 6.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.431 ' N ' ' OE2' ' A' ' 272' ' ' GLU . 23.3 m-80 -151.42 -175.39 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.18 -21.94 49.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -36.49 70.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 269' ' ' ASN . 0.9 OUTLIER -104.76 165.29 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.801 HD11 ' SG ' ' A' ' 305' ' ' CYS . 6.7 tp -120.35 148.42 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.414 ' N ' ' HG ' ' A' ' 273' ' ' LEU . 36.7 tt0 -72.48 145.56 47.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.622 HD21 HD13 ' A' ' 309' ' ' LEU . 11.1 mt -115.73 135.51 53.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.492 HG13 ' HD2' ' A' ' 277' ' ' PRO . 58.5 t -127.54 134.81 26.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 111.16 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.492 ' HD2' HG13 ' A' ' 276' ' ' VAL . 53.3 Cg_endo -69.76 113.54 3.41 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 109.57 5.78 29.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.525 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -110.82 165.4 11.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.817 0.342 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.536 ' O ' HD13 ' A' ' 281' ' ' ILE . 28.2 m-85 -107.28 163.46 13.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 280' ' ' PHE . 15.1 mm -146.09 122.85 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.51 ' CE2' ' CD1' ' A' ' 301' ' ' LEU . 41.3 m-85 -81.93 128.83 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -98.96 129.39 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.476 ' HB3' ' CD2' ' A' ' 256' ' ' HIS . 0.4 OUTLIER -128.12 108.21 19.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.723 0.773 . . . . 0.0 110.901 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -3.11 11.34 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.695 2.263 . . . . 0.0 112.33 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -88.88 -24.89 22.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 297' ' ' TYR . 55.3 mm-40 -122.97 40.85 3.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.34 109.12 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.452 ' O ' HD11 ' A' ' 308' ' ' LEU . 21.0 p -114.05 119.26 36.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 15.9 m 67.36 27.78 8.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.837 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 33.6 p -87.85 -41.22 13.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.8 t -49.28 -27.06 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 294' ' ' GLY . 4.9 pt-20 -70.9 -42.96 69.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 293' ' ' GLU . . . 173.77 -25.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.485 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 296' ' ' ILE . 73.5 m95 -80.54 179.28 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.717 0.294 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 311' ' ' GLU . 1.1 pt -156.83 126.43 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 287' ' ' GLU . 29.9 t80 -84.66 111.76 19.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . -133.65 -173.56 13.26 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 91.8 m -133.21 141.03 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.7 t -74.74 149.6 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.51 ' CD1' ' CE2' ' A' ' 282' ' ' PHE . 13.1 tp -96.08 -39.36 9.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.5 m -71.35 -39.95 71.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 42.0 p -100.04 -63.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.84 10.66 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.511 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.801 ' SG ' HD11 ' A' ' 273' ' ' LEU . 2.3 p -79.53 153.77 29.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.4 p -120.25 147.86 44.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 176.79 -175.54 47.65 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 289' ' ' THR . 18.1 mt -94.79 140.1 30.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.622 HD13 HD21 ' A' ' 275' ' ' LEU . 0.2 OUTLIER -142.74 157.13 62.31 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.59 0.71 . . . . 0.0 110.913 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 313' ' ' TYR . 53.5 Cg_endo -69.81 116.04 4.38 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.654 2.236 . . . . 0.0 112.327 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.415 ' HA ' HD11 ' A' ' 296' ' ' ILE . 5.2 pt-20 -55.0 -15.52 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -88.74 19.69 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.544 ' CG ' ' HG2' ' A' ' 310' ' ' PRO . 7.4 m-85 -127.69 -2.57 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.963 HD13 HD13 ' A' ' 259' ' ' LEU . 2.9 pp -128.41 173.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' THR . . . . . . . . . . . . . 3.3 t -147.79 151.78 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 316' ' ' LYS . 0.1 OUTLIER -59.49 142.83 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.39 86.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -106.38 16.91 24.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.457 ' CD ' ' O ' ' A' ' 319' ' ' GLU . 2.5 pp20? -104.17 106.85 17.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 56.5 m 48.67 35.81 6.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -145.28 120.93 10.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 325' ' ' PHE . 1.5 p -48.89 161.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' TRP . . . . . 0.801 ' CZ2' HD12 ' A' ' 324' ' ' ILE . 2.1 p-90 -90.17 -39.62 12.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.801 HD12 ' CZ2' ' A' ' 323' ' ' TRP . 20.7 mt -130.16 -46.57 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.521 ' HB2' HG21 ' A' ' 322' ' ' THR . 61.9 m-85 -34.51 126.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -91.92 172.66 8.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -42.82 -39.99 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.518 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' SER . . . . . . . . . . . . . 1.5 t -153.04 136.31 15.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.818 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . . . . . . . . . 53.2 m -101.66 149.94 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -159.87 -97.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.532 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -11.02 29.94 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.682 2.255 . . . . 0.0 112.382 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 72.3 m -114.19 107.71 15.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.7 t -58.45 -59.41 5.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.966 . . . . . . . . 0 0 . 1 stop_ save_